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Summary 
 
Background 
A policy of centralisation of symptomatic breast services was implemented in 
Ireland in 2009. This included centralising surgical services in eight 
Symptomatic Breast Disease (SBD) units and introduction of evidence-based 
GP referral guidelines for suspected cancer. 
 
Aim 
To investigate the factors influencing GP referrals to SBD units in Ireland.  
 
Methods 
Four individual studies were conducted in a mixed-methods design. Study 1 
analysed breast cancer referral and detection rates. Studies 2 and 3 
comprised in-depth interviews with 9 cancer centres (hospitals) and 28 
randomly-selected GPs to explore factors influencing GP referral. The impact 
of centralisation on referral patterns was analysed in Study 4, using the 
national cancer database. 
 
Results  
Referrals to breast units in Ireland increased by almost 60% in five years, 
without a corresponding increase in breast cancers detected. Reasons for 
referral included mastalgia (15%) and family history (9%). Clinical and non-
clinical factors were identified as influencing referrals, such as;  
 
• GP factors, including fear of missing a cancer and risk aversion  
• Resources, including ease of access to breast clinics and high quality 
of the service   
• Social influences, such as patient anxiety, media and patient 
expectations.  
 
15 
 
A significant increase was identified in analysis of national data of the 
proportion of patients having their diagnosis and surgery at designated 
cancer centres rather than non-cancer centres, indicating a high level of 
policy implementation. Cox proportional-hazards regression showed prompt 
access for GP referrals.  
 
Conclusions  
This is the first study to examine the effects of centralisation of breast cancer 
services in Ireland. The results provide useful evidence on the impact and 
effectiveness of this policy initiative and show early indicators of success. 
GP referrals are influenced by GP, health service, social and clinical factors, 
which can be both social and contextual in nature. GP beliefs about 
consequences coupled with social influences are challenging barriers to 
address and will require multifaceted interventions to overcome.  
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Chapter 1:  Introduction 
 
1.1 Introduction 
This health services research thesis examines factors influencing GP breast 
cancer referrals from primary to secondary care in the Republic of Ireland. 
The phenomenon of unexplained increases in referrals from General 
Practitioners (GPs) has been identified as a key issue by practitioners and 
policy makers in the Irish healthcare system and internationally (1-5). The 
increase in GP referrals to SBD Units in Ireland between 2006 and 2010 was 
identified as an issue requiring investigation by breast care consultants and 
in the Health Information and Quality Authority (HIQA) report on 
Symptomatic Breast Services in 2010 (6).  This thesis investigates whether 
organisational structures, medical factors, non-medical factors, or a 
combination of factors influence GP referral patterns to symptomatic breast 
clinics in Ireland.  
 
The impact of organisational factors is investigated through examination of 
the impact of reconfiguration (centralisation) of breast cancer services in 
Ireland on breast cancer outcomes and referral patterns, respectively.  
 
The impact of reconfiguration on breast cancer referrals is investigated 
through examination of breast cancer referral patterns and outcomes before 
and after a major reconfiguration of cancer services in Ireland in 2009. 
Evidence-based GP referral guidelines for suspected cancers were 
introduced as part of the centralisation process. The impact of these GP 
referral guidelines is investigated by examining GP referrals from primary to 
secondary care and exploring the opinions of clinicians on the health service 
factors, GP factors and social factors influencing referrals to breast cancer 
units in Ireland.  
 
The thesis aims to identify factors influencing GP referral patterns and to 
make recommendations to ensure that urgent cases are seen quickly and 
non-urgent cases are seen in the most appropriate setting. 
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1.2 Background and context of the study  
Centralisation of breast cancer surgery in high-volume specialist centres has 
been shown to improve patient outcomes (7-10). Based on the 
recommendations of the Irish National Cancer Strategy (2006) (11), the 
National Cancer Control Programme (NCCP) was established in 2007 to 
manage, organise and deliver cancer services on a whole-population basis.  
 
In accordance with the cancer strategy, the NCCP has centralised cancer 
surgery for the main invasive cancers. Breast cancer surgery is now carried 
out at 8 designated public Symptomatic Breast Disease (SBD) units and one 
satellite unit, compared to 35 public hospitals providing SBD services in 2007 
in the Republic of Ireland (12). This centralisation of services is shown in 
Figure 1.1 below.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1:   Hospitals providing symptomatic breast services. 
Source:  Health Atlas Ireland  
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Mater Misericordiae Hospital
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As a result of this centralisation process, patients attending the SBD units in 
Ireland are now treated by cancer specialists in multidisciplinary teams. 
 
Primary care is usually the first point of access for the patient into the health-
care system and the role of the General Practitioner as gatekeeper is widely 
acknowledged (13, 14). The GP role in the care of the patient with suspected 
cancer is key to early detection and referral at an early stage of disease to 
improve prognosis. Wide variation in all aspects of care has been found 
consistently in general practice research (15).  Explanatory factors have 
been divided by Wilkin (15) into 3 broad categories: healthcare system 
variables, patient variables and provider variables. Wilkin discusses the 
consequences of variation and questions whether some patients are being 
treated unnecessarily, with possible adverse consequences in terms of 
iatrogenic disease. He asks “Are we wasting scarce hospital resources in 
treating patients whose problems could be dealt with at least as well in 
general practice?” (p.87)(15).  
 
Based on the evaluation of the 1996 cancer strategy by Deloitte in 2003 (16) 
which recommended enhanced coordination of cancer services and 
optimisation of primary care, the second Irish National Cancer Strategy 
(2006) (11) recommended that GPs should have comprehensive information 
available to enable them to assess a patient with suspicious symptoms and 
findings, and to make an informed referral for specialist assessment (17).  
The recent centralisation of cancer services in Ireland has streamlined the 
GP referral pathway for patients with cancer. GP referral guidelines for 
suspected breast cancer were developed by the NCCP in 2009, with 
comprehensive education for GPs, as part of the centralisation process (3). 
These referral guidelines (included in Appendix A) were disseminated to GPs 
nationally in 2009  with the following objectives (18):  
 
• Provide accurate and clear information for GPs referring patients 
to the designated Symptomatic Breast Disease Units 
• Streamline the symptomatic breast referral process 
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• Improve the quality of referral information and thereby improve 
accuracy of triage by the hospital clinical teams 
 
The total number of new referrals for  breast disease nationally has 
increased substantially (23,575 referrals to 37,631) in the last five years (3), 
without a corresponding increase in breast cancers detected. This increase 
is in addition to the effect of reconfiguration, where cancer centres are now 
taking patients who would previously have gone elsewhere. 
 
Breast cancer services in Ireland are provided through two routes: a 
screening service and a symptomatic service, as shown in Figure 1.2 below. 
The screening service is a national population breast screening service for all 
women aged 50-65 years (to be extended to 69 years end 2015). Women 
are invited through a call-recall system every two years. These are 
asymptomatic women and the service aims to detect breast cancers before 
they become palpable. This is a free service and is operated by the national 
breast screening service (BreastCheck). Where something suspicious is 
detected in BreastCheck, these women are treated in BreastCheck i.e. the 
route for these women is different to referral to the SBD units. 
 
The Symptomatic Breast Service, as the name suggests, is for those patients 
of any age who present to their GP with breast symptoms.  
 
These two breast services (screening and symptomatic) are totally separate 
services in the Irish health care system, as shown in Figure 1.2 below. The 
BreastCheck screening service was established by an independent agency 
‘BreastCheck’, which has subsequently been subsumed into the HSE.  This 
research examines the phenomenon of increased GP referrals to the 
symptomatic breast disease service and therefore focuses on factors 
influencing GP referrals to the Symptomatic Breast Disease (SBD) units.  
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This thesis aims to examine both the medical and non-medical influences on 
GP referrals to Symptomatic Breast Disease Units in the Republic of Ireland. 
The overall impact of centralisation of breast cancer services will be 
examined using National Cancer Registry data, thus providing evidence on 
the effects of the Cancer Control Programme shortly after its implementation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 1.2:  Structure of breast services in Ireland  
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1.3 Research overview  
This thesis comprises 4 individual studies as part of a mixed methods 
design. 
 
Chapter 1: An introduction to the context and rationale for the research is 
presented to set the scene for this study.  
 
Chapter 2: A summary of the key literature in this area is presented, 
commencing with the international profile of breast cancer and then focuses 
on patterns in Ireland. The evidence from the literature is presented on 
clinical, patient, provider and health service factors influencing breast cancer 
referral patterns.   
 
Chapter 3: An overview of national research, policy and strategic frameworks 
is given as a backdrop for the rationale for this study.   
 
Chapter 4: The aims and objectives of the overall thesis and individual 
studies are presented and the anticipated impact of the research is 
described.  An overview of international research and strategy is outlined.  
 
Chapter 5: The key models and conceptual frameworks considered to 
underpin this thesis are discussed.   
 
Chapter 6: The methodology used for this study and the rationale for using 
this approach is described.  Details of the mixed-methods iterative sequential 
design are provided and the integration of each of the individual studies 
within the mixed-methods study is described. 
 
Chapters 7-10: These chapters present the methods and results for each 
individual study.  A comparison of results between the hospital and GP 
interviews is also discussed. 
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Chapter 11-12:  These chapters discuss the results, and provide a critique of 
the strengths and limitations of the research. They also highlight practical 
implications for patients and health services and suggest areas for future 
research.  
 
1.4 Summary  
This study investigates the factors influencing GP referrals to symptomatic 
breast disease units in Ireland, including the impact of centralisation and GP 
referral guidelines. This research question originated from questions arising 
within cancer services delivery in the health service. Findings are intended to 
contribute to international HSR literature and the development and 
implementation of evidence-based cancer policy.    
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Chapter 2: Literature Review of the Factors 
Influencing Referrals to Breast Cancer Units 
 
A comprehensive literature search was conducted. Studies which examined 
factors associated with cancer referral patterns were identified through 
electronic searches of relevant databases.  Bibliographic databases used for 
this study included the Cochrane Collaboration, Pubmed, Medline, Embase, 
CINAHL and Web of Knowledge.  Reference lists from retrieved articles, 
policy documents, grey literature, unpublished work, personal contacts with 
experts and recently published abstracts at scientific meetings were also 
used to identify relevant literature.  
 
The research question in PICO format (population-intervention-control-
outcome) was used for the literature search strategy. Boolean operators 
were used to link the terms in the overall research question: “Or” was used to 
expand the search to include any descriptor or synonym of the population or 
interventions being considered.  “And” was used to narrow the search to 
papers that addressed both the population and intervention components of 
the question. A detailed description of the literature search strategy including 
search terms is contained in Appendix B. 
 
The original database searches were carried out in June 2010. This search 
yielded 1,989 articles. Following duplicate removal, title and abstract 
screening, and retrieval of papers, 267 studies were included in the initial 
literature review of the research question.  E-mail alerts were set up to 
update these searches.  A complete update of the literature search was 
carried out in September 2014. 
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Additional focussed literature searches were conducted for some of the key 
influencing factors which emerged from the initial research, including: 
 
• diagnostic yields for breast cancer   
• mastalgia/breast pain  
• family history of breast cancer  
• seasonal variation in breast cancer  
 
The literature review will present the available literature on breast cancer, 
centralisation in health services and factors influencing referral patterns.  
 
2.1  Cancer  
2.1.1  Cancer epidemiology  
While cancer comes second to diseases of the circulatory system as the 
leading cause of mortality in OECD (Organisation for Economic Co-operation 
and Development) countries, it is considered a larger burden than heart 
attacks and stroke in terms of potential years of life lost (19). The OECD also 
estimates that a third of cancer cases could potentially be cured if they are 
detected on time and treated properly (19).  Modifiable risk factors for cancer 
include smoking, alcohol, overweight, lack of physical activity, unhealthy diet 
and sexually-transmitted HPV infection (20).  
 
The OECD recommends that, for cancer care, we “follow evidence-based 
guidelines covering the whole patient pathway: early detection, diagnosis, 
treatment, monitoring and palliative care” (p.11) (19). Three priorities for 
action are identified in their 2013 policy report Cancer Care: Assuring Quality 
to Improve Survival:  
 
• Resources (workforce, equipment, drugs)  
• Practices (affordable and timely access to evidence-based health 
care)  
• Governance (national plans, targets, guidelines and monitoring) 
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The policy report highlights in particular that: 
 
“Perhaps the most critical element in improving an individual’s chances 
of surviving cancer is diagnosing it at an early stage and starting 
treatment quickly...once cancer is diagnosed, patients need to access 
high quality care quickly, with minimal waiting times to see specialists.  
As a policy priority, countries should develop a clear understanding of 
the pattern of excessive or inequitable waiting times for cancer care in 
their population and respond with policies suited to the local context” 
(p.12) (19).  
 
The three cancers that currently cause the most economic impact across the 
world have been identified as lung cancer (US$188/€168 billion), colorectal 
cancer (US$99/€88 billion) and breast cancer (US$88/€79 billion) (19).  The 
OECD recommends the development of national clinical guidelines for the 
management of the most common cancers in order to reduce variation in 
processes or standards of care. Combining these developments with 
equitable access to multidisciplinary care and specialist cancer centres, the 
efficiency and quality of cancer care can be improved.  
 
2.1.2  Cancer incidence 
Over 5 million new cancer cases are diagnosed each year in OECD 
countries, averaging approximately 261 cases per 100,000 population (19). 
The OECD report in 2013 on assuring quality to improve survival reports that 
cancer incidence is higher among men than women across OECD countries, 
with the gender gap ranging from 10% (in Denmark, Israel and Mexico) to 
50% (in Poland, Turkey, Spain and Japan).  Another recent OECD report 
states that colorectal and lung cancer are currently the most common 
cancers in OECD countries, with prostate cancer being the most common 
cancer in men and breast cancer the most common in women (21).  
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2.1.3  Cancer mortality  
The OECD estimates that cancer is responsible for more than 25% of all 
deaths (19). After diseases of the circulatory system, cancer is the second 
leading cause of death. With the decline in cardiovascular diseases, cancer 
has become the number one cause of death in some OECD countries, such 
as Canada, Denmark, France, Japan and the Netherlands (21). Both female 
and male mortality rates for cancer in Ireland are close to those found in the 
UK (22). 
 
2.1.4  Cancer in Ireland  
2.1.4.1  Cancer incidence in Ireland  
An average of 18,500 invasive cancers (excluding non-melanoma skin 
cancer) were diagnosed in Ireland per year between 2008 and 2010 – an 
incidence rate of 423 cases per 100,000 population per year, which is higher 
than the OECD average. This may reflect variation in screening activities 
between countries, particularly for breast and prostate.  Incidence rates were 
26% higher in men than in women and the cumulative risk of cancer 
diagnosis over a lifetime was 1 in 3 for men and 1 in 4 for women.  The most 
common invasive cancers diagnosed in Ireland during this period were non-
melanoma skin cancer, breast, prostate, colorectal and lung cancer (22).  
Figure 2.1 shows the relative frequency of the main invasive cancers 
diagnosed in Ireland from 2008 – 2010. 
 
 
Figure 2.1:  Relative frequency of the main invasive cancers diagnosed in 
Ireland, 2008 – 2010. 
Source: NCRI 2013. Cancer in Ireland 2013. Annual Report of the National 
Cancer Registry (22) 
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For females, the most commonly diagnosed invasive cancers (excluding 
non-melanoma skin cancer) were breast, colorectal, lung and melanoma.  
The median age of patients when diagnosed with invasive cancer was 66 
years in Ireland for the years 2008-2010. This varied considerably between 
cancer types e.g., the mean age of those diagnosed with in-situ cervical 
cancer (31 years), Hodgkin’s lymphoma (32 years) and invasive testicular 
cancer (33 years), compared with over two thirds of patients with cancer of 
the lung, prostate, oesophagus, stomach and colo-rectum diagnosed when 
aged 65 or over. The median age of patients diagnosed with invasive breast 
cancer was 59 years (22).  
 
Prevalence of cancers in Ireland can be calculated from 1994, when national 
cancer registration commenced in Ireland. From 1994 to 2010, 242,058 
patients were diagnosed with cancer in Ireland (116,081 females and 
125,977 males). Total prevalence for this 17-year timeframe shows that 
104,367 patients in this cohort were still alive at the end of 2010 (40% of 
male patients and 47% of female patients) (22). 
 
2.1.4.2  Cancer mortality in Ireland 
The frequency of the main cancer deaths in Ireland in 2010 is shown in 
Figure 2.2.  Lung, breast and colorectal cancer were the highest causes of 
cancer mortality for females while lung, colorectal and prostate cancer were 
the highest for males. Cancer mortality was 35% higher in males than in 
females.  
 
Figure 2.2: Relative frequency of the main cancer deaths in Ireland, 2010. 
Source: NCRI 2013.  Cancer in Ireland 2013. Annual Report of the National 
Cancer Registry (22) 
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In 2010, the median age at death from cancer in Ireland was 73 years. 
Almost half of cancer patients were over 75 years at death. Cancer 
accounted for 30% of all deaths in Ireland in 2010 and was the second most 
common cause of death, after circulatory diseases (34%) (22). 
 
2.1.4.3  Cancer projections in Ireland  
Cancer incidence data from the National Cancer Registry Ireland (NCRI) 
from 1994 to 2010 and population projections from the Central Statistics 
Office (CSO) have been combined to estimate the number of new cancer 
cases expected in Ireland, in five-year intervals, from 2015 to 2040 (23). The 
number of cases of invasive cancer is projected to increase from 28,480 in 
2010 to almost 60,000 in 2040, based on demographic change alone, in the 
absence of any change in incidence rates (23). 
 
The total number of new invasive cancer cases (including non-melanoma 
skin cancer) is projected to increase by 84% for females and 107% for males 
between 2010 and 2040, based only on changes in population size and age 
distribution (demography). If trends in incidence since 1994 are also taken 
into account, the number of cases is expected to increase by  86%-125% for 
females (depending on the method of projection used) and by 126%-133% 
for males (23). 
 
The NCRI cancer projections in 2014 estimated that demographic change 
will be the main factor driving the increase in numbers of cancers in Ireland. 
However, trends in risk factor prevalence such as tobacco, diet, obesity, 
alcohol and low physical activity will also have an impact (23). The median 
age of cancer patients at diagnosis is expected to increase, based on ageing 
population and improving life expectancy in Ireland (23). One of the NCRI 
population projections, based on CSO data, projects a 14% increase in the 
female population and a 15% increase in the male population between 2015 
and 2040 in Ireland, with a decrease in the population aged 35-49 years and 
an increase in the population over 85 years. 
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2.1.4.4  Cancer in Ireland compared to other European countries  
Cancer incidence in Ireland is amongst the highest in Europe, with females 
ranked 5th and males 8th of 27 countries.  Incidence rates were 15% higher 
for females and 10% higher for males than the overall EU average. However, 
variability between countries was low and Irish incidence rates were 
generally close to those found in several other north-western European 
countries (22). The incidence rate of prostate cancer in Ireland was 4th in the 
EU and the incidence rate for breast cancer was 6th in the EU in 2012, 
possibly reflecting the impact of increased screening for these two cancers 
(22).   
 
 Figure 2.3 shows the estimated cancer incidence and mortality in Europe in 
2012 for all invasive cancers, excluding non-melanoma skin cancer.  
 
 
Figure 2.3: Estimated cancer incidence and mortality in Europe 2012.  
Source: Cancer in Ireland 2013, (NCRI, 2013)(22). 
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Irish females ranked 6th in EU mortality rates (13% higher than the EU 
average), with Irish males ranked 21st (9% lower than EU average), similar to 
UK rates (22). 
 
The OECD reports that cancer incidence rates tend to be higher in high-
income countries, as people in these countries are more likely to consume 
more alcohol, be overweight and inactive (19). In addition, lower detection 
rates in lower income countries may contribute to the lower reported 
incidence (24). Within Europe, an east-west gap still exists despite recent 
improvements in cancer control and screening programmes in eastern 
European countries (19, 25).  
 
2.1.5   Summary  
In summary, the data on cancer incidence and mortality is readily available 
from well developed cancer registries. However, the quality of data differs 
within and between countries, particularly in relation to staging data. This 
may result from incomplete staging information or the level of specialist 
imaging performed, which can result in stage migration (26).  Cancer 
incidence data is also influenced by screening. Countries with population 
screening programmes (such as BreastCheck in Ireland) will impact on 
detection rates and may not be directly comparable to other countries without 
established national population screening programmes, such as the US. 
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2.2  Breast Cancer  
 
2.2.1  Epidemiology of breast cancer   
The main risk factors for breast cancer are early age at menarche (27), late 
age at first birth (28), low parity (27, 28) and late menopause (27). Risk 
factors for breast cancer also include family history of breast cancer, alcohol 
consumption, oestrogen replacement therapy and obesity (19, 23, 29, 30).  
 
2.2.2  Incidence of breast cancer  
While incidence rates have been decreasing in recent years in some 
cancers, such as cervical, lung and colorectal cancers, the incidence of 
breast cancer has increased in almost all OECD countries, mostly due to 
improvements in detection through screening and improved diagnostic 
investigations (19). Breast cancer was the most common cancer among 
women in the OECD in 2008, with 639,000 cases (27% of all new female 
cancers) (24). 
 
2.2.3  Mortality from breast cancer  
Breast cancer is the most prevalent type of cancer in women worldwide and 
accounted for almost 508,000 deaths in 2011, according to the WHO Global 
Health Estimates (31).  According to the OECD, one in every nine women in 
the western world will develop breast cancer during her lifetime and one in 
thirty will die from the disease.  In the USA, patients  without health 
insurance were more likely to have a higher mortality rate from breast cancer 
(32) and to have late-stage cancer (33). 
 
2.2.4  Survival and breast cancer 
Breast cancer survival has improved with the introduction of screening 
programmes and improved treatment (19).  The survival estimates for breast 
cancer in most OECD countries is over 80% at 5 years. Staging data, 
including stage at diagnosis, is considered important when examining 
survival rates for cancer (34-36).  Improvements in diagnostics may lead to 
stage migration (37), lead-time bias (38), or the detection of early-stage 
cancers which may never have developed symptoms (39).   
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Multidisciplinary care incorporating surgery, chemotherapy and radiation has 
also improved treatment, with many women now receiving breast 
conservation therapy (breast conserving surgery plus local radiation) and an 
increase in the use of neo-adjuvant chemotherapy and systemic therapies 
(40).   
 
2.2.5  Breast cancer in Ireland  
2.2.5.1  Breast cancer incidence in Ireland  
The annual average incidence of invasive breast cancer between 2009 and 
2011 in Ireland was 2,805 cases per annum, which represents 31% of 
female invasive cancers, excluding non-melanoma skin cancer.  The 
incidence rate per 100,000 females was 123.7.  The 2012 estimated 
incidence rates of female breast cancer (122.4) in Ireland was 5% lower than 
in the UK (129.2) but 13% higher than the European average (108.8).  The 
majority of cases of breast cancer occur in women aged over 50 years.  On 
average, 23 men are diagnosed with breast cancer in Ireland annually (41).   
  
2.2.5.2  Breast cancer mortality and survival in Ireland  
The number of deaths from breast cancer in 2010 in Ireland was 649 women 
and 10 men, a death rate of 26.5/100,000 for females and 0.5 per 100,000 
for males.  Ireland improved 5-year relative survival rates for breast cancer 
from 72.3% in 1997-2002 to 80.3% in 2004-2009 (19). Breast cancer is a 
very treatable disease when detected at an early stage, which is reflected in 
the increase in survival rates.  The five-year age-standardised estimates of 
cumulative net survival for Irish female breast cancer patients has increased 
from 72% in the period 1994-1999 to 81% in the period 2006-2011 (42). 
 
2.2.5.3  Projections for breast cancer in Ireland  
Cancer incidence data from the NCRI from 1994 to 2010 and population 
projections from the CSO have been combined to estimate the number of 
new cancer cases expected in the years 2015 - 2040.  The NCRI describes 
how: 
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“Trends in cancer incidence are determined principally by two elements: 
population change and changes in risk factor prevalence.  Case numbers 
may also be affected by a number of other factors: screening programmes, 
changes in medical practice leading to the discovery of more incidental 
cancers, changes in diagnostic or histological classification and changes in 
the completeness of registration” (p.64) (23). 
 
There was a significant upward trend in female breast cancer between 1994 
and 2010 of 4% annually.  Projections for breast cancer were made more 
difficult, due to recent short-term variation in incidence trends influenced by 
the introduction of a national breast cancer screening programme. Breast 
cancer is expected to increase in Ireland by about 130% between 2010 and 
2040 (23). Table 2.1 shows the projected numbers of incident cases 2015- 
2040, based on demography only, with percentage increase compared to 
2010. 
 
Table 2.1:  Projected numbers of breast cancer cases 2015-
2040  
 
  
 
 
 
 
 
      
Source: Cancer Projections for Ireland 2015-2040. (NCRI, 2014)(23) 
 
2.2.5.4 Breast cancer in Ireland compared to other European countries  
The European Cancer Observatory has produced estimates of national 
cancer incidence and mortality for all European countries for 2012. Female 
breast cancer incidence in Ireland was 12.5% higher than the EU average 
and ranked 6th highest of 27 countries overall. Irish mortality rates were 3rd 
highest, after Belgium and Denmark and were 22% higher than the EU 
overall, as shown in Figure 2.4 (22). 
Cancer of the Female breast 
 
Year  Projected incidence (n) Percentage increase (%) 
2015 3,209 11 
2020 3,577 24 
2025 3,937 36 
2030 4,252 47 
2035 4,514 56 
2040 4,701 63 
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Figure 2.4: Estimated cancer incidence and mortality in Europe 2012, 
female breast cancer. 
Source: Cancer in Ireland 2013. (NCRI, 2013)(22). 
 
2.2.6  Diagnostic yields for breast cancer  
The diagnostic yield is the proportion of referrals with a cancer diagnosis 
relative to the overall number of referrals.  The diagnostic yield in breast 
clinics is typically low, i.e., the majority of patients referred to breast cancer 
clinics will not be diagnosed with cancer.  
 
Studies in the UK have reported diagnostic yields ranging from 6% to 10% 
(5, 43-46). In a study with symptomatic patients in Wales, the rate was 6.3% 
(44).  Cochrane and colleagues found a rate of 6%, which was unchanged 
following  the introduction of GP referral guidelines in Wales in 1995 (43). In 
contrast, Imkampe (47) compared diagnostic yields before and after the 
introduction of the 2-week rule in the UK (an initiative to see all urgent cancer 
referrals within 2 weeks of referral) and found that the rate dropped from 
10% in 1999 to 7% in 2003-2004, after the introduction of the rule. A similar 
UK study (5) found a drop in the percentage of patients diagnosed with 
cancer, from 12.8% in 1999 to 7.7% in 2005, in the group referred under the 
2-week rule. 
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The proportion of referrals to breast clinics in Ireland which had a cancer 
detected was 9.1% in 2006 before centralisation, 5.8% in 2009 during the 
centralisation process and 5.3% in 2010 after centralisation of breast cancer 
surgery was complete (12, 48). A single centre study in a breast unit in 
Ireland in 2011-2012 yielded 4.9% primary breast cancers (49). In this thesis, 
the factors influencing this increase in benign referrals to breast clinics will be 
explored.  
 
2.2.7 Summary  
In summary, the incidence and prevalence of breast cancer is rising 
internationally, with improvements in breast cancer survival, a trend which is 
replicated in Ireland. The risk factors for breast cancer are well defined and 
treatment at an early stage of disease offers a good prognosis.  
The number of GP referrals for benign breast disease is high in studies 
conducted in the UK and Ireland. However, literature is scant on 
characteristics of GP referrals in other countries, which tend to focus on the 
diagnosed breast cancers and not the overall cohort of benign and malignant 
referrals.  
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2.3  Centralisation   
2.3.1  Introduction  
The centralisation of breast cancer services and of cancer services in 
general continues to be debated in the international literature. This review of 
the current literature will examine the policy and practice of centralisation in 
healthcare in general, followed by a more focussed examination of 
centralisation in the area of cancer and then breast cancer specifically.  Each 
section will commence with the international literature, followed by the UK 
and then Ireland. The terminology in the literature varies between 
centralisation, specialisation and the volume-outcome debate. A 
comprehensive literature search of published papers, policy documents and 
grey literature was conducted. The literature search strategy with details of 
search terms is contained in Appendix B. 
 
2.3.2 Health policy and centralisation of services 
Health policy in the area of centralisation of health services continues to 
evolve internationally, but the level of implementation varies.  There 
continues to be ongoing tension between access and quality in the provision 
of healthcare.  Some areas of centralisation derive from professional sub-
specialisation, requiring a high volume of procedures to maintain skill, and 
others from advances in technology such as telemedicine (50, 51). A brief 
overview of general health policy analysis theory is included here, focussing 
on policy implementation, before specifically focusing on discussion of 
implementation of cancer centralisation policy.  
 
Walt and Gilson (52) developed the health policy analysis framework, 
outlining the traditional approaches of rationalism, incrementalism and public 
choice theory, while highlighting the importance of the role of ‘actors’ in 
policy analysis, in addition to the content, context and process of the policy 
(policy triangle framework).  They explain how health policy can fail to deliver 
the desired outcomes if we focus too much on the content of the policy 
without understanding the implementation process and the factors 
influencing this process. Walt and colleagues (53) describe several 
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approaches to health policy analysis, including  the stages heuristic (54) (55), 
the policy triangle framework (52), multiple streams theory (56) and 
punctuated equilibrium theory (57).  Several approaches to stakeholder 
analysis are presented within these theories, which include 3 distinct 
activities; identifying the policy actors, assessing their political resources and 
understanding their position and interests (53, 58, 59). Each of these 
theories is described in more detail below.  
 
The stages heuristic (54) (55) is a framework which divides the public policy 
process into four stages: agenda setting, formulation, implementation and 
evaluation. This framework assists in the understanding of the public policy 
process, however, it assumes a linear process with defined steps in the 
public policy process which rarely happens in reality (53). While the 
development of national cancer strategies in Ireland has traditionally followed 
defined 10-year time intervals (1996, 2006, 2016), which included evaluation 
processes, this has not been planned according to a particular framework. 
 
The policy triangle framework developed by Walt and Gilson (52) considers 
how actors, context and processes interact to shape policy formulation (53). 
This framework has been used in the areas of health service reform, 
reproductive health and mental health (60) but not cancer services 
specifically. 
 
Punctuated equilibrium theory (57) proposes that “the policy making process 
is characterized by periods of stability with minimal or incremental policy 
change, disrupted by bursts of rapid transformation” (p.311)(53).  This theory 
has been used to examine policy making in the areas of control of malaria, 
polio and tuberculosis (61) and US tobacco policy (57). Some similarities can 
be seen in the reorganisation of cancer services in Ireland, when rapid 
transformation followed a series of high profile cancer misdiagnosis (62, 63).  
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The Kingdon model of agenda setting (56) is described by Buse et al. (64). 
They describe how policy windows can provide optimal opportunities for 
issues to be addressed on the Government agenda.  This necessitates the 
convergence of three streams at the same time; the problem stream, the 
policy stream and the political stream. This multiple streams theory (56) 
describes the policy stream, the problem stream and the political stream as 
independent streams in agenda setting. Windows of opportunity arise in the 
public policy process when these three streams merge and governments 
make a decision to act (53).  This theory has been used to explain how 
certain health issues progressed in the public policy process, for example, 
child health (65) and tuberculosis (66) (53). Just such a policy window 
materialised for cancer control policy in Ireland in 2006, with the concurrent 
national focus on the burden of disease from cancer, the publication of the 
National Cancer Strategy by the Department of Health and political will from 
the Minister for Health, Mary Harney TD. Multiple streams theory can 
therefore be used effectively to describe the accelerated progress of cancer 
control in Ireland.   
 
Gilson (67) reviews implementation gaps through health policy analysis and 
highlights the significance of how stakeholders use their power in taking 
forward, resisting, blocking or challenging policy implementation.  Lipsky (68) 
found that the practices of street level bureaucrats can effectively become 
public policy rather than the intentions or objectives developed at a central 
level.  Buse et al. (64) describe the process of policy making as a contextual 
one, whereby the content of a policy is shaped by pressures from the various 
stakeholders as well as the evidence base. The policy triangle (52) is 
influenced by actors such as individuals, organisations and groups. This 
paper also describes Public Choice Theory;  how power is distributed in 
policy making and lists lobby groups and the state/government as individual 
interest groups in this process (64). The strength of local lobby groups was 
demonstrated during the centralisation of cancer services in Ireland, such as 
the local support to retain a breast unit in Sligo.  
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While aspects of a number of theories are reflected in the development of 
cancer services in Ireland as described above, the Government approach to 
hospital reconfiguration and to centralisation of particular services in Ireland 
appears to have followed a mixed scanning approach traditionally: the use of 
evidence-based healthcare combined with decisions that are made on the 
basis of geography or politics.  
 
Local politics has been heavily involved in the centralisation debate of Irish 
healthcare. However, the incrementalist approach to decision making of local 
politics, or ‘muddling through’,  has been fostered by pluralistic approaches 
of local lobby groups to maintain the status quo within their local/regional 
area of interest (69). Policies developed to promote equity can challenge the 
existing structures and eligibility criteria, questioning the status quo (70).   
 
The policy of centralisation can also be viewed as challenging existing 
equitable structures, such as the former provision of cancer services in all 
acute hospitals in Ireland.  There was significant press coverage following 
the centralisation of cancer services in Ireland. For example “Medical experts 
fury at blunder over cancer test” in the Irish Daily Mail, in August 2007 (62), 
relating to a case in Galway and “60 women to return to Portlaoise Hospital 
for review following misdiagnosis”, relating to a case in Portlaoise, reported 
in the Irish Independent, in November 2007 (63).  
 
Whilst the cancer services in Ireland have not followed one designated 
model or framework throughout its development, the Kingdon model of 
agenda setting best describes the process and success of the centralisation 
of cancer services in Ireland.   
 
2.3.3 Rationale for centralisation of health services  
Centralisation of health services has been promoted on the basis of 
improved quality of care leading to improved patient outcomes.  The Institute 
of Medicine (IOM) in the USA has described quality of care as “the degree to 
which health services for individuals and populations increase the likelihood 
of desired outcome and are consistent with current professional knowledge” 
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(p.21) (71). Quality of care can be evaluated on the basis of structure, 
process and outcome (72-74). Brook advises assessing quality largely based 
on process criteria, in order to ensure patients receive quality care (74) while 
Donabedian focuses on the link between outcome and organisational 
characteristics within the process of care (72). Centralisation encompasses 
structural and process aspects of this quality framework and uses patient 
outcomes to measure its effectiveness.  
 
In the USA, the Institute of Medicine’s (IOM) aims for the 21st-century health 
care system (75) recommends that health care should be safe, effective, 
patient centred, timely, efficient and equitable. The IOM proposes that 
improvement in these six dimensions would better meet the needs of 
patients and that patients would receive care that was “safer, more reliable, 
more responsive, more integrated and more available” (p.6) (75).  Quality 
has become a powerful health policy driver (76).  This IOM model has 
previously been used to assess quality of cancer care (77) and  care of the 
dying (78).  
 
Components of this model can be seen in the centralisation of cancer 
services in Ireland, with key performance indicators established for access to 
services.  Quality assurance criteria have been established for the 
symptomatic breast service (79). These criteria are structured around the 
eight themes of quality and safety developed by HIQA in ‘Safer Better 
Healthcare’ (80) to provide high quality safe and reliable care, centred on the 
service user. This framework has not yet been evaluated by HIQA.  
 
2.3.4  Centralisation in health services 
2.3.4.1  Centralisation – international 
In a European Observatory report on health systems and policies, Ettelt et 
al., (81) propose that the extent to which healthcare is retained centrally or 
devolved to regions is a function of the size of the country. There is strong 
evidence supporting the volume-outcome debate, that units with high-volume 
activity have better clinical outcomes, in particular for the specialised areas 
of cancer (82, 83) and cardiac surgery (84).  
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The majority of routine services can continue to be provided locally and a 
WHO report concludes that with imaginative approaches to service redesign, 
smaller hospitals can be sustainable (85).  Large-scale health care reforms 
cause years of disruption (86). Roland estimated that health care in England 
would go through 3 – 4 years of disorganisation before benefits would be 
seen following a change programme such as the NHS ‘Equity and 
Excellence: liberating the NHS’ in 2010. Also in the UK, Farrington (87) 
makes the case that “more lives can be saved if services are centralised in 
more specialist hospitals” (p.9). Improvements in mortality and length of stay 
were also observed following centralisation of acute stroke services in 
London and Manchester (88).  Posnett (89) argues that, with centralisation, 
“the trade-off is that greater concentration leads, inevitably, to reduced 
patient access” (p.100) and advises service planners to ensure that hospital 
services are locally provided and easily accessible (90). 
 
43 
 
2.3.4.2  Centralisation – Ireland  
A number of policies and strategies have shaped the structure of acute 
hospital services in Ireland, which are summarised below. A broad spectrum 
of acute services has traditionally been provided in all acute hospitals in 
Ireland, with few tertiary specialist centres.  
 
1968 
The Fitzgerald report in 1968 (91) initiated the debate about hospital 
location in Ireland through its recommendations on rationalising hospitals 
into a national network, with 4 regional specialist centres, 12 general 
hospitals and the remaining centres as community health centres.  
However, these recommendations were not included in the 1970 Health 
Act and were not activated in terms of implementation for several 
decades.   
1993 
The Medical Manpower (Tierney) report in 1993 (92) analysed medical 
staffing in acute hospitals in Ireland, highlighting the low number of 
consultant posts in place to provide specialist care for all specialities.   
1994 
In 1994, the Department of Health and Children developed the first 
National Health Strategy ‘Shaping a Healthier Future’ (93). This strategy 
recommended that acute hospitals in the Republic of Ireland should be 
organised into a network of larger specialist units and smaller local units. 
2001 
The second National Health Strategy ‘Quality and Fairness – A Health 
System for You’ (2001) (94) built on the previous strategy’s 
recommendations of hospital networks and was based on four key 
principles:   
• Better health for everyone 
• Fair access 
• Appropriate care in the appropriate setting  
• High performance  
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2001 
A parallel government strategy document for primary care was also 
released in 2001 ‘Primary Care: a new direction’ (13). This strategy 
outlined plans to strengthen the primary care system through 
establishment of primary care teams in the community, with the “potential 
to deliver much of the care currently provided by specialist services” 
(p.27). Enhanced integration between primary and acute care was 
proposed through:   
• referral guidelines and protocols for consultant care and 
diagnostics  
• integrated care pathways 
2001 
A third report examining the economic implications of these proposed 
reforms of the health system, entitled  “Audit of the Irish Health System 
and  Value for Money” (95) was published the same year.  This report 
also endorsed the model of hospital networks and criticised the existing 
hospital structures for their lack of integration and economic 
effectiveness.  Wren (96) commented on the findings of the Value for 
Money audit and agreed  that local politicians had shown no political will 
to make “hard political decisions about hospital rationalisation” (p.197).   
2003 
The Report of the National Task Force on Medical Staffing (Hanly report) 
was commissioned to provide updated information on medical staffing  
This report in 2003 (97) described the historical evolution of acute 
hospitals in Ireland. It described how acute hospitals “were developed in 
response to local needs, or owe their origins to history, rather than to 
clear national or regional priorities” (p.60). The Hanly report outlined the 
benefits of centralisation or ‘regional hubs’ in terms of benefits for patients 
and cost effectiveness: “Better clinical outcomes are achieved in units 
with appropriate number of specialist staff with relevant skills and 
experience, high volumes of activity and access to appropriate diagnostic 
and treatment facilities” (p.72).  However, there was no implementation 
plan, no timeframe and no budget to support this plan (98). Local 
campaigners and health services action groups labelled the policy ‘anti-
rural’ and ‘socially destructive’ (98), an example of public choice theory in 
action.  
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2003 
In 2003, Michael Martin TD, the then Minister for Health, announced the 
Health Service Reform Programme (99), calling for significant reform in 
the structure, funding and management of the health service through the 
development of the Health Service Executive (HSE).  At the same time, 
the Prospectus report which audited the structures and functions of the 
health system (100) recommended the consolidation of fragmented 
structures in the health service to ensure high quality services and value 
for money.  The same year, the Brennan report carried out an 
examination and review of the financial management and control systems 
in the health service in Ireland (101) and recommended substantial 
changes in relation to the structure and management of the health 
service.  
2006  
The HSE Transformation Programme (2007-2010) (102) recommended 
that hospital services needed to be configured to deliver optimal and cost-
effective results. In relation to hospital reconfiguration, the report 
recommended an integrated care model that is “evidence-based, 
efficiently run and quality assured” (p.14), focussing on maternity, 
paediatric and emergency services.  
2006 
A subsequent (2006) report Improving Health and Achieving Better 
Standards, referred to as the “Teamwork report” (103), found that the 
number of acute hospitals in the Northeast region of Ireland could not be 
justified.  
2008  
The review of acute hospital services in Cork and Kerry in 2008 (104) 
recommended a regional specialised centre with a network of local 
general hospitals while the HSE action plan for the Mid West region (105), 
also in 2008, supported the policy of centralisation and specialisation of 
services in large regional hospitals, whilst strengthening local primary, 
community and continuing care services (98). 
2008 
An OECD report in 2008 on integrated public services in Ireland (106) 
promoted centralisation of health services, stating “It is better to 
rationalise the delivery of highly specialised surgical and acute medical 
procedures so that surgeons are given the chance to perform procedures 
often enough to maintain their skills” (p.39) but criticised the lack of 
concurrent development of primary, community and continuing care 
services to support and enable the downgrading of local hospitals. 
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2009 
An Irish report from the Economic and Social Research Institute (ESRI) in 
2009 (107) advised that in order to moderate future demand for hospital 
services, the development of integrated care in the community is 
essential. 
2012  
Future Health: A Strategic Framework for Reform of the Health Services 
2012-2015 (108). This framework outlines the programme for government 
to introduce universal health insurance.  Service reform will include 
moving away from the current hospital-based model of care towards a 
new model of integrated care.  
2013 
The establishment of Hospital Groups as a transition to independent 
Hospital Trusts (109) is outlined in the Higgins report (2013) which 
reiterates the policy of centralisation of specialist and complex care and 
outlines the formation of hospital groups to facilitate integration and 
patient flow across the continuum of care.   
 
The debate about provision of acute hospital services in Ireland has been 
documented in policy and strategy documents since 1968. These strategies 
outline the government direction towards specialised centralised services 
based on international evidence and best practice. However, implementation 
of these recommendations has been poor historically, due to opposition from 
local politicians and residents, lack of implementation plans, lack of sufficient 
medical manpower, and fragmented primary care services. The formation of 
independent Hospital Trusts in Ireland aims to provide “optimum 
configuration for hospital services to deliver high quality, safe patient care in 
a cost effective manner” (p.8) (109). The efficacy of this approach will need 
be monitored to assess patient outcomes.    
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2.3.5  Centralisation – cancer 
2.3.5.1  Centralisation – cancer – international 
The OECD have reported that centralisation of cancer care delivery seems to 
have contributed to “higher quality cancer care and improved evidence 
based care delivery” (p.58)(19), although strategies differ across countries. 
The association between hospital or physician volume and patient outcomes 
for cancer has been debated in the literature since the 1970s, when Luft 
demonstrated a relationship between surgical volume and mortality (110). 
Hannan (111) builds on Luft’s (112) previous theory in relation to volume 
outcome and poses the question:  
 
“Do higher-volume hospitals have better outcomes because their 
experience enables them to improve their performance (practice makes 
perfect) or do hospitals with better outcomes have higher volumes 
because their competence is well known and rewarded (selective-
referral hypothesis)” (111) (p.1678).  
 
He cautions that volume “should not be considered the final determinant of 
quality” (p.1678) and recommends that more accurate data should be 
collected on the relationship between process and outcome. 
 
Begg et al. (113) studied the impact of hospital volume on 30-day mortality 
for major cancer surgery. They found that mortality rates for complex cancer 
surgery were lower in specialist centres, in particular for oesophagectomy 
and pancreatectomy. However, breast cancer surgery was not included in 
the Begg et al. study and is not considered a particularly complex surgery.  In 
order to ascertain if specialist centres were operating on a more favourable 
group of patients, the distribution of co-morbidity, age and cancer stage were 
examined and found to be independent of hospital volume.  
 
Smith et al. (114) found the volume–outcome evidence so pervasive and 
persuasive, that they recommended that public and private funders should 
set requirements of a minimum case volume as a condition for 
reimbursement. The authors added that clinical outcomes can also be 
improved with clinical practice guidelines and with standardised care.  
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Lipscomb (115) questioned whether the benefit of surgeon volume on patient 
outcome in cancer care is due to specialty training and exposure or to 
“technical skills enhancement through repetitive performance of the 
procedure itself” (p.151) and recommends that additional factors should be 
considered, including patient choice, physician speciality and processes of 
care.  
 
Weitz (116) carried out a review of the impact of volume and specialisation 
for cancer surgery. He concurred with previous studies on the volume–
outcome relationship, but observed that the magnitude of this relationship 
varied between malignancies. He also questioned the threshold that should 
be used to define a high-volume provider, a question also raised by Hannan 
(111) and by Epstein (117). While volume most likely affects quality of care, 
better hospitals and clinicians could potentially attract more patients (111, 
118). Hannan also cautioned against using volume as the final determinant 
of quality.  
 
Two studies commissioned by the Institute of Medicine (IOM) in the USA 
outlined the benefits of centralisation of cancer care  (118, 119).  Hillner et al. 
(118) reviewed the literature from 1988-1999 on the relationship of volume 
and outcome in cancer care and summarised the benefits of higher 
caseloads for complex surgery such as oesophageal, gastric, pancreatic  
and non-small-cell lung cancer. However, Hillner acknowledged the 
possibility of publication bias of the included studies and noted that less 
research had been carried out for less complex surgery, such as breast 
cancer.  This was consistent with Halm’s (119)  subsequent systematic 
review, which also included breast cancer surgery, showing that higher 
surgical case volume was associated with better peri-operative and 30-day 
mortality, but the magnitude of this association varied greatly. Halm’s 
systematic review included 135 published studies across a range of 27 
surgical procedures and conditions which examined both individual surgeon 
caseload and hospital caseload. The majority of studies found a direct 
relationship between case volume and patient outcomes, which was 
strongest for complex surgery and cancer treatment. However, 
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methodological weaknesses of individual studies made it difficult to make 
robust recommendations for policy making. For example, most studies 
examined the effect of hospital volume or physician volume only, the quality 
of risk adjustment techniques varied between studies, only two studies 
measured the appropriateness of patient selection and only 10 studies 
examined different processes of care between high volume and low volume 
providers. 
 
Learn and Bach (120) discussed the possible reasons behind the lack of 
centralisation policy in the USA. These include concerns about the “validity 
and reliability of the volume–outcome relationship as a policy tool” (p.1041) 
(121-123),  as well as concerns about diminution in patient access (124) 
(125, 126) and an increase in volume of patients and associated activity at 
specialised centres, which could affect quality (127, 128). The authors 
discussed how the question of improving outcomes for high-risk oncological 
surgery “remains highly charged by substantial competing interests, valid 
logistical concerns and a dearth of solid prospective data” (p.1048).  In their 
study of high-risk cancer surgeries which included pancreatectomy, 
oesophagectomy, gastrectomy and major lung resection, they concluded that 
the generalised decreases in in-patient mortality were due to improvements 
within volume categories.  
 
Collective evidence on this debate appears to favour the volume–outcome 
argument, although the thresholds and parameters for volume varied. For 
example, some studies measured practitioner volume while others measured 
hospital volume.  In a study on colorectal cancer surgery, Harmon (129) 
found that surgeons with medium annual case volume (5 – 10) achieved 
results equivalent to surgeons with high-case volume (>10), when they 
operated at high (>70) to medium-volume (40 – 70) hospitals. A systematic 
review to assess the impact of specialisation on processes and outcomes of 
care for cancer patients was conducted by Grilli et al. (130) which included 
46 eligible studies.  Specialised centres/clinicians were found to have lower 
mortality rates. However, methodological flaws were noted in the included 
studies, such as lack of comparability of patients seen at specialised and 
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non-specialised centres, findings derived from secondary analysis and 
possible publication bias. A systematic review and meta-analysis from Gruen 
et al. (131) on the effect of provider case volume on cancer mortality 
included 101 publications involving greater than one million cancer patients 
(oesophageal, gastric, hepatic, pancreatic, rectal and colon cancer).  A 
significant volume–outcome effect was found for the majority of 
gastrointestinal cancers.  However, heterogeneity of results from individual 
studies was noted.  
 
Billimoria et al. (132) examined whether differences in hospital surgical 
volume for complex cancers had a greater effect on peri-operative mortality 
(60 days) or on long-term survival (5 years). The cancers included were 
colon, oesophageal, gastric, liver, lung, pancreatic and rectal cancers. While 
the results showed that quality improvement initiatives were required to 
address peri-operative mortality, the authors concluded that more deaths 
could be avoided if quality initiatives were focused on factors related to long-
term survival.  The authors emphasised the importance of hospital 
characteristics and processes of care for improving patient outcomes, both in 
low-volume and high-volume hospitals.  
 
A German study (133) examining variation in breast cancer care identified 
potential for improvement in the areas of early detection and adherence to 
treatment standards for breast cancer. The development and implementation 
of national guidelines for cancer was identified as a priority, in line with the 
Council of Europe (134) and WHO directives (135).   
 
In summary, the debate on volume-outcome continues in the extant 
literature. It is apparent that both physician caseload and hospital volume 
need to be considered as individual factors influencing patient outcomes. 
However, other factors such as clinical practice guidelines, standardised care 
and care processes will also influence patient outcomes. The balance 
between patient access and centralised specialist care is a policy decision to 
be made by individual cancer control programmes. The OECD recommends 
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coordination of care across providers, including primary care, as not all 
cancer care is delivered in specialist centres (19).  
 
2.3.5.2  Centralisation – cancer – UK 
The UK  Calman-Hine report on cancer services was developed by the Chief 
Medical Officers  in England and Wales in 1995 (136). This report 
recommended that all patients should have access to a uniformly high quality 
of cancer care wherever they may live. This report aimed to improve cancer 
outcomes and reduce inequalities through the establishment of specialist 
cancer centres with multidisciplinary teams.  Prior to the Calman-Hine report, 
cancer care in the UK had been described as the ‘cancer lottery’, referring to 
patient’s access to cancer specialists (137).  
 
In an editorial on the launch of the Calman-Hine report, Haward (138) 
commented that “cosmetic changes in hospital designation will not achieve 
the consistent quality of cancer service that is the cornerstone of the Calman 
policy” (p.531). In 2006, he reported on the implementation of the Calman-
Hine report and concluded that the implementation was not sufficiently 
addressed, resulting in variation both across and within sites (137).  He 
reported that shortages in staffing and facilities were exposed and the lack of 
cohesion between the commissioners of the process and the managers of 
the service impeded its effective implementation (137).  Morris (139) found a 
major shift in the specialisation of colorectal and breast cancer surgery in 
Yorkshire. She found that the level of specialisation varied across Hospital 
Trusts and that the centralisation process had commenced before the 
publication of the Calman-Hine report.     
 
The recommendations of the Calman-Hine report were accepted by the 
Campbell report in Northern Ireland in 1996 (140, 141). This report 
recommended similar changes in cancer care, including centralisation, 
increased specialisation, multi-disciplinary care, enhanced communication 
between GPs and secondary care, and enhanced palliative care.  
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The UK Department of Health produced the National Cancer Plan in 2000 
(142). This plan made cancer networks responsible for improving care, with 
financial resources provided for staffing and equipment. Following publication 
of this plan, 34 cancer networks and 1,600 multidisciplinary cancer teams 
were established, with a commitment of significant investment.  Key areas for 
development included prevention, screening, community services, reduction 
in waiting times, clinical guidelines, palliative care, workforce planning, 
cancer research and investment in equipment. The NHS Cancer Reform 
Strategy (2007)(143) and the UK 2011 Cancer Strategy  ‘Improving 
Outcomes: a Strategy for Cancer’ (144) built on the progress of the National 
Cancer Plan. The achievements of the Cancer Plan were acknowledged in 
the areas of survival, screening services, smoking cessation, 
multidisciplinary teams, expanded workforce and faster access to treatment. 
A programme for further action was outlined in the areas of prevention, 
diagnosing cancer earlier, ensuring better treatment, living with and beyond 
cancer, reducing cancer inequalities, and delivering care in the appropriate 
setting.  
 
Proposals to consolidate cancer services in England through the 
commissioning process have been challenged in some areas, such as 
Manchester, on the basis of anti-competitiveness (145).  
 
2.3.5.3  Centralisation – cancer – Ireland  
The first National Cancer Strategy in Ireland (146) entitled Cancer Services 
in Ireland, was published in 1996 and included the following 
recommendations:   
 
• Services must be of uniformly high quality throughout the country  
• The services should be based on an integrated multi-disciplinary 
approach, determined by patient needs rather than by accidents of 
domicile, location of services or traditional patterns of referral  
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• There must be agreement about the types of cancer which would be 
inappropriate to particular hospitals because of size, expertise or other 
factors  
• There must be agreement regarding the minimum and maximum 
caseloads for clinicians  
 
The structure of cancer services was proposed as follows:  
 
• Regional services provided by designated groups of hospitals with a 
remit to treat specific cancers according to agreed protocols and best 
practice 
• Supra-regional services responsible for treating the full range of 
cancers and for providing the more highly specialised therapies not 
available in regional services 
 
The outcome of this strategy was that, whilst there were some developments 
in the areas of regional coordination and cancer care nursing coordinators, 
the structure of cancer services remained largely unchanged.   
 
The second National Cancer Strategy; A Strategy for Cancer Control in 
Ireland was published ten years later, in 2006 (11). This second strategy 
focussed on the restructuring of cancer services into managed cancer control 
networks and quality in cancer control. Based on the recommendations of 
this second  National Cancer Strategy (11), the National Cancer Control 
Programme (NCCP) was established in 2007 to manage, organise and 
deliver cancer services on a whole-population basis. As a result, cancer 
surgery has been centralised in Ireland by the NCCP for a number of 
cancers including breast, lung, prostate, pancreatic, rectal, oesophageal and 
brain tumours.  
 
The National Cancer Strategy (11) also recommended that GPs should have 
comprehensive information available to enable them assess a patient with 
suspicious symptoms and findings, and to enable them to make an informed 
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referral for specialist assessment (17).  The NCCP GP referral guidelines for 
suspected cancers (commencing with breast, prostate and lung cancers) 
were developed and disseminated in 2009 to provide the following benefits 
(18):  
• Provide accurate and clear information for GPs referring patients  
• Streamline the symptomatic breast referral process 
• Improve the quality of referral information and thereby improve 
accuracy of triage by the hospital clinical teams 
 
These GP guidelines have been in use since 2009. This thesis will examine 
the effects of the implementation of these referral guidelines on a number of 
outcomes, to be described in detail in Chapter 9.  
 
2.3.6 Centralisation – breast cancer  
2.3.6.1  Centralisation – breast cancer – international 
Studies of breast cancer have shown that variability in treatment can be 
reduced by implementing treatment protocols (147, 148). Centralisation of 
breast cancer surgery in high-volume specialist centres has been shown to 
improve patient outcomes (7-9, 149, 150) and quality of care (150).  Many 
volume–outcome studies focus on in-patient or 60-day mortality as their 
primary outcome variables.  However, as deaths following breast cancer 
surgery are rare, long-term survival is a more useful parameter to examine 
for this cohort.  
 
Skinner et al. (8) found a 33% reduction in the 5-year risk of death for breast 
cancer patients being treated by specialist surgical oncologists compared to  
non-specialists in a study conducted in Los Angeles with 29,666 eligible 
patients. This study also demonstrated a 23% reduction in the risk of death 
at 5 years in hospitals treating >125 breast cancer patients per year. The 
authors attribute the differences to several factors including volume, surgical 
skill, multidisciplinary care and more appropriate use of adjuvant therapies. 
The authors conclude that “long-term survival in breast cancer can be 
improved by concentrating the care of these patients in high volume centres 
55 
 
where the patient will be treated by a surgeon who performs such surgeries 
regularly” (p.614)(8). Whilst data from population based tumour registries 
provide large numbers, with reduced risk of institutional or selection bias, 
they are limited by the quality and validity of those data.   
 
These results from Skinner and colleagues in 2003 are consistent with an 
earlier study in New York State by Roohan (151), which found that at 5 
years, patients from very low-volume hospitals (≤ 10 cases per year) had a 
60% greater risk of all-cause mortality than patients from high-volume 
hospitals (performing >150 breast cancer surgeries per year). Factors other 
than surgery may also contribute to survival and Roohan recommends 
examining the process of care, including adjuvant treatment post-surgery. 
Both Roohan (151) and Morrow et al. (152)  documented improved long-term 
survival after mastectomy for breast cancer at high-volume centres.   
 
In a systematic review to assess the impact of specialisation on processes 
and outcomes of care for cancer patients conducted by Grilli and colleagues  
(130), specialised centres/clinicians were found to have lower mortality rates, 
as indicated earlier in this chapter. For breast cancer, a pooled estimate of 
the effect of specialisation showed that specialised cancer care was 
associated with an 18% reduction in mortality. The level of specialisation 
(hospital level, clinician level) varied between individual studies. The authors 
commented on the lack of studies with conflicting results in this area, raising 
the possibility of publication bias.  
 
Nattinger (153) also raises the possibility of selection bias in volume–
outcome studies which could over-state the benefit of specialisation. The 
direction of the causal relationship has also been debated – whether volume 
affects quality or whether better units and clinicians attract more patients 
(111, 118, 154).  In an observational cohort study in the USA using tumour 
registry and Medicare claims data for 12,216 women with breast cancer, 
Nattinger found that the relationship between surgeon volume and patient 
outcome was due to all-cause mortality as opposed to breast cancer 
mortality.  She found that “treatment by a high-volume surgeon was 
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associated with younger patient age, white race, less co-morbidity and 
residence in a more affluent zip code” (p.1958)(153). 
 
Despite some concerns raised about possible publication bias and patient 
selection processes, there is considerable evidence that higher volume of 
breast cancer surgery is associated with better patient outcomes and it is this 
evidence that largely has informed the development of policy in this area.   
 
2.3.6.2  Centralisation – breast cancer – UK 
Griffith and Turner presented a national approach for the redesign of cancer 
services in the UK in 2004 (155).  They identified major issues for breast 
cancer including: access to services and rapid access clinics, multi-
disciplinary team working and pathways of care.  
 
A number of UK studies have reported a significant relationship between 
surgeon caseload and patient outcomes.  For example, one study (156) 
involving 12,861 women found improved outcomes where surgeon caseload 
was greater than 30 cases per year. Survival benefit was also found to be 
attributed to greater use of chemotherapy. However, this study was 
conducted over a nine year period and the authors acknowledge that 
treatment types, chemotherapy regimens and multidisciplinary care have 
changed in cancer care during that timeframe.  In a study on surgeon 
workload and survival from breast cancer,  Mikeljevic (157) found that 
patients treated by low case volume surgeons (<10/year) had poorer 
survival.  The 5-year survival rate for this group was 60%, compared to 68% 
in the high volume (≥50/yr) group. The authors concluded that greater 
specialisation in addition to improved diagnostics and multidisciplinary 
organisation of breast cancer services, have contributed to improved survival 
for breast cancer patients in the UK.   
 
In relation to surgeon specialisation in the west of Scotland, Gillis  (158) 
found that the 5-year survival rate was 9% higher and the 10-year survival 
rate 8% higher for patients cared for by specialist breast surgeons, for all 
patient, clinical and social categories.  This study found a reduction of 16% in 
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5-year risk of death from breast cancer in patients treated by a breast 
surgeon in a dedicated multidisciplinary breast clinic, compared with non-
specialists. This retrospective study with 3,786 patients was adjusted for age, 
tumour size, socioeconomic status and nodal involvement, but not for 
speciality training or individual surgeon case volume.  A subsequent Scottish 
study by Kingsmore et al. (9) found improved surgical management, lower 
local and regional recurrences and better survival in specialised breast units. 
They concluded that adequate surgical management and “adequacy and 
appropriateness of all treatment is the key to explaining improvements in 
survival outcomes” (p.1924).   
 
Morris (159) examined the impact of the UK Calman-Hine report for breast 
cancer patients in Yorkshire. She found that, while the level of 
implementation of the Calman-Hine recommendations varied, there were 
improvements in processes and outcomes of care for breast cancer patients.  
Rouse (160) examined the case volume of breast cancer surgeons before 
and after the Calman-Hine report in the UK. Whilst a move towards 
specialisation was found, this trend had commenced prior to the publication 
of Calman-Hine.  
 
Singhal et al. (161) reviewed the fast-track breast cancer referral system in 
Birmingham following the introduction of the 2-week rule. Of those referred, 
71.7% met the referral criteria. The authors concluded that the system of 
categorising into urgent and non-urgent referrals should continue despite 
calls to move to a 2-week wait for all referrals. Since the introduction of the 2-
week rule, longer waiting times for patients referred routinely have been 
reported in the breast clinics (162). A study in Northern Ireland examining the 
2-week rule concluded that “the safest and fairest policy would be to 
abandon the concept of urgent referral criteria and see all patients in a timely 
fashion” (p.71)(162).  
 
The Northern Ireland Health and Social Services Board has established 
triple-assessment clinics and multidisciplinary teams for breast cancer, in 
accordance with the Campbell report (163). Collaborative links have been 
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established between the Northern Ireland Cancer Registry (NICR) and the 
National Cancer Registry of Ireland (NCRI) and all-Ireland cancer reports 
have been jointly published, thus facilitating an all-island perspective on 
cancer strategy and management, as well as enabling important 
comparisons of cancer management and outcomes between the different 
health systems in the two jurisdictions.  
 
A study on the reorganisation of the breast cancer service was carried out in 
Northern Ireland following the centralisation process (164). It found that 
breast cancer surgery was being carried out in fewer hospitals by fewer 
surgeons, in line with the specialisation policy, but that further research was 
required on patient outcomes.  
 
A study in Northern Ireland compared breast cancer services in 2006 to 
2001, following centralisation of services into Trusts, which was completed in 
2001. Survival had improved (observed survival 94.3% after one year and 
90.6% after two years, compared to 92.7% and 87.7% in 2001). The 
proportion of patients referred to oncology centres had increased from 87% 
in 2001 to 93% in 2006. Patients diagnosed in 2006 were diagnosed at a 
later stage of disease, which was attributed to stage shift, due to changes in 
diagnostic imaging technology. However, there was a reduction in the 
proportion of patients being seen within 14 days of referral and proportion of 
patients having surgery within 14 days of diagnosis (165).  
 
2.3.6.3  Centralisation – breast cancer – Ireland  
The National Cancer Forum published the ‘Development of Services for 
Symptomatic Breast Disease’ in 2000 (166), the first report of its kind in 
Ireland. This report outlined the recommended structure for specialist breast 
units, diagnostic principles, treatment principles and quality-assurance 
standards.  The National Cancer Strategy (2006) (11) built on this report and 
recommended that the newly-established Health Service Executive should 
conduct a review of the number of centres required for the management of 
symptomatic breast disease. The National Quality Assurance Standards for 
Symptomatic Breast Disease Services were published by The Health 
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Information and Quality Authority (HIQA) in 2007 (167).  HIQA conducted a 
national review of the Symptomatic Breast Disease (SBD) Services in 2009. 
Their report set out 18 recommendations on clinical governance, standards, 
audit and system assurance. These recommendations are detailed in Table 
2.2 below (6).  
 
Table 2.2: Recommendations from the HIQA review of SBD services 
(2010)       Source: HIQA, 2010 (6) 
 
 HIQA Recommendation 
1 The HSE should formally establish a national network of the SBD lead 
clinicians with a view to identifying and addressing mutual development 
and support needs. 
2 The HSE together with the designated centres should formally evaluate 
the implementation of Standard Operating Procedures on a phased 
and prioritised basis, to ensure that they are fully embedded and being 
applied consistently within and between designated centres. 
3 The HSE should ensure that designated centres have robust 
governance arrangements in place, including a Service Level 
Agreement, to effectively manage relationships with third-party 
providers. Such arrangements for the outsourcing of radiation oncology 
should be established promptly. These should cover the requirements 
of the Standards and in particular quality, safety and the formalised 
exchange of information. 
4 The HSE should put in place formal national clinical governance 
arrangements, to ensure that the eight centres build on robust local 
clinical governance arrangements, in order to operate as a cohesive 
national clinical network for the purposes of clinical audit, sharing of 
good practice and problem solving. 
5 The HSE should put specific actions in place to ensure that its new 
directorate structure incorporates a clear mandate for describing and 
implementing the National Cancer Control Plan. In particular this 
should include clarity in the governance, accountability, responsibility, 
authority and resource allocation for the eight designated centres. 
6 The HSE should work with designated centres, to assess the 
organisational development needs of the newly-established designated 
centres and introduce focussed support as required. 
7 The HSE together with the designated centres should carry out a risk 
assessment to identify areas in the designated centres where service 
continuity and sustainability, or the ongoing meeting of Standards, 
could be threatened by the absence of key staff and ensure that 
contingency plans are in place as needed. 
8 The HSE should work with the designated centres, and the relevant 
training bodies, to develop a standardised framework for assuring the 
skills, education and training of staff in the centres are maintained at 
the necessary levels. 
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 HIQA Recommendation 
9 The HSE, with the designated centres, should establish effective ways 
of enhancing the continuity of patient care. This should include the 
introduction of the “Most Responsible Clinician” for patients within the 
SBD service. This should also be inclusive of aspects of care provided 
by third-party providers. 
10 The HSE should require all centres to have in place robust 
arrangements for ensuring that all information relevant to patients’ care 
is accessible as needed by patients and clinicians, irrespective of 
where the care is provided or the information is generated. 
11 The HSE should identify those designated centres where data 
management capability, and the use of data, are still in development 
and instigate ongoing evaluation and, where needed, provide focussed 
support for those designated centres. This should include targeted 
support and development for SBD clinicians in the capture and use of 
data as an intrinsic facet of clinically effective care. 
12 The HSE together with the designated centres should coordinate, as 
part of its wider development of clinical audit systems, a review of 
referral and triage processes, aimed at understanding and addressing 
any unnecessary variations in referral or triaging practices between the 
designated centres and their referring clinicians. 
13 The HSE should coordinate, with the designated centres and the wider 
health system, the development of a differentiated service response 
that reflects the profile of patients being referred to the service, 
whereby patients with a lower risk of breast cancer are seen in a timely 
way and with the necessary clinical assessment. 
14 The HSE together with the designated centres should develop 
mechanisms for monitoring the numbers of newly-diagnosed patients 
seen and treated by individual clinicians with a view to developing 
benchmarks for the relevant clinical specialties. 
15 The HSE should develop, with the designated centres, a national 
clinical audit programme for SBD services that includes as a minimum: 
patients triaged as non-urgent and subsequently diagnosed with breast 
cancer, delayed diagnoses, longer-term clinical outcomes and survival 
rates. The national key performance indicator set should be reviewed 
regularly based on the outcomes of these audits. 
16 The HSE together with the designated centres should put in place 
arrangements to begin publicly reporting performance against the 
NCCP Key Performance Indicators during 2010. 
17 The HSE should undertake a formal evaluation of the change 
programme that has created the eight designated centres with a view 
to identifying lessons for future similar programmes of change. The 
changes that have been made in improving the symptomatic breast 
disease services should be used as a template to be adapted and 
modified for other services. 
18 The HSE should nominate a national director to be responsible for 
developing and monitoring an implementation plan for these 
recommendations and should ensure that these actions are delegated 
as necessary. It should put in place arrangements for reporting 
progress with implementation to the HSE Board and the public. 
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The NCCP was established in 2007 to implement the recommendations of 
the 2006 National Cancer Strategy.  While some of the smaller hospitals had 
already ceased breast cancer surgery, the main centralisation process into 
designated cancer centres took place throughout 2009.  This centralisation of 
breast cancer surgery was completed in December 2009, facilitated by 
strong political support. There are now 8 designated public Symptomatic 
Breast Disease (SBD) Units and one satellite unit, compared to 35 public 
hospitals providing SBD services in Ireland in 2007 (12).  Patients attending 
the SBD Units in Ireland are treated by cancer specialists in multidisciplinary 
teams. In tandem with centralisation of breast cancer surgery, GP referral 
guidelines with standardised referral forms for suspected cancers were 
developed and introduced nationally by the NCCP in 2009, with 
comprehensive education on their use provided for GPs (3).  
 
 
2.3.7 Disadvantages of centralisation  
2.3.7.1 Disadvantages of centralisation in healthcare 
While the weight of evidence appears to support the benefits of healthcare 
centralisation, there is also evidence to the contrary. One report from Wales 
(168) claims that “the link between volume and outcome for many surgical 
procedures is often overestimated, the financial benefits do not always 
materialise and access is reduced with a greater burden on older and poorer 
people” (p.6). A Canadian study (169) on equity in health and healthcare in a 
decentralised context concluded that within-area variation is the most 
important source of income-related inequalities, while income-related 
inequities in health care use are mostly driven by differences between 
provinces.  This has implications for service centralisation in Ireland as the 
HSE regional networks vary greatly in terms of rurality and demographics. 
However, the centralisation process in Ireland has been structured such that 
each cancer network provides services for approximately 500,000 people.  
 
2.3.7.2  Disadvantages of cancer centralisation  
Centralisation of cancer services has also been documented as having some 
disadvantages.  
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 Surgical training 
Greenberg and colleagues (170) outlined their concerns for the impact of 
centralisation of cancer surgery on surgical training, in particular for general 
surgery as the majority of cancer surgery is carried out by general surgeons.  
 
Access 
Posnett (90) advised that the indirect costs of centralisation “in terms of 
patient access should not be ignored” (p.1065) and cautions that decreased 
access is generally associated with a shift in costs from the NHS to patients, 
rather than with a reduction in use, with the exception of diagnostic or 
screening services.  
  
 
Rurality 
A number of studies highlight the potential introduction of inequity in 
healthcare access through centralisation of services.  A study by Baird, a GP  
in rural Scotland (171) on the experiences of cancer patients in his area, 
found that a significant proportion of their time was spent travelling for care. 
He recommended improved transport options and mobile 
imaging/investigations. Patients from more remote rural areas have been 
found to have more advanced disease at diagnosis and poorer survival (172-
174).  A study from Liff et al. (174) which included patients with breast 
cancer, found that patients from rural areas had more advanced disease 
than patients from urban areas.  Stevenson (175)  conducted a study with 
health professionals in Scotland who were treating cancer patients in rural 
areas. Participants agreed on priorities for cancer care for people in remote 
and rural areas, which included fast access to diagnostic services, a link 
person at the local general hospital, effective multidisciplinary team-working 
and good transport to specialist centres. Carr-Hill et al. found that reducing 
access did not deter patients from seeking health care (176). However, 
Mungal (51) describes ‘distance decay’ as the inverse relationship between 
the distance of the patient from the hospital and the utilisation of services, 
and describes how this affects certain populations more than others, e.g., 
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lower socioeconomic groups, those with poorer access to transport and older 
people.  
 
Access to colorectal cancer care in cancer centres vs. non-cancer centres 
was assessed in Scotland. Pitchforth et al. (177) found that patients admitted 
to a non-cancer hospital were less likely to receive chemotherapy as part of 
their treatment.  The authors highlight that it is “crucial that any increase in 
physical distance from specialised services does not exacerbate inequalities 
in uptake of specialist care” (p.1221).   
 
Geographical variation  
Geographic variation in breast conserving treatment is described by 
Nattinger (178).  Following adjustment for hospital and patient 
characteristics, this study found significant variation in the use of breast 
conservation therapy, which was more commonly used in urban areas, 
teaching hospitals and hospitals with radiation oncology services.  
 
Structure of services 
A study in the breast clinic in a Dublin hospital in 2004 (179) concluded that 
rapid-access clinics are “an efficient method of dealing with symptoms 
suspicious of cancer” (p.2966) but that low-risk patients should be dealt with 
in a different forum. 
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2.4  Factors influencing GP referrals  
Wide variation in all aspects of care has been found consistently in general 
practice research (15).  Explanatory factors have been divided by Wilkin (15) 
into 3 broad categories:  
• Patient variables  
• Provider variables  
• Healthcare system variables   
 
He discusses the consequences of variation and questions whether some 
patients are being treated unnecessarily, with possible adverse 
consequences in terms of iatrogenic disease. He asks “are we wasting 
scarce hospital resources in treating patients whose problems could be dealt 
with at least as well in general practice?” (p.87).  
 
The Health Belief Model (180) (181) has also been used in the area of breast 
cancer screening to predict attendance at screening visits (182).  
 
Non-clinical influences on decisions in clinical practice have been studied 
internationally.  Hajjaj (183) concluded that these non-clinical influences may 
be the “biggest obstacle to the reality of practicing evidence-based medicine” 
(p.178).  Examples of these non-clinical influences included:   
• Socio-economic status  
• Patient expectations  
• Patient wishes  
• Clinician characteristics   
• Private vs. public practice 
 
Hillner et al. (118) reviewed the evidence on the effect of hospital or 
physician volume on the outcome of cancer care. The authors presented a 
framework of factors affecting treatment processes and outcome which 
included:   
• Physician / Provider factors: specialist training/focus, case volume  
• Health-system factors: multidisciplinary care, type of centre, case 
volume 
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• Patient and geographical factors: education, income, co-morbidity, 
location, distance from treatment 
 
This review of relationship between volume and outcome concluded that 
despite weaknesses such as dated data, different methods in controlling for 
case mix and possible publication bias, most of the evidence supported a 
positive volume-outcome relationship in cancer treatment. However, the 
direction of the causal relationship was questioned; i.e. whether the case 
volume affects quality of cancer care or alternatively, that specialist units and 
physicians attract more patients (118).   
 
Each of these factors will now be examined individually in relation to breast 
cancer referral. 
 
2.4.1  Patient factors influencing GP referrals  
 
2.4.1.1  Clinical / patient factors  
A clinical prediction rule for breast cancer, developed and validated in Ireland 
in 2014, found that independent clinical predictors for breast cancer were: 
increasing age, breast lump, nipple changes and nipple discharge (49). This 
is consistent with a clinical prediction rule previously developed in the UK 
(184). However, it is well established that patients are referred to specialist 
centres for further investigation for a range of reasons and symptom 
presentations (46, 118, 183). Most notable among these is referral because 
of family history of breast cancer and referral for mastalgia (179, 185-187). 
 
2.4.1.1.1  Family history of breast cancer  
GPs have been found more likely to refer women who have a family history 
of breast cancer in a UK study (185). Women with a family history of breast 
cancer have been found to overestimate their risk of breast cancer (188) 
(189). 
 
Strict adherence to referral guidelines has been recommended for referral of 
patients with a family history of breast cancer (190). However, an Irish study 
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(179) reported that while rapid-access breast clinics experienced “cluttering 
by low risk women” (p.2961), 10% of those with a benign diagnosis had a 
significant family risk and required assessment of future risk. This cohort 
study of 1,429 women attending a rapid assessment breast clinic in Dublin 
found that 143 patients with a benign diagnosis had significant family risk, 
which was separate to the reason for their initial referral. Future risk was 
based on NICE guidelines for familial breast cancer (www.nice.org.uk).  
 
Another Irish study on the development and validation of a clinical prediction 
rule for breast cancer using regression analysis found that family history was 
not predictive of breast cancer despite the fact that family history was 
present in one third of the cohort (49). This study derived a clinical prediction 
rule for breast cancer in women attending one of the Symptomatic Breast 
Units in Ireland.  A total of 6,590 patients were included in the derivation 
cohort of this prospective study, of which 4.9% were diagnosed with cancer. 
However, this was a single centre study, with the validation cohort from the 
same centre, which can result in over-estimation of model fit. 
 
 
2.4.1.1.2  Mastalgia 
Mastalgia (breast pain) can affect 10-30% of women (191).  Joyce et al. 
(186) conducted a prospective study with 14,325 patients referred to two 
SBD units in Ireland to identify a cohort of women who could be suitable for 
management by their GPs. 3,331 of these patients were referred with 
mastalgia as their only symptom and the incidence of breast cancer in this 
group was 1.2% (40 patients), all of whom were over 35 years of age. The 
authors recommended that women under 35 with mastalgia could be suitable 
for management in the primary care setting and outlined the resources in 
terms of time and costs of assessing these women in the hospital setting 
(192).  
 
Several studies in the UK and Ireland found that the presence of breast pain 
was not associated with the presence of breast cancer (187) (49, 184).  
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Campbell et al. (187) in a prospective study with 2,064 patients referred to a 
breast clinic in the UK found that the presence of breast pain was not 
associated with the presence of cancer. In a study to develop a clinical 
prediction rule for breast cancer in Ireland, Galvin et al. (49) found that 
although almost a third of their cohort presented with mastalgia, this was not 
independently predictive of breast cancer. In an additional study developing 
a clinical prediction rule in the UK, McCowan (184) found similar results. 
 
2.4.1.1.3  Follow-up after breast cancer  
Long-term follow-up of women with early breast cancer in specialist breast 
units has been found not to confer a survival advantage (193, 194).  The 
National Institute for Health and Care Excellence (NICE) in the UK 
recommends that routine follow-up visits for breast cancer should be limited 
to 2 – 3 years, as the practice has not been shown to be effective beyond 
this timeframe (195). This policy formed part of the strategy to increase clinic 
capacity for new referrals in the UK (196).  
 
Smyth, McCaughan et al. (197) discussed the need for follow-up care and 
support programmes for breast cancer survivors and recommended that 
future research should focus on the needs of specific age-groups. A 
systematic review of patient and healthcare professionals’ views about 
cancer follow-up concluded that “GPs are thought to be unwilling and to have 
insufficient time and expertise to conduct follow-up” (p.248) (198). 
 
The follow-up policy in Ireland was developed in 2010 and is more liberal 
than the UK, recommending discharge to primary care after five years (199).  
A review of follow-up processes in Ireland (200)  found that 15.4% of clinic 
appointments were used for routine follow-up, with a third of these patients at 
least five years post-surgery. The study found that intensive follow-up 
investigations did not confer any additional survival benefit or improved 
quality of life.  
 
Patients attending follow-up clinics have reported an ‘attachment’ to the 
specialist service and sought clarity on responsibility for care between the 
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specialist hospital service and the GP. Some women felt that follow-up in 
primary care would not provide the same level of reassurance and had 
expectations of long-term follow-up in the acute setting (200).  McCaughan 
and McSorley (201) also found that attending review clinics were ‘an integral 
part’ of the patients’ treatment and “were necessary to help them cope with 
the continuous uncertainty they now experienced” (p.421). This study in 
Northern Ireland found that many psychosocial needs were not addressed at 
follow-up clinics and recommended a nurse-led follow-up service as an 
alternative model of service delivery. However, another Irish study found that 
64% of patients were satisfied with cancer follow-up provided by their GPs 
(202).  
 
Approximately half of GPs supported the NCCP policy of transfer of follow-up 
to general practice after five years, in a recent study with Irish GPs in 2014 
(203). However, concerns were expressed about possible increased 
workload and medico-legal risks.  
 
There is a concern that routine follow-up provides false reassurance and 
may delay patients’ presentation until their next scheduled visit (196).  Lewis 
et al. (198) found that patients were anxious about recurrent disease and 
were reassured by regular follow-up. However, the authors concluded that 
although the service was intended to allay the patient’s anxiety, it 
exacerbated their need for reassurance.  
 
2.4.1.2  Patient demographics  
Non-medical factors such as gender, age, quality of life, socioeconomic 
status, patient wishes and expectations influence medical decision-making in 
general (151, 183, 204). Patient characteristics can explain much of the 
variation in GP referral rates (205-207).  
 
Healthcare rationing by a patient’s insurer is described by Hillner (118) as 
hindering prompt access to cancer care. An editorial by Woodman (208) 
comments on the report by the Campaign for Effective and Rational 
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Treatment in the UK which outlines concerns about unequal access to 
treatments in the NHS.  However, a study by McKinlay (209) found that 
patient attributes (age, race, gender, socio-economic group) had no influence 
on clinical decision making.  
 
The majority of urgent referrals to breast units have been found to be 
younger women, despite the fact that only 1% of breast cancers were in 
women under 30 years (210).  Zafar describes a “numerical age bias against 
treating older patients” (p.119)(211).  
 
Deprivation was found to be associated with a higher referral rate in a GP 
study in the UK (212). While this could be due to GP referral decisions, it 
may also be due to co-morbidities in this population. In the USA, primary 
care physicians were found to be influenced by socio-economic status and 
changed the patient management plan accordingly, based on what they 
perceived was affordable and feasible for the patient, e.g., cheaper 
medications for those with income or insurance restrictions and “excessive 
care for more affluent patients” (p.56) (213-215).   
 
The relationship between hospital admission rates and travel time has been 
explored in Scotland (171).  The authors found that patients travelling more 
than one hour to the specialist cancer centre had lower admission rates and 
concluded that the inverse care law appeared to apply to these more remote 
patients. A Welsh study describes ‘the edge effect’, where rurality affects 
patient’s decisions to attend appointments, based on distance, accessibility 
and travel time (216). 
 
McCaughan and McKenna (217) discuss how gender may influence the 
assessment of needs of cancer patients. Men tend to visit their GPs less 
frequently than women, which could delay the referral process. The authors 
recommend ‘gender friendly’ cancer care services, including enhanced 
communications with male patients.  
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2.4.1.3  Patient expectations  
The relationship between the patient and the referring doctors can influence 
GP referral decisions (218).  Referral rates can be influenced by the extent 
that GPs perceived patient pressure (219, 220).  Younger GPs and GPs with 
higher referral rates have reported perceiving greater pressure from patients 
to be referred to specialist services, in particular from patients referred 
privately or referred for reassurance (219, 220). 
 
The wishes and preferences of patients can influence referral and treatment 
decisions, even in cases where this treatment is not evidence-based or 
necessary (183). Patient’s wishes were found to be the most important non-
medical factor related to GP referral decisions in a study with GPs and 
consultants in Canada (221). Doctors working in practices which are client-
dependant have been  found to “respond more readily to the wishes of 
patients” (p.184) (183). 
 
Patient expectations, patient’s ability to assert their views and the doctor-
patient relationship have been described as important non-medical factors 
influencing referrals (218). In a study with GPs examining attitudes to clinical 
guidelines, Carlsen et al. (222) found that GPs’ desire to respond to patients’ 
needs and requests frequently conflicted with adherence to GP guidelines, 
and was related to GPs’ fear of jeopardising the GP-patient relationship 
(223). The influence of patient expectations on referral has been 
documented in the area of breast disease (220, 224).  
 
The Common Sense Model (CSM) of illness representation (225) addresses 
how cognitive factors can influence illness coping behaviours and outcomes.  
Hagger and Orbell (226) reviewed the model and concluded that “moderate-
to-strong relationships exist between illness cognitions, coping behaviours 
and illness outcomes” (p.181).  
GPs in the UK have reported a loss of autonomy since the introduction of the 
2-week rule for cancer referrals and have “acknowledged an element of over-
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referral under this rule due to the effects of clinical uncertainty and patient 
pressure” (p.82) (227). 
 
2.4.1.4   Patient pressure 
Little et al. (228) examined doctor’s perception of patient pressure and found 
that doctors’ perception of patient pressure was strongly associated with 
prescribing, examination, referrals and investigation. The doctor’s perception 
of patient pressure in this study was found to be a stronger predictor than the 
patient’s preference. The authors recommend that doctors should ask 
patients directly about their expectations, to avoid iatrogenesis and 
unnecessary use of resources. 
Salmon et al. (229) conducted a study examining why primary care 
practitioners propose medical care to patients with medically unexplained 
symptoms. This study found that the medical care provided was unrelated to 
patient demands and that patients’ overt pressure for treatment was rare 
(230). There was a higher likelihood of referral for specialist review or 
investigations after patients elaborated on their symptoms. Salmon attributed 
this to the physician’s reactions to extended accounts of symptoms (229).  
However, an alternative interpretation is provided by Persaud (230) who 
proposes that when patients and doctors “depart from the reassuring 
moorings of physical disease” (p.993)(230) into non-physical or 
psychological mechanisms, the pathways are less clear and the patient may 
not be ready to relinquish the ‘sick role’. 
 
The assumptions that doctors make about patient preferences may not 
always be accurate, with research suggesting that “pressure from patients 
may be stronger in the doctor’s mind than in the patient’s mind” (p.416)(231). 
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2.4.1.5  Patient anxiety 
Patel and colleagues found that an increase in demand for access to 
specialist cancer services appeared to be mainly a reflection of increased 
media attention: “asymptomatic patients simply suffering from media-induced 
anxiety about breast cancer could also be appropriately reassured by their 
GP” (p.454) (46).  
 
The influence of patient anxiety as well as patient expectation of referral in 
breast disease should be considered in the development of guidelines (224).  
The psychological morbidity experienced by routine, non-urgent patients, as 
they wait several weeks for an appointment has been documented (196). 
However, Campbell (187) recommends that “anxiety alone should not be an 
indication for referral” (p.248) and cautions that an urgent referral can 
actually increase anxiety and distress.  
 
GP’s empathy for anxious patients can overrule clinical guidelines in their 
decision-making process (232). A considerable number of women who 
present to the breast clinics over-estimate their risk of breast cancer and are 
seeking reassurance (179, 233).  An Irish study (49) recommended 
alternative pathways than referral, such as watchful waiting and reassurance 
in primary care. A systematic review and meta-analysis (234) of patients with 
a low pre-test probability of serious illness on the effect of diagnostic tests on 
anxiety and worry about illness found that diagnostic tests did little to 
reassure patients or decrease their anxiety. However, another Irish study by 
Toomey et al. (179) advised that many of these patients require assessment 
of future risk in addition to reassurance. 
 
2.4.2  Provider factors influencing referrals 
Wide variation in GP referral rates for suspected cancer has been 
documented. Baughan (235) suggested that “there are significant differences 
in the thresholds for individual GPs to refer symptomatic patients for further 
investigation” (p.703). The authors recommended further evaluation of 
variation in GP referral rates and the development of guidelines, referral 
pathways and education for GPs.   
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 The personal characteristics of physicians can influence their decision-
making process – physicians characterised as interventionists have been 
found to be more disease-oriented and more likely to take immediate action 
whilst  physicians who focused more on health maintenance  were more 
patient-oriented, willing to observe the situation (236).  
 
McCowan et al. (184) identified several factors driving a lower referral 
threshold for GPs in the UK, including; patient preferences, risk aversion and 
ease of access to breast clinics, characteristics which are similar to the 
structure and trends observed in recent years in Ireland.  
 
The Health Information and Quality Authority (HIQA) in Ireland conducted a 
national review of the Symptomatic Breast Disease (SBD) Services in 2009, 
and made several key recommendations regarding cancer referral practices, 
including:  
 
“The HSE, together with the designated centres should coordinate, as 
part of its wider development of clinical audit systems, a review of 
referral and triage processes, aimed at understanding and addressing 
any unnecessary variations in referral or triaging practices between the 
designated centres and their referring clinicians” (p.75) (6).  
 
This thesis will examine these referral processes in Ireland. 
 
2.4.2.1  GP characteristics        
Characteristics of physicians (age, race, medical specialty) can  influence 
medical decision-making (209) (237, 238).  McKinlay (209) in his results on 
an experiment, questioned whether economics, organisation interests and 
social prejudices also influence clinical decisions. In France, female 
physicians were found to be more likely to refer patients for breast screening 
than male physicians, but physicians’ age did not have an impact (239). 
Female doctors have also been found to have higher referral rates (237) and 
are more likely to be influenced by patient expectations and patient 
psychosocial factors (240). Chan (241) found that female primary-care 
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physicians made 8% more referrals than male physicians and that older 
physicians referred more patients to specialists, because they saw more 
older patients.  
 
A review by Hajjaj et al. in 2010 (183) discussed the influences of physician 
gender, age and ethnicity on referral decisions, e.g., female clinicians were 
more likely to spend more time with their patients and be influenced by 
patient expectations, younger clinicians were more likely to order more tests 
and cultural differences influenced the intensity of treatment for end of life 
care. The authors found lack of uniformity in clinical decisions between 
physicians and between hospitals, leading to lack of equality of treatment for 
patients.  
 
The gatekeeping role of the GPs is considered an efficient system to 
prioritise referrals to the symptomatic breast clinics (184, 206).  GPs’ 
attitudes to their role were investigated in a UK study (242). The authors 
noted that GPs in the UK were taking an “increasingly restricted view of their 
core responsibilities” (p.143) and that this could impact on the volume of 
referrals to specialists. GPs  have been found to support the protection of 
professional autonomy, in particular when guidelines appear to be 
economically motivated (232). 
 
2.4.2.1.1  Beliefs about capabilities  
Beliefs about capabilities has been defined as ‘acceptance of the truth, 
reality or validity about an ability, talent or facility that a person can put to 
constructive use’ (243). Beliefs about capabilities is one of the domains in the 
‘Theoretical Domains Framework’ (244), a theoretical framework developed 
for use in implementation research of evidence-based practice. Fourteen 
domains relevant to changing the behaviour of healthcare professionals were 
included in this framework, which can be used to assess barriers and 
facilitators to implementation of evidence-based practice, such as clinical 
guidelines (245).  Examples of beliefs about capabilities include self-
confidence, perceived competence, self-efficacy, beliefs, self-esteem, 
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empowerment and professional confidence (245). This framework is 
described in detail in Chapter 5 in this thesis. 
 
GP confidence has been identified as an important factor in GP referral 
decisions (246).  Younger doctors have been found to order more tests than 
older doctors, using hypothetical scenarios (209). Langley describes how 
referral decisions can be influenced by the GP’s uncertainty about their 
ability to deal with the clinical problem, previously termed ‘the uncertainty 
hypothesis’ by Wennberg (247).  
 
GP’s skills and beliefs about their own capabilities can influence their use of 
clinical guidelines and their negotiation with patients to provide reassurance 
when specialist review and imaging is unnecessary (248, 249). Using 
psychological theory to understand factors influencing clinical behaviour can 
assist in designing and implementing effective interventions for behaviour 
change (244, 248-251).  
 
 
2.4.2.1.2  Beliefs about consequences  
Beliefs about consequences is also a domain in the Theoretical Domains 
Framework (244) and is defined as ‘Acceptance of a truth, reality or validity 
about outcomes of a behaviour in a given situation’ (243). Examples of 
beliefs about consequences include outcome expectancies and anticipated 
regret (245). 
 
Doctor’s anxiety about legal implications, their tendency to take risks, and 
tolerance of uncertainty are important non-medical factors influencing 
referrals (205, 206, 218). Newton (218) found that some doctors in their 
study referred ‘just in case’ while others adopted watchful waiting. Bailey 
(252) questions whether GPs are “less willing to take risks in the face of 
uncertainty or because they simply experience greater uncertainty” (p.14). 
 
Dowie modelled the referral process on the Janis and Mann conflict model, 
where the GP referral decision is based on the coping mechanism adopted 
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to deal with the uncertainties and risks involved (253-255). The GP’s 
“emotional burden of missing a diagnosis and fear of litigation” (p.974) (232) 
has been described as a reason for risk aversion, defensive practice and the 
subsequent increase in total referrals (256).  
 
Beliefs about consequences can influence referral behaviour through 
reflective motivation (251). The GP’s beliefs about positive and negative 
consequences of their behaviour, e.g., the possibility of missing a cancer, 
can influence their referral decisions (248). Using the Theoretical Domains 
Framework to understand barriers and facilitators to implementation of 
evidence-based practice can assist in the design and implementation of 
effective interventions and policies to reduce the gap between evidence and 
practice (244, 248, 249, 251).  
 
2.4.2.2  Knowledge and skills  
The capability of the referring physician can influence referral decisions 
(257).  The knowledge, skills and attitudes of individual practitioners can 
affect the quality of diagnosis in primary care (238).  
 
The influence of knowledge and skills on GP cancer referral patterns has 
been widely debated in the literature. Clinicians’ knowledge, experience and 
confidence has been found to influence their referral decisions (218, 257). 
High referral rates may reflect GPs’ excessive use of expensive hospital 
resources or, alternatively, low referral rates may indicate that the GP is not 
sufficiently sensitive to the specialist care requirements of their patients 
(258). Wilkin (259) found a greater proportion of more experienced doctors in 
those with high referral rates.  Similarly, in an Irish study with GPs (260), 
experienced GPs felt they had a higher index of suspicion for cancer.  Tracy 
(240) found that clinicians who identified strongly with evidence-based 
medicine were less likely to consider contextual factors in their clinical 
decisions. Referral accuracy of GPs has been shown to improve following 
education sessions but the benefits have been found to be short-lived (261). 
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In study of cancer referral patterns in England, Lyratzopoulos et al. (262) 
found that the probability of 3 or more consultations before referral was 
greater in younger patients, those from ethnic minorities and women. The 
authors proposed that increased professional awareness of cancer 
symptoms may be an influencing factor for some of the more common 
cancers. A postal survey of GPs in the UK highlighted the knowledge and 
education gap within primary care in relation to urgent referrals (263). The 
authors concluded that these factors in part explain the variability in referral 
practice and recommended GP education to improve implementation of 
referral guidelines. A systematic review (264) of primary care innovations 
and patterns of referral found that interventions such as guidelines or 
education had an impact on clinical behaviour, but less of an impact on 
referral rates.  
 
A study with GPs in Ireland (260) found that GPs would welcome further 
education and clinical practice guidelines on identification of early-stage 
cancer “with appropriate investigative pathways and referral criteria” (p.73). 
The Irish National Cancer Strategy (2006) (11) recommended that GPs 
should have comprehensive information available to enable them to assess a 
patient with suspicious symptoms, and to make an informed referral for 
specialist assessment.  The National Cancer Control Programme (NCCP) 
developed national GP referral guidelines and standardised referral forms for 
Symptomatic Breast Services in 2009 which were disseminated to all GPs in 
April 2009 and also made available on the NCCP website. GP guidelines 
were developed, agreed, designed, printed and distributed by the NCCP.  
These breast cancer referral guidelines and referral forms were distributed to 
all GP in the country, to provide the following benefits (18): 
 
• Provide accurate and clear information for GPs referring patients to 
the NCCP Symptomatic Breast Clinics 
• Streamline the GP symptomatic breast referral process 
• Improve the quality of referral information and thereby improve 
accuracy of triage by the hospital clinical teams 
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 GP education was carried out by the NCCP through Continuous Medical 
Education (CME) groups, hospital GP study days, newsletters, conferences 
and other educational events. These included input from consultants and 
their teams from the Cancer Centres (3).  
 
2.4.2.3  Referral practices  
With the transfer of power on deciding the urgency of referrals from the 
specialist to the GP, Khawaja and colleagues (265) concluded that there has 
been a decline in the diagnostic accuracy of GPs in the UK. This was a 
single centre study with small sample size. An audit of referrals to a rapid-
access breast clinic in the UK  found that 20% of GP referrals were 
inappropriate (266).  
 
Newton (218) describes referral as a social act which is a complex 
interaction between non-clinical and clinical factors.  McKinlay (209) 
discussed the ‘social control’ of the clinician in the doctor-patient relationship, 
while remaining non-judgemental. In a study on breast cancer, Ludke (267) 
found that the attitude of the clinicians’ colleagues towards referring was an 
important factor relating to referral decisions.  
 
The responsibility for decision-making in relation to referral priority has been 
discussed in the context of the UK 2-week rule (47, 162, 268, 269). 
Consultants have complained that the transfer of responsibility to the non-
specialist compromises the consultant’s professional autonomy, while GPs 
are referring patients urgently due to fear of missing a cancer (269, 270). 
 
Referral rates were higher in wealthier areas and in urban areas in a 
Canadian study, after adjusting for case mix. Wilkin (259) also found higher 
rates of referral of patients in higher social classes. Studies in England and 
Canada have shown higher referral rates in urban GPs closer to hospitals 
compared to rural GPs (271) (257).  Higher referral rates have also been 
found in single-handed practices (212) and in smaller practices (272).  
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 Galvin et al. (49) discuss the “trade-off between clinical utility and patient 
referral” (p.7), and the need to explore the optimal referral threshold while 
considering the risks of missing some cancers, and the corollary of 
unnecessary investigations. Watchful waiting and reassurance in the primary 
care setting is recommended as an option for consideration. However, GPs’ 
referral threshold to specialist breast cancer clinics is reportedly falling. 
McCowan et al. (184) attribute this lowering of the referral threshold to a 
number of factors, including: 
  
• “Patient preferences (women being averse to reassurance without 
specialist assessment) 
• Health professional related factors (lack of awareness concerning 
indicators for referral or risk aversion, missing a case of breast 
cancer). 
• Health-system related factors (ease of availability of breast care 
clinic)”  (p.212) (184). 
 
Appropriate referral makes the best use of resources, skill and time (210).  
According to Coulter (273), each referral should be necessary, timely and 
effective.   
The Kings Fund (238) described how a high quality referral involves several 
key elements:  
 
• Necessity: patients referred when necessary 
• Destination: patients referred to the most appropriate place 
• Process: referral letters contain all necessary information, patients are 
involved in the decision making process and appropriate 
investigations are performed.  
 
Studies of appropriateness of GP referral need to acknowledge the different 
needs and perspectives of the referring GP, the specialist and the patient 
(274).  GPs may have unique referral thresholds based on characteristics 
80 
 
such as training, experience, tolerance of uncertainty, sense of autonomy 
and personal enthusiasm (275).  
 
2.4.2.4  Clinical decision making  
In investigating decision-making for hospital referrals, Jones (276) divided 
clinical decision-making into two areas – decision analysis and the 
psychological approach.  Decision analysis often uses decision trees or 
algorithms to chart “a rational course through a diagnostic and therapeutic 
maze, from which outcomes are judged on the basis of their clinical efficacy 
and cost effectiveness” (p.93).  The psychological approach “seeks to 
analyse the thought processes occurring in the mind of the decision-maker in 
an attempt to provide a description of the cognitive events leading to a 
clinical decision” (p.93). 
  
Bayes’ theorem of diagnostic reasoning, published by Thomas Bayes (an 
English clergyman and mathematician) in 1763 is a mathematical formula 
used for calculating conditional probabilities.  Decision-making is made in the 
light of external evidence and prior plausibility of hypothesis (277-281). The 
rule is defined as “a mathematical relationship between conditional 
probabilities that relates the posterior probability of parameter values, on the 
one hand, to the probability of the data given the parameter values, and the 
prior probability of the parameter values, on the other hand” (p.293) (279). 
Applying Bayes’ theorem, Summerton (280) examined the likelihood of 
disease in identical patients presenting in primary and in secondary care. He 
found that the probability of disease in secondary care is higher, as the 
interpretation of the clinical presentation should depend on the prior 
probability of disease (281). 
 
McKinlay (282) investigated the non-medical influences on medical decision-
making and found that variability in decision-making was “not entirely 
accounted for by strictly rational Bayesian inference” (p.769). The authors 
found that non-medical factors such as patient’s age, gender and health 
insurance also had significant influences on medical decisions.  However, 
the use of Bayesian reasoning has raised the possibility that “acting as a 
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good Bayesian makes for a bad diagnostician”  (p.104)(209), if physicians 
are not considering patient attributes in their medical decision-making.  
Clinicians’ clinical diagnostic decision-making may differ depending on 
whether it is based on Bayes’ theorem or clinical intuition (278). The authors 
suggest that clinical reasoning in experienced physicians is linked to pattern 
recognition. A Bayesian approach is more likely to be used by clinicians 
trained in evidence-based medicine (283).  Alternatively, medical decision-
making can be viewed as a social construct, with factors other than 
biomedical factors influencing decision-making, which cannot be explained 
purely by Bayesian inference (282).  
 
Clinical decisions involve making choices to maximise effectiveness and 
minimise harm (284). The role of the GP involves decision making to 
marginalise danger, and maximise clinical outcomes and patient safety (75, 
238), using mental shortcuts to make reasonable decisions (285).  
Evidence based medicine (EBM) was developed in the 1990s to promote 
evidence based decision making in health care (286) (287) and is defined as 
‘the conscious, explicit and judicious use of current best evidence in making 
decisions about the case of individual patients” (p.71)(288). However, 
guidelines and rule-based reasoning may not accommodate the complexity 
of clinical decision making, patient values and patient preferences (289) 
(290) (291). An alternative approach using epistemological responsibility has 
been proposed, where the doctor is accountable for their clinical decisions 
(289). Van Baalen (289) proposed in 2015 that doctors should take 
responsibility for their clinical decisions, using a more subjective approach, 
instead of deferring responsibility to clinical guidelines.  
The nature of presentation in primary care can make clinical decision making 
a challenge in the absence of diagnostic tests and medically unexplained 
symptoms (238). “The diagnostic process in general practice is more often a 
combination of shortcuts, loops and dead ends than a straight line from 
presentation to diagnosis” (p.12) (238). A summary of the diagnostic 
strategies used in consultations was presented by Heneghan et al. (285) as 
shown in Table 2.3 below. 
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Table 2.3:  Diagnostic strategies in primary care  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source:  The Kings Fund (2010)(238), adapted from Heneghan et al. 
(2009)(285) 
 
Clinical decision analysis was developed to apply the concept of decision 
analysis to healthcare, using methodologies for decision making such as 
Diagnostic strategies in primary care 
 
Stage 1: Initiation of diagnostic hypotheses 
• ‘Spot’ diagnoses (unconscious, almost instantaneous, pattern recognition) 
• Self-labelling (patient tells you what they perceive to be the diagnosis) 
• Presenting complaint (most often used) 
• Pattern-recognition trigger (elements in the history or examination 
or both). 
 
Stage 2: Refinement of the diagnostic hypotheses 
• Restricted rule-out (depends on learning the most common cause of the 
presenting problem and a shortlist of more serious diagnoses to rule out) 
• Step-wise refinement (based on either the anatomical location of the 
problem or the putative underlying pathological process) 
• Probability-based reasoning (specific but probably imperfect use of 
symptoms, signs, and tests to rule in or rule out a diagnosis) 
• Pattern recognition fit (most often used – symptoms and signs are compared 
with previous patterns or cases and a disease recognised) 
• Clinical prediction rule (formal version of pattern recognition fit, 
based on a widely validated series of similar cases). 
 
Stage 3: Defining the final diagnosis 
• Known diagnosis (<50 per cent cases, sufficient level of certainty to start 
treatment or rule out serious disease) 
• Ordering further tests (to rule in or rule out a disease, or if no obvious pattern 
of disease) 
• Test of treatment (response to treatment used to refute or confirm diagnosis) 
• Test of time 
• No diagnostic label applied (strategies could include re-calling patient for 
further review, using an exploratory investigation, sharing uncertainty with 
patient, and referral for second opinion).  
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Bayes theorem, decision tree design, receiver-operating-characteristics 
curves, sensitivity analysis and utilities assessment (286). However, clinical 
decision analysis has been shown to be time consuming in a busy clinical 
setting and factors such as patient preference and cost implications may not 
be accurately reflected (292) (286). 
There is so much information available to a decision maker, it is frequently 
not possible to process;  a situation known as ‘bounded rationality’ and 
clinicians rely on truncated information or evidence to make a good decision, 
a term known as ‘satisficing’ (293).  Bate et al. (293) described two key 
processes used in dual process theory of decision making; system 1 which 
uses quick intuitive decisions and system 2 which uses an analytical 
approach.  
System 1 is used unconsciously, based on experience, repetition and 
patterns (293). It is considered independent of language and general 
intelligence and based on the ability to recognise patterns (294).  However, 
there is a concern that clinicians may rely on this pattern of knowledge 
without activating the system 2 analytic approach to check for new 
innovations or evidence (291), termed “dysrationalia over-ride” (p.617)(293). 
Hazard alerts on medication prescribing systems have been used to alert 
clinicians to this risk (293).  System 2 involves a rational analysis of the 
available evidence, involving the mental and cognitive faculties associated 
with logical thinking and is often rule-based (293) (294) (291). However, this 
approach can be time consuming and not always feasible in a clinical 
environment such as a GP practice. 
Marcum (294) developed a model of clinical reasoning which integrates both 
the dual process theory of cognition (system 1 and system 2) with meta-
cognition theory which feeds back to reinforce or alter the cognitive process. 
The benefits of this process are to enhance accuracy of future decisions 
termed “the paradoxical relationship between experience and expertise” by 
Marcum (p.954) (294). 
Ingemansson (291) conducted focus groups with GPs in Sweden in 2014 to 
explore how GPs use practice guidelines in their decision making process. 
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This study found that GP decision making involves both intuition and analytic 
thinking (dual process theory). Key influencing factors included GPs own 
experiences, access to short trustworthy guidelines and feedback through 
peer learning and collaboration. However, GPs who participated in this study 
felt controlled by strict practice guidelines and disrespected as specialists. 
This has implications for the uptake and adherence to GP referral guidelines 
here in Ireland.  
 
Hypothetico-deductive model 
The hypothetico-deductive model is a form of clinical reasoning described by 
Elstein (295). Elstein found that clinicians formulate a number of hypotheses 
to resolve medical problems and make a diagnosis. These hypotheses are 
then used to obtain additional evidence to ultimately make a diagnosis and 
plan treatment (294).  
The information processing model is common in medical decision making 
and uses the hypothetico-deductive approach (296). This approach can 
incorporate decision trees to assist decision making. However, the use of 
decision trees may be flawed if there are inaccurate probabilities in its 
structure (296). The hypothetico-deductive model is also limited by its 
inability to incorporate implicit cues (294) and has been criticised for its lack 
of consideration of context, intuition, experiential learning, affect and emotion 
(297). 
 
Intuitive-humanist model  
The intuitive-humanist model is based on intuition, gained from knowledge 
and experience. Recognition of cues or pattern recognition are 
characteristics of clinical decision making using intuition.  The pattern 
recognition model has been proposed as a more holistic model than the 
hypothetico-deductive model, but critics claim that this “trivializes the 
complex cognitive activities” (p.956) (294) involved in clinical reasoning and 
lacks scientific reasoning (296).  Seidel (298) discusses the tension between 
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intuition and evidence based medicine and recommends additional research 
on the relationship between literature reviews and intuition. 
 
Clinical prediction rules 
Clinical prediction rules are “mathematical tools that are intended to guide 
clinicians in their everyday decision making” (p.8312) (299) and provide a 
mechanism of implementing evidence based medicine (49) (184). Clinical 
prediction rules have several advantages over human decision making, 
including multi-factorial statistical models, consistency of results and 
accuracy (299).  Clinical prediction rules have been criticised for their lack of 
universal high quality (238),  not being user-friendly and the fact that there 
are a multitude of models available (299). However, initiatives such as the 
Standards for Reporting of Diagnostic accuracy studies (STARD) (300) aim 
to improve this. In a review of clinical prediction rules, Toll et al.  (301) found 
that despite the growing number of publications on clinical prediction rules, 
very few described validation or clinical impact. A clinical prediction rule for 
breast cancer was developed and validated in Ireland in 2014 (49) in 
response to the exponential rise in breast referrals to SBD units. However 
the uptake and use of this CPR by GPs in Ireland has not yet been 
assessed.  
 
Mindlines 
Mindlines are defined as “collectively reinforced, internalised tacit guidelines, 
which were informed by brief reading, but mainly by their interactions with 
each other and with opinion leaders, patients and pharmaceutical 
representatives and by other sources of largely tacit knowledge that built on 
their early training and their own and their colleagues experience” (p.1013) 
(302). Gabbay (302) reported that clinicians make medical decisions based 
on mindlines rather than formal written guidelines.  A systematic review of 
mindlines (290) in 2015 found that mindlines accommodate context, which 
may be absent in conventional evidence based medicine.  
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Shared decision making 
Shared decision making, involving the patient in decisions about their care 
(293) enables informed choices by patients (238). Shared decision making 
provides an opportunity for patients to become engaged in their own health 
(303), where patients and clinicians share the responsibility of clinical 
decision making (304). This compares to the paternalistic model (305) where 
the patient has little input and the informed model where the patient is the 
sole decision maker (304). 
In the US, shared decision making is also helping to control the care cost 
(303).  Legare et al. (303) described three essential elements of shared 
decision making:  
• Recognising and that a decision is required 
• Understanding the best available evidence 
• Incorporating  patient preferences and values  
 
However, it was recognised that in order to adopt a shared decision making 
approach, clinicians required additional training, patients required access to 
the available evidence in suitable and accessible format and GPs required 
more time with their patients (303) (306) (307).  Elwyn et al. (306) highlight 
that there is currently a lack of guidance on how to accomplish shared 
decision making in routine clinical practice.  
 
Shared decision making is most appropriately used in areas of uncertainty 
(308), when there are several clinical options to choose from, or when the 
evidence is scant or conflicting (303). Time constraints have been identified 
by clinicians as a barrier to shared decision making (303) (307). Clinical 
guidelines have been criticised for overlooking the importance of shared 
decision making, and for not outlining all the available clinical options (303). 
The role which patients wish to play in decision making about their own 
health has not been extensively researched. Thompson (309) conducted a 
study with patients in England and found that the level to which individual 
patients wished to be involved in clinical decision making varied depending 
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on the type of illness, seriousness of the disease, and their relationship with 
health professionals.   
 
Can we afford shared decision making? A study in the UK (307) questioned 
whether GPs could manage the dual responsibility of individual patient care 
and equitable use of NHS resources. This may pose a conflict to 
practitioners who are employed by the state and have a responsibility of a 
gatekeeping role. However GPs in Ireland are independent practitioners 
running their own business and are not responsible for managing the scarce 
resources in secondary care. 
 
The models which relate most closely to GPs referral include evidence based 
medicine, shared decision making and the intuitive-humanist model. GPs 
must assess the clinical signs and symptoms, appraise the relevant 
evidence, discuss options with the patient and make a decision based on the 
clinical factors, research evidence, their own experience and contextual 
factors which are unique for each patient.   
 
Biases in clinical decision making  
Bate et al. (293) describes cognitive and affective biases in decision making, 
including personal problems, stress and fatigue.  Cognitive bias is “a pattern 
of deviation in judgement” (p.618)(293). Bate et al. outlined some of the 
cognitive biases in clinical practice, which are outlined in Table 2.4 below.  
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Table 2.4: Cognitive biases in clinical practice  
Cognitive bias  Definition  
Anchoring bias  Undue emphasis is given to an early salient feature in 
a consultation  
Ascertainment bias  Thinking shaped by prior expectation  
Availability bias  Recent experience dominates evidence  
Bandwagon effect  ‘We do it this way here’, whatever anyone else says or 
whatever the data say  
Omission bias  Tendency to inaction, as events that occur due to 
natural disease progression, are preferred to those 
due to action of physicians  
Sutton’s slip  Going for the obvious diagnosis  
Gambler’s fallacy  The tendency to think that a run of diagnosis means 
the sequence cannot continue, rather than taking each 
case on its merits 
Search satisficing  Having found one diagnosis, other co-existing 
conditions are not detected  
Vertical line failure  Routine repetitive tasks lead to thinking in silos  
Blind spot bias  ‘Other people are susceptible to these biases but I am 
not’ 
Source: Bate et al. (2012). How clinical decisions are made (293)  
 
In summary, the literature on clinical decision making can be divided into 2 
approaches.  
 
One system evaluates probabilities through information processing and rule 
based systems such as referral guidelines and decision support tools while 
the other involves negotiation between the GP, patient and secondary care 
providers as part of a social process of diagnosis and referral through 
communications and shared decision making (238).  Current quality and 
evaluation measures tend to focus on the first approach, measuring 
compliance with evidence.   
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2.4.2.5  GP referral guidelines  
GP referral guidelines have been introduced in many areas to manage 
referrals from primary to secondary care. Guidelines can improve the 
standardisation and consistency of care, ensuring that the patient receives 
the same treatment regardless of location or clinician (310). The Institute of 
Medicine has defined clinical practice guidelines as   “systematically 
developed recommendations about some or all aspects of decision-making 
for a particular condition or clinical situation” (311) (p.164).  Clinical 
guidelines, particularly evidence-based guidelines, can improve the quality of 
clinical decisions and highlight ineffective practice (310).  In the context of 
cancer, clinical practice guidelines were found to improve the management 
and outcomes of patients with cancer by bridging the gap between research 
results and clinical practice (312). In a systematic review of referral 
guidelines from primary to secondary care (313), Clarke and colleagues 
found that, while guidelines can improve appropriateness of care, they did 
not find strong evidence of improved practitioner knowledge. 
 
A BMJ paper on potential benefits, limitations and harm of clinical guidelines 
concluded that “clinical guidelines can promote distributive justice, 
advocating better delivery of services to those in need” (310) (p.527). 
 
In the UK, the ‘2-week wait rule’ for cancer referrals from primary to 
secondary care became effective in December 2000 for all cancers treated 
by the National Health Service, whereby urgent cancer referrals were 
guaranteed to be seen within 2 weeks.  The aim of this initiative was to 
improve access to specialist services, thus facilitating early diagnosis and 
treatment (5).  Reduced waiting times for urgent referrals have been reported 
in the UK since this rule was introduced (227). However, other UK studies 
report unchanged waiting times for urgent referrals, with increased waiting 
times for non-urgent referrals (162, 265, 314). 
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Potter and colleagues (5) questioned the scientific foundation of the 2-week 
rule: “the poor predictive value of fast-track referral guidelines, together with 
poor adherence in primary care has flooded one-stop clinics with large 
numbers of inappropriate referrals” (p.288).  This had been predicted several 
years earlier by Fentiman (315) who warned that  “if GPs do not act as a 
screen but as an open gateway, there is  a risk that specialist one-stop 
clinics will become over-run by the worried well” (p.1251). He recommended 
the establishment of nurse-led clinics for those with a family history of 
cancer, for example, instead of referral to Symptomatic Breast Units. 
 
A study of urgent GP referrals by Allgar et al. (256),  suggested that the 
increase in total referrals was caused by “GPs gaming the system by 
referring patients in order to get them seen within 2 weeks and GPs being 
anxious at missing a diagnosis” (p.361). They concluded that “the predictive 
power of the referral guidelines as  a marker for cancer diagnosis is low, 
resulting in significant numbers of patients who are urgently referred but do 
not have cancer” (p.361). This is consistent with a study from Jones and 
colleagues, who found the predictive values of symptoms suggestive of 
cancer in primary care to be poorly defined (316).  
 
The breast clinics in the UK have become victims of their own success (46). 
Patel and colleagues found that an increase in demand for access to 
specialist cancer services appeared to be a reflection mainly of increased 
media attention: “asymptomatic patients simply suffering from media-induced 
anxiety about breast cancer could also be appropriately reassured by their 
GP” (p.454)(46).  
 
A review of the ‘2-week rule’ by Hanna and colleagues concluded that 
common concerns included the low yield of malignancy, quality of referral 
guidelines and adherence to guidelines (317). The development and 
validation of a clinical prediction rule for breast cancer in Scotland (184) 
found that the 2-week rule for cancer referrals in the UK had not improved 
the diagnostic process.  They suggest that “the poor performance of breast 
cancer referral guidance is attributed to the limited diagnostic value of the 
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clinical criteria on which the guidelines are based” (p.205). Their clinical 
prediction held that “increasing age, presence of a discrete lump, presence 
of a lump ≥2cm in size, thickening of the breast, lymphadenopathy and the 
presence of a lump tethered to the skin or chest wall, all independently 
increase the probability of a woman having breast cancer” (p.209).    
 
Clinical guidelines may increase GP referrals to secondary care by reducing 
“their willingness to tolerate uncertainty and manage problems in primary 
care” (p.462)(206). O’Donnell recommends focusing on increasing the 
number of appropriate referrals through joint working between hospitals and 
GPs. A study of GPs’ attitudes to the use of guidelines (223) concluded that 
the process for development of GP referral guidelines should be transparent  
and should be explicit in relation to the evidence base and any economic 
considerations, as GPs’ adherence to guidelines can be influenced by 
whether they consider the guidelines trustworthy.  In a qualitative study by 
Cornford et al. (269), clinicians reported that the 2-week rule in the UK 
compromised their professional autonomy. This was a small study with 20 
participants including nine GPs and eleven secondary care providers.   
 
The report of the UK National Audit Office ‘Progress in improving cancer 
services and outcomes in England’ (2015) reviewed the progress of the UK 
Cancer Strategy ‘Improving outcomes – Strategy for cancer’ (2011) (144).  
Progress was reported in improving cancer services but it found that 
significant variations in outcomes and access to services persisted across 
England.  An increase of 51% in urgent GP referrals for suspected cancer 
was reported between 2009-10 and 2013-14. The report outlined the 
commitment to the current commissioning process established in 2012 for 
certain cancer services and the roles of clinical commissioning groups, 
strategic clinical networks and the care quality commission. However, 
concerns were expressed about the lack of national oversight of cancer 
commissioning across a range of complex treatment pathways.  This report 
also described the plans announced by NHS England in January 2015 to set 
up a taskforce to develop a 5-year action plan for cancer services by summer 
2015, with the aim of improving survival rates (318). 
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2.4.2.5.1 Evaluation of referral guidelines  
In a systematic review of referral guidelines from primary to secondary care 
in 2010, Clarke and colleagues found that guidelines can improve 
appropriateness of care by improving diagnostics and treatment prior to 
referral, but did not find strong evidence of additional benefits such as 
practitioner knowledge or health outcomes (313). The authors advised that 
referral guidelines on their own are unlikely to improve referrals and 
concluded that high-quality evaluations of referral guidelines were still 
needed. None of the 24 eligible studies in this review included guidelines for 
cancer. The authors acknowledged possible publication bias in the included 
studies, they noted that all included studies were from high income countries 
and there were disparities in treatment interventions, definitions and outcome 
measures between studies, which hindered the formulation of overall 
quantitative conclusions.   
 
Gagliardi et al. (319) conducted a systematic review of guideline 
implementation and found that education and print material were most 
commonly used for dissemination. Interventions designed to address specific 
barriers to implementation are more likely to improve professional practice 
(320).   
 
A Cochrane systematic review in 2008 (321) of interventions to improve 
outpatient referrals from primary care to secondary care, found that 
strategies that were effective included dissemination of guidelines with 
structured referral sheets and involvement of consultants in educational 
activities. This is consistent with an earlier systematic review on interventions 
to improve professional practice (322) which found that dissemination alone 
was not effective and that outreach visits or local opinion leaders were 
useful.  
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An evaluation of GP referrals to breast clinics in Wales (323) found that the 
UK national guidelines could be useful in the targeting of resources towards 
high-risk urgent referrals. Cabana (324) cited lack of agreement with existing 
guidelines, differences in interpretation of the evidence, loss of clinician 
autonomy and belief that the risks to the patient outweighed the benefits as 
reasons for non-adherence to clinical practice guidelines.  
 
A 3-month single-centre prospective study was conducted in the 
Symptomatic Breast Unit in Galway University Hospital in 2010 to evaluate 
the efficacy of the breast cancer referral guidelines at identifying patients with 
breast cancer. The study found that the NCCP referral criteria were 91% 
sensitive for triaging breast cancer patients into the correct (urgent) category, 
with a specificity of 69%.  Neary and colleagues concluded in this study that  
“the NCCP guidelines are accurate and should be considered the gold-
standard for referral to the symptomatic breast service” (p.39) (325), as these 
guidelines were 91% sensitive for triaging patients with breast cancer into the 
correct (urgent) category. The authors recommended the NCCP referral 
guideline as a tool for GPs to prioritise patients for referral to SBD units.  
 
Hospital consultants, hospital managers and referring GPs may have 
different opinions on what constitutes an appropriate referral. An audit of 
compliance with cancer guidelines and referrals in 516 GP practices in 
Scotland (235) found that compliance with referral guidelines was 91%.  
They found wide variation in GP referral rates for suspected cancer and 
suggest that “there are significant differences in the thresholds for individual 
GPs to refer symptomatic patients for further investigation” (p.703). 
 
2.4.3  Health service factors  
2.4.3.1  Environmental context and resources  
A distinction has been made between medical appropriateness and societal 
decisions about what our health services can afford (274). In a needs 
assessment for early diagnosis of cancer with GPs in Ireland, Daly and 
Collins (260) found that poor communications between GPs and hospital 
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services, and lack of equity in access to hospital services, were barriers to 
the early detection of cancer in primary care. A Scottish study with GPs (326) 
found similar results and recommended improved communication between 
primary and secondary care and the development of referral guidelines.  
 
In a GP study by the King’s Fund (327) in the UK,  access, geography and 
transport were key considerations in the referral process.  
 
In a study on breast cancer, Ludke (267) found that the most important factor 
relating to referral decisions was quality of patient management in the 
hospital, i.e., the type and quality of medical care the patient would receive, 
as determined by the referring clinician.  
 
2.4.4  Other factors influencing referrals 
2.4.4.1  Media 
Mass media interventions have been shown in a Cochrane review to be 
effective in promoting health service utilisation (328) but the duration of effect 
was uncertain. The methodological quality of the 20 included studies was 
reported to be variable, with nine studies using inappropriate statistical tests 
(328).   Mass media has been recommended to “encourage the use of 
effective services and discourage those of unproved effectiveness” (p.7) 
(328).  
 
Patel and colleagues found that an increase in demand for access to 
specialist cancer services in the UK appeared to be mainly a reflection of 
increased media attention, resulting in the breast clinics becoming victims of 
their own success (46).  
 
GPs have reported over-referring due to media pressure (5, 227).  Elstein 
and Schwartz (278) described how diseases that get considerable media 
coverage are often thought of as occurring more often than they actually do. 
The authors also suggest that the probability of more serious diseases can 
be overestimated because the treating clinician would hate to miss one. They 
conclude that even with the introduction of clinical decision support, expert 
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clinical judgement is still required. RoshanLall describes how media 
coverage, education and screening have increased the GP workload by 
increasing the awareness of breast disease in the population (210). 
 
In the UK, the effect of the singer Kylie Minogue’s breast cancer diagnosis on 
breast clinic referrals has been studied. There was a significant increase 
(61%) in referrals in the month after Kylie’s diagnosis, but no increase in 
breast cancers detected (329).  Twine et al. concluded that “the media 
played on the susceptibility of young women to breast cancer” (p.669). 
Concerns were expressed about the increased exposure to radiation from 
diagnostic imaging and also an increase in anxiety and cancer phobia.  
Celebrity illness in relation to breast cancer was also seen in the 1980s with 
the US Presidential wives Betty Ford and Nancy Reagan in the USA (330). 
More recently, ‘the Angelina Jolie effect’ was seen following media coverage 
of the decision of the actress Angelina Jolie to undergo genetic testing for the 
BRCA1 gene and subsequently undergo risk-reducing mastectomy. 
Referrals to family history and genetic services increased by more than 2.5-
fold in the UK (331) and a 3-fold increase was reported in Australia during  
this period (332). 
 
Cultural changes, such as increased awareness of breast cancer and patient 
assertiveness are seen as important contextual factors in referrals for 
suspected breast cancers (269).  Patient information leaflets and media 
messages have been criticised for encouraging younger women to seek 
specialist referral, while the incidence of breast cancer in younger women is 
low (210). 
 
The role of education in Irish public service broadcasting has been reviewed 
by Grummell (333). She discusses the balancing act between the public 
service and commercial elements and the shift in broadcasting from the 
cultural and social needs of the population to the needs of the population as 
consumers. She describes how the “institutional demands of the political and 
economic systems” (p.5) have shaped the contribution of education in Irish 
broadcasting and the lack of attention to the civic role of broadcasting.   
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2.4.4.2  Seasonal variation 
A Swedish study examining seasonal variation in cancer diagnosis (334) 
found that the number of new breast cancer cases diagnosed were lower 
during the summer months and in December, with the highest mean number 
of cases reported in November.  The decrease in June and July was 
attributed to reduced activity in mammography screening programmes in the 
summer months and may also be due to patient delay during vacation time. 
Similarly, it was suggested in a study in Singapore (335) that self-referrals 
fell during the New Year festivities (December – February).  The Cardiff 
Breast Group (43) noted some seasonal variation in their breast cancer 
referrals, with peaks observed in the spring and autumn.    
 
Hormonal variation across the seasons has been examined in breast cancer 
(336, 337).  A study in New Zealand examined the season in which breast 
cancers were detected as a predictor of survival. The study found that 
women who detected their breast cancer in spring/summer (which is 
September – February in New Zealand) had significantly longer survival and 
suggested that this may reflect seasonal changes in hormone-dependent 
growth of the tumour (338).  
 
2.4.4.3  Social influences   
Social influences include societal decisions and prejudices. There is a 
distinction between medical appropriateness and societal decisions about 
what our health services can afford (274). Variation in medical decision-
making may also “reflect economic and organizational interests and social 
prejudices” (p.94) (209). 
 
Where medical decisions are made based on social attributes, these 
attributes “should reflect the social patterning of disease” (p.93) (209). It is  
the responsibility of breast cancer charities to ensure that breast cancer 
awareness is focussed on the appropriate age group “without causing 
distress to younger women” (p.263) (339).  
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Medical decision-making can be viewed from two perspectives; a prescriptive 
view based on probability and rates, and a descriptive view highlighting the 
influence of unrelated social factors, i.e., consideration of “who the patient is 
as much as what the patient has” (p.769) (282).  
 
2.5  Conclusion  
The literature describes the burden of cancer worldwide and in Ireland. 
Cancer incidence in Ireland is higher than the EU average, with mortality 
lower than the EU average.   
 
The epidemiology of breast cancer outlines the risk factors and prognosis of 
this disease. The National Cancer Registry predicts that breast cancer in 
Ireland will increase by approximately 130% between 2010 and 2040 
signifying the need for service planning, early detection and prevention.  
 
The evidence for centralisation and specialisation of cancer services has 
underpinned cancer policy and organisational change in many countries, 
including Ireland.    
 
The literature outlines many factors influencing GP referrals to specialist 
care, including social factors, clinical factors, GP factors and health system 
factors, which consist of both medical and non-medical reasons.  
 
Some of the more recent literature e.g. personal and public involvement 
(PPI) and implementation science has not yet been implemented and 
evaluated widely and evidence of its efficacy is lacking. Other literature, such 
as the health belief model is quite old. There were gaps in the literature in 
relation to national reorganisation of cancer services, such as in Ireland. 
Many of the studies investigating cancer services were single-site or regional 
studies or single method (qualitative or qualitative) studies. While 
considerable research has been undertaken with GPs in the UK regarding 
cancer referrals, the primary care structure in the UK has little application in 
a health system like our own.  
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The combination of evidence based healthcare and patient values needs to 
be considered by clinicians. Shared decision making also needs to be 
debated alongside value for money and the possible iatrogenic side effects 
of unnecessary treatment. The literature outlines many approaches to GP 
referral , however, the context is not always comparable to Ireland e.g. GPs 
in the UK are employed by the NHS and the US does not have a population 
based national breast screening service.  
 
GP referrals from primary to secondary care will be explored in this thesis in 
the context of symptomatic breast services in Ireland.  
 
This literature review highlighted that there is a gap in the evidence relating 
to national reorganisation of cancer services and referral patterns in a similar 
health care system to Ireland using a mixed methods approach. There is also 
a lack of research with GPs in Ireland using a random sample regarding 
factors influencing their referrals. This gap analysis led to the choice of 
methods for this thesis which are discussed in detail in Chapter 6.  
 
Chapter 3 will outline the relevant health-care structures, strategies and 
systems in Ireland and provide a summary of previous research and recent 
policy developments in the area of breast cancer referral patterns.   
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 Chapter 3:  Breast Cancer Services:  
The Irish Context 
 
3.1 Introduction  
The healthcare system in Ireland is delivered through primary care services 
in the community (GPs and primary care teams) and secondary care in acute 
hospitals (both public and private).  The Health Service Executive (HSE) is 
responsible for the public health services and contracts certain services from 
independent contractors, such as GPs.  The organisation of health services 
in Ireland has gone through a number of reconfigurations in recent decades, 
moving from eight autonomous health boards to a national health system 
under the HSE. The HSE, with four administrative regions, was established 
by the Health Act, 2004, and came into official operation on January 1st 
2005. These configurations are shown in figure 3.1 below.  
 
 
 
Figure 3.1: Health service reconfiguration in Ireland 
Health Boards 1-8                     HSE regions A-D 
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Further hospital reconfiguration is currently underway, with the establishment 
of six hospital groups and a paediatric group within the HSE in 2013 and 
2014. 
 
Cancer services in Ireland have also undergone significant change and 
development since the publication of the first National Cancer Strategy in 
Ireland in 1996 (146) and the second National Cancer Strategy in 2006 (11). 
Prior to the first cancer strategy, there had been limited targeted investment 
in cancer services in Ireland.  Cancer services, along with the other health 
services in Ireland, were originally delivered by the eight autonomous health 
boards, each to be self-sufficient for the needs of its population.  Currently, 
delivery of cancer services is the responsibility of the HSE, through the 
National Cancer Control Programme (NCCP), based on the 
recommendations of the 2006 National Cancer Strategy. Prior to the 2006 
strategy, there was a lack of national evidence-based guidelines, standards, 
quality indicators or quality assurance processes for cancer services. The 
Eurocare-4 report on cancer outcomes at that time (2000-2002) also showed 
that Ireland lagged behind other European countries in relation to cancer 
outcomes (25). This fragmented system of cancer service delivery provided 
the opportunity for the NCCP to standardise cancer care across the country.  
 
The National Cancer Control Programme was established to implement a 
comprehensive cancer control programme in Ireland, based on the 
recommendations of the 2006 cancer strategy. The NCCP designated four 
geographical cancer networks and eight designated cancer centres to deliver 
a full range of cancer services. The essential components of the designated 
cancer centres included;   
 
• Each cancer centre to serve a population at least 500,000 
• Rare and complex cancers to be treated by a subset of the eight 
cancer centres, consistent with incidence of disease and evidence 
based practice  
• Multidisciplinary teams (340) 
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The Kingdon model of agenda setting (64) can be effectively used  to 
describe the accelerated progress of cancer control in Ireland. The Kingdon 
model describes how a policy window can emerge when 3 streams collide - 
the problem stream, the policy stream and the political stream. A policy 
window in cancer services in Ireland resulted from the convergence of the 
problem stream, the policy stream and the political stream in 2006. The 
problem stream was highlighted through a series of high-profile cancer cases 
of missed diagnosis, delayed diagnosis and unopened GP referrals in 
hospitals in Ireland (62, 63, 341). The 2006 Cancer Strategy (11) constituted 
the policy stream and the strong support from the Minister for Health and 
Government at the time (Mary Harney TD) provided the political stream. This 
Kingdon model of agenda setting provided optimal opportunity for 
development of cancer services in Ireland. 
 
3.2 Healthcare structures, strategies and systems  
A series of reports and strategy documents have been published on the 
structure and integration of health services in Ireland, which have been 
described in the literature review chapter (Chapter 2). While these reports 
are not focused on cancer services specifically, they formed the basis for the 
planning of specialist services and integration of primary and secondary 
care.  The key strategy documents which influenced the healthcare system in 
Ireland were outlined in Chapter 2 and include the following:  
 
The Fitzgerald report in 1968 (91) initiated the debate about hospital location 
in Ireland.  
 
• The first national health strategy ‘Shaping a Healthier Future’ in1994 
(93) and the second national health strategy ‘Quality and Fairness – A 
Health System for You’ in 2001 (94) built on the previous 
recommendations made in the Fitzgerald report of establishing 
hospital networks. 
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• The Primary Care Strategy ‘Primary Care: a new direction’ (13), also 
in 2001,  outlined plans to strengthen the primary care system through 
establishment of primary care teams.  
 
• The Value for Money report (2001) (95) and the Prospectus report 
(2003) (100) also endorsed the model of hospital networks to ensure 
high quality services and value for money.   
 
• The Hanly report on Medical Staffing (2003) (97) outlined the benefits 
of centralising services, with specialist staffing, in terms of benefits for 
patients and cost-effectiveness. 
 
In tandem with the numerous reports on developing and improving the 
quality of Irish healthcare in general, there were also focussed developments 
in relation to cancer care, resulting in the development of specific cancer 
strategy documents and reports. 
 
3.3 Cancer strategy and development  
While cancer services were highlighted in broader health strategies in Ireland 
such as the national health strategy in 1994 (93), the first national strategy 
focussing exclusively on cancer services in Ireland was published in 1996.  
 
National Cancer Strategy (DoH 1996)  
The first National Health Strategy ‘Shaping a Healthier Future’ (1994) (93)  
prioritised areas of premature mortality in Ireland, including cancer, 
cardiovascular disease and accidents, which led to the development of 
specific national strategies in these areas (146, 342, 343).   
 
The first national cancer strategy in Ireland ‘Cancer services in Ireland: A 
National Strategy’ (146) was published in 1996 and aimed to review the 
existing range of preventive, treatment and palliative services relating to 
cancer in Ireland, and to set out a plan for their further development and 
improvement, including staffing. Specialist cancer posts received 
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government funding through this strategy, including 85 consultant posts and 
245 clinical nurse specialists. The target for this cancer strategy was to 
reduce the death rate from cancer in the under-65 age group by 15% within 
10 years.  This first national cancer strategy was evaluated in 2003 and the 
evaluation concluded that the target of reducing the death rate from cancer in 
the under-65 age group by 15% had been achieved. The report 
recommended the development of a second cancer strategy, focussing on 
reconfiguration of existing services, enhanced coordination, redefining of 
work practices and service management (16). 
 
Second National Cancer Strategy (DoH 2006) 
The second National Cancer Strategy in 2006 (11) reported on the 
improvement in capacity resulting from the first cancer strategy. However, 
the delivery of cancer services was still fragmented and spread across 35 
hospitals.  Many services were provided in small volumes, without a full 
multidisciplinary team approach, which was not in accordance with 
international best practice. The strategy built on the second national health 
strategy ‘Quality and Fairness – A Health System for You’ (2001) (94) and 
the primary care strategy ‘Primary Care: a new direction’ (2001) (13).  Key 
recommendations were outlined in relation to centralisation and 
standardisation of cancer services as follows (see Appendix C for the full list 
of recommendations from the 2006 cancer strategy):   
 
• Recommendation 12: the HSE should put in place arrangements to 
monitor inequalities in cancer risks, cancer occurrence, cancer 
services and cancer outcomes. 
• Recommendation 19: opportunistic testing of asymptomatic individuals 
for cancer is not recommended. 
• Recommendation 20: the HSE should develop specific programmes 
that promote early detection of cancer. 
• Recommendation 21: All cancer care should be delivered through a 
national system of four managed cancer control networks, each 
serving a population of approximately one million people. 
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• Recommendation 23: A lead clinician for each cancer centre should 
be appointed. In addition a clinician should be appointed to lead the 
development of cancer care pathways for each major site-specific 
cancer (e.g., breast cancer) in partnership with all stakeholders in the 
network. 
• Recommendation 24: The HSE should develop care pathways for 
cancer care to link primary care services, hospital services and other 
relevant services.  
• Recommendation 25: Improved cancer information services should be 
available to primary care. 
• Recommendation 31: Patients should have their diagnosis established 
and their treatment planned by site-specific multidisciplinary teams. 
• Recommendation 32: The HSE should conduct a review of the 
number of centres required for the management of symptomatic 
breast disease to bring them into line with designated cancer centres.  
• Recommendation 41: The Health Information and Quality Authority 
(HIQA) should establish site-specific multidisciplinary groups at a 
national level to develop guidelines for quality in major cancers.  
• Recommendation 47: General Practitioners should have 
comprehensive information that enables informed referral and other 
management decisions. 
 
Review of the 2006 cancer strategy (NCCP 2014) 
The National Cancer Control Programme published a report in 2014 on the 
implementation of the 2006 cancer strategy (4). Significant progress was 
seen in the areas of cancer prevention, community oncology, screening, 
radiation oncology and the development of evidence-based tumour 
guidelines. Challenges were outlined in the areas of increased incidence and 
prevalence of cancer, fiscal and recruitment constraints and the need for 
further investment in IT infrastructure. The rise in benign referral to 
Symptomatic Breast Units was noted and recent developments to address 
this trend were described.  
 
105 
 
This report will assist the development of a third national cancer strategy. 
This has been identified as a Ministerial priority and is due for publication in 
2016.  
 
National Cancer Control Programme 2007 
Based on the recommendations of the second National Cancer Strategy 
(2006) (11), the National Cancer Control Programme (NCCP) was 
established in 2007 to manage, organise and deliver cancer services on a 
whole-population basis. This set in motion a series of fundamental changes 
to the delivery of cancer care in the Republic of Ireland which remains 
ongoing.  
 
In addition to  recommending centralisation of cancer services, the National 
Cancer Strategy (11) recommended that GPs should have comprehensive 
information available to enable them assess a patient with suspicious 
symptoms and findings, and to make an informed referral for specialist 
assessment.  GP referral guidelines with standardised referral forms for 
suspected cancers (breast, prostate and lung cancers) were introduced 
nationally by the NCCP in 2009, with comprehensive education for GPs, 
through  a collaborative process with the Irish College of General 
Practitioners (3).  
 
National Quality Assurance Standards for Symptomatic Breast Disease 
Services, HIQA 2007  
In 2007, the Health Information and Quality Authority (HIQA) adopted the 
National Quality Assurance Standards for Symptomatic Breast Disease 
Services (167) developed by an expert group in 2006. These standards 
define what is expected of the providers of symptomatic breast disease 
services and provided the basis for service planning, development and 
continuous improvement.  They describe the essential elements that are 
fundamental to providing safe care for individual patients on a day-to-day 
basis and others that are important for the sustainable and consistent 
delivery of quality care to patients over time. This set of Quality Standards 
outlined a total of 297 recommendations, which formed the basis for the 
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NCCP Key Performance Indicators for Symptomatic Breast Disease in the 
designated cancer centres. 
 
Framework to implement the National Cancer Strategy (NCCP 2007)   
In line with the recommendations of the National Cancer Strategy, the HSE 
developed a framework for the ‘Establishment of Managed Cancer Control 
Networks and Designation of Eight Cancer Centres’ in September of 2007 
(340).  This framework defined the criteria for the delivery of cancer services, 
based on the recommendations of the National Cancer Strategy (11).  The 
report recommended that the treatment of symptomatic breast disease 
should be delivered at eight Cancer Centres nationally, with Letterkenny 
(County Donegal) providing a satellite service for Galway in the North West 
of the country.  
 
The report mandated that breast services be withdrawn sequentially from 
hospitals which did not meet the defined criteria for delivery of symptomatic 
breast care, commencing with the lowest-volume hospitals and ultimately 
including all hospitals which did not meet the guideline standards.  Hospitals 
with low case volumes were directed to no longer provide symptomatic 
breast services and surgical treatment with immediate effect.  The 
centralisation of Symptomatic Breast Disease services from 35 acute 
hospitals into 8 designated cancer centres (and a satellite unit at Letterkenny 
General Hospital) took place during 2009. Since centralisation of publicly-
provided breast cancer services, all patients attending the SBD Units in 
Ireland are treated by cancer specialists in multidisciplinary teams. 
 
Professor Tom Keane from Canada was appointed as the first Director of the 
National Cancer Control Programme in 2007 and Dr. Susan O’Reilly took 
over as Director from 2010 – 2014. Concerted efforts to manage a 
fundamental reconfiguration of services ensued, with a radical change in the 
centralisation of cancer surgical services, followed by considerable 
expansion of radiation oncology and medical oncology services. Strong 
leadership, with political and financial support, was instrumental in the 
successful implementation of the second national cancer strategy.  
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Development of Key Performance Indicators (KPIs) for breast disease, 2009 
The 2006 National Cancer Strategy recommended that ‘the HSE should put 
in place arrangements to monitor inequalities in cancer risks, cancer 
occurrence, cancer services and cancer outcomes’ (recommendation 12). 
 
A suite of Key Performance Indicators (KPIs) for breast disease was 
developed by the NCCP in 2009, along with data definitions, based on the 
HIQA national standards for Symptomatic Breast Disease (167). Data 
collection of KPIs commenced in 2010, with a total of 28 KPIs for breast 
disease across the areas of; access, imaging, diagnosis, multidisciplinary 
working, time to treatment (surgery, chemotherapy, radiation therapy) and 
pathology.   
 
Each public cancer centre reports on this set of Key Performance Indicators 
(KPIs) monthly, which continue to be published on the NCCP website.  
These KPIs are designed to assist patients, staff and the NCCP in assuring 
themselves that all designated cancer centres are adhering to the required 
standards of practice. Prompt access to cancer services has been one of the 
key deliverables for this service.  
 
HIQA National Quality Review of Symptomatic Breast Disease Services, 
2009 
In 2009, the Health Information and Quality Authority (HIQA) carried out a 
national quality review of Symptomatic Breast Disease Services in the public 
system. Individual reports were published for each breast unit in addition to 
an overall national report; ‘Report of the National Quality Review of 
Symptomatic Breast Disease Services in Ireland’ (6). The HIQA national 
report set out 18 recommendations on clinical governance, standards, audit, 
system assurance and the role of the Clinical Lead for Symptomatic Breast 
Disease services in each centre. The NCCP worked with each of the 
designated centres to implement the individual hospital recommendations 
and the overall national recommendations. The recommendations of the 
HIQA Quality Review are outlined in Table 2.2 in Chapter 2.  The majority of 
recommendations were implemented by 2014, while others are ongoing. The 
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recommendation which was particularly relevant to this thesis was that the 
HSE should coordinate “a review of referral and triage processes, aimed at 
understanding and addressing any unnecessary variations in referral or 
triaging practices between the designated centres and their referring 
clinicians” (p.75)(6). The HIQA review found that an average of 17 patients 
with benign breast disease were seen for every one patient diagnosed with 
breast cancer. There was wide variation found across cancer centres, with a 
range of 14 to 37 (6). 
 
Establishment of a national governance model for Symptomatic Breast 
Disease, 2010 
In 2010, the NCCP held a Governance Forum for Symptomatic Breast 
Disease with the Chief Executive Officers (CEOs), clinicians and clinical 
directors of the designated cancer centres. This forum developed a national 
governance model for breast services, based on the recommendations of the 
National Quality Review of Symptomatic Breast Services (6).  This 
governance model recommended the establishment of a national group of 
lead clinicians for Symptomatic Breast Disease and the establishment of a 
national tumour group for the development of clinical guidelines.  These 
groups are now established. The clinical leads group meet quarterly and also 
host an annual audit quality and risk forum. National guidelines for the 
diagnosis, staging and treatment of breast cancer were completed by the 
Tumour Group in 2014.  
 
3.4 Recent developments in national policy  
Several publications since the centralisation of cancer surgery have 
recommended a similar approach for the wider health system, such as 
integration with primary care, specialisation within hospital groups and 
guidelines for evidence-based practice.  
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Future Health; A Strategic Framework for Reform of the Health Service 
2012-2015 (2012) 
Following a change in Government in Ireland in 2011, the programme for 
Government announced major reform of the health services. A new strategy 
was launched entitled; Future Health – A Strategic Framework for Reform of 
the Health Service 2012 – 2015 (2012)(108). It outlines the reform agenda, 
which includes:  
 
• Focus on waiting lists and inequitable access to care  
• Better integrated delivery systems based on multidisciplinary care  
• Models of shared care which set out the roles and responsibilities of 
primary care and specialist services 
• Clinical protocols and guidelines for use in primary care and specialist 
services 
• More responsive and equitable access to vital services for all patients  
• Enable quality and safety through indemnity: The Department of 
Health, with the HSE and the State Claims Agency are working to 
ensure that the indemnity provided to clinical services aligns with 
health systems policy. For example, if it is deemed appropriate that all 
specialised surgery for a given cancer be provided in identified 
centres, then indemnity will not extend for that service to be provided 
in other locations. 
 
The priorities for implementation of Future Health in 2015 are the formation 
of hospital groups, activity-based funding (money follows the patient) and 
access to primary care, as announced by the Minister for Health in January 
2015 (344).  
 
Review of referral and triage processes in Symptomatic Breast Units 2012  
The HIQA review of SBD services in 2009 found significant hospital and 
regional variation in referral patterns. HIQA made several key 
recommendations with regard to cancer referral practices, including that a 
review should be carried out of referral and triage processes. 
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This review of referral processes in Symptomatic Breast Units was 
conducted in 2012 as one component of this thesis (Study 2: qualitative 
study with hospitals).  
 
National Standards for Safer Better Healthcare, HIQA 2012  
In 2012, the Health and Information Quality Authority (HIQA) in Ireland 
published the National Standards for Safer Better Healthcare (80). These 
describe the means by which a public healthcare service provides high 
quality, safe and reliable care, centred on the service user, and are 
structured around eight themes for quality and safety as seen in Figure 3.2 
below, including:   
• Person-centred care and support 
• Effective care and support 
• Safe care and support  
 
The National Standards provide a basis for those planning, funding or 
providing healthcare services to work towards achieving and maintaining 
high quality, safe and reliable care.  Safer Better Healthcare has been used 
as a framework for quality assurance in cancer programmes, including 
guideline development and implementation (79, 345). 
 
 
Figure 3.2: Safer Better Healthcare (HIQA, 2012).   
Source: HIQA, Safer Better HealthCare, 2012 (80) 
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 Cancer Projections (NCRI, 2014) 
The National Cancer Registry in Ireland (NCRI) published projections for 
cancer in Ireland in 2014 up to the year 2040 (23). These projections show 
an increase in incidence and prevalence of breast cancer.  Based on 
demographic trends alone, the NCRI predict an 84% increase in breast 
cancer incidence in females and a 107% increase in males by 2040. The 
NCRI has also reported the number of breast cancers requiring treatment in 
2010, and the estimated number requiring treatment in 2025, for the first year 
following patient diagnosis, as shown in Table 3.1 below. These projections 
estimate a 36% increase in surgery, chemotherapy and radiotherapy by 
2025.   
 
Table 3.1:  Breast cancer projections in Ireland 
Female breast  2010 
2025 projections  
(Based on demography only) 
Surgery 2,541 3,461 
Chemotherapy 1,388 1,890 
Radiotherapy 2,058 2,803 
Source: Cancer Projections for Ireland 2015-2040, NCRI, 2014 (23) 
National clinical guidelines for diagnosis, staging and treatment of breast 
cancers, NCCP 2014 
The 2006 Cancer Strategy (11) recommended that HIQA should establish 
national multidisciplinary groups to develop guidelines for major cancers. The 
NCCP  completed the development of national evidence-based clinical 
guidelines for the diagnosis, staging and treatment of breast cancers in 2014 
(345). These guidelines include recommendations relating to the patient 
pathway in acute services in the areas of radiology, surgery, medical 
oncology and radiation oncology.  Referral pathways from primary care had 
already been completed in 2009.  
 
Evaluation of the 2006 National Cancer Strategy (2014) 
In 2014, the Department of Health commissioned an international review of 
the implementation of the 2006 Cancer Strategy.  A report on the 
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implementation of the 2006 cancer strategy was published by the NCCP as 
part of the external review (4).  
 
HSE and hospital restructuring 2013 - 2014  
The eight designated specialist cancer centres were originally located and 
networked within each of four administration regions in the HSE (Dublin 
North-East, Dublin mid-Leinster, West, South), each centre serving a 
minimum population of 500,000.  
 
In 2013, a fundamental reconfiguration of Irish hospital services was 
announced. This reconfiguration is the implementation of a report to the then 
Minister for Health (Dr. James Reilly TD) in 2013 entitled ‘The establishment 
of hospital groups as a transition to independent hospital trusts’, also known 
as the Higgins report (109). These hospital groups have been established as 
a transition to the eventual establishment of independent hospital trusts. 
Interim boards have been established to oversee the delivery of high quality, 
safe patient care and these boards report to the Director General of the HSE. 
Governance of the hospital groups is outlined in the Higgins report, which 
includes the main functions of the hospital boards; strategic planning, policy 
making, supervision and challenge of executive management and 
accountability to stakeholders (109).   
The introduction of hospital groups in 2013 has resulted in a change in the 
governance of these cancer centres to the hospital groups.  Standards and 
policy remain the responsibility of the NCCP.   
 
Additional structural changes at primary care and community level such as 
primary care networks and Community Healthcare Organisations (CHOs) do 
not impact on the restructuring of cancer services. 
 
Collaborative links have been established between the Northern Ireland 
Cancer Registry (NICR) and the National Cancer Registry of Ireland (NCRI) 
for all-Ireland research activities. The Cancer Consortium has also been 
established with the National Cancer Institute (NCI) in the USA, as part of an 
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all-Ireland initiative to facilitate interaction among the US, Ireland, and 
Northern Ireland cancer-control communities and provide educational 
programmes in cancer control.  
 
3.5 Previous health services research on cancer  
The following section will outline previous health services research related to 
cancer referral patterns which are of particular relevance to this thesis.  
These include both Irish and international studies which have provided the 
context and evidence-base for this thesis to build upon. 
 
3.5.1 Irish College of General Practitioners (ICGP) 
In 2006, the Irish College of General Practitioners (ICGP) carried out a needs 
assessment of General Practitioners  for the early detection of cancer in 
primary care (260). The aim of the study was to identify the barriers 
experienced by GPs to early diagnosis of cancer in order to improve early 
detection, increase the number of patients diagnosed at an early stage and 
maximise potential for cure.  The needs assessment included five focus 
groups (n = 47 participants) and a postal survey.  A total of 950 GPs (47% of 
the ICGP membership) responded to this survey. This study was conducted 
for all cancers and not breast cancer specifically.  
 
The findings of the qualitative study component of this needs assessment 
showed that barriers to early detection of cancer identified by GPs in 2006 
were predominantly:  
 
• Delay in patient presentation 
• Lack of GP direct access to radiological and endoscopic investigation 
• Difficulty with referral of patients to hospital services for investigations 
and/or assessment 
• Lack of clear recommendations for cancer screening 
• Poor communication with hospital staff 
• Inequitable access, with long waiting lists for investigations and 
referral for patients who cannot afford to pay privately 
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 In the ICGP quantitative postal survey, the factors identified which would 
assist GPs in the early detection of cancer were listed, commencing with 
those of highest importance to the GPs, as:  
 
• Agreed criteria for screening high-risk individuals 
• Agreed referral criteria for suspected cancers  
• A ring-fenced budget for community diagnostic services 
• Increased public awareness of early cancer symptoms 
• Earlier patient presentation/increased patient awareness  
• Further GP education on identification of early-stage cancer  
• Clinical practice guidelines  
• Appropriate investigative pathways  
• Hospital-based GP liaison nurse 
• Meaningful GP representation at senior level of local hospitals  
 
Areas of cancer in the 2006 study, which GPs wished to receive further 
education and clinical practice guidelines included; identification of early-
stage cancer; appropriate investigative pathways for suspected cancer; 
referral criteria for suspected cancer; hospital cancer treatment care 
pathways; familial cancers; identification of high-risk individuals; and targeted 
cancer screening for high-risk individuals.  
 
This current thesis assesses whether the priorities for early detection of 
cancer identified by GPs in the 2006 study, have been addressed. The 
researcher (NO’R) has collaborated with the ICGP since the inception of this 
study to optimise the relevance of the study and its findings to health 
services research, policy and practice.  
 
3.5.2 Audit of GP referral guidelines 
An audit of local GP referral guidelines for suspected cancer was carried out 
in Ireland in 2009 (346) in the East Coast Area Health Board (a sub-division 
of the HSE in South Dublin and Wicklow, now subsumed into a larger region 
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following reconfiguration in 2005). The majority of GPs reported that they 
usually or sometimes use the guidelines, found them useful, usually adhered 
to the agreed guideline referral criteria and considered their compliance with 
the guidelines was good or reasonable. They recommended that guidelines 
be developed on a national basis to provide streamlined referral pathways. 
The authors found that whilst GPs welcomed national referral guidelines, 
they wished to retain independence to act on clinical judgement.  
There are also a number of international strategic documents and reports 
that identify current and future issues that need to be addressed to enable 
efficient referral of suspected cancers from primary to secondary care, which 
are summarised below.  
 
3.5.3 The Institute of Medicine (IOM) 
The Institute of Medicine (IOM) in the USA describes how primary care 
clinicians are often the first clinician that patients see when they have signs 
or symptoms of cancer. Access to care, or “the timely use of personal health 
services to achieve the best possible health outcomes” (p.4)(347) is an 
important aspect of high quality cancer care (348).  Recent IOM 
recommendations identify a vision for accessible cancer care. This vision 
involves evidence-based cancer care, coordinated team-based cancer care, 
accessible affordable cancer care and quality measurement (14).  
 
3.5.4 OECD cancer policy study 
This OECD policy study Cancer Care: Assuring Quality to improve Survival 
(19) makes recommendations on health systems and cancer policy in the 
fight against cancer. It identifies three main policy areas that help improve 
the quality of cancer care: 
 
• Resources (drugs, equipment, institutions and workforce) 
• Practices (timely and affordable access to evidence-based care) 
• Governance (national plans setting out targets, guidelines for care and 
means for monitoring progress)  
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Key recommendations from the OECD include ensuring that cancer care is 
of high quality and is rapidly accessible. The OECD report considers the 
most critical element influencing cancer survival is diagnosing the cancer at 
an earlier stage of disease and starting treatment quickly. In particular, 
breast, colorectal and cervical cancers are considered curable if they are 
detected early enough. 
 
As a policy priority, the OECD indicate that “countries should develop a clear 
understanding of the pattern of excessive or inequitable waiting times for 
cancer care in their population and respond with policies suited to the local 
context” (p.142).   
 
3.5.5 National Health Service UK: 2-week rule  
The experience of reorganisation of breast cancer services in other 
jurisdictions, such as the UK, has been described in the literature review 
(Chapter 2).  In the UK, the ‘2-week wait rule’ for cancer referrals from 
primary to secondary care became effective in December 2000 for all 
cancers treated by the National Health Service, whereby urgent cancer 
referrals were guaranteed to be seen within 2 weeks.  The aim of this 
initiative was to improve access to specialist services, thus facilitating early 
diagnosis and treatment (5).  Whilst improvement in waiting times for urgent 
referrals have been reported in the UK, GPs have reported a loss of 
autonomy and have “acknowledged an element of over-referral under this 
rule due to the effects of clinical uncertainty and patient pressure” 
(p.82)(227).  Potter and colleagues (5) questioned the scientific foundation of 
the 2-week rule: “the poor predictive value of fast track referral guidelines, 
together with poor adherence in primary care, has flooded one-stop clinics 
with large numbers of inappropriate referrals” (p.288).  This had been 
predicted several years earlier by Fentiman (315) who warned that  “if GPs 
do not act as a screen but as an open gateway there is  a risk that specialist 
one-stop clinics will become overrun by the worried well” (p.1251).  
 
Increases in overall volume of referrals were reported in the UK following the 
introduction of this rule  (5, 339).  An increase of 9% in breast referrals was 
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found in one study (5).  However, this increase was seen mostly for those 
referred under the 2-week rule (urgent referrals), which increased by 42%, 
while routine referrals decreased by 24%. The total number of cancers 
detected remained fairly constant. The UK National Audit Office reported an 
increase of 51% in urgent GP referrals for suspected cancer between 2009-
10 and 2013-14 (318). Concerns have been expressed that this restructuring 
of referral pathways has resulted in longer waiting times for non-urgent 
referrals, some of which had cancers diagnosed (5, 162, 339).  
 
3.6 Summary  
The convergence of the problem, policy and political streams in 2006 
described in the Kingdon model (64) resulted in a  policy window in Ireland, 
which provided an excellent opportunity for successful implementation of the 
national cancer strategy.  
 
The National Cancer Control Programme was established to implement the 
recommendations of the 2006 cancer strategy. In relation to breast cancer 
this resulted in the centralisation of breast cancer surgery into eight 
designated cancer centres with GP referral guidelines to rapid access breast 
clinics.  Since the establishment of the specialist centres and GP referral 
guidelines, there has been a sizable increase in GP referrals to breast 
clinics.  
 
This thesis will examine the impact of this process on breast cancer referral 
patterns, focussing on access to services and patient outcomes.   
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Chapter 4:  The Current Study  
 
4.1 Introduction  
Whilst the initial focus of this thesis was to determine the impact of 
centralisation of breast cancer services in Ireland on breast cancer referral 
patterns – a ‘natural experiment’ in the Irish healthcare system, the literature 
identified additional factors influencing GP referrals and hence the research 
was broadened to examine the wider influences on GP referral patterns.  
 
4.2 Structure 
Based on the multi-factorial nature of the factors influencing referrals to 
breast cancer units described in the literature, a mixed-methods research 
design was chosen for this study. 
 
This thesis comprises 4 individual studies as part of an iterative sequential 
mixed-methods design, as described by Teddlie and Tashakkori (349). The 
findings of each individual study informed the development of the 
subsequent study. These four distinct components each build on the 
evidence base, while seeking to answer one common overarching research 
question “What are the factors influencing GP referrals to symptomatic 
breast units in Ireland?”  Key developments in the Irish healthcare system 
such as centralisation of cancer services and adherence to GP referral 
guidelines were examined to assess their impact on breast cancer referral 
patterns.   
 
An overview of the thesis structure is provided in Figure 4.1 below.  
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What are the factors influencing GP referrals to SBD units in Ireland? 
Has centralisation of cancer services in Ireland 
had an impact on breast cancer referral 
patterns? 
Aim: to determine the impact of centralisation 
policy on breast cancer referral patterns 
Study 4
Secondary data analysis of national cancer database:
• n = 6,624 
• Before-and-after study
• Ordinal logistic regression
• Cox proportional hazards regression  
Overall methodology:   Mixed-methods iterative sequential study 
Methodology
• Examine the pattern of GP 
referrals to SBD units.
• Examine diagnostic yield.
• Determine the proportion of  
GP referrals for family history 
of breast cancer. 
• Determine the proportion of  
GP referrals for mastalgia.
• Determine if there is evidence 
of seasonal variation in GP 
referrals to SBD units.
• Explore perceptions of GPs and hospital 
SBD teams on the factors contributing to 
the increase in GP referrals to SBD units.
• Explore potential reasons for the 
decrease in proportion of GP referrals 
diagnosed with cancer. 
• Identity potential barriers & facilitators to 
implementation of evidence based        
GP referral guidelines.
• Investigate whether centralisation of 
cancer services has impacted on GP 
referral practices.
• Identify referral routes of patients with 
breast cancer in Ireland.
• Determine proportion of patients with breast 
cancer being diagnosed and treated at 
designated cancer centres vs. non-cancer 
centres.  
• Determine if patients with breast cancer are 
being referred/diagnosed at an earlier stage 
of disease.
• Determine if waiting times from GP referral 
to diagnosis and treatment have changed 
since centralisation.
Objectives
What are the referral patterns for  
GP referrals to SBD units in 
Ireland?
Aim: to examine GP referrals to 
SBD units in Ireland  
What are the factors which influence GP 
referrals to SBD units in Ireland? 
Aim: to explore the perceptions of 
hospitals and GPs on factors influencing 
GP referrals to SBD units
Research question
+ Aim
SBD: Symptomatic Breast Disease 
• Qualitative study 
• Semi-structured interviews 
Study 1
• Mapping study
• Descriptive statistics
• Preparatory developmental stage
Study 2
Hospitals x 9 
Study 3
GPs x 24
Figure 4.1:  Thesis overview.   
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4.3 Thesis aim 
This thesis sought to identify the factors influencing GP referrals to SBD units 
in Ireland and to make recommendations regarding future delivery of 
services, to ensure that those with urgent symptoms are seen quickly and 
those with non-urgent symptoms are seen in the most appropriate setting.    
 
4.4 Thesis objectives  
The objectives of the overall thesis were as follows:  
 
• To identify the factors influencing GP referrals to Symptomatic Breast 
Disease (SBD) units in Ireland. 
• To investigate the impact of centralisation on breast cancer referral 
patterns in Ireland. 
• To describe the implications of referral patterns for quality health 
service provision, including implications for current service provision, 
and recommendations for improvement and policy implications.   
 
In order to explore comprehensively the study objectives, four inter-
connected studies were conducted, as follows:  
 
Study 1: Mapping study 
 
Aim:  
To examine GP referral patterns to Symptomatic Breast Disease units in 
Ireland. 
 
Objectives:  
1. To examine the pattern of GP referrals to SBD units in Ireland over 
time (volume of referrals, triage categorisation, cancers detected).  
2. To examine diagnostic yield (proportion of GP referrals diagnosed as 
breast cancer) over time (pre- and post-centralisation). 
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Secondary objectives: 
During the pilot hospital interview, additional phenomena were raised which 
warranted further investigation.  A decision was made to expand this 
mapping study to include an exploration of certain types of referral, as these 
particular referral patterns had not heretofore been investigated on a national 
basis in Ireland.  The following objectives were therefore added:  
 
• To determine the proportion of GP referrals to SBD units for family 
history of breast cancer. 
• To determine the proportion of GP referrals to SBD units for mastalgia 
(breast pain).  
• To determine if there is evidence of seasonal variation in GP referrals 
to SBD units. 
 
Study 2: Qualitative study with hospital SBD units 
 
Aim: 
To explore the perceptions of hospital SBD staff on the factors influencing 
GP referrals to Symptomatic Breast Disease Units in Ireland. 
 
Objectives:  
1. To explore perceptions of hospital SBD teams on the factors 
contributing to the increase in GP referrals to SBD units in Ireland. 
2. To explore potential reasons for the decrease in proportion of GP 
referrals diagnosed with cancer.  
3. To ascertain the views of hospital SBD teams on the accuracy and 
adequacy of GP referrals.  
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Study 3: Qualitative study with GPs 
 
Aim:  
To explore the perceptions of GPs on factors influencing GP referrals to 
Symptomatic Breast Disease Units in Ireland. 
 
Objectives:  
1. To explore perceptions of GPs on the factors contributing to the 
increase in GP referrals to SBD units in Ireland. 
2. To explore potential barriers and facilitators to implementation of 
evidence-based GP referral guidelines. 
3. To investigate whether centralisation of cancer services has impacted 
on individual GP referral practices/behaviour.  
 
Study 4: Impact of centralisation on cancer referral patterns 
 
Aim: 
The aim of this study is to determine the impact of the policy of centralisation 
of cancer services on breast cancer referral patterns in Ireland and to 
ascertain if this policy has achieved early indicators of success.  
 
Objectives: 
1. To identify referral route (method of presentation) of patients with 
breast cancer in Ireland (e.g., screening programme, GP referral).  
2. To determine proportion of patients with breast cancer being 
diagnosed and treated at designated cancer centres vs. non-cancer 
centres, since service centralisation.   
3. To compare breast cancers referred before and after centralisation, in 
terms of patient, tumour and hospital characteristics. 
4. To determine if patients with breast cancer are being referred and 
diagnosed at an earlier stage of disease since service centralisation. 
5. To determine if waiting times from GP referral to diagnosis and 
treatment (biopsy, surgery, chemotherapy) have changed since the 
centralisation policy. 
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4.5 Research impact   
Research impact refers to the contribution research makes “to achieve 
desired societal outcomes” (p.1)(350). Using citation analysis on its own is 
not sufficient for assessing research impact and “is not predictive of 
subsequent clinical applications resulting in meaningful health outcomes”. 
(p.17)(351). The research conducted for this thesis provides important data 
and information to both policy-makers and service providers in relation to 
optimising referral patterns for breast cancer to maximise patient outcomes, 
in addition to efficiency and effectiveness of the service. To capture the 
potential impact of this thesis, the Kuruvilla Research Impact Framework 
(352) was used, as seen in Table 4.1 below. This framework was developed 
to assist researchers to identify and describe research impacts and has 
previously been used in the areas of surgical audit, healthcare financing, 
public health implications of climate change and public health implications of 
the trafficking of women and adolescents (353).  It is used here to outline 
areas where this research thesis is likely to have an impact, under the 
following headings:   
 
• Research-related impacts 
• Policy impacts 
• Societal impacts  
• Service impacts 
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 Table 4.1:  Expected research outcomes  
Area of 
Impact  
Expected research outcomes from this study 
(based on Kuruvilla et al., 2006) (352) 
Research  • Establish baseline data to enable monitoring of referral 
trends over time. 
• Establish if changes are required to current GP referral 
guidelines.    
• Build the evidence-base to inform policy.  
• Identify non-medical factors influencing GP referrals.  
• Contribute to the evaluation of the policy of centralisation 
of cancer services in Ireland.  
Policy  • Contribute to policy development in cancer control.  
• Contribute to development of policy to integrate primary 
and secondary care.  
• Evaluation of the policy of centralisation of cancer services 
in Ireland. 
• Contribute towards the review of the implementation of the 
2006 cancer strategy and development of the 2016 cancer 
strategy.  
Societal  • Patient centred: Identify and address the need for 
additional patient information on breast disease.  
• Examination of patient pathways which may contribute to 
improvement of services for the patient.  
Service  • Identification and prioritisation of service needs for 
resource allocation.  
• Identification of variation in referral practices between 
designated centres and their referring clinicians.  
• Identification of education and training needs for targeted 
GP education/awareness where necessary.  
Source: Developed by the author for this study, based on Kuruvilla et al., 
2006 (352) 
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4.6 Summary  
The four components of this research explore referral patterns from a 
number of perspectives, while addressing one common overarching research 
question: ‘What are the factors influencing GP referrals to symptomatic 
breast units in Ireland?’   
 
The research findings will be discussed in terms of research impact in the 
areas of research, policy, societal and health service impact. Chapter 5 will 
explore the theoretical frameworks considered to underpin this study.   
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Chapter 5:  Conceptual Framework 
 
5.1 Introduction  
Chapter 4 summarised the aims and objectives of the thesis and the 
expected outcomes in relation to research impact, policy impact, societal 
impact and service impact.  A key challenge in healthcare is implementing 
new initiatives. Theoretical frameworks to design interventions and 
understand facilitators and barriers to implementation are recommended for 
use in implementation research.  This chapter will present the models and 
frameworks considered to underpin this research.  
 
In implementation science, the ‘implementation gap’ refers to the difference 
between the evidence of what works in theory and what is delivered in 
practice. Implementation of evidence-based healthcare has had varied 
success (354).  Michie advises that “improving implementation depends on 
changing the behaviour of health professionals, managers, commissioners 
and others working within and with the health care system” (p.9)(354). 
Theory can assist in the identification of the mechanisms of behaviour 
change in clinical practice, allowing programmes and health systems to focus 
on the areas requiring change in order to implement an intervention. The use 
of theory can assist the development and tailoring of more effective 
interventions, based on a better understanding of the causal mechanisms by 
which interventions work (355).  
 
The UK Medical Research Council (MRC) has produced guidance on 
developing and evaluating complex interventions (356).  The MRC 
recommends that when designing and implementing an intervention, 
organisations should develop a theoretical understanding of the likely 
process of change by drawing on existing evidence and theory (357). Key 
elements of the development and evaluation process of complex 
interventions include development, feasibility and piloting, evaluation and 
implementation (356).  For developing and evaluating complex intervention 
studies, the MRC guidance recommends that a good theoretical 
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understanding is needed of how the intervention causes change, so that 
weak links in the causal chain can be identified and strengthened (356).  The 
guidance recommends developing interventions systematically, using the 
best available evidence and appropriate theory (357). 
 
Michie et al. (358) found that, for implementation of clinical guidelines, 
changing clinical behaviour is more likely if the behaviour is identified and 
specified precisely in the implementation plan.  In this study, the impact of 
clinical guidelines on GP referrals is explored as one of the potential factors 
influencing referral.  
 
5.2 Background 
Centralisation of breast cancer services in Ireland was completed in 
December 2009. In tandem with centralising services, GP referral guidelines 
were developed to inform referral from primary care to specialist services in 
the area of breast cancer.  
 
Health behaviour change by healthcare professionals is the crucial outcome 
variable in most health interventions and implementation of evidence-based 
practice in healthcare depends on “changing multiple behaviours of multiple 
types of people” including managers, administrators and health professionals 
(p.1) (245). However, changing behaviour is a challenging and complex task. 
The provision of information alone is not an effective way to change 
behaviour (359). The National Institute for Health and Care Excellence 
(NICE) in the UK has published guidance on behaviour change for 
individuals and for broader population interventions (360, 361). 
 
The House of Lords Behaviour Change report (362) in the UK looked at 
evidence for effectiveness of interventions based on principles of behavioural 
economics. This report described the ‘nudge’ approach (363-365) and the 
‘intervention ladder’ from the Nuffield Council on Bioethics (366), as 
approaches to intervention implementation.   
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In an overview of systematic reviews of interventions, Grimshaw et al. (367) 
concluded that multifaceted interventions targeting different barriers to 
change are more likely to be effective than single interventions. Increasing 
recognition of the failure to translate research findings into practice “has led 
to a greater awareness of the importance of using active dissemination and 
implementation strategies” to maximise translation (p.2) (367). 
 
In a systematic review of the use of theory in the design of guideline 
dissemination and implementation strategies (250), only 6% of the 235 
studies reviewed explicitly used theory to underpin their guideline 
implementation strategy.  Michie (354) recommended that, to achieve and 
maintain behaviour change as part of evidence-based medicine, an 
intervention requires the following steps:  
 
• “A systematic method for analyzing the target behaviours in their 
context as a starting point for designing an intervention 
• selecting interventions that are most likely to be effective given this 
analysis 
• specifying the intervention in sufficient detail in trial protocols and 
published reports to allow accurate replication and evidence 
syntheses 
• drawing on relevant theory to guide both the intervention design and 
evaluation” (p.9) 
 
5.3 Overview of models and frameworks 
 
The following models and frameworks were considered to underpin this 
research:  
• Bayesian theory (278) (279)  
• Institute of Medicine (IOM) USA. Aims for the 21st century healthcare 
system (75)  
• Safer Better Healthcare (HIQA), Ireland (80)  
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• Medical Research Council (MRC), UK. Developing and evaluating 
complex interventions (357)  
• Health Belief Model (180, 181) 
• Theory of Planned Behaviour (368)  
• Behaviour Change Wheel (251) and Theoretical Domains Framework 
(TDF) (244). 
 
Bayes theorem 
Bayes’ theorem of diagnostic reasoning, which is based on the probability of 
disease, was considered and compared with the Social Constructivist Model 
of Medicine, which looks at non-medical influences on medical decision 
making.  
Bayes’ theorem, published by Thomas Bayes (an English clergyman and 
mathematician) in 1763 is a mathematical formula used for calculating 
conditional probabilities.  Bayes’ theorem of diagnostic reasoning undertakes 
a statistical diagnostic decision, considering the patient’s clinical information 
in the context of the probability of the disease. The post-test probability of 
disease is a function of the pre-test probability, which is measured by the 
likelihood ratio (278). Decision making is made in the light of external 
evidence and prior plausibility of hypothesis (277). 
The rule is defined as “a mathematical relationship between conditional 
probabilities that relates the posterior probability of parameter values, on the 
one hand, to the probability of the data given the parameter values, and the 
prior probability of the parameter values, on the other hand” (p.293) (279). 
Summerton (280) examined the likelihood of disease in identical patients 
presenting in primary and in secondary care. Applying Bayes’ theorem, the 
probability of disease in secondary care will be higher, as the interpretation 
of the clinical presentation should depend on the prior probability of disease 
(281). 
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Alternatively, medical decision making can also be viewed as a social 
construct, with factors other than biomedical factors influencing decision 
making. In this context, variability in medical decision making cannot be 
explained purely by Bayesian inference (282).  
Bayes’ theorem of diagnostic reasoning, while contributing to the 
understanding of medical decision making, was not chosen as the theoretical 
model for this thesis as a deeper understanding and interpretation of GP 
referrals than the dichotomy of Bayesian reasoning was required.  
 
Medical Research Council  
The UK Medical Research Council has produced guidance on developing 
and evaluating complex interventions (357).  The Medical Council 
recommends that when designing and implementing an intervention, 
organisations should develop a theoretical understanding of the likely 
process of change by drawing on existing evidence and theory (357). 
Key elements of the development and evaluation process of complex 
interventions include development, feasibility and piloting, evaluation and 
implementation (356). 
The MRC model was considered as a potential theoretical framework for this 
study as it linked the theoretical basis with implementation of interventions. 
However, this research thesis examined an intervention which had already 
been implemented and sought to understand the barriers and facilitators to 
implementation retrospectively.  Craig et al. (356) recommend that theory 
and evidence should ideally be identified before an intervention is designed 
to have the greatest chance of success. 
 
Institute of Medicine   
The US Institute of Medicine’s (IOM) aims for a 21st century health care 
system (75) state that health care should be safe, effective, patient centred, 
timely, efficient and equitable. Whilst this model contributes to the 
assessment of quality of health services and would have been considered in 
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the development of the policy of centralisation, it was not chosen as a model 
for this thesis as it does not provide an explanatory framework for the 
development or implementation of health service interventions.  
 
Safer Better Healthcare  
In 2012, the Health and Information Quality Authority (HIQA) in Ireland 
published the National Standards for Safer Better Healthcare (80). These 
standards describe how a service provides high quality, safe and reliable 
care, centred on the service user. Safer Better Healthcare has been used as 
a framework for quality assurance in cancer programmes in Ireland, including 
guideline development and implementation (345) and quality assurance (79) 
but was not considered broad enough for use as a model for this thesis as it 
focuses exclusively on standards. 
 
Health Belief Model  
The health belief model (HBM) (180) (181)  explains risk reducing behaviour 
in health and predicts the likelihood of patients taking recommended action 
to avoid a health threat or disease (369).  This model of behaviour change 
proposes that demographic factors and a person’s beliefs such as perception 
of threat and behavioural evaluation will influence the likelihood that 
individuals will engage in particular health behaviours (370).  Cues to action  
(371) was added to the model in 1975 and health motivation was added in 
1977 (372) to further develop this model. 
 
The health belief model has been used for studies on attendance for breast 
cancer screening (182) and for predicting self-breast examination (373)   
(374). Limitations of the Health Belief Model include that there are several 
versions available, the manner in which the different variables interact are 
not specified, it assumes that people are rational decision makers, it may 
overestimate the role of threat and it takes limited account of social factors in 
behaviour change (370).  
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While the Health Belief Model has been used as a useful predictor of 
prevention activities, in particular cues to action to attend screening, the 
HBM has been criticised for its failure to address contextual constraints 
influencing behaviour (375). 
 
The Health Belief Model was not used to underpin this research as this study 
focussed on the behaviour of health professionals in relation to making 
referrals to hospital and the area of social influences was a key area to be 
investigated.  
 
Theory of Planned Behaviour   
The theory of reasoned action and the subsequent theory of planned 
behaviour are social cognition models which “assume that social behaviour is 
determined by a person’s beliefs about behaviour in given social contexts 
and by their social perceptions and expectations” (p.127) (370).  The Theory 
of Planned Behaviour (TPB) (368) has also been used to explore the uptake 
of cancer screening (376) and for patients with breast symptoms (377) to 
examine predictors of the patient’s intention to seek help from their GP.  The 
TPB has also been used in implementation science to study the 
determinants of clinical behaviour change (287).  Limitations of the Theory of 
Planned Behaviour include that prediction of behaviour using this model is 
lower than prediction of intentions and the need to incorporate the influence 
of other variables such as anticipatory regret, moral norms, self identity and 
implementation intention (370). 
 
While the Theory of Planned Behaviour was considered for use in this 
research, based on its inclusion of social context, it was not used to underpin 
this research as this study focussed on the behaviour of health professionals 
in relation to making referrals to hospital and the area of anticipatory regret / 
beliefs about consequences was a key area to be investigated.  
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5.3.1 Behaviour Change Wheel   
The behaviour change wheel (251) was developed in 2011 as a tool for 
designing and evaluating behaviour change interventions. “Improving the 
design and implementation of evidence-based practice depends on 
successful behaviour change interventions. This requires an appropriate 
method for characterising interventions and linking them to an analysis of the 
targeted behaviour” (p.1) (251). The authors assessed existing frameworks 
of intervention functions and policies to enable their implementation. The 
Behaviour Change Wheel (BCW) is a synthesis of those frameworks.    
 
The Behaviour Change Wheel approach is based on a comprehensive 
causal analysis of behaviour and starts with the question; “what conditions 
internal to individuals and in their social and physical environment need to be 
in place for a specified behavioural target to be achieved?” (p.9) (251).  
 
The BCW is used for characterising and designing behaviour change 
interventions, using the COM-B system (capability, opportunity, motivation, 
behaviour) (251).  The COM-B model is at the hub of the BCW and is a 
model to understand behaviour in context, a principle that has been used in 
US criminal law (287). This model, with its components of capability, 
opportunity and motivation is shown in Figure 5.1 below and is used to 
understand behaviour in context.   
 
 
Figure 5.1: The COM-B model.  
Source: Michie et al., 2011 (251) 
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 The components of the COM-B model associated with capability, opportunity 
and motivation, along with their definitions are shown in Table 5.1.  
 
Table 5.1: COM-B model components  
COM-B 
Capability  Physical 
Capability 
Physical skill. 
Psychological 
Capability 
The capacity to engage in the necessary thought 
processes: comprehension, reasoning. 
Motivation  Reflective 
Motivation 
Reflective processes, involving evaluations and 
plans; beliefs about what is good and bad; 
conscious intentions; decisions and plans. 
Automatic 
Motivation 
Automatic processes involving emotions and 
impulses that arise from associative learning 
and/or innate dispositions. Emotional responses, 
desires, impulses and habits resulting from 
associative learning and physiological states. 
Opportunity  Physical 
Opportunity 
Opportunity afforded by the environment. 
Social 
Opportunity 
Opportunity afforded by the cultural milieu that 
dictates the way that we think about things (e.g., 
the words and concepts that make up our 
language). 
Source: Michie et al., 2011 (251) 
 
Figure 5.2 below, shows the sources of behaviour, intervention functions and 
policy categories in the Behaviour Change Wheel. 
 
Figure 5.2:  The Behaviour Change Wheel.  
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Source: Michie et al., 2011 (251) 
 
Each component can be mapped onto nine different intervention functions, 
which are activities aimed at changing behaviour.  Intervention functions and 
their definitions are shown in Table 5.2 below.  
 
Table 5.2:  Intervention functions  
Intervention function  Definition  
Education Increase knowledge or understanding 
Persuasion Using communication to induce positive or 
negative feelings or stimulate action 
Incentivisation Creating expectation of reward 
Coercion Creating expectation of punishment or cost 
Training Imparting skills 
Restriction Using rules that limit engagement in the target 
behaviour or competing or supporting behaviour 
Environmental 
Restructuring 
Changing the physical or social context 
Modelling Providing an example for people to aspire to or 
imitate  
Enablement Increasing means/reducing barriers to increase 
capability or opportunity 
Source: Michie et al., 2011 (251) 
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Examples of these interventions in breast cancer services could include 
provision of information on cancer risk (education), skills to deal with patient 
expectations (training), confidence in referral decisions (enablement), 
reorganisation of cancer clinics (environmental restructuring), sanctions for 
inappropriate referral (coercion), reporting/rewarding areas of good practice 
(incentivisation) and advice on appropriate referral from a representative 
body (persuasion).  
 
Using this framework can assist intervention designers and policy makers to 
identify and consider all potential options, including the behaviour change of 
individuals and external influences. The context of the intervention can be 
considered  in the choice of intervention functions, thereby increasing the 
effectiveness of  design and implementation of the intervention (251).    
 
The COM-B model links to these interventions through its component parts, 
as indicated in Figure 5.3.  
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Sources of behaviour Intervention functions 
 
Capability
Opportunity
Motivation
Physical 
Capability
Psychological 
Capability
Reflective 
Motivation
Automatic 
Motivation
Physical 
Opportunity
Social 
Opportunity
Persuasion
Incentivisation
Coercion
Environmental restructuring
Modelling
Enablement
Training 
Education
Persuasion
Incentivisation
Coercion
Education
Training
Enablement
Training
Enablement
Restrictions
Environmental  restructuring
Enablement
Training 
Restrictions
Environmental  restructuring
Enablement
Modelling
 
 
 
Figure 5.3:  Linking COM-B to intervention functions.  
Source: NCCP 2014 (345), based on Michie et al., 2011 (251) 
 
These intervention functions can then be mapped onto seven possible policy 
categories to enable or support their delivery:  guidelines, 
environmental/social planning, communications/marketing, legislation, 
service provision, regulation and fiscal measures. These policies are defined 
in Table 5.3.  
 
Improving implementation of evidence-based practice depends on 
channelling the behaviour of health professionals, managers and 
other health care staff. Using the COM-B approach, behaviour 
change techniques can be selected to deliver the intervention based 
on the intervention strategy (354).
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Table 5.3: Policy categories  
Guidelines  
 
Creating documents that recommend or mandate practice. 
This includes all changes to service provision  
Environmental / social 
planning 
Designing and/or controlling the physical or social 
environment  
Communications / 
marketing 
Using print, electronic, telephonic or broadcast media 
Legislation Making or changing laws 
Service provision Delivering a service  
Regulation Establishing rules or principles of behaviour or practice  
Fiscal measures Using the tax system to reduce or increase the financial 
cost  
Source  Michie et al., 2011 (251) 
 
Examples of these policy functions include evidence-based guidelines for 
cancer (guidelines), breast cancer awareness campaigns or activities 
(communications/marketing), development of specialist breast services 
(service provision) and regulation through professional bodies (regulation). 
 
5.3.2 Theoretical Domains Framework (TDF) 
The Theoretical Domains Framework (TDF) can be used as an elaboration of 
the COM-B model. Michie et al. (244) developed a theoretical framework for 
use in implementation research of evidence-based practice. This model was 
developed in the UK by inviting three groups of experts to contribute to the 
project:  
 
• Health psychology theorists with an interest in the theoretical 
approaches to behaviour change and implementation research.  
• Health services researchers who were involved in implementation 
research. 
• Health psychologists who did not have specific expertise in theory, 
behavioural change or implementation research were included as a 
validation group.   
 
The purpose of this project was to “simplify psychological theory relevant to 
behaviour change and to make it accessible to those involved in EBM 
implementation” (p.29) (244).  
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The groups identified psychological theories and theoretical frameworks 
relevant to the implementation of evidence-based practice. Relevant 
psychological theories were identified in motivational theory, action theory 
and organisational theory. A total of 33 psychological theories and 123 
explanatory constructs were identified (244). Constructs particularly relevant 
to changing the behaviour of healthcare professionals were then selected. 
The domain list was validated through backward validation to ensure that the 
domains identified reflected the underlying theoretical constructs.  
 
Twelve domains were initially identified as a framework for studying the 
implementation of evidence-based practice. The theoretical domains 
framework was refined in  2012 (245) and extended to 14 domains. The 
group separated the original domain of ‘motivation and goals’ into two 
domains of ‘intentions’ and ‘goals’ and added two new domains of 
‘reinforcement’ and ‘optimism’. The domain ‘nature of the behaviour’ was 
dropped by the group as the influences on behaviour were being examined, 
as opposed to the nature of the behaviour.  
 
The fourteen domains of the revised Theoretical Domains Framework are as 
follows: physical skills/cognitive and interpersonal skills, knowledge, memory 
attention and decision processes, behavioural regulation, environmental 
context and resources, social influences, professional/ social role and 
identity, beliefs about capabilities, optimism, beliefs about consequences, 
intentions, goals, reinforcement and emotion.  
 
The Theoretical Domains Framework (TDF), as an elaboration of the COM-B 
model, can be used to identify problems with intervention implementation 
and to aid implementation design. The validity of the TDF framework was 
investigated by Cane et al. (245).  This validation study resulted in a 
refinement of the framework with 14 domains. The authors outlined three 
advantages of the TDF framework:  
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• Comprehensive coverage of the possible influences on behaviour 
• Components of each domain are specified, providing clarity  
• Links are made between behaviour change theories and behaviour 
change techniques to tackle implementation problems  
 
The authors concluded that the TDF is a useful framework to inform 
interventions to improve implementation (245). 
 
Figure 5.4 shows the behaviour change wheel incorporating both the COM-B 
components and the theoretical domains framework.  
 
 
 
 
Figure 5.4: The Behaviour Change Wheel and Theoretical Domains 
Framework. 
Source: Behaviour Change Summer School, Centre for Behaviour Change, 
University College London, August 2014.  
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A number of criteria have been identified to support the Behaviour Change 
Wheel, known as the APEASE criteria (affordability, practicability, 
effectiveness, acceptability, side effects/safety and equity) (378).  These 
criteria are used to assess the appropriateness of intervention functions, 
policy categories and behaviour change techniques for proposed 
interventions, under the headings of affordability, practicability, effectiveness 
and cost effectiveness, acceptability, side effects/safety and equity. 
 
The Behaviour Change Taxonomy (BCT) (251), (379), (378) has been 
developed to standardise the content and reporting of intervention studies 
and is used in this study to describe the specific components of proposed 
interventions based on the findings of this research (Appendix D).   
 
Michie et al.’s COM-B model with its Theoretical Domains Framework (244) 
was chosen as the theoretical framework for this study. This framework was 
considered appropriate, given the context of implementation of an evidence-
based policy of centralisation of breast cancer services in Ireland which 
included evidence-based GP referral guidelines. Behaviour change is a key 
component required for the uptake of evidence based practice in healthcare  
(380).  The TDF has been used to assess barriers and facilitators to 
guideline development and implementation in a range of studies, such as 
pregnancy weight management and obesity guidelines (381); diagnosis, 
management and implementation of guidelines for  dementia (249); theory-
informed behaviour change for low back pain (248); and using psychological 
theory to investigate difficulties implementing a mental health guideline (382).   
 
The TDF has been used to advance the science of implementation research 
by theoretically assessing implementation problems, identifying barriers and 
facilitators to implementation and identifying intervention components to 
overcome the modifiable barriers and enhance the enablers (245, 248, 380). 
The TDF can also be used as a coding framework for analysis (380).  
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A review of the Theoretical Domains Framework (380) concluded that its 
strength was its theoretical coverage and ability to elicit beliefs signifying key 
mediators of behaviour change.  
 
The use of the TDF as an interview topic guide has been criticised as being 
too focussed and constraining. However, a study on hand hygiene (383) 
compared results using TDF and atheoretical methods and concluded that 
the TDF methodology was both comprehensive and inclusive. A limitation of 
the TDF is that it is a framework rather than a theory and as such, the 
relationships between the domains are not specified (380). Inter-coder 
agreement has also been reported as low in interview studies using the TDF 
(384).  
 
The authors concluded that the TDF provided “a useful conceptual basis for 
assessing implementation problems, designing interventions to enhance 
healthcare practice and understanding behaviour-change processes” (p.35) 
(380).   
 
The TDF has been used widely to investigate the behaviour of health 
professionals, with several recent studies designed specifically to identify 
barriers and levers to uptake of a guideline (249) (385) (386) (387) (388) 
(389) (390) (391) (392) (393). The TDF is cross disciplinary and has been 
used to examine behaviour in wide range of health care settings (380). The 
TDF is used in this thesis to explain GP referral patterns and inform 
implementation interventions.  
 
The TDF has been described as “the most comprehensive framework for 
designing implementation interventions as it offers broad coverage of 
potential change pathways” (p.6) (248). However, the authors recommend 
further research examining the links between theoretical assessment and 
behaviour change techniques.  
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5.4 Summary 
Through identification of barriers and facilitators in relation to implementation 
of national policy of cancer centralisation, referral practice and use of 
guidelines, this study sought to explain implementation facilitators and 
problems and inform implementation intervention. 
 
The mapping study (Study 1) and quantitative analysis of national cancer 
registry data (Study 4) assessed the level of compliance with and the impact 
of the policy of centralisation of breast cancer services in Ireland. The 
qualitative research component of this research sought to understand and 
explain professional and social processes of referral patterns from the 
perspective of the hospital consultant or their nominee (Study 2) and to 
explore GP’s self-reported referral practice (Study 3) to describe the reasons 
for adherence or non-adherence to evidence-based referral guidelines, using 
theory of behaviour change. The interaction of capability, opportunity and 
motivation in supporting behaviour change was explored. The Theoretical 
Domains Framework (TDF) supported the description of these factors in 
more detail to identify implementation problems and aid future 
implementation design.  
 
In the development of the current research, a number of models and 
frameworks were considered as potential theoretical frameworks to underpin 
this study. These models included the Institute of Medicine (IOM) aims for 
the 21st century healthcare system (75),  Bayesian theory (278, 279), Health 
Belief Model (180) (181), Theory of Planned Behaviour (368), the Behaviour 
Change Wheel (251) and the Theoretical Domains Framework (244).   
 
Davis et al. (394) conducted a review of theories of behaviour change across 
the social and behavioural sciences. The authors found that most theories 
used in public health interventions had limited reference to social and 
contextual factors and recommended drawing on a wider range of theories to 
increase intervention effectiveness.  
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The model deemed most relevant and applicable to this study was the 
Theoretical Domains Framework (TDF) (244, 251).  The TDF is useful in the 
context of the current study as it can be used to identify problems with 
intervention implementation and aid implementation design and has 
previously been used to assess barriers and facilitators to guideline 
development and implementation (381) (249) (248) (382).  The TDF has also 
been used in this study as a coding framework for analysis.   
 
This theoretical approach can assist the identification of the mechanisms of 
behaviour change in clinical practice, thus allowing programmes and health 
systems to focus on the areas requiring change in order to implement an 
intervention successfully. While theories of behaviour change have more 
generally been used to examine individual behaviours, or possibly 
organisational levels, the Theoretical Domains Framework identified domains 
particularly relevant to changing the behaviour of healthcare professionals.  
This facilitates a deeper insight into macro-level forces which affect health 
service provision and enables intervention planning based on the specific 
behavioural components which need to change. 
 
A psychological framework has been chosen to underpin this research. The 
next chapter (Chapter 6) builds on this model to describe the overall 
research methodology used for this thesis.  
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Chapter 6:  Methodology  
 
6.1  Introduction   
This chapter presents the research methodology chosen for this thesis. As 
described in the previous chapter on models and frameworks, this is a health 
services research project using a psychological framework. The professional 
and academic background of the researcher in nursing and health services 
management has informed the research interests and research approach.  
 
This research was originally planned to investigate the impact of the policy of 
centralisation of cancer services on GP breast cancer referral patterns.  A 
review of the literature found that many factors, including centralisation, can 
affect GP referral patterns.  In addition, reports on a national review of the 
Symptomatic Breast Disease Services by the Health Information and Quality 
Authority (HIQA) in 2010 (6) and from the National Breast Cancer Audit, 
Quality and Risk Conference in 2011 (1) and 2012 (2)  identified a need to 
explore the factors influencing breast referrals from primary to secondary 
care in Ireland. The scope of the study was broadened accordingly.  
 
As discussed in Chapter 2, the choice of methods was informed by a review 
of the literature and the gaps in the current evidence.  
 
6.2  Research methodology 
Researcher reflexivity is important in the overall quality of a study (395) and 
in assessing whether the researcher has interacted with the phenomenon 
under investigation (396). In line with this view, it is important to articulate the 
researcher’s position as an integral element of reflexivity within the research 
project. With a professional and academic background in nursing, public 
health medicine and health services management, this researcher’s PhD 
topic was influenced by her work as an employee of the National Cancer 
Control Programme (NCCP) from 2010 – 2014. While the researcher was 
working in the area of cancer control, she had not formed relationships with 
prospective participants at the time of the study, as the researcher was new 
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to this post. In terms of other potential conflicts of interest, self-reflection was 
used to assess possible biases between the dual roles of researcher and 
health service employee, for example, in discussions with consultants and 
GPs on health service impacts.  
 
As described in the previous chapter, this research uses a psychological 
framework (the Theoretical Domains Framework). With a background and 
work area (cancer control) in which quantitative methods are often the 
instrument of choice for data collection, this researcher chose to adopt a 
mixed-methods approach for this PhD research in order to incorporate 
qualitative methods which can bring richness, depth and broader findings, 
while allowing the researcher to consider different realities articulated by 
research participants. During this research project it became evident that 
factors influencing GP breast cancer referrals are multi-level, spanning 
macro, meso and micro levels. This research methodology thus sought to 
take account of the multi-factorial nature of the phenomenon under study, 
including micro-level influences.  
 
Issues of objectivity and subjectivity go to the core of differences between 
quantitative and qualitative research and these two investigative approaches 
were amalgamated within this research project in the form of mixed-methods. 
The utilisation of mixed-methods within this project are discussed in detail in 
the next section, yet it is important to acknowledge from the outset that some 
debate surrounds the use of mixed-methods, as qualitative and quantitative 
research are derived from “opposing philosophical backgrounds” (p.433) 
(397).  As Creswell and Plano Clarke (398) explain, all research has a 
philosophical foundation that encapsulates certain assumptions about 
knowledge, which in turn shapes the research process.  
 
6.3  Overview of mixed-methods research  
The underlying logic of mixed-methods research is that neither quantitative 
nor qualitative methods may be sufficient on their own (399). When used in 
combination, this approach facilitates a better understanding of a research 
phenomenon than either approach in isolation and yields a more 
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comprehensive analysis (398, 399).  The findings from mixed-methods 
research integrate to create “a whole more than the sum of the parts” (p.40) 
(400).   
 
Using mixed-methods, the inherent limitations in one approach can be 
tackled through an additional different methodological approach.  Creswell 
and Plano-Clarke (398) outline the weaknesses of single-approach 
methodology –  it is considered difficult to explore context and setting in 
quantitative research, and the voice of the participants can be lost. 
Qualitative research, on the other hand, has been criticised for its lack of 
generalisability and its subjective interpretations.  Creswell and Plano-Clarke 
recommend mixed-methods research to offer strengths that offset these 
individual weaknesses (398).   
 
The complexity of health-care requires a range of methodologies for 
assessment and a mixed-methods approach is often used in health services 
research for comprehensiveness (401) (402) (396). Mixed-methods can be 
used “in a series of studies that investigate the same underlying 
phenomenon”  (p.267)(403), to conduct both exploratory and confirmatory 
research (404), particularly in real-world settings.  The quality criteria for 
good reporting of a mixed-methods study (GRAMMS) (405) were used for 
this study. 
 
6.4 Philosophical paradigms  
Creswell (p.6) (406) highlights how different philosophical approaches can be 
understood as ‘paradigms’ or ‘worldviews’, which he refers to as a “general 
philosophical orientation of the world and the nature of research that a 
researcher brings to a study”. Guba and Lincoln  describe how paradigms 
define the world view of the researcher (407). Creswell identifies four main 
worldviews evident in social science research;  post-positivism, 
constructivism, transformative, and pragmatism, and  points out that 
“pragmatism is not committed to any one system of philosophy or reality” and 
it allows the researcher to draw from both qualitative and quantitative 
assumptions, providing a “freedom of choice” (p.11) (406). For these 
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reasons, in the current study the researcher chose to adopt a pragmatist 
approach, using qualitative and quantitative methods as tools to serve the 
questions pursued, rather than allowing the methods to “constrict the range 
of inquiry” (p.4)(408). Furthermore, mixed-methods can be used to answer 
research questions that could not be answered by a single paradigm alone 
(403).   
 
6.4.1   Pragmatist paradigm  
Mixed-methods research has its primary philosophy in pragmatism and 
“attempts to consider multiple viewpoints, perspectives, positions and 
standpoints” (p.113)(409). Pragmatism gives primacy to the importance of 
the research question (410) and values both objective and subjective 
knowledge. 
 
The benefits of pragmatism include the following:   
 
• The flexibility to use the method which best answers the question 
(402) (411)  
• Solving practical problems in the real world (412) 
• Methodological pluralism leads to more effective research (413) 
 
Pragmatism is based on “situational responsiveness and a commitment to an 
empirical perspective” (p.9) (411), providing an innovative approach to 
address contemporary issues in the health services (402). 
 
Morgan (410) discusses the theory-driven deductive mode and the data-
driven inductive mode and describes the pragmatic approach as “abductive 
reasoning that moves back and forth between induction and deduction – first 
converting observations into theories and then assessing those theories 
through action”  (p.71) (410). This approach has been used in this research 
by using data in the initial quantitative study to design the qualitative 
deductive phase and assessing the theories generated using another data-
driven inductive study.  Feilzer describes pragmatism as a commitment to 
149 
 
uncertainty (412), offering an alternative worldview and a focus on the 
research, and solving practical problems in the real world.  
 
6.5  Choice of study design for this thesis  
There are four distinct components to the research conducted for this thesis, 
each building iteratively on the previous studies, while seeking to answer one 
common overarching research question “What are the factors influencing GP  
referral patterns to Symptomatic Breast Units in Ireland?”  Based on the 
multi-dimensional nature of the factors influencing breast cancer referrals 
described in the literature, a mixed-methods research design was chosen for 
this study. The phenomenon being studied is a health service research issue 
which was examined before and after major restructuring of the cancer 
services in Ireland. The referral practices of GPs in the context of changes in 
evidence-based practice, referral guidelines and centralisation policy were 
examined.   This, in effect, constituted a natural experiment in the Irish 
healthcare system.  Mixed-methods have been central to the design of this 
study, due to the complex nature of both medical and psychosocial 
influences on cancer referral patterns.   
 
Mixed-methods research has several structural designs, mostly based on the 
sequence or the prominency of the individual components. In a sequential 
approach, quantitative or qualitative data collection serves as a basis for the 
next data collection and analysis stage (399). This structure has been used 
in this study, whereby using an iterative design, results from one study were 
used for the development of the next study. “With multiple iterations, the 
study enables a progressive reconfiguration of substantive findings and 
interpretations in a pattern of increasing insight and sophistication” (p.23) 
(414). Explanatory and exploratory mixed methods are described by 
Creswell and Plano Clarke (398) and are shown in Figure 6.1 below.  The 
explanatory sequential design commences with the collection and analysis of 
quantitative data, which is followed by the subsequent collection and analysis 
of qualitative data.  The qualitative data builds on the quantitative results.  
The exploratory sequential design begins with and prioritises the collection of 
qualitative data.  Building on the results of this qualitative data, the 
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researcher then conducts a second quantitative phase to test or generalise 
the initial findings.  
 
 
 
 
Figure 6.1:  Creswell’s mixed-methods sequential designs.  
Source: Creswell and Plano-Clarke, 2011 (398) 
 
The model chosen for this study is the iterative sequential mixed design. This 
design is described by Teddlie and Tashakkori (349) as a more complex 
design with more than two phases.  This iterative sequential model facilitates 
research evolving as new salient events occur. In this study, this particular 
approach facilitated the addition of sub-studies in this research, which were 
added to the study in response to initial early findings.  
 
Convergence coding has been used in this study to report the yield of the 
integrated approach used.  Convergence coding was used to assess to what 
extent the different findings show convergence (meaning and prominence of 
themes presented), complementarity (multiple dimensions for the same 
research question to ensure completeness in perspective), dissonance 
(disagreement/divergence) or silence (one set of findings is silent on a theme 
(415, 416).   
 
151 
 
Palinkas (404) investigated the role of mixed-methods in implementation 
research. In this area of research, qualitative methods are often used to 
explore reasons for success or failure in implementation of evidence-based 
practice, while quantitative methods are used to test and confirm 
hypotheses.  Mixed-methods have also been used in implementation 
research “to develop a science base for understanding and overcoming 
barriers to implementation” (p.44)(404), in particular in the area of evidence-
based medicine.  
 
The Theoretical Domains Framework (TDF), as described in Chapter 5, is 
the framework upon which this study is based and is used in this study to 
identify barriers to implementation of evidence-based practice in cancer 
control, and to make recommendations to aid implementation of cancer 
policy. Whilst theories of behaviour change have been used more commonly 
in studies relating to individual behaviours, or organisational level change, 
the TDF has been used to include macro level forces which affect health 
service provision, including a meta-synthesis of barriers and facilitators to 
implementation of pregnancy weight management and obesity guidelines 
(381); understanding diagnosis and management of dementia (249); 
development of interventions to implement evidence into practice for acute 
low back pain (248); and investigation into difficulties associated with 
implementing a mental health guideline using psychological theory (382). It’s 
use in examining the behaviour of health professionals is of particular 
relevance to this study.  
 
Using a mixed-methods approach facilitated the exploration of breast cancer 
referral patterns at various levels, from a micro and meso level to a macro 
level. The use of the Behaviour Change Wheel (BCW) and the Theoretical 
Domains Framework (TDF) as the analytical framework provided a model to 
identify the sources of behaviour (capability, opportunity and motivation), and 
link these to the relevant intervention functions and policy categories to 
address these. This broad approach to both methods and models facilitated 
the exploration of a ‘real world’ problem in the Irish health services and the 
development of an implementation plan to address the issues identified.   
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As this research focussed on GP referrals from primary care to symptomatic 
breast units in secondary care, interviews with both primary and secondary 
care providers were included in this research. 
 
A summary of the methodological approach for this thesis is outlined in 
Figure 4.1 (Chapter 4). 
 
6.6 Summary of methodological approach  
The methodological approach used for the different study components of this 
thesis is outlined below.  A detailed methodology for each study is contained 
in the chapters presenting the results for each study (Chapter 7 – 10). 
 
6.6.1  Study 1: Mapping study 
The initial exploratory study was conducted to review breast cancer referral 
patterns in Ireland.  Existing routine data from the Symptomatic Breast 
Disease Units were analysed for patterns and trends in breast cancer 
referrals.  The mapping study was expanded to include data on family risk, 
mastalgia and seasonal variation following the pilot hospital interview. 
Conducting this preparatory mapping phase allowed the quantitative findings 
to inform the development of the qualitative phases. This strategy ensured 
that the focus of the qualitative phase was underpinned by national and local 
data, which facilitated in-depth focussed discussion on possible influencing 
factors.  Morse’s taxonomy of mixed-methods design (417) describes this 
approach as a ‘development’ function in mixed-methods research.  
 
The exploratory mapping study provided national data on referral patterns. In 
order to explore the factors influencing these referral patterns and to provide 
richness to the quantitative data, two qualitative studies were designed as 
the next phases of this study.  
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6.6.2  Study 2:  Qualitative study with hospital SBD units 
This first of the qualitative studies was conducted with the lead SBD 
consultant or their nominee in each of the 8 cancer centres and the satellite 
centre, to explore the data trends generated in Study 1 and to identify 
potential factors influencing referrals.  Interviews are considered the most 
suitable method to investigate opinions, values  and motivations (418).  The 
data from Study 1 were circulated to the interviewees in advance to stimulate 
discussion.  While this data was already in the public domain, it helped to 
focus the discussions in the limited time available. The Theoretical Domains 
Framework (244) was used in analysis of the interviews to identify factors 
influencing referral patterns.  Although some of the observed quantitative 
trends were explained by the hospital interviews, the majority of consultants 
concluded that many factors influencing referrals to the cancer centres 
originated at General Practice level. This required further qualitative research 
with referring GPs. 
 
6.6.3  Study 3:  Qualitative study with GPs  
The second qualitative study was conducted with a random sample of 24 
GPs across the four HSE geographical networks to explore factors 
influencing their referral decisions. The Theoretical Domains Framework 
(244, 245) was used in analysis of the interviews to identify barriers and 
facilitators to referral practices. The findings from the consultant and GP 
interviews were then compared to address completeness, convergence and 
dissonance of key themes (415). A number of additional factors were raised 
by consultants and GPs in relation to factors influencing referral patterns, for 
which data had not previously been collected on a national basis in Ireland. 
An assessment of these factors (family risk of breast cancer, mastalgia and 
seasonal variation) were subsequently added to the quantitative component 
of the study.  
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6.6.4  Study 4:  Impact of centralisation on breast cancer referral patterns  
Secondary data analysis of the National Cancer Registry database was used 
to investigate the impact of centralisation on breast cancer referral patterns. 
Both the consultants and GPs highlighted the impact of centralisation of 
cancer services on referral patterns, but this had not yet been quantified in 
Ireland, as the centralisation process was only completed in 2009.  Whilst it 
is too early to show a difference in survival rates following the policy of 
centralisation (5-year survival rates for patients referred from 2010 onwards 
will be available after 2015), it is possible that stage of disease at diagnosis 
and a number of process outcomes may be seen at this early stage. To 
broaden the range and depth of the research, secondary data analysis was 
conducted with anonymised datasets from the National Cancer Registry of 
Ireland (NCRI) to compare breast cancers diagnosed in 2008 (pre-
centralisation) with those diagnosed in 2010 (immediately post-
centralisation), in relation to method of presentation, proportion of patients 
who were treated in cancer centres, stage of disease at diagnosis and 
waiting times for diagnosis and treatment.  
 
6.7  Analysis of findings 
In the interpretation of the overall results, convergence assessment was 
used to review the level of convergence across all studies, i.e., to what 
extent does a coherent picture about causal relationships emerge from the 
data. Completeness assessment was conducted by comparing each data 
source,  highlighting similar and unique contributions to the research 
question and examining what is missing from the analysis (415).  
 
A visual model of the points of integration in this mixed-methods study can 
be seen in Figure 6.2 below. The initial exploratory study (Study 1) was used 
to develop the qualitative studies (Study 2 and 3). Initial findings in Study 2 
resulted in expansion of the mapping exercise in Study 1 to include 
additional parameters to answer the questions raised. Hypotheses were 
generated in Study 2 with hospitals consultants, which were elaborated on in 
Study 3 with GPs. The results of the two qualitative studies were also 
compared for agreement, partial agreement, silence or dissonance. There 
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was complementarity between studies, in that findings from several 
perspectives addressed the research question.  The hypotheses generated 
in the qualitative studies (Study 2 and 3) were tested in Study 4 with a 
national quantitative dataset.  The results of Study 4 confirmed the initial 
trends mapped in Study 1 and expanded on the interpretation of referral 
trends discussed at the qualitative stages.  The overall interpretation of 
results used convergence assessment and completeness assessment to 
assess the level of convergence across all studies.   
 
Study 1: Quantitative  
study: mapping of 
referral patterns
Study 4: Quantitative 
analysis of NCRI 
database: impact of 
centralisation 
Study 2: 
Qualitative study 
with hospitals: 
Factors influencing 
GP  referrals 
Study 3: 
Qualitative study 
with GPs: Factors 
influencing GP 
referrals 
Development
Hypothesis testing 
Expansion 
 
Figure 6.2: Integration of studies in a mixed methods design. 
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The research question for this thesis could not be answered using a single 
method alone. Nor did it lend itself a simple left to right flow. The individual 
studies related an organic way e.g. Study 4 was not interpretable without 
reference to other studies.  The iterative sequential mixed method design 
chosen for this thesis added an additional layer of meaning, facilitating the 
completion of the loop. 
 
6.8  Summary  
Examination of the National Cancer Registry data was the most 
comprehensive method of investigating trends in diagnosed breast cancers.  
However, this approach alone would not explain the reasons for referral, in 
particular the benign referrals, where the biggest changes had occurred.  
Interviews with hospital consultants were chosen as the research method to 
elicit the broad factors influencing referrals to hospital breast clinics from the 
hospital viewpoint and interviews with GPs were carried out to examine the 
factors influencing GP referral decisions.  
 
A number of patient factors have been described in the literature which can 
affect GP referral decisions, in addition to the patient’s medical condition e.g.   
age, anxiety, socio-economic group. Patient interviews did not form part of 
this research as the phenomenon under investigation was the GP referral to 
specialist units, as opposed to the patient presentation to primary care. 
Interviewing patients would have provided an insight into patients’ 
perceptions of why the GP did or did not refer them to specialist centres but 
would have not have addressed the research question as to the actual 
factors influencing GP referrals.   
 
Factors influencing patient presentation to primary care has been researched 
previously for cancer in general (419-424) and for breast cancer specifically 
(425-431). Using a meta-ethnographic approach, Khakbazan et al. (432) 
investigated the factors influencing patient delay in patients with breast 
cancer symptoms. Eight key concepts were identified, which included 
symptom detection, interpretation and monitoring, emotional reaction, social 
reaction, priority of medical help, personal-environmental factors and 
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appraisal of health services in terms of accessibility and acceptability. Whilst 
the focus of this thesis was on factors influencing the GP referral, any delay 
in presentation to the GP will have an impact on subsequent decisions, 
treatment options and prognosis. 
 
Given the complex and ‘real world’ nature of the study, a pragmatic approach 
was used for the research design. The dual role of the researcher as PhD 
candidate and health service employee was both challenging and useful. 
Researcher reflexivity was employed to address the challenge of potential 
biases arising from this dual role. The advantages of working in the health 
services at the time of the research included:  
 
• the identification of an existing issue in the health service which 
required investigation  
• the design of a study which was feasible in relation to availability of 
data and required minimal time and input from overstretched health 
personnel  
• the enhanced possibility of research outcomes in the areas of 
research impact, policy impact and service impact, as health service 
personnel advised on the process and key areas requiring 
investigation throughout the process 
 
Mixed-methods were chosen as the most appropriate and comprehensive 
method to answer the research question. Based on the rationale and overall 
methodological approach described in this chapter, the next chapters 
(Chapters 7 – 10) detail the methodology and results of each of the four 
inter-connected studies of this thesis.  
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 Chapter 7:  Study 1: Referral Patterns   
  
7.1  Introduction  
This thesis, based on a recommendation from the Health Information and 
Quality Authority (HIQA), aimed to explore the referral and triage patterns in 
the Symptomatic Breast Disease (SBD) units in Ireland. 
 
In 2009, HIQA conducted a national review of Symptomatic Breast Disease 
(SBD) services in Ireland (6) which found significant hospital and regional 
variation in referral patterns from primary to secondary care.  HIQA made a 
specific recommendation to investigate referral processes in SBD clinics 
“aimed at understanding and addressing any unnecessary variations in 
referral or triaging practices between the designated centres and their 
referring clinicians”  (6) (p.75).        
 
The centralisation of breast cancer surgery in Ireland was completed in 2009.   
 
7.2  Aim and objectives 
 
Aim:  
To examine GP referral patterns to SBD units in Ireland  
 
Objectives:  
• To examine the pattern of GP referrals to SBD units in Ireland over 
time (volume of referrals, triage categorisation, cancers detected)  
• To examine diagnostic yield (proportion of GP referrals diagnosed as 
breast cancer), over time (pre- and post-centralisation) 
 
7.3  Study design   
This study was an exploratory mapping study to examine breast cancer 
referral patterns in Ireland and constitutes one component of the mixed-
methods approach used for this thesis.   
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Data from the Symptomatic Breast Disease units (n = 9) were analysed for 
patterns and trends in GP referrals.  The results of this initial mapping study 
were used to inform the development of the subsequent qualitative studies. 
This strategy ensured that the qualitative interviews were underpinned by 
local and national data, which helped to identify tangible reasons for variation 
in referral and triage patterns, as identified in the HIQA report. Morse’s 
taxonomy of mixed-methods design (417) describes this approach as a 
‘development’ function in mixed-methods research. 
 
During the pilot qualitative studies with hospitals, additional phenomena 
relating to referrals which warranted further investigation were raised in the 
interviews.  A decision was made to expand this mapping study to include an 
exploration of certain types of referral, as these particular referral patterns 
had not heretofore been investigated on a national basis in Ireland. These 
data were obtained through the lead clinicians participating in the qualitative 
interviews. For clarity of presentation, the methods and results for these 
additional components are reported with the findings of this initial mapping 
exercise. Additional data were collected to explore the following issues 
raised by hospital consultants as part of an iterative approach to this 
research:  
 
• Reported increase in referrals for family history of breast cancer 
• Reported increase in referrals for mastalgia (breast pain) 
• Reported increase in referrals during breast cancer awareness month 
in October each year 
 
Secondary objectives were added to the study as follows: 
 
Objective 3:  
• To determine the proportion of GP referrals to SBD units for family 
history of breast cancer 
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Objective 4:  
• To determine the proportion of GP referrals to SBD units for mastalgia  
 
Objective 5:  
• To determine if there is evidence of seasonal variation in breast 
cancer referrals 
 
7.4  Sample 
7.4.1  Data sources  
Data from the National Cancer Control Programme were used to map  
existing breast cancer referral patterns to identify trends (Table 7.1). The 
data used were routine data submitted by the cancer centres to the National 
Cancer Control Programme for the purposes of performance monitoring and 
assurance of compliance with the HIQA standards for Symptomatic Breast 
Disease (167).  These data are identified by hospital but do not contain any 
patient-identifiable data. The data are available to the public and are 
reported on the Health Service Executive (HSE) website as part of routine 
HSE performance monitoring.  Each cancer centre reports Key Performance 
Indicator (KPI) data for all patients referred to the Symptomatic Breast 
Disease service. These are reported in the HSE performance monitoring 
reports on the HSE website www.hse.ie and also in the NCCP annual reports 
for Symptomatic Breast Disease on the NCCP website 
www.cancercontrol.hse.ie  
  
Table 7.1:  Data sources  
a. 2006 data: NCCP review of activity in breast clinics (NCCP, 2009)(48) 
b. 2009 HIQA: HIQA national quality review of the SBD service (HIQA, 
2010)(6) 
c. 2009 NCCP: NCCP KPI data (NCCP, 2012)(3)  
d. 2010 NCCP: NCCP KPI data (NCCP, 2011)(12) 
 
 
7.4.2  Data variables  
Data variables included in this study were as follows:   
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 Objective 1:  
• To examine the pattern of GP referrals to SBD units in Ireland  
 
Variables: 
• Number of breast referrals (to each cancer centre and nationally)   
• Number of referrals triaged as urgent and as non-urgent (to each 
cancer centre and nationally)   
• Number of breast cancers detected (in each cancer centre and 
nationally)   
 
Objective 2:  
• To examine diagnostic yield (proportion of referrals diagnosed as 
breast cancer)  
 
Variables:  
• Number of referrals diagnosed as malignant (cancer)  
• Number of referrals diagnosed as benign (non-cancerous) 
 
These data were mapped for the years 2009 and 2010, and were presented 
both as national data and hospital-level data (Appendix E). These referral 
trends were provided to the participants in the hospital and GP interviews by 
post or by e-mail in advance of their interviews to facilitate the discussion on 
referral patterns.  
 
7.5  Analysis  
Objective 1: To examine the pattern of GP referrals to SBD units in Ireland  
(volume of referrals, triage categorisation, cancers detected).  
 
Descriptive statistical analysis was conducted to examine the following:  
7.5.1  Volume of referrals  
The data on number of new attendances every month to each of the cancer 
centres have been collected nationally by the NCCP since 2009. These data 
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were obtained from routine NCCP KPI data for the years 2009 and 2010 for 
this study.  In order to compare to referral patterns prior to centralisation, 
2006 data were obtained from a review of activity in the SBD units (48). 
 
7.5.2  Triage categorisation 
The NCCP dataset includes the triage category for all referrals and is divided 
into urgent and non-urgent referrals.  Referrals are triaged as urgent (to be 
seen in SBD clinic within 2 weeks) or non-urgent (to be seen within 12 
weeks), based on their presenting features. Categories of urgent and non-
urgent (early/routine) symptoms are outlined in the NCCP referral guidelines 
for GPs, as seen in Figure 7.1 below. A copy of the full GP referral guideline 
can be seen in Appendix A.  
 
 
Figure 7.1: Referral categories:  GP referral guideline for breast referrals.   
Source: National Cancer Control Programme, GP referral guideline 
 
7.5.3  Cancers detected and diagnostic yield  
Objective 2: To examine diagnostic yield (proportion of referrals diagnosed 
as breast cancer), over time.   
 
Studies in the UK have reported rates of diagnostic yield (proportion of 
referrals with a cancer diagnosis), also referred to as positive detection rates, 
of 6% to 10% (5, 43-46). Imkampe (47) compared diagnostic yields before 
and after the introduction of the 2-week rule for cancer referrals in the UK 
and found that the proportion of referrals diagnosed with breast cancer 
dropped from 10% in 1999 to 7% in 2003-2004, after the introduction of the 
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rule. The diagnostic yield in each cancer centre and nationally in Ireland was 
examined during this exploratory phase.  
 
HIQA reported emerging evidence of a decrease in diagnostic yields and 
also found geographic variation in diagnostic yields in their national audit 
carried out in 2009 (6).  In order to examine this phenomenon over time, 
NCCP full-year data for 2009 and 2010 for diagnostic yield were examined. 
The numbers of breast cancers detected each month in each of the cancer 
centres were obtained from these data.  
 
7.5.4  Family history of breast cancer  
Objective 3: To determine the proportion of referrals due to family history of 
breast cancer. 
 
Hospital consultants reported an increase in the numbers of patients referred 
for assessment of their family risk of breast cancer post-centralisation of 
services. The volume of referrals in this category had not heretofore been 
quantified on a national basis in Ireland.  An Irish study (179)(p.2961) 
reported that, while rapid-access breast clinics experienced “cluttering by 
low-risk women”, 10% of those with a benign diagnosis had a significant 
family risk and required assessment of future risk.  Inheritance of a mutated 
susceptibility gene is the underlying cause of 12% of breast cancers.  Strict 
adherence to referral guidelines is recommended for referral of patients with 
a family history of breast cancer (190). 
 
To investigate referral to SBD units for family risk, data were collected from 
hospitals on the proportion of GP referrals received for family history of 
breast cancer. A chart review was conducted in the SBD units of one 
month’s GP referrals to the breast units in 2011, to determine the proportion 
of referrals with family history of breast cancer as their primary reason for 
referral. Data were collected prospectively, as the reason for referral had not 
been routinely and consistently recorded in previous years.  
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7.5.5  Mastalgia 
Objective 4: To determine the proportion of referrals for mastalgia.   
 
Hospital consultants reported an increase in the numbers of patients referred 
for assessment of mastalgia post-centralisation of services. Similar to family 
risk, the volume of referrals in this category had not previously been 
quantified on a national basis in Ireland.   
 
The risk of cancer in a woman presenting with breast pain as her only 
symptom is extremely low (433). An audit of GP referrals for breast pain to 
rapid-access breast clinics in North Cheshire in the UK found that 23% of 
their referrals were for breast pain but there were no malignancies detected 
in this group (434).  Joyce et al.(186) recommended that women in Ireland 
under the age of 35 with mastalgia could be suitable for management in the 
primary care setting and outlined the resources in terms of time and cost of 
assessing these women in the hospital setting. 
 
To investigate this phenomenon, data were collected from hospitals on the 
proportion of GP referrals received for mastalgia. A prospective chart review 
was conducted in 8 hospitals of one month’s GP referrals to the breast units 
in 2011, to determine the proportion of referrals with mastalgia as the primary 
reason for referral.  
 
7.5.6  Seasonal variation  
Objective 5: To determine if there is evidence of seasonal variation in breast 
cancer referrals. 
 
Hospital consultants reported an increase in the number of GP referrals 
around the time of breast cancer awareness month in October each year, but 
this had not been examined on a national basis in Ireland.  The Cardiff 
Breast group noted some seasonal variation in their breast cancer referrals, 
with peaks observed in the spring and autumn (43).  
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In order to explore this hypothesis, the number of referrals and number of 
new breast cancers detected by month were examined using NCCP KPI 
data.  
 
7.6  Results  
The results from this study (Study 1) have been published as a report 
‘Review of Referral Patterns and Triage Processes in Symptomatic Breast 
Units’ in 2012 and is available on the NCCP website (3). 
 
Objective 1: To examine the pattern of GP referrals to SBD units in Ireland  
(volume of referrals, triage categorisation, cancers detected). 
 
7.6.1  Volume of referrals   
Figure 7.2 shows the total number of new attendances nationally to 
symptomatic breast units in 2006 (prior to centralisation), 2009 (during 
centralisation) and 2010 (immediately post centralisation). This includes 
referrals to all public hospitals for symptomatic breast disease, excluding 
patients who did not attend for their appointment (DNAs). The outcome in 
relation to benign diagnosis and breast cancers detected is also shown.  
 
These data represent the patients attending symptomatic breast services in 
the public hospitals and do not include the National Breast Screening 
Programme (BreastCheck) or the private hospitals. The Breast screening 
service and the symptomatic service are two separate but parallel services in 
the Irish health care system. This study examines GP referrals to the 
symptomatic service.  
National data collection on referrals to the SBD Units commenced in 2009.  
Data from 2006 is from an audit of symptomatic breast clinic activity in public 
hospitals undertaking primary surgical treatment of breast cancer (48). 
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Figure 7.2: GP referrals to symptomatic breast clinics. 
Source: Review of referral patterns and triage processes in Symptomatic 
breast units. O’Rourke (2012)(3).  
 
Figure 7.2 shows that new referrals to the symptomatic breast disease units 
in Ireland have increased rapidly, without a corresponding increase in breast 
cancer incidence. There were 23,575 new referrals for breast disease in 
2006, which increased to 32,249 new referrals in 2009 (48) and to 37,631 
new referrals in 2010, an increase of almost 60% in five years (12). The 
small decline in breast cancer incidence in the symptomatic service 
coincides with the national roll-out of the breast screening programme which 
is a separate service and is not included in this data. The reasons for the 
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overall increase in GP referrals to the symptomatic service and the 
proportionate reduction in diagnostic yield were explored in this study. 
 
Table 7.2:    Referrals to symptomatic service and breast cancers 
detected  
Year 2006 2009 2010 
Breast cancers detected 2,137 1,879 2,012 
Benign diagnosis 21,438 30,370 35,619 
Total referrals to symptomatic service 23,575 32,249 37,631 
Sources: National Cancer Control Programme (NCCP, 2009) (48) (NCCP, 
2011) (12) 
 
Table 7.2 shows the total number of referrals to the symptomatic breast 
service, the number of breast cancers detected and the number of benign 
referrals. The number of hospitals providing symptomatic breast clinics 
decreased to nine designated units in 2010 as part of the centralisation 
process in the public hospitals.  In individual symptomatic breast units,  the 
highest number of annual referrals was  4,913 referrals to Beaumont Hospital 
in 2009 and  5,738 referrals to Galway University Hospital in 2010. 
 
7.6.2  Triage categorisation 
Figure 7.3 displays the proportion of referrals  to symptomatic units triaged 
as urgent and non-urgent across all centers. While the total number of 
referrals to the symptomatic service increased nationally, the proportion of 
urgent referrals remained stable at 33% in both 2009 and 2010. These data 
were not available in previous years. 
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Figure 7.3: Triage categorisation. 
Source: Review of referral patterns and triage processes in Symptomatic 
breast units. O’Rourke (2012) (3).   
 
There was some variation in the proportion of urgent and non-urgent 
referrals between hospitals with a range  of 17% – 54% urgent referrals from 
GPs in 2009 and 15% – 47% urgent referrals in 2010. This may be due to 
variation in the population who present to each GP or may be due to the 
referral practices of individual GPs. There are currently no defined catchment 
areas for these hospitals and GPs can refer to any of the cancer centres. As 
the triaging of patient referrals by GPs occurs outside of the hospital, 
controlling for inter-hospital variation was not applicable and therefore 
clustering by hospital site was not applied.  
 
7.6.3 Diagnostic yields  
Objective 2: To examine diagnostic yield (proportion of referrals diagnosed 
as breast cancer). 
 
The HIQA review of Symptomatic Breast Disease (SBD) Services (6) 
highlighted significant variation between hospitals in the proportion of breast 
cancers detected.  
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Table 7.3: Diagnostic yield in breast referrals to symptomatic 
service 
Year  2006 2009 2009 2010 
Proportion of new 
referrals with breast 
cancer detected  
9.1% 5.6% 5.8% 5.3% 
Data source NCCP audit HIQA audit 
(7 months) 
NCCP NCCP 
  
Table 7.3 shows the proportion of new referrals to the symptomatic breast 
service with breast cancer diagnosed. An NCCP audit found that, in 2006,  
prior to centralisation of breast cancer services in Ireland, the proportion of 
referrals for breast disease that had breast cancer detected was 9.1% (48). 
 
In 2009, during the seven months of the HIQA review, 17 benign referrals 
were seen for every one cancer diagnosed (i.e., the proportion of referrals 
diagnosed with breast cancer was 5.6%, with a range between hospitals of 
2.6% - 7.1%).  The remaining referrals were seen and diagnosed as having 
benign conditions (6). Full-year 2009 data from the NCCP found a similar 
proportion of 5.8% (3). 
 
By 2010, the proportion of referrals diagnosed with breast cancer was 5.3% 
(12), with a range between hospitals of 4.2% - 7.1%, showing that while the 
proportion of cancers detected has fallen, the variation between hospitals 
reported in the 2009 HIQA review has reduced considerably.  
 
7.6.4  Cancers detected  
The number of new cancers detected was examined across SBD units. Of 
the 32,249 new attendances to SBD Units nationally in 2009, 1,879 had a 
primary breast cancer diagnosed.  Of the 37,631 new attendances in 2010, 
2,012 had a primary breast cancer diagnosed (12) (see Table 7.2). The 
number of new cancers diagnosed in individual cancer centres was highest 
in University Hospital Galway in 2009 (319 cases) and Cork University 
Hospital in 2010 (336 cases). 
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7.6.5  Family history of breast cancer  
Objective 3: To determine the proportion of referrals due to family history of 
breast cancer. 
 
To investigate specific referral patterns in relation to family history, a chart 
review was conducted to assess GP referrals for one month to the 
Symptomatic Breast Disease Units (n = 2,980 referrals). All SBD units except 
Galway agreed to participate in the study on family history referrals.  
 
 
Figure 7.4: Proportion of referrals for assessment of family history. 
Source: Review of referral patterns and triage processes in Symptomatic 
breast units. O’Rourke (2012) (3). 
 
 
LGH: Letterkenny Regional Hospital   MMUH: Mater Misericordiae 
University Hospital  
ULH: University of Limerick Hospital  BH: Beaumont Hospital  
WUH: Waterford University Hospital SJH: St James’ Hospital  
CUH: Cork University Hospital SVUH: St Vincent’s University 
Hospital  
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Findings indicated that an average of 9.1% of GP referrals were for 
assessment of family history of breast cancer as the primary reason for 
referral, ranging from 3.9% to 14.2% between hospitals. Clustering by 
hospital site was not applied, as the reason for referral (family history) is 
based on the GP referral, which can be to any one of the SBD units 
nationally. Figure 7.4 shows that the highest proportion of referrals for 
assessment of family history was seen in St Vincent’s University Hospital 
(Dublin) and Cork University Hospital, with the lowest in Waterford and 
Limerick.  
 
For the data on family risk and mastalgia, patients were allocated to these 
categories if mastalgia or family risk was their primary reason for referral. 
E.g. if a patient presented with family risk and a breast lump, they were not 
included as a family risk referral for this research.  Therefore the number of 
patients presenting with family history or mastalgia is likely to be higher.  
 
7.6.6 Mastalgia 
Objective 4: To determine the proportion of referrals for mastalgia (breast 
pain). 
 
The chart review also assessed GP referrals for mastalgia for the same 
month to the SBD Units (n = 2,980 referrals). All SBD units except Galway 
agreed to participate in the study on mastalgia referrals.  
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Figure 7.5:  Proportion of referrals for mastalgia. 
Source: Review of referral patterns and triage processes in Symptomatic 
breast units. O’Rourke (2012) (3). 
 
Findings indicated that an average of 15.3% of GP referrals were for 
mastalgia as their primary reason for referral, ranging from 10% to 18.6% 
between hospitals. Inter-hospital variation was not examined, as the reason 
for referral (mastalgia) is based on the GP referral, therefore clustering by 
hospital site was not applied, for reasons detailed earlier.   
 
Figure 7.5 shows that the highest proportion of referrals for mastalgia was 
seen in St Vincent’s (Dublin), Letterkenny (satellite unit in Donegal) and 
Limerick, with the lowest in Waterford.  
 
7.6.7 Seasonal variation  
Objective 5: To determine if there is evidence of seasonal variation in breast 
cancer referral patterns. 
 
Figure 7.6 shows the total number  of referrals (urgent and non-urgent) seen 
in the SBD units, by month, over the 3 years 2009 - 2011. 
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Figure 7.6:  Number of referrals to SBD units per month. 
Source: Review of referral patterns and triage processes in Symptomatic 
breast units. O’Rourke (2012) (3). 
 
In 2009, the highest number of referrals was seen in October, which 
corresponds with reports of an increase in referrals during Breast Cancer 
Awareness Month (annually in October).  In 2010, there were several peaks 
and troughs throughout the year. Data for 2011 shows peaks in  March, May 
and November.  When all three years are examined together, the month in 
which most referrals are seen is November (average 3,396 referrals), 
followed by March (averge 3,355 referrals). There does not appear to be a 
marked increase in October.  
 
An alternative explanation for the perceived ‘October surge’ could be that 
breast clinics may have been quieter during the summer months due to 
patients and staff being away on holidays. The month the patient is seen 
may not be the same month as they are referred eg. patients may be 
referred at the end of one month and are seen the following month if they are 
referred urgently or possibly later if they are non-urgent referrals.   
 
Statistical analysis using time series analysis (Poisson segmented 
regression) is recommended to examine this phenomenon in more detail. 
Interrupted time series analysis is the strongest quasi-experimental study 
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design to analyse longitudinal effects of interventions (435-437), including 
natural experiments or ‘real world events’, such as this study.   
 
A minimum number of data points and a sufficient number of observations at 
each data point is recommended.  Detecting cyclical patterns of seasonal  
variation  requires a baseline series that spans enough time periods. A 
minimum of 50 time points is recommended for using these models (435). 
Therefore, as the data available did not reach this minimum criterion, this 
analysis was not possible with the data available. It is recommended that 
additional statistical analysis is carried out on this phenomenon when over 
four years national data is available.  
 
ARIMA (autoregressive integrated moving averages) models could also be 
used to smooth out curves and test for trend. However, this would require an 
increased number of data points, not currently available.  
  
 
Figure 7.7:  Number of newly-diagnosed breast cancers, by month. 
Source: Review of referral patterns and triage processes in Symptomatic 
breast units. O’Rourke (2012) (3). 
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Figure 7.7 shows the number of newly-diagnosed breast cancers in the 
Symptomatic Breast Units by month. This is based on the date of the 
histology report, which is normally within 10 days of attendance.  For patients 
attending the Triple Assessment Clinic (TAC), the biopsy is normally taken 
on the day of attendance.  Triple Assessment Clinics provide clinical 
examination, diagnostic imaging (e.g., mammogram) and biopsy for patients 
referred to the clinic requiring triple assessment. 
 
In 2009, the months in which the highest numbers of breast cancers were 
diagnosed were July (184) and November (176).  In 2010, there were several 
peaks in numbers of cancers diagnosed, in April (188), July (185) and 
September (186). Data for 2011 show the highest peak in November (212). 
When all three years are examined together, the month in which most 
cancers are diagnosed is July, followed by September and November. 
Overall, there does not appear to be a seasonal trend or seasonal variation 
in the detection of breast cancers in the SBD units in Ireland. Further 
analysis with longer-term data is required. 
 
7.7  Summary  
The pattern of referrals to the SBD units shows an increase in referrals but 
without a corresponding increase in breast cancers detected, i.e., the 
increase in referrals is comprised of predominantly benign (non-cancerous) 
referrals.  The factors influencing this trend were explored in the qualitative 
studies presented in the next chapters.  
 
In 2011, of the total of 37,955 referrals to the SBD units in Ireland, 
approximately 3,454 patients were referred for assessment of breast cancer 
family risk (9.1%), with an additional 5,807 referrals for mastalgia (15.3%). 
Management of these women in primary care would significantly reduce the 
number of referrals to Symptomatic Breast Units.  Factors influencing these 
types of referrals and recommendations for interventions were explored in 
the qualitative studies with both hospital consultants and GPs.  
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While increases in referrals were seen in some years in the months following 
breast cancer awareness campaigns, this was not consistent across all 
years.  Statistical analysis using time series analysis over a longer time 
frame is recommended to analyse seasonal variation in more detail.  
 
The HIQA report recommended a review of referral and triage processes to 
assess variation in referral patterns (6).  This current review of referral 
patterns has established that the level of variation between hospitals found in 
the 2009 HIQA review has decreased considerably by 2010. The HIQA 
review was based on data for the first 7 months of 2009, before national 
availability of breast cancer screening and before centralisation of breast 
cancer surgery was complete.  The interventions which have been 
implemented since this time include:  
 
• the completion of centralisation of breast cancer surgery (December 
2009) 
• the development of GP referral guidelines and standardised referral 
forms (2009) 
• the completion of the national roll-out of the national breast screening 
programme (December 2011)   
 
Since the implementation of these initiatives, the major geographical 
variation in referral patterns seen in 2009 has declined substantially. 
However, the volume of referrals continues to increase. To investigate this 
phenomenon, an in-depth qualitative study with consultants in the cancer 
centres was designed as the second study (Study 2) in this thesis to explore 
their views on the rapid increase in referrals to SBD units, in the absence of 
an increase in cancers detected. 
 
In addition, a before-and-after study was carried out using the National 
Cancer Registry database of breast cancers diagnosed pre-centralisation 
(2008) and post-centralisation (2010) to examine the impact of centralisation. 
This study is described in Chapter 10. 
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 For the qualitative studies (Study 2 and 3), the data generated in Study 1 
was circulated to all participants in advance of the interviews, to facilitate 
targeted discussion (Appendix E).  Participants were asked at interview to 
comment on the data on breast cancer referral patterns and to identify local 
and national factors influencing referrals.  
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Chapter 8: Study 2: Qualitative Study with  
Hospitals  
 
8.1  Introduction  
Hospital consultants have expressed concerns about the increasing volume 
of GP referrals to symptomatic breast clinics in Ireland (1, 2).  The first of the 
qualitative studies (Study 2) for this thesis was conducted with hospital 
consultants in the symptomatic breast units, or their nominee, to explore the 
data trends of referrals generated in Study 1. Participants were asked their 
views on local and national factors influencing GP referrals and for 
recommendations on interventions which could be implemented to address 
these. 
 
The HIQA national review of the Symptomatic Breast Services in 2009 found 
variation in referral patterns from primary to secondary care and 
recommended that  the HSE review referral processes to examine variations 
in referral practices between the designated centres and their referring 
clinicians (6).  Study 1 of this thesis investigated whether these variations 
persisted post-centralisation of cancer services. Although the variation was 
not as pronounced as previously, some variation persisted.  The trend of 
increasing numbers of referrals to the breast units was mapped in Study 1, 
showing an increase in GP referrals of almost 60% in 5 years. The reasons 
for this increase formed the focus of enquiry for this qualitative study with 
hospital consultants.  
 
8.2  Aim and objectives  
This qualitative study sought to identify factors influencing referral patterns 
by examining both the medical and non-medical influences on referrals from 
GPs to Symptomatic Breast Disease (SBD) Units in Ireland, from the 
perspective of SBD unit consultants (or their nominee).  
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Aim:  
• The aim of this study was to explore the perceptions of hospital staff 
on the factors influencing GP referrals to Symptomatic Breast Disease 
Units in Ireland.  
 
Objectives:  
Primary objectives:  
• To explore perceptions of hospital SBD teams on the factors 
contributing to the increase in GP referrals to SBD units in Ireland. 
• To explore potential reasons for the decrease in proportion of GP 
referrals diagnosed with cancer.  
• To ascertain the views of hospital SBD teams on the accuracy and 
adequacy of GP referrals.  
 
8.3  Design 
The research with hospitals was qualitative in design, using in-depth semi-
structured interviews. This method was chosen as detailed exploration of the 
views and experiences of participants was required. Interviews are 
considered the most suitable for this exploratory research, investigating 
opinions, values and motivations (418).  Semi-structured interviews were 
conducted with the hospital consultant or his/her nominee in each of the 
eight specialist cancer centres and the satellite centre in Letterkenny, Co 
Donegal (See Figure 8.1). 
 
8.3.1  Study participants  
All SBD Units were invited to participate in the study – the eight designated 
cancer centres and the unit in Letterkenny, Co Donegal, which is a satellite 
of the SBD Unit in Galway University Hospital. The key informant in each 
hospital was the Lead Clinician for Symptomatic Breast Services or their 
nominee. Figure 8.1 shows the location of these hospitals within the four 
HSE regional networks.  
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Figure 8.1:  Designated cancer centres and cancer networks. 
Source: Health Atlas 
 
These 9 hospitals are located in the four HSE geographical regions 
(networks), as outlined in Table 8.1 below.  
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 Table 8.1:  HSE Cancer Networks  
HSE Region / 
Network  
Hospital  
 Dublin North East  
 (DNE) 
Beaumont Hospital (BH), Dublin  
Mater Misericordiae University Hospital (MMUH), 
Dublin  
 Dublin mid Leinster 
 (DML) 
St James’s Hospital (SJH), Dublin  
St Vincent’s University Hospital (SVUH), Dublin   
South  Cork University Hospital (CUH)  
University Hospital Waterford (UHW)  
West  University of Limerick Hospital (ULH) 
University Hospital Galway (UHG) 
Letterkenny General Hospital (satellite unit) (LGH) 
 
8.3.2  Recruitment and response rate 
A letter of invitation was sent to each clinical lead for SBD services in the 9 
hospitals. This was followed up with a phone call where necessary.  All units 
agreed to participate in the study.  
 
8.4  Procedure  
The principles outlined by Kvale (438) for qualitative research interviewing 
were employed, including questions which were introductory, follow-up, 
prompts and probes, direct and indirect.  The use of silences was also used 
to encourage the participants to elaborate on points raised (439).  
 
To facilitate targeted discussion on trends and variances, national and 
hospital-level data from Study 1 was circulated to participants in advance of 
the qualitative interviews (Appendix E). This helped to avoid or move beyond 
‘talk tracks’ focussed on participant’s own areas of interest (438). At 
interview, the participants were asked to comment on the possible reasons 
for the upward trend in referrals both locally and nationally.  This approach 
served to overcome the lack of depth of the quantitative data available and 
provide richness through a qualitative approach.  Where data were 
presented by hospital, each hospital was given the identity code for their 
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hospital only and asked at interview to comment on any variation between 
their hospital and others, and on possible reasons for this variation, if known.  
 
The hospital interviews were conducted between December 2010 and May 
2011. The Lead Consultant for each SBD Unit was invited to participate in a 
Key Informant Interview lasting approximately 40 minutes. The interview was 
based on a topic guide (Appendix F), which was circulated to participants in 
advance of the interview, along with a participant information leaflet and 
consent form (Appendix G, H).  
 
Interviews were conducted either face-to-face (n = 7) or by telephone (n = 2), 
based on the preference of the individual clinicians. Telephone interviews 
can be used productively in qualitative research and the method of 
interviewing (telephone vs. face-to-face) has been shown not to influence 
responses (440, 441).  They are considered a more practical approach for 
more geographically-dispersed participants and for reluctant respondents.  
 
Telephone interviewing allows participants to feel relaxed and can facilitate 
disclosure of sensitive information (442), with considerable value to health 
services research (443).  
 
There are a number of limitations with telephone interviewing. Irvine (444) 
found that the duration of telephone interviews was generally shorter than 
face-to-face, as a result of participants speaking for less time and providing 
more succinct responses, with less detail or elaboration. The absence of 
visual cues may also affect the depth of meaning (445). However a number 
of studies have found the quality of data from telephone interviews not to be 
noticeably different from face to face interviews (446) (447)  and evidence is 
lacking that telephone interviews produce lower quality data (442) (443). 
 
One pilot interview was conducted prior to commencement of the study and 
this interview was included in the study as there was no change to the study 
instrument.  The same interviewer (NO’R) conducted all interviews. Written 
consent was obtained from all participants.  
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The interviews were arranged at a time and place to suit the interviewee and 
were digitally recorded with the consent of the participants and transcribed 
verbatim.  Field notes and attributes such as gender and HSE network were 
also recorded and linked to each case using NVivo software. Typed 
transcripts were returned to participants to check for accuracy.  The identity 
of the participants was kept confidential – a participant study number was 
allocated to each hospital at the point of data collection.  Any information 
which could identify the respondent or hospital was removed and stored in a 
secure codebook (see section 8.4.3). The presentation of the results was 
anonymous; management of data was through use of codes.  Interviews 
ranged from 28 to 58 minutes, averaging 42 minutes.  
 
The lead clinicians who participated were six Consultant Breast Surgeons 
and one Consultant Radiologist. In the remaining two hospitals, the Cancer 
Nurse Specialist was nominated by the lead consultant to represent them. 
The participants who took part by telephone interview were two consultant 
breast surgeons. 
 
8.4.1  Interview topic guide 
The review of the literature found that variances in referrals, which are not as 
a result of clinical need, may be as a result of patient/clinical, provider or 
health service factors (15, 183, 206). Additional factors such as media and 
publicity are also known to impact on referral patterns (5, 46, 210, 227, 329). 
These broad categories were used to develop the interview topic guide. 
 
Figure 8.2 shows a conceptual map for the study instrument, which was 
informed by the literature.  
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Figure 8.2: Conceptual map for this study. 
 
Open-ended questions were used in the interviews and, if required, prompts 
were also used, as shown in Table 8.2 below. The interview topic guide and 
participant information leaflet are contained in Appendix F and G.   
 
Table 8.2: Summary of interview topic guide  
• GP referral patterns to Symptomatic Breast Disease Units.   
• Factors influencing local referral patterns:  
 -   health service factors  
 -   patient factors  
 -   provider factors  
• Possible actions/solutions 
 
8.4.2  Research ethics  
Research ethics applications were made to the Research Ethics Committee 
in each of the 9 participating hospitals. Research ethics approval was 
received from the 9 hospitals between December 2010 and May 2011. 
Copies of approval letters can be found in Appendix I. 
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8.4.3  Data handling and data confidentiality  
Data storage procedures are in accordance with the RCSI Division of 
Population Health Sciences Data Handling Guidelines. Interviews were 
digitally recorded, transcribed and stored electronically on a password-
protected computer. Details which could be identifiable from individual 
interviews were anonymised in any reports and recorded in a codebook. A 
participant study number was allocated at the point of data collection. As 
there are only two cancer centres in most of the regional networks, the 
network has not been identified in the results.  
 
The measures to ensure confidentiality of collected data  also complied with 
the HSE Information Security Policy (V2.0 Nov 2010), the HSE Data 
Protection Breach Management Policy (2010), the National Hospitals Office 
Code of Practice for HealthCare Records Management (2007) and the HSE 
Standards and Recommended Practices for Healthcare Records 
Management (V3.0 2011). 
 
8.5  Data Analysis  
8.5.1  Analytic structure 
Qualitative thematic analysis was carried out using NVivo10 to identify 
emerging themes.  Credibility and interpretation was established through the 
‘constant comparative method’ (448, 449) involving constant and repeated 
checking and interpretation of data (450).  Two people checked the de-
identified interview transcripts for accuracy. The second person (HM) was a 
breast cancer nurse specialist familiar with the structure of the breast 
service.  Using analytic software such as NVivo facilitates an audit trail which 
ensures that the results and recommendations are routed in the data (451). 
 
The analytic strategy for this study is based on the principles of thematic 
analysis (452) and is adapted from a QDA NVivo training workshop (453). 
There were eight discrete cycles of analysis for this study. These cycles  
involved three separate cycles of coding, two cycles of managing codes, one 
for data reduction through consolidating codes into a more abstract 
theoretical framework and three using writing itself as a tool to prompt 
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deeper thinking of the data (451), leading to findings from which conclusions 
could be drawn.  
 
Phase 1: Generating initial ideas  
Each transcript was read several times for data familiarisation and transcribed 
verbatim. Broad open coding of each transcript was conducted in QSR 
NVivo10 to deconstruct the data into general themes, using thematic analysis. 
The constant comparative method (448, 449) or ‘accuracy of fit’ (454) was 
used by comparing themes across different cases. The data were broken 
down into discrete incidents (454) or units (455), which were then coded into 
thematic categories. These categories were not pre-defined but, rather, 
derived from the data, through a process of inductive reasoning.  
 
Clear labels and definitions were assigned to each theme as rules for inclusion 
(449). Researchers should stay “as close to the construction of the world as the 
participants originally experience it”  (p.18)(449), therefore participant’s own terms 
and language were used to construct initial themes.  These definitions were 
recorded and stored in NVivo to ensure consistency in coding throughout the 
process. The same person (NO’R) carried out the coding for all phases.    
 
Coding was independently reviewed by a Breast Care Nurse Specialist (HM) from 
the National Cancer Control Programme who assisted the study through 
interpretation of observations and confirmation of findings. HM attended four of the 
hospital interviews and listened to all of the audio recordings. The coding structure 
was reviewed with this independent reviewer and any differences were discussed 
and resolved. These steps were taken to enhance the validity of the study.  
 
Phase 2: Categorisation of codes into potential themes 
Themes identified and coded in Phase 1 were re-ordered into categories of 
themes by grouping related themes under these categories and organising 
them into a framework. In this phase, smaller related categories were 
merged and some larger categories were distilled into several themes and 
re-labelled where necessary. Each coding phase was saved in the NVivo 
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programme to allow for review and revision. This also served as a tool for 
transparency and audit.  
 
Phase 3: Reviewing themes 
The restructured themes were broken down into sub-themes to offer more in-
depth understanding of the highly qualitative aspects under scrutiny such as  
attitudes, beliefs and behaviours coded to these categories, and to offer 
clearer insights into the meanings embedded therein, a process referred to 
as  ‘coding on’. Divergent views and negative cases were used to challenge 
generalisations (451).  As Taylor and Bogdan (456) describe “the researcher 
refines these concepts, identifies their properties, explores their relationships 
to one another and integrates them into a coherent explanatory model” 
(p.126). 
 
Phase 4: Data reduction 
This involved consolidating the codes into a more abstract and conceptual 
map of a final framework of codes. The Theoretical Domains Framework 
(TDF) (244) was used to further analyse the data following the initial 
identification of themes.  This framework was not applied a priori. This 
approach was chosen to ensure that the initial analysis did not become 
‘hijacked by a method’ or ‘writing to the method’ as described by Bazeley 
(451).  This allowed the data to speak for itself, without a predefined 
framework and facilitated the emergence of additional unprompted themes 
(450).  Once the initial themes and sub-themes developed in Phase 3 were 
completed, these were also mapped onto the 14 domains of the Theoretical 
Domains Framework, Version 2 (244, 245), as described in Chapter 5. This 
double coding framework can be seen in Appendix J.  
 
The fourteen domains of the Theoretical Domains Framework are as follows;  
skills; knowledge; memory attention and decision processes; behavioural 
regulation; environmental context and resources; social influences; 
professional/social role and identity; beliefs about capabilities; optimism; 
beliefs about consequences; intentions; goals; reinforcement; and emotion.  
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Coding reliability was checked by a second coder trained in the Theoretical 
Domains Framework (AF).  
 
Phase 5: Summary statements 
Summary statements were written against smaller sub-themes to offer a 
synthesis of the coded content they contained; using writing itself as a tool to 
prompt deeper thinking about the data (451).  
 
Phase 6: Analytical memos 
Analytical memos were written against the major themes, to summarise the 
content of each category and its codes, and to propose empirical findings 
against such categories. These memos considered key areas such as 
content of coding clusters, coding patterns and linking data to participant 
attributes, using matrices. Themes were situated in the storyboard – the 
relatedness of individual themes to other themes and their relevance to the 
research question were considered. Field notes and demographics were 
reviewed to examine any patterns linked to participant’s profiles. Findings 
were considered in the context of the current literature and gaps in the 
literature were also identified.  
 
Phase 7: Cross tabulation with attributes 
This phase included testing, validating and revising analytical memos to self-
audit proposed findings by seeking evidence in the data beyond textual 
quotes to support the stated findings and seeking to expand on deeper 
meanings embedded in the data. This process involved interrogation of data, 
drawing on relationships across and between categories and cross-
tabulation with demographics. This phase resulted in evidence-based 
findings, as there is a clear audit trail linking each finding with the data. 
Lincoln and Guba  describe how “The process of comparative analysis 
stimulates thought that leads to both descriptive and explanatory categories” 
(p.341)(455). 
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Phase 8: Findings and discussion 
This final phase involved the synthesis of analytical memos into a coherent, 
cohesive and well-supported outcome statement or findings report. “Themes 
only attain full significance when they are linked to form a coordinated picture 
or an explanatory model” (p.9) (457). 
 
One weakness of qualitative research identified by Bazeley (457) is that 
researchers can rely simply on the presentation of key themes supported by 
quotes. She recommends that the first draft of qualitative results is written 
without quotes to ensure that the results are based on the wider evidence, 
rather than superficial reporting of themes using segments of text as 
evidence. This approach was used for this research and verbatim examples 
from the transcribed interviews were identified for inclusion only after the 
identification of key themes and writing up of initial findings.  
 
8.5.2  Research quality  
A number of the steps taken to ensure the rigour and validity of this research 
have been outlined in the analytic strategy above. Confirmability of findings, 
trustworthiness, consistency and dependability are all terms used to describe 
reliability in qualitative research (450). The use of in-depth interviewing as 
the study method increased the richness of the data, thus increasing 
credibility and internal validity (458). 
 
The documenting of each phase of analysis in NVivo provided an audit trail 
throughout the analytical process (451). Memos, field notes and attributes 
were documented and linked to the cases in NVivo. Deviant case analysis 
was used to ensure that outliers were not ignored (459).  Quotes were used 
to illustrate findings and provide validity (460). As recommended by Barbour 
(461), a second individual reviewed the coding framework at two stages 
during the process, firstly a breast care nurse (HM) reviewed the initial Phase 
1 coding of the transcripts and secondly a PhD scholar familiar with the TDF 
framework (AF) reviewing the Phase 4 coding, where the codes were 
mapped onto the theoretical framework.  
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With regard to transferability, every symptomatic breast unit in the country 
participated in this research. A theoretical framework was used for the 
analysis to enable the transfer of findings at a theoretical level.  The 
development and circulation of a report on the findings to the SBD unit 
consultants was used to enable a discussion of findings and 
recommendations at policy and strategy level  (Review of Referral Patterns 
and Triage Processes in Symptomatic Breast Units – a hospital perspective, 
2012)(3).      
 
8.5.3  Models and frameworks   
Michie’s COM-B model with its Theoretical Domains Framework (244)  was 
used as the theoretical framework for this study, as described in Chapter 5. 
Informed thematic analysis was conducted with reference to the Theory of 
Behaviour Change.  This model, with its components of capability, 
opportunity and motivation, was developed as a tool for designing and 
evaluating behaviour change interventions (251). The TDF framework was 
considered appropriate to this study given the context of implementation of 
an evidence-based policy of centralisation of breast cancer services in 
Ireland which included GP referral guidelines.  
 
Theory can assist the identification of the mechanisms of behaviour change 
in clinical practice, allowing programmes and health systems to focus on the 
areas requiring change in order to implement an intervention. The 
development of effective intervention strategies using behaviour change 
theories has been shown to be effective (355). This qualitative research 
sought to understand and explain professional and social processes of 
referral patterns from the perspective of the hospital SBD unit consultant or 
his/her nominee. 
 
8.6  Results  
Table 8.3 shows the domains identified in hospital interviews, ranked in order 
of the frequency with which they were discussed. The main TDF domains 
emerging from the hospital interviews were environmental context and 
resources (volume of referrals, ease of access, diagnostic imaging), 
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knowledge (knowledge, education) and social influences (media and 
publicity, patient expectations). Domains which did not emerge as prominent 
during the hospital interviews were intentions, goals and emotion. The results 
are presented in order of decreasing prominence.  
 
A small number of comments in one hospital interview were retracted during 
the transcript review stage. These were deleted from the transcripts and 
were not used in the analysis. Based on this learning and feedback from 
participants on the time required to review the transcripts, a decision was 
made not to use transcript review for the subsequent GP qualitative study. 
However, GPs were given the option of reviewing the transcript if they 
wished.  
 
Table 8.3: Ranking of theoretical domains: hospital interviews     
Primary TDF domain  
References from 
hospitals  
 1 : Environmental context & resources 219 
 2 : Knowledge 80 
 3 : Social influences 73 
 4 : Memory, attention & decision  processes 61 
 5 : Skills 59 
 6 : Behavioural regulation 44 
 7 : Beliefs about consequences 28 
 8 : Social/Professional role and identity 21 
 9 : Beliefs about capabilities 20 
10 : Emotion 15 
11 : Reinforcement 4 
12 : Optimism 0 
13 : Intentions 0 
14 : Goals 0 
 
Definitions of domains are taken from the TDF validation study by Cane et al. 
(245) and are based on definitions from the American Psychological 
Association’s Dictionary of Psychology (243). 
 
As the TDF framework was applied after initial coding was carried out, this 
framework did not inhibit the transcription and analysis of the transcripts.  
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A number of themes arose which did not fit the TDF domains which included:  
 
• Other cancers: participants spoke about service developments 
required for other cancers such as colorectal, testicular and 
gynaecological cancers, commenting that these were not as well 
developed as breast cancer services. 
• Mode of referral: the mode of referral (letter, fax, electronic) and the 
benefits and challenges associated with these modes of referral were 
discussed. 
 
These additional themes were not directly applicable to this study. The 
themes were coded but were not reported in the results. 
 
In presenting the results, quotes are included  to provide validity for the 
findings (460).  
 
8.6.1  Environmental context and resources 
Definition: Any circumstance of a person’s situation or environment that 
discourages or encourages the development of skills and abilities, 
independence, social competence, and adaptive behaviour. 
 
Themes mapped to this domain included: 
• Centralisation/reconfiguration  
• Public vs. private health services  
• Volume of referrals  
• Geographical factors  
• Health service factors: access to breast units, access to diagnostic 
imaging, breast screening, hospital-GP interface, resources and costs.  
 
A screen shot from NVivo in Figure 8.3 below shows the coding framework 
for the domain or ‘tree node’ of ‘environmental context and resources’, with 
its component ‘child nodes’.  
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Figure 8.3: Coding matrix within Nvivo (environmental context and 
resources). 
 
Centralisation / reconfiguration 
The centralisation of cancer services by the NCCP into eight designated 
cancer centres was seen as a positive development and participants shared 
a view that members of the public appear to have greater confidence in the 
new centralised service with specialist multidisciplinary teams. However, the 
overall decrease in number of units as part of the centralisation process has 
transferred additional referrals to the remaining units.  
 
“There has been a great turn-around since the NCCP.” (Hospital A) 
 
“I think the NCCP is doing a very good job. When this all started, we 
were all looking over our shoulders. We’ve much more ownership of the 
process now, we’re much more empowered.” (Hospital I)  
 
“When Hospital X closed in 2009, we started getting more referrals from 
Hospital X catchment area – it had an impact on our referral patterns as 
well.” (Hospital G) 
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Public vs. private services 
A proportion of patients are having their breast surgery carried out in private 
hospitals.  However, participants noticed a shift back to the public system 
since the designated cancer centres were established. Consultants felt this 
was due to confidence in the service and efficiency of the service. This 
phenomenon was observed by consultants in relation to patients who had 
private health care insurance but still wished to attend the public breast 
service. Thus, this phenomenon did not appear to be linked to austerity or 
recession.  It was also remarked that the cancer service in the public system 
was more comprehensive than in the private sector. Consultants expressed 
pride in the service they provided. 
 
“There is now confidence in public care with NCCP.” (Hospital A) 
 
“Because we’re so efficient with the public system, most of the 
patients are coming through the public system.” (Hospital H) 
 
“The other negative side of going private....they don’t actually get to 
see a breast nurse specialist, they don’t get the support systems in 
the private sector.” (Hospital B) 
 
Volume of referrals 
The increase in numbers being referred to the SBD Units was a common 
concern, with some participants expressing hope that the numbers will 
eventually level off. The increase in demand was also seen by some to be as 
a result of the quality of the service.  
 
“The current monthly referrals are at about 500, and that’s really 
exploded in the last 6 months.” (Hospital H) 
 
“It’s increased significantly over the last number of years.  There is a 
steady increase in referrals constantly.” (Hospital C) 
 
“We are victims of our own success.”  (Hospital I) 
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This research was conducted at a time when budgetary constraints were 
being introduced in hospitals and a moratorium had been placed on staff 
recruitment, placing additional pressures on existing staff. It is possible that 
staff perceived their overall workload to be greater. Alternative agendas may 
also have influenced responses, to support proposals for additional 
resources for their units. However, the increase in numbers of patients 
referred to the individual clinics is validated by the quantitative data from 
hospital Key Performance Indicators (KPIs).    
 
Geographical factors 
Geography, distance to travel and physical location were seen as factors 
influencing GP referral patterns.  Motorway infrastructure and availability of 
public transport were also seen to influence the hospital of choice.  The 
referral process of the National Cancer Control Programme facilitates 
referrals to any of the 8 designated cancer centres, giving GPs and patients 
a choice of where to be referred to. However, there was a belief that some 
patients attended several different units in order to get a second opinion. 
Some participants commented on the distance the patients had to travel to 
the breast units, particularly in rural areas. However, there were no concerns 
raised by consultants about other negative impacts on patients, such as 
removal from family support systems.  
 
“The highly rural population and the great distance for a lot of patients 
to travel to hospital......The road with the new motorway actually makes 
a huge difference.” (Hospital E)  (in relation to local factors affecting 
referral patterns) 
 
“Public transport influences where patients go. 600 GPs are referring to 
us.” (Hospital A) 
 
“The phenomenon that we refer to as the ‘breast tourist’.” (Hospital I) 
 
“It depends on what part of the county you’re living in.  Some places are 
very remote from here – it can take an hour and 15 minutes from some 
of the places to get here.” (Hospital G) 
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Health service factors    
Health service factors included access to breast units, access to diagnostic 
imaging, breast screening, hospital-GP interface, resources and costs.  
 
Access to clinics 
Ease of access to the SBD units was identified as a major factor influencing 
referrals. Consultants felt that access was perhaps too easy now and this 
was fuelling the rise in referrals.  
 
“There is very good access now.” (Hospital A) 
  
“I think perhaps because it’s so quick, and it happens so quickly, no 
effort involved, that it’s not a problem.” (Hospital B) 
 
“I also think we have made this incredibly easy for the patient and 
incredibly easy for the GP and so there’s no requirement to be selective 
about who you refer, because you can refer everybody and we all bend 
over backwards to see them.” (Hospital I) 
 
Access to diagnostic imaging (mammography, ultrasound)  
The availability of local breast imaging (mammography) through GP referral 
was cited as a factor influencing GP referral decisions.  Hospitals not 
providing this service felt that in the absence of GP direct access to imaging, 
GPs refer all patients to the Symptomatic Breast Service to rule out cancer 
and to reassure their patients. Access to private mammography varied, with 
some units having private service providers in the area and others not. 
Access to mammography was recommended, where this is required.  
 
“There’s no GP access, lots of these women are the ones the GP gets 
to send in here for screening mammogram.”  (referring to GP access to 
mammography) (Hospital H) 
 
“The worried well and the need for mammography, that would be a 
large proportion of it.” (Hospital E) 
 
“They would just send them in. It’s the only way patients can actually be 
seen, because we don’t have the direct access.” (referring to GP 
access to mammography)  (Hospital G) 
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Breast Screening (BreastCheck) 
The National Breast Screening Programme (BreastCheck) commenced in 
Ireland in 2000 and provides free mammography to women aged 50 – 64, 
every two years. At the time of the interviews there was regional variation in 
availability of BreastCheck, such that first-round screening had not yet been 
completed in all areas of the country and this was reflected in the interviews.  
First-round screening had been completed in all areas nationally by 
December 2011.   
 
BreastCheck was cited as a factor influencing local referral patterns for a 
number of reasons. In areas where BreastCheck was not yet fully rolled out 
at the time of the study, hospitals cited the absence of BreastCheck as being 
a factor which increased referrals to their unit, as patients had nowhere else 
to go. Full rollout of the BreastCheck screening programme was 
recommended. A reduction in referrals had been noted in other areas where 
the BreastCheck programme had already commenced.  
 
“We didn’t have BreastCheck in the region.  It only came late 2010, so 
a lot of patients had no other way of getting seen unless they came 
through the symptomatic service.”  (Hospital G) 
 
“It’s a lot to do with the screening process not being really in place 
fully.” (Hospital E) 
 
“There’s a significant cohort of patients that might otherwise have been 
coming to us that are captured by the screening programme and are 
reassured by their mammogram and they don’t come I suppose.” 
(Hospital I) 
 
BreastCheck is currently provided for women aged 50-64. Emerging cohorts 
of ‘post-BreastCheck women’ are now seeking regular screening 
mammography in the SBD Units following their discharge from BreastCheck 
at the age of 65. Participants in one hospital voiced their concern about the 
perception among some women that they cannot get breast cancer after the 
age of 65. Extension of the BreastCheck programme beyond age 65 was 
recommended.  
 
198 
 
“There’s a phenomenon that we are starting to see now because of 
increased awareness and education is the post-BreastCheck patient, 
and increasingly we’re getting referrals now, you know, ‘this woman 
was having BreastCheck screening and she’s now past the screening 
age, please arrange routine mammography’ so that’s something that’s 
going to need to have to be looked at......most women say “sure, I can’t 
get breast cancer, I’m 66” - they actually believe that. It’s very 
worrying.” (Hospital I) 
 
Hospital - GP interface  
Consultants felt there was a good working relationship with the local GPs 
and felt GPs could contact them directly if they had concerns about their 
patients.  
 
“We have a good relationship with GPs...they would ring us if they’re 
concerned about somebody.” (Hospital F) 
 
“They don’t need to refer everybody, and they need to be sure that they 
will be backed up. We’ve been very good to the GPs, we give a 
fabulous service.” (Hospital I) 
 
“We try to engage a lot more with GPs in the last couple of years.” 
(Hospital B) 
 
Resources and costs  
The cost of providing Triple Assessment Clinics (TAC) was also raised, 
although only by one unit. Triple Assessment Clinics provide clinical 
examination, diagnostic imaging (e.g., mammogram) and biopsy for patients 
referred to the clinic requiring triple assessment. The costs resulting from 
patients who did not attend (DNA) for their out-patient appointment was also 
raised. 
 
(Referring to TAC clinics) “The cost per patient in TAC clinic is 
absolutely phenomenal. It has to be the most expensive activity in the 
hospital. …..we need to have some fiscal responsibility in this.....Not 
only do we have to be efficient clinically, we also have to be cost 
effective in what we’re doing.” (Hospital F) 
 
“We estimate that a DNA costs about €80.  There seems to be very 
little value out there perceived by the patient.” (Hospital B) 
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Interestingly, although ‘environmental context and resources’ was the 
domain most frequently referred to, key issues such as centralisation and 
reconfiguration were not discussed critically and participants did not 
problematise these issues, as this process was considered a successful 
policy intervention. However, this study only included the designated cancer 
centres and the views of the breast teams working there – the views of 
hospital staff working in hospitals which are not designated cancer centres 
may be different.  
 
Only one hospital referred to the cost of providing a Triple Assessment 
Clinic. Additional references to resources were that perhaps the breast 
service had received too much funding, which could have been used in other 
less resourced sectors of the health service.   
 
8.6.2 Knowledge 
Definition: An awareness of the existence of something.  
 
Themes which were mapped to this domain included: 
 
• GP knowledge/education   
• Electronic referral 
 
Knowledge and education  
Increased information, education and training for GPs in the areas of 
mastalgia, family risk and breast examination was recommended by 
participants, to assist GPs in the management of mastalgia and benign 
breast disease in primary care.  In order to include as many GPs as possible, 
it was recommended that all GPs should be offered additional training and 
support. No education needs were identified by the consultants for the 
hospital staff.  
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“We’re waiting on the mastalgia materials [from NCCP], which will be 
fantastic, because even if it doesn’t discourage people from coming in, 
at least it puts them off for 3 months and they realise, actually, you 
know, I have to get on with this, there’s no magic answer to it.” 
(Hospital H) 
 
“GP education, giving them the confidence and competence.”   
(Hospital E) 
 
 “I think GPs really do need to be given a bit of ownership over what 
symptoms are a worry and what ones aren’t.” (Hospital I) 
 
Electronic referral  
Participants encouraged the promotion of the Healthlink electronic referral 
system and questioned whether all GPs were aware of this system. 
Consultants recommended the inclusion of mandatory fields on the electronic 
referral form to ensure all relevant information was included. The integration 
of Healthlink electronic referral into the GP software systems was strongly 
recommended and was in the process of being implemented at the time of 
this study. The benefits of the electronic referrals were seen by hospitals in 
terms of level of information received, legibility of information, efficiency of 
the process and tracking of referrals.  
 
“The Healthlink system, it’s fantastic when it’s used.” (Hospital B) 
 
“If they were all Healthlink it would be much easier, it would be 
readable.” (Hospital I) 
 
“The NCCP development of electronic referral has made the system 
more efficient. Proper electronic tracking is now in place for both the 
breast unit and the GP.” (Hospital A) 
 
Participants questioned whether it was the type of GP using electronic 
referral which resulted in improved referrals and suggested that it may be the 
more informed GPs that have been the early adopters of this system.  
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“The electronic are better but I’m not sure if that’s a reflection of the fact 
that GPs that use it are more proactive.” (Hospital C) 
 
“I think the users of Healthlink are perhaps the more innovative and 
informed people.” (Hospital I)  
 
8.6.3 Social influences 
Definition: Those interpersonal processes that can cause individuals to 
change their thoughts, feelings or behaviours. 
 
Themes mapped onto this domain included: 
 
• Patient anxiety 
• Media and publicity  
• Patient awareness and education  
• Patient expectations  
• The ‘worried well’  
• Seasonal variation  
 
A screen shot from NVivo in Figure 8.4 below shows the coding framework 
for the domain or ‘tree node’ of Social Influences, with its component ‘child 
nodes’.  
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Figure 8.4:  Coding matrix within Nvivo (social influences).  
 
Patient anxiety 
Consultants discussed the sources of patient anxiety and perceived that in 
addition to the time of diagnosis, much anxiety was generated from media 
and awareness campaigns. There were some repercussions from historic 
high-profile cases which took place before the current reorganisation of 
cancer services. 
 
“There is a lot of education for breast, but the problem sometimes it’s 
hysteria; sometimes it’s too high sometimes.” (Hospital I) 
 
“There’s a lot of panic, isn’t there, particularly here locally because of 
what happened with X.” (Hospital E) 
 
“People tend to come, you know, worrying about things they really 
shouldn’t be worrying about.” (Hospital G) 
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Media and publicity 
As outlined in the literature review chapter (Chapter 2), media and publicity 
are  known to impact on referral patterns (5, 46, 210, 227, 328, 329). 
Participants commented on the power of the media and publicity, and the 
impact of media and publicity on referrals to the breast clinics.  
 
One factor which influenced referral patterns through impacting individual’s 
behaviour was the visit of a celebrity singer with a history of breast cancer 
(Kylie Minogue).  This also affected the age profile of patients referred. This 
was consistent with the finding of a UK study on ‘Kylie Minogue’s breast 
cancer: effects on referral to a rapid access breast clinic in the UK’ (329), 
which found that despite increased referrals there was no increase in the 
number of malignant diagnoses.  
 
“We do get quite a few younger women whenever Kylie Minogue 
comes to the country, for whatever reason.  She’s just been and the 
profile of the clinics was quite young.”  (Hospital H) 
 
“It’s lovely to say that we haven’t had Kylie or any other celebrities 
since, no more celebrities so we haven’t had the Kylie factor, it’s 
amazing.”  (Hospital I) 
 
The power and impact of publicity was discussed. Some participants felt that 
some of the messages were not suitable for all age-groups and tended to 
heighten anxieties, e.g., the message that 1 in 10 or 11 women will get 
breast cancer.  More measured and appropriate messages were 
recommended. The impact of publicity was highlighted, both for its positive 
and negative effects. Consultants discussed the reputational damage done 
to the entire service based on a few heavily-reported cases which took place 
before the reorganisation of the cancer services. 
 
“I really think that until the whole country settles and goes ‘OK breast 
cancer is being properly managed’, that will be the only time that people 
will be comfortable enough to say “I won’t send you into the clinic, 
you’re fine.”   (Hospital H) 
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“We all know the publicity around the process, whether that is good 
publicity, i.e., increased patient awareness through advertising etc., or 
negative publicity through media hype and reporting of events, adverse 
events and incidences.” (Hospital I) 
 
“I think we’re just suffering an awful lot from the damage that was done 
in the media to breast services.  I think hopefully it will begin to turn 
around.”  (Hospital F) 
 
In relation to public health campaigns, there was recognition among 
participants about macro level processes and policies which impact on micro 
and meso level behaviours. It was recommended that an age-specific 
message be given for the annual Breast Cancer Awareness Campaign in 
October, so that people know that the risk of breast cancer increases with 
age.  Education of helpline staff was also recommended.  
 
“In the October campaign you will hear “one woman in 11 will get breast 
cancer”.  There will be a group of teenagers sitting around in college 
thinking “which one of us has it”.  It needs to be said that it is age-
specific and that there is a much smaller risk in younger women 
compared to those over 70.”  (Hospital A) 
 
“A lot of people are ringing help-lines, so you don’t just educate the 
GPs; you’ve got to educate all those at the end of help-lines as well.  
They just want the responsibility gone from the end of their phone on to 
the next step.” (Hospital F) 
 
“The older women aren’t being targeted at all.” (Hospital I) 
 
Patient awareness   
Awareness of breast cancer and awareness of the breast services was 
perceived to increase demand for the service. However, it was felt that the 
level of breast self-examination in women was lower than expected.  
 
“I think women are quite aware, although I would say you would be 
surprised the amount of people who don’t examine.” (Hospital H) 
 
“People are so much more aware now, aren’t they?  And I think if 
anyone kind of gets any sort of a little niggling pain, they automatically 
go. I suppose from a GPs point of view, there’s easy access. The other 
side of it is it’s important that they are referred if they do have a 
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symptom……it’s hard to know what the right thing to do is.”       
(Hospital G) 
 
“There is undoubtedly a hugely increased level of consumer 
awareness, i.e., patient or women’s awareness, I think at one level 
there is a huge increase in the demand from women for breast 
assessment.” (Hospital I) 
 
Patient education 
Information for patients was recommended in relation to breast pain, breast 
self-examination and when to visit their GP. Clear information for patients on 
what to expect in the Symptomatic Breast Unit such as appointment 
scheduling, investigations and waiting times was also suggested.  
Information for older patients, particularly advice for those who have been 
discharged from BreastCheck at the age of 65 was seen as an emerging and 
growing need.  The role of the Practice Nurse in patient education was 
identified as an opportunity.  
 
“Key messages for patients – when to worry and when really not to 
worry.  When you should really go to the doctor and when you don’t 
need to go to the doctor.” (Hospital G) 
 
“The problem with patient education is, the people who are aware are 
the young patients and actually, the post BreastCheck age are not 
aware …..when they are being discharged from BreastCheck, they 
need to be told that the incidence of Breast Cancer increases with age, 
because I can’t tell you the number of women I had to tell last week 
“you can still get breast cancer after the age of 65” and they are 
horrified, so education, it seems to be at the younger patient level.  
They need to be informed, but actually the BreastCheck age and the 
older women, education is not hitting them.” (Hospital I) 
 
“The majority of lumps you feel are not cancer, that’s a huge message.” 
(Hospital E) 
 
Patient expectations  
Hospitals perceived that patient expectations and patient demand, as well as 
an increased awareness of the breast service and an increased confidence 
in the public system had increased the number of referrals.      
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“Public are aware of the centres of excellence – they are good for 
urgent, but for routine, there is now an expectation that Triple 
Assessment will be provided for everyone in one day, including breast 
pain.  Expectations have been raised.” (Hospital A) 
 
“It’s about expectations.” (Hospital D) 
 
“it’s too easy and we’re all very proud of what we do, but I just think, 
there are no obstacles to every single woman in the country who wants 
some form of breast assessment, just for a check-up, to be referred to 
the symptomatic breast unit and furthermore, being guaranteed an 
appointment within 12 weeks, and I think that’s the problem.”    
(Hospital I) 
 
The worried well 
The ‘worried well’ was a term generally used to describe a cohort of people 
without any symptoms who wished to undergo breast assessment as a form 
of regular screening for reassurance. This group were perceived to account 
for a large proportion of referrals to the SBD units.  
 
“I think when GPs hear ‘rapid access’ they suddenly think this is  their 
way to get their patients  seen, and so I do think that they are sending 
in a lot of worried well.” (Hospital H) 
 
“The worried well and the need for mammography, they would be a 
large proportion of it all right.” (Hospital E) 
 
“I think we’re not responding to a clinical requirement, we’re responding 
to a kind of perceived need.” (Hospital I) 
 
Seasonal variation 
Concerns were expressed about seasonal variation in the autumn, 
corresponding with the traditional Breast Cancer Awareness Month in 
October each year.  Participants felt that although there was an increase in 
referrals resulting from this campaign, there weren’t any additional cancers 
detected.  
 
“We would see a huge increase in referrals from October, all the way 
through January / February would just be a surge. I don’t think there’s 
an increase in cancer over those months, no increases in actual 
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cancers during those months, it’s more an increase in referrals”. 
(Hospital E) 
 
“Breast awareness month would have had an impact.”  (Hospital F) 
 
“We used to say “oh my God, here it comes, breast cancer awareness 
month”. We were already so swamped, it wasn’t possible to increase 
the referrals, you would always see it around October, as you know, but 
I think it’s maxed out at this stage, we see it all the time!”  (Hospital I) 
 
8.6.4 Memory, attention and decision processes 
Definition: The ability to retain information, focus selectively on aspects of the 
environment and choose between two or more alternatives.  
 
Themes mapped to this domain included: 
• Family history of breast cancer 
• Mastalgia (Breast pain) 
 
Family history of breast cancer  
Participants reported an increase in patients referred for review of their family 
history of breast cancer, and felt many of these referrals did not require 
referral to the specialist units. Two units had dedicated family risk clinics, 
with the remaining units seeing these patients in the general SBD clinics.  
The absence of dedicated family risk clinics was seen as a deficit. The 
introduction of these clinics was recommended in areas where these were 
not established.  
 
“I think we should be encouraging the GPs to hold on to all their family 
history, unless there’s more than one first degree relative.” (Hospital F) 
 
“There’s no dedicated family history clinics in the centres.  We would 
get a lot of family history referrals.” (Hospital G) 
 
“A deficit in the breast referral patterns is the absence of established 
family history clinics and funding for those.” (Hospital D) 
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Clear information for GPs and patients on what constitutes a family risk of 
breast cancer was considered necessary. The development and circulation 
of guidelines from the NCCP was recommended.  
 
“There wouldn’t be an accurate family history or certainly what you 
wouldn’t call a family history, maybe a first cousin or something like that 
... People think that if they had an aunt who died in her eighties that 
they have a family history and a cousin or whatever, and I suppose they 
don’t know what the true family history is.”  (Hospital G) 
 
“If we could draw up guidelines to inform GPs as to what exactly 
constitutes a family history requiring referral.” (Hospital H) 
 
“I know ye (NCCP) are working on a national referral guideline and 
form. And that will be great if that could be rolled out. It would divert a 
lot of what would take up a large amount in our triple assessment 
clinics.” (Hospital E)   
 
Mastalgia 
Participants reported a sizable number of referrals with mastalgia and felt 
many of these patients could be managed by GPs in Primary Care. The 
number of referrals with mastalgia was reported to be increasing. 
Consultants concluded this was partly due to ease of access to the breast 
services and partly due to patient anxiety.  
 
“Our cancer services have been taken over by benign disease, by 
mastalgia. We’ve the best mastalgia service in the world, which is an 
unintended side effect of developing a cancer programme.” (Hospital C) 
 
“Breast pain – we understand it, but the patients think they have cancer 
until proven otherwise. Patients need education and written information 
about breast pain to allay their anxiety, as many patients think breast 
pain may mean cancer. If GPs could look after mastalgia, it would 
reduce our clinics by approx. 900 patients in one year.” (Hospital A) 
 
“We have to go back and think of some sort of public health initiative, 
which I think will re-educate women that breast pain the week before 
your period does not mean you have breast cancer.” (Hospital I) 
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8.6.5  Skills (Cognitive and interpersonal skills, physical skills) 
Definition: An ability or proficiency acquired through practice. 
 
Themes mapped to this domain included: 
• Skills and training  
• Accuracy of referrals 
• Patient reassurance 
 
Skills and Training  
When discussing educational needs, additional training for GPs in clinical 
breast examination was recommended by participants.  On-site training in a 
breast unit was suggested, which was already happening in some units. 
Participants did not identify any skills training required for the hospital team. 
 
“The GPs also need to be happy doing the breast exam. Breast 
examination, the interpretation of symptoms, obviously the clinical 
assessment of the patient, the clinical assessment of the breast.” 
(Hospital I) 
 
“The GPs have commented that asymmetric nodularity, lumps, fibrous 
tissue and cysts are difficult for GPs to differentiate.” (Hospital A) 
 
“I think there needs to be some training for GPs in terms of using the 
NCCP referral form.” (Hospital B) 
 
Accuracy of referrals 
Hospitals reported the quality and accuracy of referrals received from GPs to 
be varied.  Referrals using the official referral form were generally better than 
a GP letter.  
 
“The form, when it’s used, is the best. Often the letter just says “thank 
you for seeing patient x who is complaining of…” and that’s it.” (Hospital 
E) 
 
“Generally, I would have to say that more often than not, it’s pretty 
accurate what the GP has referred as urgent.” (Hospital D) 
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The level of urgency GPs assigned to referrals was also discussed. 
Consultants questioned whether individual GPs were ‘gaming the system’ to 
get their patients referred earlier. 
 
“They know exactly when they say urgent on the triage; they know 
they’ll get an appointment within 2 weeks.” (Hospital E) 
 
“All these TAC forms that say they have a lump and they never have a 
lump... We need to prove to the GPs that we know they are bluffing the 
request forms and we can’t keep this up nationally.” (Hospital F) 
 
“GPs understand there is no screening now, so they are giving, I think 
some patients are getting symptoms they don’t have, just to get into the 
clinic.” (Hospital H)  
 
“GPs sometimes refer patients with symptoms and when they arrive 
they don’t have the symptoms that they have said they had.  And 
obviously it’s because they want them to be seen at the clinic.” 
(Hospital G)  
 
“Regarding the information, we wouldn’t have triaged it as urgent, so it’s 
not accurate, no.” (Hospital B) 
 
Patient reassurance  
Hospitals alluded to the additional time required to reassure patients and the 
need to enable GPs to take on this role. The skills required to provide patient 
reassurance were not raised.  
 
“The amount of time it takes the girls to reassure these patients.” 
(Hospital F) 
 
“We need to try and empower the primary care physician to take more 
ownership in terms of reassuring them.” (Hospital I) 
 
“They get sent in for a second opinion and for reassurance and that has 
impacted hugely on us; we’ve seen a lot of that.” (Hospital H) 
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 8.6.6  Behavioural regulation  
Definition: Anything aimed at managing or changing objectively observed or 
measured actions.  
 
Themes mapped to this domain included: 
• GP referral practices 
• Referral form and guideline  
• Protocols and compliance 
 
GP referral practices / patterns  
Participants commented on the alleged GP practice of sending a referral to 
several hospitals simultaneously, with the intention of taking the earliest 
appointment offered.  There was also evidence of some patients attending 
several SBD units.  Participants also believed that some GPs were ticking 
the box marked ‘breast lump’ in order to get an urgent appointment.  
 
“They know that if they put the word lump down, that it’s automatic.  If 
you are going to put everybody down as a lump, this system is not 
going to work.” (Hospital F) 
 
“Breast tourists, these people, I don’t know whether it’s the patient or 
the GP or both, but they send the letter to whatever number of centres, 
and they may take the first appointment but some of them actually go to 
two centres.” (Hospital I) 
 
“Whichever hospital gets the first appointment, it’s common practice 
with GPs.” (Hospital B) 
 
 
Referral form and guideline  
The GP referral guideline and form were regarded as useful, with a high level 
of sensitivity.  There were suggestions made in relation to the specificity and 
format of the GP referral form, with some changes recommended to the 
indicators for referrals, such as mastalgia.    
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“I think it works pretty well for most of the GPs. Again, it’s user 
dependent.” (Hospital I) 
 
“I think we should remove breast pain as an indicator for referral 
completely.” (Hospital C) 
 
Protocols and compliance 
The success of the National Cancer Control Programme and the HIQA 
review of the Symptomatic Breast Services were acknowledged. It was also 
noted that breast cancer has the most comprehensive set of standards of all 
the cancers.  
 
“HIQA has been a good thing. We are all measuring our performance 
now and this has a direct effect on patient care......everything in the unit 
is done according to protocol.” (Hospital A) 
 
“Prof O’Higgins and his colleagues produced that fantastic set of 
recommendations which is what informed the HIQA standards. There’s 
no other cancer that has those standards, so they will have to do a lot 
more work.” (Hospital I) 
 
8.6.7  Beliefs about consequences 
Definition: Acceptance of the truth, reality or validity about outcomes of a 
behaviour in a given situation. 
 
Themes mapped on to this domain included: 
• Risk  
• Reliance on diagnostic imaging 
• GP reassurance 
 
Risk  
Discussion on risk focused on cautious management of breast referrals in 
primary care, risk aversion and medico-legal implications. Consultants 
recognised that GPs do not wish to take a risk in the area of breast disease. 
This was seen to be partly due to the media coverage of investigations into 
individual cases.  Consultants understood that GPs were referring patients 
for fear of missing a cancer.   
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 “GPs have said ‘we are afraid not to send them in’.” (Hospital A) 
 
“It impacts on the amount of referrals we get in because nobody is 
willing to take a chance.” (Hospital H) 
 
“I think with the whole media perception and the number of 
investigations and difficulties has led general practitioners taking a 
decision to step back.” (Hospital C) 
 
Reliance on diagnostic imaging    
Participants commented on the perceived patient and GP dependence on 
diagnostic imaging for reassurance, with many women being referred for 
mammography imaging in the absence of any symptoms.  
 
“If I was a GP and a woman came to me whose mother had breast 
cancer, there is no way in the world I’d send that women home without 
a mammogram, because that’s your patient, you want to do the best 
for her.” (Hospital F) 
 
“They just say, ‘I know she’s OK but I’ll just send her in and just be 
sure, and let her have her mammogram and ultrasound done’.”  
(Hospital E) 
 
GP reassurance 
Hospitals acknowledged that some referrals were made to provide 
reassurance for the GP.  Whilst consultants were happy to review any 
patients the GP was concerned about, they were cognisant of the impact on 
referral numbers.  
 
“I don’t mind the GPs sending in anyone they are genuinely worried 
about.” (Hospital F) 
 
“They are going to be told by their GP ‘I’m sending you in just in case.  
I’m happy, but just in case, just to be sure’. ” (Hospital I) 
 
“They get sent in for a second opinion and for reassurance and that has 
impacted hugely on us; we’ve seen a lot of that.” (Hospital H) 
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8.6.8 Social/Professional role and identity 
Definition: A coherent set of behaviours and displayed personal qualities of 
an individual in a social or work setting.  
 
Themes mapped to this domain included:    
• GP responsibility and ownership 
• Gatekeeping 
 
GP responsibility and ownership 
Consultants perceived a current lack of ownership of breast disease in 
primary care and discussed the need to give some ownership back to GPs, 
especially as the GPs know the patients so well. 
 
“Here the GPs know everybody and they know what they had for 
breakfast and they know when they are not at mass on Sunday that 
there’s a big problem, they know people so much better.” (Hospital H) 
 
“I don’t think General Practice currently is prepared to take any 
ownership of the process... I do think that if we in some way give some 
ownership back to the GPs in this process, that would have an impact.” 
(Hospital I) 
 
“The perception in the units would be that primary care has abdicated 
pretty much all interest in symptomatic breast disease and every patient 
gets referred.” (Hospital C) 
 
Gatekeeping 
Participants believed a gatekeeping process was required and that this was 
the role of the GP. Consultants felt there was a certain proportion of referrals 
which did not require specialist review and could be managed by the GP in 
primary care. Consultants focussed on changing individual GP referral 
behaviour as opposed to systematic changes such as increasing the 
capacity of the hospital SBD clinics.  
 
“I think we need to educate the consumer, we need to give the GP 
some help in terms of managing these women in primary care  and I 
think we actually  need to make it a bit more difficult, we need to put in 
a bit of a gatekeeping process.” (Hospital I) 
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“I think we should be encouraging GPs to hold on to all their breast 
pains, all their bilateral nodularities unless there’s something 
particularly worrying.” (Hospital F) 
 
8.6.9 Beliefs about capabilities 
Definition: Acceptance of the truth, reality or validity about an ability, talent, 
or facility that a person can put to constructive use. 
 
Themes mapped on to this domain included:  
• Empowerment of GPs  
• GP confidence 
 
Empowerment of GPs  
Participants discussed the role of the GP and empowerment of the GP to 
manage non-urgent cases in primary care. Participants discussed 
disempowerment of GPs in the management of breast disease.  Referrals for 
a second opinion or for patient reassurance were seen as reasons for many 
referrals. 
 
“I think we have disempowered our GPs in terms of decision making..... 
they get disenfranchised and they send them all to the clinic.”   
(Hospital I) 
 
“We have to empower them; we haven’t empowered the GPs...I think 
we have to empower the GPs to keep some of their women in General 
Practice.”   (Hospital F) 
 
GP confidence 
Many of the hospital respondents felt that there may be a lack of confidence 
in managing breast disease in primary care and that GP anxiety and GP 
level of experience in breast examination could be increasing the numbers of 
referrals received in the hospitals.  
 
“The GPs need to be happy doing the breast exam.  It’s the nodularity 
the GPs worry about.” (Hospital I) 
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I think if GPs were educated in treating mastalgia and had confidence 
in doing, treating it.  I think it’s a confidence thing.” (Hospital B) 
 
“They just have so many women coming in to them and they just, rather 
than take it on themselves, there are patients who could be managed in 
primary care, but they just feel they are safer, they’re just not 
confident.” (Hospital E) 
 
8.6.10  Emotion 
Definition: A complex reaction pattern, involving experiential, behavioural, 
and physiological elements, by which the individual attempts to deal with a 
personally significant matter or event.  
 
Themes mapped onto this domain included provider anxiety (GP/ consultant 
anxiety). 
 
Hospital participants acknowledged the anxiety of the GPs and understood 
that they were fearful of missing a cancer.  There was less emphasis on 
consultant anxiety.  
 
“Their fear is that they will miss a cancer.” (Hospital I) 
 
“GPs have said ‘we are afraid not to send them in’.” (Hospital A) 
 
“It’s just the GP worry factor.” (Hospital E) 
 
“We do have a couple of BRCA1 families and other hereditary style 
breast cancers, so I’m more than anxious to keep an eye on all of 
them.” (Hospital H) 
 
8.6.11     Reinforcement  
Definition: Increasing the probability of a response by arranging a dependent 
relationship, or contingency, between the response and a given stimulus.  
 
Themes mapping onto this domain included HIQA. 
1 BRCA is a human gene. Mutations in this gene are often found in breast and ovarian cancer 
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The Health Information and Quality Authority (HIQA) and the National 
Cancer Control Programme (NCCP) were viewed as the enforcement bodies 
to which hospitals were accountable for maintaining the standards of the 
breast service. The success of the National Cancer Control Programme and 
the HIQA audit of the Symptomatic Breast Services were acknowledged.  
However, the unintended consequence of providing a successful service was 
also raised. 
 
“HIQA has been a good thing. We are all measuring our performance 
now and this has a direct effect on patient care.” ....... “I wonder, are we 
victims of our own success?” (Hospital A) 
 
“I think the 2-year audit process was a very useful and informative 
process at the time, but I don’t think it needs to be repeated again”. 
(Hospital I) 
 
8.6.12     Optimism 
Definition: The confidence that things will happen for the best or that desired 
goals will be attained.  
 
There were no themes which mapped directly onto this domain as their 
primary focus. Related themes included NCCP and the cancer centralisation 
process. The success of the National Cancer Control Programme and the 
HIQA review of the Symptomatic Breast Services were acknowledged.  
 
“There is now confidence in public care with NCCP..........There’s been 
a great turn-around since the NCCP, people know about the 9 centres.  
People are now phoning to come here and are well informed about the 
centres of excellence (public SBD unit) instead of private.” (Hospital A) 
 
“I think that the NCCP is doing a very good job. When this all started, 
we were all looking over our shoulders.  We’ve much more ownership 
of the process now, we’re much more empowered.” (Hospital I) 
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8.6.13     Intentions 
Definition: A conscious decision to perform a behaviour or a resolve to act in 
a certain way. 
 
There were no themes which mapped directly on to this domain as their 
primary focus. Related themes included protocols and compliance.  
Consultants acknowledged the NCCP Key Performance Indicators and 
reiterated their intentions to achieve these targets within their hospital. 
 
“I think this process should inform improvement and change and 
enhance patient care.” (Hospital I) 
 
8.6.14  Goals 
Definition: Mental representations of outcomes or end states that an 
individual wants to achieve. 
 
There were no themes which mapped directly on to this domain as their 
primary focus. Related themes included protocols and compliance. 
 
Consultants and their teams wanted to provide the best possible care for 
their patients. Consultants acknowledged the success of the centralisation 
process and aimed to meet the quality standards and Key Performance 
Indicators (KPIs) set by HIQA and the NCCP.  
 
“Meeting timelines has had a huge impact on service and the message 
out there.” (Hospital A) 
 
“We’ve all settled down with our KPIs.” (Hospital I)  
 
Content that was raised in the hospital interviews that was not included in 
this report related to discussions about other cancers (e.g., prostate, 
colorectal). Consultants felt that although breast services had been 
developed and enhanced, there was a need to replicate this level of service 
to other cancers.  
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8.7  Summary of findings  
Participants focussed attention on structural or macro level forces which 
affect health service provision, such as distribution of resources and use of 
evidence-based medicine. There were conflicting views on the management 
of benign breast conditions in primary care and only one hospital mentioned 
costs. Factors influencing referrals are summarised into health service 
factors, provider (consultant) factors, social and patient factors.  
 
Health service factors  
Consultants and their teams felt they provided a quality service, particularly 
since the establishment of the designated cancer centres.  However, it was 
recognised that the health service would not be able to continue to provide 
this level of service, especially if the number of referrals continued to rise 
(environmental context and resources). This was considered by consultants 
to be a referral issue rather than a resource issue.  
 
The scope of the Symptomatic Breast Service was questioned, as it accepts 
all breast referrals.  The appropriate setting for treating patients with benign 
breast disease was an area of debate, with the view that the time and 
resources of Symptomatic Breast Clinics should be focussed on those with 
suspected cancers (environmental context and resources). 
 
The efficiency and ease of access was seen as both complimentary and 
problematic and possibly fuelling the increase in referrals. The demand for 
the service has become greater than the capacity and consensus was that 
“we have become victims of our own success” (environmental context and 
resources, social influences). 
 
Patient and social factors influencing GP referral 
There was a perception among hospitals/consultants that increased patient 
information and awareness has led to increased patient expectations and 
perceived need (social influences). Whilst increased patient awareness was 
seen as positive in terms of patients recognising abnormal symptoms,  there 
was a perception that media coverage and awareness campaigns appeared 
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to raise women’s anxiety and messages were currently aimed more at the 
younger age group, where there is a lower incidence of breast cancer (social 
influences). Although consultants reported a high level of patient confidence 
in the public cancer service, the need for reassurance through 
mammography imaging was a strong patient expectation noticed by 
respondents, particularly those patients outside the BreastCheck screening 
age (beliefs about consequences).   
 
Provider factors (hospital consultants)  
Participants in the hospital interviews articulated a great pride in the service 
they provide but questioned whether such ease of access to the service was 
appropriate or desirable (environmental context and resources). Consultants 
considered a system of gatekeeping necessary to ensure appropriate referral 
and optimum use of limited resources (professional role and identity/ 
decision processes). 
 
Consultants perceived that a variety of factors in primary care may have 
influenced the referral patterns, including GP anxiety (emotion); level of 
ownership in primary care (professional role and identity); and the need for 
enhanced training for GPs in breast examination (skills). The fear of missing 
a cancer and the cautious management of these patients was thought to 
increase referral numbers (beliefs about consequences).  There were 
concerns from the hospital consultants about the possible disempowerment 
of GPs and an acknowledgement that GPs need to be supported in their role 
(beliefs about capabilities).  
 
None of the emerging themes were coded to the TDF domains of optimism, 
intentions or goals as their primary domains and these appeared to be a 
poorer fit than other components in the framework. However, optimism was 
closely linked to the discussions around the cancer control programme, 
which was coded as ‘environment context and resources’ and the domains of 
intentions and goals were closely linked to the theme of ‘protocols and 
compliance’ which was coded as behavioural regulation. In these cases, 
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themes were allocated a secondary code in addition to a primary code, as 
seen in Appendix J.   
 
The main recommendations made by the hospitals in relation to referrals to 
SBD units are listed below.  As the interviews were conducted in 2010 and 
2011, a number of these recommendations have already been initiated or 
implemented.  These initiatives have been included in parentheses and are 
presented in more detail in the discussion chapter (Chapter 11).  
 
• GP education, training and support – in the areas of breast 
examination, mastalgia, family risk and completeness of referral 
information (GP education programme commenced). 
• Patient information on mastalgia, family risk and breast self-
examination (patient information developed for mastalgia). 
• Family risk – clear information for patients and clear guidelines for 
GPs on what constitutes a family risk for breast cancer.  Consider the 
establishment of family risk clinics separate to the TAC clinics (GP 
referral guideline updated with advice on family risk).   
• Mastalgia – information for GPs and patients on the management of 
breast pain. Consider the establishment of nurse-led clinics separate 
to the TAC clinics (Information developed for GPs and patients on 
mastalgia).   
• Imaging – Clear national evidence-based guidelines on indicators for 
imaging and imaging requirements for asymptomatic women (breast 
cancer guidelines for diagnosis and staging developed).  
• BreastCheck – continue national rollout of BreastCheck. Information 
for women being discharged from BreastCheck in relation to risk of 
breast cancer and access to services in the event of symptoms 
developing. Consider extending the BreastCheck age range above 65 
(BreastCheck age-range to be extended in 2015). 
• Integration of Healthlink (electronic referral) into ICGP accredited GP 
software management systems (Healthlink integrated into accredited 
GP software systems).  
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• Promotion of use of Healthlink and standard referral form by GPs (use 
of Healthlink promoted through CME, GP study days and articles in 
GP publications).  
• Public information – Age-specific messages. Measured targeted 
messages for Breast Cancer Awareness Campaigns such as older 
age-group, symptomatic patients and post BreastCheck age-group 
(joint planning between NCCP and advocacy groups for awareness 
campaigns).  
• Nurse training – training for nurses in the area of patient education 
(national training programme commenced for nurses caring for cancer 
patients).  
 
The review of referral patterns in Study 1 established that the level of 
variation found in the 2009 HIQA review has decreased substantially. 
However, some variation between centres remained. Current geographical 
variances in cancer referral patterns may be as a result of patient, provider or 
health service factors. The finding of this qualitative study reflect a 
consensus in SBD units that patients should receive care in the most 
appropriate setting and should not be subjected to the stress of unnecessary 
investigation. Effective referral and triage processes should ensure the most 
effective use of available resources, better management of referrals and 
ultimately better outcomes for patients.   
 
Participants in this qualitative study attributed this variation to several factors, 
including the remaining roll-out of the BreastCheck Screening service. 
BreastCheck is a population screening programme for women aged 50-65, 
with a structured call-recall system, separate to the Symptomatic Breast 
Service. According to participants, the BreastCheck service influenced 
referral patterns in several ways:   
 
• In areas where BreastCheck was not yet fully rolled out, women in the 
BreastCheck age group of 50-64 were being referred to the 
Symptomatic Breast Unit as ‘there was nowhere else to go’.  
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• Women who have been discharged from BreastCheck after the age of 
65 are being referred back into the Symptomatic Breast Units to 
continue screening.   
 
The overall increase in referrals nationally was perceived by the hospital 
consultants and their teams to be as a result of increased patient awareness, 
media-induced anxiety, ease of access to breast clinics and level of 
ownership in primary care. 
 
Solutions recommended by the hospitals to address the volume of referrals 
included further education for GPs in breast examination; information for GPs 
and patients on mastalgia and family risk; and public information which is 
measured and targeted. Whilst acknowledging the anxiety of missing a 
cancer, the hospitals considered a gatekeeping process to be necessary.  
The opportunities to increase efficiencies through more accurate and 
complete referral information, electronic referral and the management of the 
patient in the most appropriate setting were widely endorsed.  The cost of 
providing the TAC service was only alluded to by one hospital.  However, the 
breast service was recommended as a system to be replicated for additional 
cancers and other diseases, which has resource implications for the health 
service if adopted. 
 
The NCCP referral guidelines and referral form, with facility for electronic 
referral, were seen as positive developments, with a high level of sensitivity.  
There were some recommendations regarding specificity of the referral form.  
There was a high level of pride from health service personnel in the service 
they provided and they also remarked on the level of confidence of patients 
in the public breast cancer services.  Hospital consultants and their teams 
contributed to the understanding of national and local factors influencing GP 
referrals to the breast clinics.  However, this was from just one perspective, 
the hospital perspective. To ensure a more comprehensive understanding of 
factors influencing GP referrals, the third study in this thesis involved 
interviews with GPs referring to these breast clinics, to explore the factors 
influencing their referrals.  
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Chapter 9: Study 3: Qualitative Study with GPs  
 
9.1  Introduction  
Recent centralisation of cancer services in Ireland has streamlined the 
referral pathway for cancer patients, with the designation of eight specialist 
centres for cancer surgery and the introduction of GP referral guidelines and 
standardised referral forms. Referrals to Symptomatic Breast Disease (SBD) 
Units in Ireland have increased rapidly since this centralisation process, 
without a corresponding increase in breast cancer incidence. The reasons for 
this phenomenon were explored in this study.  
 
The qualitative study with hospitals in Study 2 (Chapter 8) concluded that 
many factors influencing referrals to the cancer centres originated in General 
Practice, including adherence to referral guidelines, management of benign 
breast disease and seeking reassurance through specialist review and 
diagnostic imaging. Study 3, described in this chapter, presents research 
with referring GPs/family doctors who are central to this process. SBD units 
felt that existing national GP cancer referral guidelines were not being 
adhered to by referring GPs and that benign breast disease could be 
managed in primary care.  Understanding the factors influencing GP referral 
practices could assist the development of effective health service 
interventions. In line with the Medical Research Council guidance on 
developing and evaluating complex interventions, stakeholder views and 
experiences can inform content and delivery of interventions (357).  
 
This qualitative study with GPs sought to identify barriers and enablers to the 
implementation of evidence-based referral guidelines for breast cancer in 
order to explain referral patterns and inform future implementation 
interventions. 
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9.2  Background  
GP referral guidelines for suspected cancers were introduced nationally by 
the National Cancer Control Programme (NCCP) in Ireland in 2009, with 
comprehensive education for GPs (3), as part of the centralisation of cancer 
services in Ireland.   
 
Primary care is usually the first point of access for the patient into the 
healthcare system and the role of the General Practitioner as gatekeeper is 
widely acknowledged (13, 14). The GP role in the care of the patient with 
suspected cancer is key to early detection and referral at an early stage of 
disease (235).  
 
9.3  Aim and objectives 
This study aimed to determine the factors influencing referrals to 
Symptomatic Breast Disease (SBD) clinics in Ireland, by building on the 
issues raised in the hospital interviews, examining both the medical and non-
medical influences on referrals from GPs to SBD Clinics.  
 
Aim: To explore the perceptions of GPs on factors influencing GP referrals to 
Symptomatic Breast Disease Units in Ireland.  
 
Objectives:  
 
• To explore perceptions of GPs on the factors contributing to the 
increase in GP referrals to SBD units in Ireland. 
• To explore potential barriers and facilitators to implementation of 
evidence-based GP referral guidelines. 
• To investigate whether centralisation of cancer services has impacted 
on individual GP referral practices/behaviour.  
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9.4  Design 
Current geographical variation, which are not as a result of clinical need, may 
result from patient, provider or health service factors (15).  The research with 
GPs was qualitative in design, using in-depth semi-structured interviews to 
determine the factors influencing their referral decisions. This methodology 
was used as detailed exploration of the honest views and experiences of 
participants was required (418, 450). Vignettes were considered as an 
alternative methodology for the GP study. However, discussions by the 
researcher (NO’R) with six individual GPs concluded that GPs questioned 
considered vignettes to be a test of their knowledge rather than their 
intentions and they would seek to provide the ‘correct’ answers in these 
scenarios. This approach was not considered suitable for this study as the 
GP behaviour was being investigated.  
  
Sampling was stratified across the four HSE regional cancer networks in 
Ireland (Figure 8.1) and included both urban and rural GPs, and male and 
female GPs.  Sampling was designed as criterion-based stratified sampling – 
equal numbers of GPs were interviewed from the selection criteria 
(geographical location and GP gender). Contact details for GPs were 
obtained from an existing published list – the Irish Medical Directory  (462). 
Sample size is discussed in Section 9.4.3. 
 
9.4.1  Study participants 
The random selection function in Stata (Version 10.1) was used to select 100 
GPs from the 2,466 GPs listed in the Irish Medical Directory (2011-2012 
edition)(462).  100 was chosen as the sampling frame in order to yield a 
minimum of 24 GPs to participate in the study. The ICGP database was 
considered as the sampling frame but was not used, as not all GPs are 
members of the ICGP and use of the ICGP database also has restrictions on 
number of reminders. GPs currently practicing in General Practice in the 
Republic of Ireland were eligible for inclusion in the study. Trainee GPs 
were excluded from the study.  
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Primary selection criteria were:  
 
• Geographic location (HSE region/ cancer network) 
• GP gender  
 
These selection criteria were used to achieve ‘symbolic representation’ to 
ensure representativeness (463).   
 
Attributes were recorded for each participant for type of GP practice (urban / 
rural); practice population (medical card2 / private); number of years 
practicing as a GP; structure of GP practice (single handed / group practice); 
and distance from the nearest cancer centre.   
 
9.4.2  Recruitment and response rates 
100 GPs were randomly selected and contacted. Twelve GPs were 
subsequently excluded as they had retired or were no longer working in the 
selected GP practice. From the remaining 88 GPs, 28 GPs accepted and 
further 15 GPs declined. The overall response rate was 49% (43/88) and 
acceptance rate was 32% (28/88) following one written reminder. 51% of 
GPs did not respond (Figure 9.1). This is similar to the 47% response rate in 
the ICGP postal survey of their members on a needs assessment for GPs for 
early detection of cancer in 2006 (260).   
 
The last four GPs who agreed to participate in one geographical region 
(Dublin mid-Leinster) were not included in the analysis as the quota of GPs 
for this region had already been met and data saturation had been reached. 
 
 
2 People who hold a Medical Card are entitled to a range of health services free of charge 
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Figure 9.1: GP sample and response rates. 
 
Responders were more likely to be female from urban areas.  
 
Twenty-eight GPs were interviewed in total and 24 were included in the 
analysis – six GPs from each of the four HSE cancer networks in Ireland 
(West, South, Dublin mid-Leinster and Dublin North-East). 
 
9.4.3  Sample size 
The proposed respondent sample size of 24 – 30 was an estimate of the 
number of qualitative interviews required in order to identify and 
thoroughly explore the key factors influencing GP referrals to cancer 
centres, i.e., to reach the point of data saturation – that is the point where 
an appropriate sample size has been reached with no additional 
perspectives or issues emerging from additional interviews (464). This is 
in keeping with estimate sizes of good practice for qualitative studies 
(465).  The aim is to select participants based on their characteristics and 
not to generalise across the population, but to shed light on the range of 
issues and perspectives relevant to the research questions.  Therefore, 
exact numbers are not rigidly fixed prior to the commencement of the 
study (464). The seven criteria for potential sample size described by 
Ritchie et al. (466) have been taken into consideration (heterogeneity of 
the population; number of selection criteria; nesting of criteria; special 
interest groups; multiple samples; data collection methods; budget and 
resources). Additional considerations in specifying sample size is the 
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richness of the data gathered and feasibility issues, given that qualitative 
research is a labour-intensive process including in-depth interviews, 
transcription, coding and analysis.   
 
9.4.4  Recruitment 
A letter of invitation, consent form and participant information leaflet with 
topic guide were sent to each GP being invited (Appendices K, L, M).  One 
follow-up reminder letter was sent to non-responders. A minimum of six GPs 
from each of the four Cancer Networks was interviewed. Gender was nested 
in geographic location. Equal numbers of male and female GPs were 
interviewed. This reflects the ICGP database composition of 49.8% female 
and 50.2% male GPs (467).  Additional characteristics of participating GPs 
are contained in Appendix N and are summarised in Table 9.1 below. Miles 
(1 mile=1.6 km) were chosen for measurement of distance to the nearest 
cancer centre to enable direct comparison with an ICGP study conducted in 
2006 (260).  
 
Table 9.1: Characteristics of participating GPs  
Catchment area Distance from 
nearest cancer 
centre 
Patient type Practice type 
Urban 
10 GPs 
< 5 miles (8 km) 
9 GPs 
GMS (medical card)  
6 GPs 
Single handed 
8 GPs 
Rural 
7 GPs 
5 – 25 miles 
6 GPs 
Private only 
3 GPs 
Group practice 
16 GPs 
Urban + rural mixed 
7 GPs 
>25 miles 
9 GPs 
GMS + private mixed 
15 GPs 
 
 
9.5  Procedure 
The GP interviews commenced in March 2012 and took 5 months to 
complete. Interviews were conducted either face-to-face or by telephone, 
based on the preference of the individual GPs. Telephone interviews were 
used for the majority  of the GP interviews (n = 21) and have been shown not 
to influence responses (440, 441).  Pilot interviews were conducted with 
three GPs prior to commencement of the study and these were not included 
in the data for analysis as they were a purposive sample and not randomly 
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selected. There were no modifications to the study following the pilot phase. 
The same interviewer (NO’R) conducted all interviews.  
 
The interviews were based on a topic guide, which was included in the 
participant information leaflet circulated to all participants in advance, along 
with the consent form (Appendices L, M). The data on national volume of 
referrals from Study 1 were also circulated in advance.  Participants were 
prompted to elaborate on relevant issues (450). The duration of GP 
interviews ranged from 10 – 30 minutes, averaging 20 minutes and were 
arranged at a location and time to suit the participants. Interviews in the GP 
surgeries in the pilot phase and the main study enabled the researcher to 
gain a greater understanding of the referral process in context. Written 
consent was obtained from all participants. Participants who were 
interviewed by telephone submitted consent forms by post or fax. Interviews 
were digitally recorded with the consent of participants and transcribed 
verbatim. Field notes were documented during and after each interview. 
Copies of transcripts were available to participants on request.  
 
A decision was made not to use transcript review and respondent validation 
for the GP study, based on learning gained from using this approach in the 
preceding hospital study and due to time pressure on participating GPs. The 
value of this approach has also been questioned. For example, Barbour 
found respondent validation useful to refine emerging findings but cautioned 
against the ‘collusion’ of accepting participant’s interpretations at face value 
(461). Similarly, Atkinson  has cautioned on the dangers of ‘romanticising’ 
the accounts of respondents (468).  Mays and Pope point out that while the 
process can be useful for error checking, respondents have individual 
opinions which may be discordant with the wider overall research findings 
(395).  Barbour concluded that respondent validation can be useful in action 
research projects, but otherwise “may be more trouble than it is worth” 
(p.1117) (461).  
 
231 
 
9.5.1  Interview topic guide   
The topic guide was developed based on the literature review, the consultant 
interviews and three GP focus groups held during GP training days (n = 52 
GP participants in total) in Dublin.  The focus groups concluded that GP 
referral decisions were based on more than medical factors alone. The 
conceptual approach used for this study builds on the approach used for the 
qualitative study with hospital consultants, outlined in Chapter 8 (Figure 8.2).  
 
Factors influencing variation in GP referrals may be as a result of patient, 
provider or health service factors (15, 183, 206). These can also be triggered 
or enhanced by additional factors such as media and publicity (5, 46, 210, 
227, 329).  These topics were explored during the interviews and are 
summarised in Table 9.2. Where possible, the demographic information was 
documented in advance, where this information was already available in the 
public domain, e.g., in the Irish Medical Directory, websites of the GP 
practices or the registry of smear-takers established for the national cervical 
screening programme.  
 
Table 9.2: Summary of interview topic guide  
Topic area Prompts  
Demographic information  Gender. 
Geographic location / HSE network. 
Patient catchment area: urban/ rural / mixed. 
Patient type/insurance cover: medical card/ 
private/mixed. 
Number of years practicing as a GP. 
Number of miles from nearest cancer centre. 
Factors influencing GP referral 
decisions to cancer centres  
Patient factors.  
Provider factors (GP practice/individual GP). 
Health service factors.   
Impact of centralisation of 
cancer services and 
development of GP referral 
guidelines.  
 
GP use of the national cancer referral guidelines, 
referral form, electronic referral.   
Change in referring practice (if any) since introduction 
of the GP referral guidelines.  
Change in referring practice (if any) since 
centralisation of cancer surgery.   
Barriers / pressures relating to referral of patients with 
suspected cancer. 
Recommendations from GPs  
 
Additional services / training / support required by GPs.  
Changes recommended to referral guidelines/forms. 
Recommendations regarding additional information / 
support / services required by patients.  
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9.5.2  Research ethics  
Research ethics approval was granted by the Irish College of General 
Practitioners in January 2012. A copy of the approval letter can be found in 
Appendix O.  
 
9.5.3  Data handling and data confidentiality  
Data handling procedures were in accordance with the RCSI and HSE data 
handling procedures used for the hospital study (detailed in section 8.5.3). A 
participant study number was allocated at the point of data collection which 
was not linked to identifiable details. Details which could be identifiable from 
individual GP interviews, such as place-names or hospital names, were 
anonymised in any reports.   
 
9.6  Data analysis  
9.6.1  Analytic structure 
The analytic approach used for this study replicates the approach used for 
the qualitative study with hospital consultants and is detailed in Chapter 8. 
Qualitative thematic analysis was carried out using NVivo10 to identify 
emerging themes, with eight cycles of analysis. Two people checked the 
interview transcripts for accuracy.  The same person (NO’R) carried out the 
coding for all phases and this coding was reviewed by a breast care nurse 
specialist (HM) who attended 20 of the interviews and listened to all of the 
GP interview audio-recordings. The inter-rater agreement of the coding was 
high and any differences were discussed and resolved. 
 
9.6.2  Analytic strategy  
The analytic strategy used for this study replicated the approach used for the 
qualitative study with hospital consultants and described in Chapter 8. The 
analytic plan has been described in detail in Chapter 8 and is summarised in 
Table 9.3 below (adapted from Braun and Clarke) (452). 
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Table 9.3:  Analytic plan  
Analytic 
process  
Practical application in NVivo  Strategic 
objective  
Familiarising 
yourself with 
the data 
Transcribing data, reading & re-
reading the data, noting down 
initial ideas. 
 
Data 
management  
  
 
 
 
 
Descriptive 
accounts 
 
 
 
 
 
 
Explanatory 
accounts  
Generating 
initial codes 
Phase 1 – open coding of the 
transcripts  
Searching for 
themes 
Phase 2 – categorization of 
codes into potential themes 
Reviewing 
themes 
Phase 3 – Coding on:  
More in-depth understanding of 
divergent views, negative cases, 
attitudes, beliefs and behaviours  
Defining and 
naming themes 
Phase 4 – data reduction:  
Consolidating codes into a more 
abstract and conceptual map  
Producing the 
report  
Phase 5 – Summary statements  
Phase 6  – Analytical memos  
Phase 7  – Cross tabulation with 
attributes 
Phase 8 – Synthesising analytical 
memos into findings report. 
 
9.6.3  Models and frameworks 
As with the hospital interviews, thematic analysis was conducted with 
reference to Michie’s COM-B model and the Theoretical Domains 
Framework (TDF) (244, 245) as the theoretical framework for this study 
(described in Chapter 5).  This model was chosen to explore GPs self-
reported referral practice and to describe the reasons for adherence or non-
adherence to evidence-based referral guidelines, using Theory of Behaviour 
Change.  
 
Through identification of barriers and facilitators in relation to referral practice 
and use of guidelines, this study sought to explore implementation enablers 
and barriers, and inform future implementation of guidelines.  
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9.7  Results 
The main TDF domains emerging from the GP interviews were; 
environmental context and resources, social influences, knowledge, and 
behavioural regulation, as seen in Table 9.4 below.  Domains which did not 
emerge as prominent during the GP interviews were optimism, intentions and 
goals. Definitions of domains are taken from the TDF validation study by 
Cane et al.  (245) and are based on definitions from the American 
Psychological Association’s Dictionary of Psychology (243). 
 
Table 9.4:  Ranking of theoretical domains, GP interviews  
Primary TDF domain 
References from 
GPs 
 1: Environmental context & resources 481 
 2: Social influences 204 
 3: Knowledge 119 
 4: Behavioural regulation 114 
 5: Beliefs about Consequences   91 
 6: Memory, attention & decision  processes   88 
 7: Skills   86 
 8: Beliefs about capabilities   33 
 9: Social/Professional role and identity   18 
10: Emotion   11 
11: Reinforcement    0 
12: Optimism    0 
13: Intentions    0 
14: Goals    0 
 
Additional themes which emerged and were not included in the analysis were 
discussions on services for other cancers such as prostate, colorectal, 
testicular and gynaecological cancers.  
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9.7.1  Environmental context and resources 
Definition: Any circumstance of a person’s situation or environment that 
discourages or encourages the development of skills and abilities, 
independence, social competence, and adaptive behaviour. 
 
Themes mapped to this domain included centralisation/reconfiguration, 
volume of referrals, geographical factors, public vs. private health services,  
access to services, mode of referral,  scope of service, hospital-GP interface, 
resources, breast-screening service, GP access to diagnostic imaging and 
comparisons with services for other cancers. 
 
Centralisation / reconfiguration of cancer services  
Participants compared the new centralised structure of cancer services with 
the previous service and acknowledged that they were not sure initially if it 
was going to be a success.  A number of factors acted as facilitators or 
enablers to GP referral, including confidence in the NCCP cancer services 
and ease of referral.  
 
“When Centres of Excellence were starting, we didn’t know how they’d 
work out.  I think they’re fantastic. I just think the Breast Clinics are 
fantastic.”  (GP13, Female, HSE Dublin Mid-Leinster (DML) 
 
“When we started off, it was, it seemed like a battle to get anybody 
seen, whereas really, there’s no battles anymore.” (GP 16, Female, 
HSE South) 
 
GPs were very satisfied with the SBD Units and reported positive feedback 
they had received from their patients on the care they received.  GPs 
commented on the success of the cancer services in general. 
 
“I have never had one come back and complain.  They come back and 
they’re full of praise for the centres. They say the way they’re dealt with 
is fantastic and the clarity of their results is brilliant.” (GP13, Female, 
DML) 
 
“I must say, you know, I think the breast service is excellent and I don’t 
hear complaints about it.” (GP 23, Female, Dublin North-East (DNE) 
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“Always a good standard of service.  I think the cancer service has 
really, really become very good. It’s really an excellent system.” (GP 27, 
Male, DNE) 
 
Public vs. private health care 
GPs compared public and private services for breast disease. GPs stated 
that, since the designation of the cancer centres, their preference is to refer 
their patients with suspected breast cancer to the designated cancer centres 
in the public hospitals, regardless of health insurance status. However, GPs 
reported that some of their patients opted for private care to get value from 
their health insurance. The overall preference for public hospital care was 
replicated for some other cancers but not for other diseases.  GPs 
recommended breast cancer services in designated cancer centres as an 
example for other health services to adopt.  
 
“I would actually probably tend to put them public, I probably think the 
public system is better.” (GP 11, Male, DML) 
 
“I’m not the biggest fan of our public services in general, but I have to 
say that the cancer referral services in general and the treatment the 
patient gets, I think is one of the very few parts of the health service 
where the public service far outdoes the private.” (GP 6, Female, HSE 
West) 
 
“I tell patients that they’re more likely to get a more efficient streamlined 
service if they go to the breast clinic than if they go privately to see a 
consultant.  It’s more disjointed if they go privately to see a surgeon.  
The public is better than the private in my view.” (GP 23, Female, DNE) 
 
Where patients were referred to private hospitals, GPs attributed some 
decisions to patient choice, as they wished to get value from their health 
insurance.  However, GPs sometimes worried that sending people privately 
was not necessarily better for their patient.  
 
“There’s the old fashioned idea that private equals better, and it’s 
absolutely not... It was just their decision and that’s fine too.  They’re 
paying a phenomenal amount of health insurance.” (GP 14, Female, 
DML) 
 
“I then worry slightly about referring them privately because you think, 
you know, in a way potentially, it’s almost a second class system to do 
that.” (GP 10, Female, South) 
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“I try not to refer patients to the private.” (GP 31, Male, DNE) 
 
Volume of referrals 
Participants were asked to comment on the increasing volume of GP 
referrals nationally.  A combination of factors was cited as influencing factors, 
including increased information on breast disease for patients, GP fear of 
litigation and a change in the referral pathway from private to public for some 
patients.  
 
“Nowadays, with persistent things of litigation and, you know, you just 
have to refer.” (GP 15, Female, DML) 
 
“Even private ones that went privately I’d now send publicly.” (GP 31, 
Male, DNE) 
 
“An increase in the presentation with breast-related symptoms and a 
corresponding reduction in the threshold for referring, even when there 
are perhaps no pressing clinical grounds, just because of the level of 
anxiety.” (GP 24, Male, South) 
 
Geographical factors 
Geographical factors played a role in GP referral decisions, e.g., some GPs 
in remote rural locations reported referring early, whilst others managed their 
patients’ care as much as possible in primary care, to avoid lengthy travel for 
the patient to attend a hospital consultation.  Whilst referrals of patients for 
assessment and for surgery were for single hospital visits, follow-up 
treatment such as chemotherapy and radiation therapy caused problems for 
some patients in terms of transport.  GPs had concerns about undue 
hardship, with distances to travel and costs of transport. 
 
In relation to referral to a particular cancer centre, the GP’s stability of 
intentions was influenced by an allegiance to particular cancer centres, not 
always the closest one.  This was occasionally a GP preference and other 
times a patient request, due to previous clinical experiences with family 
members or more practical issues such as transport links.   
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There were less private medical facilities outside the Dublin city area.  
However, when GPs were genuinely concerned that their patient had a 
suspected breast cancer, they preferred to refer them to a specialist cancer 
centre.  
 
“I think referral rates would probably be higher in the more affluent 
areas maybe.”  (GP 23, Female, DNE) 
 
“The issues that I’ve come across that affect referrals would be 
remoteness, would be mental health as well.”  (GP 18, Male, West) 
 
“In terms of where to go, it might be more to do with patient preference.” 
(GP 19, Female, DML) 
 
Health service factors  
There was a high level of satisfaction with the breast service in general. GPs 
acknowledged that the service was established as a Symptomatic Breast 
service but pointed out that there is no alternative service for asymptomatic 
patients, such as family history, or for screening for those age-groups outside 
the national BreastCheck screening programme age of 50 - 65.  
 
“One of the very few parts of it that’s actually working well in my opinion 
is the whole cancer service. I have no problems with it at all.  It’s one of 
the very few parts of the service I can say that about.”   (GP 6, Female, 
West) 
 
“It’s our only way of getting into the system really.” (GP 7, Female, 
South) (in relation to referral to the SBD unit)  
 
“There’s no middle tier to filter them out before they end up in the big 
system.” (GP 26, Female, DNE) 
 
Access 
Participants were very satisfied with access to the SBD units and were happy 
with the waiting time targets set up by the NCCP whereby urgent referrals 
are seen within two weeks and non-urgent referrals are seen within 12 
weeks.  
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“It’s an excellent service, particularly the way the health service is going 
that you can actually get seen. You’re guaranteed to be seen by a 
specialist in this area in twelve weeks and that’s an excellent service.” 
(GP 3, Male, West) 
 
“The system I have to say is very good in terms of time, turnover time is 
excellent.” (GP 10, Female, South) 
 
“It is one of the few things in the health service that does work; the 
breast clinic, you know, because patients get access to it.” (GP 31, 
Male, DNE) 
 
Hospital - GP interface 
The need to strengthen the interface between primary and secondary care 
was highlighted.  GPs wanted to be able to access consultants and 
radiographers more readily to discuss individual cases. GPs also wanted 
further information on clinical pathways for treatment of breast cancer so that 
they could discuss the treatment options with their patients.   
 
“Until their course of chemo’ has finished we don’t hear anything.” (GP 
13, Female, DML) 
 
“It would be nice if GPs could have a little more direct contact with the 
people at the other end of the service.  It would be nice to be able to 
ring up, you know, the radiographer and just get the verbal report 
even.” (GP 6, Female, West) 
 
“If you have worrying signs, and you pick up the phone, then you’d 
have to say, people are very good to get people sorted quickly.” (GP 
16, Female, South) 
 
Resources / costs 
In relation to resources, GPs acknowledged that with more patients being 
referred to breast clinics based on patient demand and expectations, it was 
possibly not the best use of hospital resources. It was also debated whether 
these resources could be channelled into other services. 
 
“If it’s a breast complaint, I send them all off and that’s it.  I don’t argue. 
I just send them and I don’t think that’s the best way to use our 
resource.” (GP 3, Male, West) 
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“Sometimes you think, you know, are resources put into this too much, 
because you kind of know that there’s nothing wrong with somebody, 
but yet they get an appointment in three weeks time and you kind of go, 
you know, could resources be put somewhere else?” (GP 5, Female, 
South) 
 
Access to diagnostic imaging 
Increased access for GPs to diagnostics was a strong recommendation and 
additional resources in the area of diagnostic imaging were sought.  The lack 
of GP direct-access mammography was seen to influence the volume of 
referrals to the SBD unit.  
 
“It’s very difficult to deal with people, their anxieties you know, without 
getting a mammogram, that’s the big problem I think.” (GP 25, Female, 
West) 
 
“I sometimes wonder, the fact that I can’t get a mammogram now, I 
think clogs up the clinic.” (GP 10, Female, South) 
 
“We don’t have access to mammogram or ultrasound.” (GP 23, Female, 
DNE) 
 
9.7.2  Social influences 
Definition: Those interpersonal processes that can cause individuals to 
change their thoughts, feelings or behaviours. 
 
Themes mapping onto this domain included: 
• Patient anxiety 
• Media and publicity  
• Patient awareness and education 
• Patient expectations  
• The worried well   
 
Patient anxiety 
Patient anxiety was a major theme and GPs reported a high level of anxiety 
in the patients presenting to them. GPs attributed this anxiety to a high level 
of knowledge and information of breast cancer among the population 
generally and also as a result of media and publicity in this area, resulting in 
241 
 
patient fear of having a cancer.  GPs perceived that the media were 
reinforcing patient anxiety and recommended that publicity should be 
reassuring rather than alarmist in nature.  GPs commented that patients 
were “hyped up” when they presented to them, many were “up to high doh” 
and were “not going to rest until seen” in the breast clinics.   
 
“If the patient is very concerned, you’ve got to refer.” (GP 11, Male, 
DML) 
 
“It’s a big anxiety that they have, so any complaint at all about the 
breast is breast cancer in their eyes until proven otherwise.”  (GP 23, 
Female, DNE) 
 
 “I would still say I have a low threshold for referral, especially where 
there’s a high level of anxiety.” (GP 24, Male, South) 
 
A patient’s personal knowledge of friends or family experience with a cancer 
diagnosis also heightened their anxieties.  Historical past events and 
incidents that were widely reported in the media were a constant 
reinforcement of their anxiety and there were concerns that this was leading 
to inflated norms.  The motivation to seek an appointment frequently came 
from family members, friends or advice from cancer help-lines. TV soaps, 
radio stations and lobby groups also tended to fuel patient anxieties. 
 
“I’ve had one case recently where she didn’t really need to go 
anywhere, but a friend of a similar age has breast cancer and she was 
so freaked out about it that I referred her.” (GP 12, Male, DNE) 
 
“They’ve had friends or family or they’ve seen something on the TV or if 
they’ve watched soaps. I mean it’s all very current, or if it’s been on Joe 
Duffy [afternoon radio chat-show host] – he’s probably our biggest 
nightmare.” (GP 14, Female, DML) 
 
“The health service in general are still in the process of trying to 
heighten people’s awareness of cancer and while that has a beneficial 
aspect to it, it has the negative downside of causing many people to be 
anxious where they have no real cause for anxiety.” (GP 24, Male, 
South) 
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Even in asymptomatic patients, such as patients with a family history of 
breast cancer without any symptoms, the fear of developing a breast cancer 
was driving the demand for regular check-ups and screening mammography 
to rule out cancer.  Patients were anxious to be referred on to a specialist 
breast unit and they were familiar with the referral process.   
 
 “If someone has a concern about the breast even though I feel there’s 
nothing going on, and I’m not sure, I feel that there’s nothing, but 
they’re still concerned and would like a mammogram, I’ll refer them.”  
(GP 23, Female, DNE) 
 
“Maybe it is to relieve anxiety but I don’t expect anything to be wrong 
with her.” (GP 3, Male, West) 
 
 “We have an algorithm here that was sent out and I try to follow it, but 
again you see I’m domineered by patient anxiety.” (GP 10, Female, 
South) 
 
Media and publicity   
Participants discussed the power of the media and the influence the media 
and publicity had on individuals.  GPs commented on the impact of the 
media on breast referrals, particularly in relation to fuelling people’s anxieties 
about breast disease.  
 
“I suppose if they hear something in the news they might also be more 
anxious.” (GP 19, Female, DML) 
 
 “There’s so much media coverage of it.  They’re so worried about it, 
they’re so hyped up, they want things seen quickly.” (GP 21, Male, 
DML) 
 
“Media would be a big thing really, media advertising would make 
people come in.”  (GP 5, Female, South)  
 
“There was so much hype in the media, people probably started 
thinking about their breasts more.” (GP 25, Female, West) 
 
GPs perceived that media messages and national campaigns were not 
currently in proportion to the incidence of the disease and should be more 
measured and targeted towards groups most at risk of cancer.  
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 “I think a little bit more publicity, but not too much in the negative end, 
you know.  If you have a breast lump, if you’re worried see your doctor, 
everything else, I think it should be more of a reassuring publicity.” (GP 
15, Female, DML) 
 
“I think the fear is not in proportion to the incidence of the disease.” (GP 
18, Male, West) 
 
“I know the Cancer Society brings out leaflets about, you know, bowel 
cancer and if you have rectal bleeding go to your doctor immediately 
and all the rest but I think that sometimes they cause more anxiety than 
they solve, you know.”  (GP 9, Male, South) 
 
Celebrities appeared to play a role in referral patterns.  Similar to the hospital 
interviews, GPs reported an increase in patient requests for breast referrals 
following ‘Kylie’ concerts in Ireland and cervical screening referrals following 
Jade Goody coverage, two celebrities with a cancer diagnosis. GPs also 
reported that cancer had become ‘politicised’, sometimes to the detriment of 
other disease groups.  
 
“Kylie Minogue at the time, because she was so young, I suppose 
certainly around that time there might have been a small increase in the 
amount of young women, that, you know, may have come in.” (GP 6, 
Female, West)  
 
“If somebody on Fair City [Irish soap opera] died of breast cancer, that 
always affects.” (referrals) (GP 5, Female, South) 
 
Some GPs found an increase in requests for referrals following breast cancer 
campaigns, in particular during  October, which is Breast Cancer Awareness 
Month in Ireland and internationally, but others did not notice any seasonal 
variation.  
 
“I’ve often seen a big campaign over a week or listened to the radio 
somewhere and say “that will get me busy” and no I haven’t, it hasn’t 
brought too many people in at all, no.” (GP18, Male, West) 
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“The government go into these big campaigns and they advertise them 
and like everything else, if you’re going to do that, people are going to 
start looking at themselves.” (GP 11, Male, DML) 
 
Patient awareness and education  
While patient knowledge and awareness of breast disease was high, GPs 
recommended additional and targeted patient education in the area of family 
history of breast cancer. Negotiation and shared decision-making with the 
patient was sometimes seen as ‘internet driven’.  Better-educated patients 
served as a cue or prompt for GPs, increasing the probability of an onward 
referral.  Patients were keen to attend a ‘one-stop-shop’ to be assessed and 
specifically requested a referral for this service.   
 
 “Well I mean, it probably is a lot to do with patient awareness. We 
wouldn’t be referring people if they didn’t present.” (GP 19, Female, 
DML) 
 
“Because people know the clinic is out there, I think we’re referring 
more.” (GP 3, Male, West)   
 
 “I think there’s a society-wide awareness of the prevalence of cancers 
and a sort of  growing neurosis that we’re about to be decimated in a 
way that, while appropriate to some extent, is having an adverse impact 
on peoples’ psychological wellbeing out of proportion to the reality of 
the situation.” (GP 24, Male, South) 
  
Patient expectations   
GPs perceived patient expectations as high and GPs discussed the dilemma 
between their role as the GP, use of scarce hospital resources and anxiety 
about refusing a request for referral in these patients.  Patients were, in 
general, familiar with the referral process and made specific requests for an 
urgent appointment, to be seen within 10 days. GPs reported that patients 
had great trust in the service, based on previous experience of others.  
 
GPs reported that in some cases they felt under pressure from their patients 
to refer.  Patient psychological factors also influenced the urgency of referral 
and many presented with a fear of having a cancer, seeking investigations to 
put their minds at rest. GPs indicated that demand for clinic appointments 
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was growing.  GPs attributed this increase in demand to media-induced 
anxiety, lack of GP autonomy and pressure for referral.  
 
“Any complaint at all about the breast is breast cancer in their eyes until 
proven otherwise.” (GP 12, Male, DNE) 
 
 “At the end of the day I suppose, the patient is the one that needs to be 
kept happy.” (GP 6, Female, West) 
 
“You will get some pressure from patients from time-to-time, you know, 
they’re very concerned.” (GP 30, Male, DNE) 
 
The worried well 
GPs commented on the growing number of ‘worried well’ with ‘perceived 
need’, seeking onward referral to specialist breast clinics which did not result 
in additional cancers being detected.  
 
“I think that they have a low probability of anything serious but if they’re 
not happy to wait and see type of thing, I refer them if that’s what they 
want, you know.”  (GP 9, Male, South) 
 
“All you’re doing is increasing the worried well and it’s not having any 
impact on the number of new cases that are being diagnosed.” (GP 3, 
Male, West) 
 
“To be honest, a lot of the time they would be what I would consider the 
worried well..... A lot of what I would consider the worried well are very 
much reassured by negative tests.”   (GP 6, Female, West) 
 
9.7.3  Knowledge 
Definition:  An awareness of the existence of something. 
 
Themes which were mapped to this domain included:  
• GP knowledge / education   
• Electronic referral 
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GP knowledge and education  
A number of the patient factors which influenced the GP decision to refer to 
the SBD units were linked to clinical disease factors such as family history of 
breast cancer.  GPs requested standardised information on screening for 
family risk for breast cancer.  Education to assist GPs in reassurance and 
management of patients in primary care was also suggested.   
 
“What the genetic inheritance significance of it all is, and who needs to 
be screened and who doesn’t need to be screened.”   (GP 11, Male, 
DML) 
 
“Education around GPs about being confident about reassuring patients 
with breast complaints.” (GP 23, female, DNE) 
 
“Hone people up on who to hold on to and who to wait, rather than 
refer.” (GP 19, Female, DML) 
 
Electronic referral 
A system to send GP referrals to the cancer centres through a secure 
electronic facility was introduced by the NCCP in 2010.  Knowledge amongst 
GPs of this electronic referral facility was mixed.  Some GPs, whilst aware of 
the system, were resistant to changing habits and actively disregarded the 
system.  For GPs already using the system, they identified the benefits of 
electronic referral as quick, innovative and easy to use. The automatic 
electronic acknowledgement provided confirmation and reassurance for the 
GP and the patient that the referral had been received, and GPs were very 
satisfied that rapid appointments were allocated for urgent patients. The 
early adopters of electronic referral were predominantly young urban GPs in 
computerised group practices. GPs who were not using the electronic 
referral system were not aware of the facility, did not have the required 
technology in their practices, were not using ICGP-accredited GP practice 
management software, or did not wish to change their existing practice of 
letters or faxes. 
 
“I’ve only been using it very recently and it’s excellent.” (GP 3, Male, 
West) 
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“I fax them in because I’m not electronic.  Some of us are very stubborn 
and we won’t go electronic at all.” (GP 15, Female, DML)  
 
“There’s a few older GPs definitely didn’t get computerized because 
they know they’re retiring.” (GP 26, Female, DNE) 
 
9.7.4  Behavioural regulation  
Definition: Anything aimed at managing or changing objectively observed or 
measured actions.  
 
Themes mapped to this domain included: 
• GP referral practices  
• Referral form and guideline  
• Protocols and compliance 
 
GP referral practices  
Some GPs, especially those involved in GP training provision or Continuing 
Medical Education (CME) regarded themselves as ‘rule followers’ with 
implementation intention, whilst others preferred to be guided by their own 
professional judgement.  Many GPs had incorporated the GP guidelines into 
their GP practice protocols, particularly in group practices and found them 
useful moderators of the intention-behaviour gap.  Length of experience of 
the GP had some influence on referral decisions. Some GPs felt they had 
developed a more conservative decision-making style as they got older 
whilst others felt more confident in managing their patient in primary care as 
they gained more experience. Decision-making in relation to referral was 
described as ‘not black and white’.  
 
“I’d have a very low threshold for sending people to the breast clinic, 
more so than I would have had five years ago for sure.”  (GP 16, 
Female, South) 
 
“We each individually do our own thing.” (GP 12, Male, DNE) 
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Referral form and guidelines  
There was a high level of awareness amongst GPs of the national NCCP GP 
referral guidelines for suspected cancers.  GPs regarded following the 
guidelines as important and trusted the guidelines as evidence-based and 
helpful for clinical decision-making. However, some GPs followed their 
clinical judgment instead of the guidelines and felt there may be too many 
guidelines for them to follow.  The majority of GPs were using the NCCP 
referral forms either in paper format or electronic format, though some 
preferred the traditional GP letter. 
 
“The referral for the breast is excellent. I’ve had nothing but the highest 
of praise for them.” (GP 14, Female, DML) 
 
“I probably use my head more than the guidelines.” (GP 26, Female, 
DNE) 
 
“I just think also there might be a danger of too many guidelines and too 
much information.” (GP 21, Male, DML) 
 
Protocols and compliance 
Protocols and compliance played a role in the referral process. The NCCP 
GP referral guidelines and referral forms served as a reminder of the GP’s 
gatekeeping role.  Other GPs, while familiar with the guidelines, believed in 
their capability to follow their own clinical judgement based on their 
experience and maintained their stability of intentions or engaged in joint 
decision-making with the patient. GPs were confident they had the requisite 
procedural knowledge and competence to refer appropriately.  
 
Although there are neither sanctions nor rewards for adherence to the 
national GP referral guidelines, GPs felt they acted to reinforce the clinical 
pathway.  Increased awareness amongst patients and in the media also 
reinforced the streamlining of the breast cancer referral process.  These 
environmental triggers assisted conscious decision-making as part of routine 
practice. 
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“They’re not going to rest until they get seen and if that’s the case 
there’s absolutely no point trying to follow, you know, protocols because 
it just doesn’t work, you know.”  (GP 10, Female, South) 
 
“Do I follow them to the strict letter of the law, I probably don’t. We each 
individually do our own thing.” (GP 12, Male, DNE) 
 
 “I think the guidelines are very good and that’s why if you’ve got good 
guidelines, guidelines are there for a reason.” (GP 14, Female, DML) 
 
9.7.5  Beliefs about consequences 
Definition: Acceptance of the truth, reality or validity about outcomes of a 
behaviour in a given situation. 
 
Themes mapped on to this domain included:  
• Risk 
• Reliance on diagnostic imaging 
• GP reassurance 
 
Risk   
GP discussion on risk focused on cautious management of breast referrals in 
primary care, risk aversion and medico-legal implications. 
 
Cautious management 
GPs described a cautious management approach to management of breast 
disease. GPs expressed a low threshold for referrals, tending to err on the 
side of caution and were cognisant of outcome expectancies.  
 
 “We probably do err on the side of caution and maybe that’s just 
because people present more often.” (GP 19, Female, DML) 
 
“I’d be very cautious when it comes to the breast, for fear of missing a 
cancer.” (GP 23, Female, DNE) 
 
“It seems as I get older, I get less cavalier in my approach and I 
suppose over the years would have had a couple of surprises.” (GP 10, 
Female, South)   
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Risk aversion 
Risk aversion was a consistent theme raised by GPs and was accepted as a 
growing trend based on fear of missing a cancer, fear of litigation and the 
resultant legal consequences. GPs in training practices stated that their 
registrars (trainee GPs) were more likely to refer the patient on rather than 
manage the risk themselves.   
 
“Very brave man to sit here and say no.” (GP 11, Male, DML) 
 
“There’s nobody worth their salt that will probably take the chance of 
not doing it.” (referring) (GP 12, Male, DNE) 
 
“We have GP registrars and I find that they will find relief in referral, 
rather than manage the risk themselves. It’s a great way of moving the 
problem on.” (GP 18, Male, West) 
 
Medico-legal implications 
The anticipated regret of missing a cancer coupled with the cognisance of 
medico-legal issues meant that GPs would take a cautious or guarded 
approach to patient management. 
 
“I really think that is just the whole public perception of breast cancer 
and that, if you were the one that didn’t send somebody in for six weeks 
and they had some weird thing and they had a breast cancer, it would 
be such a huge deal.” (GP 12, Male, DNE) 
 
“Now because of all the possibility of litigations and everything else, 
everybody is just trying to cover their backs and I think more people are 
referring now again.” (GP 15, Female, DML) 
 
“We live in an age of litigation.” (GP 3, Male, West)  
 
Reliance on diagnostic imaging    
Confirmation of GP diagnosis through diagnostic imaging was a strong 
recurring theme among GPs in order to provide reassurance to the GP. GPs 
sought diagnostic imaging to confirm their diagnosis/assessment and to rule 
out cancer. There were some concerns about lack of GP direct access to 
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imaging and in some cases this resulted in a referral to a breast clinic, as 
there was no other route available for them to access this imaging.  
 
“I wouldn’t feel confident in reassuring without a mammogram or an 
ultrasound.” (GP 23, Female, DNE) 
 
“You examine them and there’s no breast lumps. For me personally I 
think it’s very hard to say you don’t need a mammogram.”   (GP 5, 
Female, South) 
 
“I think because of the times we live in, doctors are less confident I 
think to diagnose a benign breast disease without a technical aid.” (GP 
3, Male, West) 
 
Breast screening was seen to provide reassurance to patients. GPs reported 
concerns that there was not a process for screening of asymptomatic women 
outside the National Breast Screening Programme (BreastCheck). When 
women outside this age-group requested screening, GPs frequently referred 
patients even if they believed this was not warranted. GPs reported referring 
for diagnostic imaging in response to patient anxiety and expectations. 
 
“If somebody is keen for a test and if I’m not sure, it’s very hard to say, 
you know, not to do the test.” (GP 19, Female, DML) 
 
“A lot of women that would be entirely asymptomatic, the problem with 
patients nowadays is they’re all on Google and they’re all on these 
different things and they put huge I suppose belief in tests, you know, 
they’re so obsessed now...... Once you go in under a machine, people 
seem to give it great scope.” (GP 6, Female, West) 
 
“Some people put a great faith in the test.” (GP 9, Male, South) 
 
GP Reassurance 
GPs reported a requirement for reassurance that their diagnosis was correct 
and that breast cancer could be ruled out.  GPs sought reassurance and 
confirmation of their diagnosis through consultant review or diagnostic 
imaging. 
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 “I reassure them and they feel reassured but at the same time I’d like to 
be reassured by the breast clinic.”   (GP 12, Male, DNE) 
 
“If you’re not totally reassured you have to send them.” (GP 26, 
Female, DNE) 
 
“In the past one might have been more ready to simply reassure and 
dismiss perhaps; now it’s my policy if anybody has a symptom referring 
to the breast at all I will usually reassure while simultaneously saying to 
them ‘look we’ll get somebody to have a little look at it’. ” (GP 24, Male, 
South) 
 
“We had gone through a phase when, you know, everything was fine, 
you were able to reassure patients and keep them going, but nowadays 
with persistent things of litigation and, you know, you just have to refer.” 
(GP 15, Female, DML) 
 
9.7.6  Memory, attention and decision processes    
Definition: The ability to retain information, focus selectively on aspects of the 
environment and choose between two or more alternatives.  
 
Themes mapped to this domain included: 
• Family history of breast cancer 
• Mastalgia 
 
Family history of breast cancer 
GPs concluded that patients are very anxious about family history of breast 
cancer but were not always aware of how to determine their own risk.  These 
patients were generally referred by GPs to the SBD Unit for assessment, 
particularly if they were outside the age-group for the National BreastCheck 
Screening Programme (50-64 years). GPs also recommended a dedicated 
service for family history of breast cancer. 
 
“If there was family history, you’d be more inclined to be cautious, the 
patient is more anxious to be seen.  If there’s a strong family history, I 
might refer them a bit sooner. Not all would have a genuine family 
history, some would be quite distant relatives.” (GP 8, Male, West) 
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“A lot of it is perceived family history.  I think it’s difficult for the patient 
to quantify how high the risk is.”  (GP 11, Male, DML) 
 
 “I think again because that it’s media driven they’re worried, say if 
they’ve had any family member who’s had cancer, I think that’s the 
problem.” (GP 14, Female, DML) 
 
Mastalgia (breast pain) 
GPs commented on an increase in patients presenting to them with 
mastalgia.  Mastalgia on its own, in the absence of clinical symptoms, is not 
an indicator for referral. However, GPs found it difficult to reassure patients 
that breast pain on its own was not an indicator of cancer. 
 
GPs discussed the materials that had recently been developed in Ireland by 
the NCCP for mastalgia, following the outcomes and recommendations of 
the hospital interviews. These materials included a referral algorithm for GPs, 
a patient booklet and a smart phone app’ for patients. GPs reported finding 
these materials useful. Their patients found the patient diary useful as it 
helped them to chart their breast pain over three months and then return for 
assessment if required. GPs reported that some patients were satisfied to be 
managed in primary care, especially as part of this monitoring process.  
 
“People are scared of lumps, they can put up with pain.” (GP 21, Male, 
DML) 
 
 “I think cancer has become politicised, so a lot of breast symptoms like 
breast pain, particularly in young women, they’re very anxious to be 
referred to the breast clinic. I think the public needs to be told that 
mastalgia is not cancer.” (GP 9, Male, South) 
 
 “The only pressure I get from patients goes with the benign breast pain 
and you try to reassure them and they keep at you, you know.” (GP 15, 
Female, DML) 
 
“It’s very hard to reassure and I think if there was more public 
awareness of breast pain as opposed to breast cancer.”  (GP 12, Male, 
DNE) 
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9.7.7 Skills (Cognitive and interpersonal skills, physical skills) 
Definition: An ability or proficiency acquired through practice. 
 
Themes mapped to this domain included: 
• GP skills  
• Patient reassurance  
• Follow-up after breast cancer 
 
GP skills and training  
GPs were asked about requirements for skills training and education. GPs 
felt their skills in some areas were sufficient, such as triage, but needed 
updating in other areas such as clinical breast examination.  A reliance on 
diagnostic imaging to back up their clinical examination findings was a 
recurring theme.  Interestingly, some GPs stated that although they had the 
requisite skills for decision-making, they felt compelled to refer the patient to 
the breast clinic due to patient pressure. 
 
GPs valued the opportunities to liaise with other GPs on clinical matters. 
However they found it difficult to attend structured sessions and tended to 
seek on-line options for convenience and accessibility.  
 
“Anything that will help improve our skills.” (GP 10, Female, South) 
 
“Teaching clinics for GPs to learn that sort of thing, you know, breast 
examination and the difference between a benign and a malignant 
lump.” (GP 5, Female, South)     
 
Patient reassurance  
GPs felt they needed to spend a lot of time reassuring the patient.  This 
required time, interpersonal skills and confidence in their ability to provide 
this reassurance as part of their role as family physician. In certain cases, 
GPs felt compelled to refer the patient on, just for patient reassurance, even 
though they were confident of their diagnosis.   
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 “I know we’re sending people to the symptomatic breast clinic and I 
know in my heart of hearts that it’s really for reassurance.” (GP 25, 
Female, West) 
 
“It’s the ones who we cannot reassure that everything is fine, we have 
to send them to the hospital, and invariably it is fine and they’re happy 
after that.”  (GP 15, Female, DML) 
 
“Sometimes you just have to refer for reassurance if they’re not going to 
take your word for it.” (GP 8, Male, West) 
 
Certainly, when GPs perceived that patients were not adequately reassured 
during the GP consultation, GPs tended to refer these patients on to the 
breast clinics for additional reassurance.  
 
“Reassurance is a hollow thing for a lot of people now.” (GP 9, Male, 
South) 
 
“You’re sitting there thinking, well okay, well ‘I’ll just send you to the 
breast clinic’ because they’ll get a mammogram or they’ll get an 
ultrasound and they will be reassured.” (GP 25, Female, West) 
 
“You err on the side of caution and try to; you know, get them checked 
and make sure they’re reassured.”  (GP 30, Male, DNE) 
 
Patient reassurance through diagnostic imaging was a common theme: 
 
“I think if somebody is determined to have a scan, I probably wouldn’t, I 
wouldn’t go against them, because it may be hard for me to reassure 
them a hundred percent clinically.” (GP 19, Female, DML) 
 
“If they just aren’t settling and are petrified, there is nothing short of the 
normal scan that’s going to reassure them that they don’t have a 
chronic problem.” (GP 26, Female, DNE) 
 
“Some people put a great faith in the test.” (GP 9, Male, South) 
 
“I could stay examining a woman’s breast all day long and tell her I’m 
feeling nothing but if she can actually get a report where it writes down 
in black and white, negative mammography, you know, that carries an 
awful lot more weight... They put huge belief in tests.” (GP 6, Female, 
West) 
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Follow-up after breast cancer 
There were a number of patient factors which influenced the GP decision to 
refer to the SBD units.  Some of these were linked to clinical disease factors 
such as follow-up after breast cancer. Current policy in Ireland is to 
discharge patients from the hospital to their GP five years after initial 
diagnosis and treatment of breast cancer, provided they have completed 
their treatment and do not have any symptoms of recurrence. Some GPs 
were confident to follow up patients with annual check-ups, as long as 
patients could be referred back to the breast units quickly if they became 
symptomatic.  Other GPs felt that they did not have the requisite skills and 
would prefer if the patient remained under the care of the hospital consultant.  
 
“Oh no, I mean anyone who’s had breast cancer I’d hope that they’d 
stay going back to the hospitals, yeah.” (GP 21, Male, DML) 
 
“I suppose as long as we have clear guidelines about what we’re to do, 
I think we’d all be happy about that.” (GP 10, Female, South) 
 
“Actually I notice that I got a couple of letters asking that we continue 
surveillance for breast cancer and organise annual mammogram and 
you know maybe six-monthly breast examination and I felt somewhat 
uncomfortable about that.”  (GP 23, Female, DNE) 
 
9.7.8  Beliefs about capabilities 
Definition: Acceptance of the truth, reality or validity about an ability, talent, 
or facility that a person can put to constructive use. 
 
Themes mapped on to this domain included: 
• Empowerment of GPs  
• GP confidence 
 
Empowerment of GPs 
Participants spoke about empowerment of GPs and some GPs felt 
disempowered in the management of this group of patients since the 
establishment of GP referral guidelines for cancer, and expressed a low 
threshold for referral.  Some GPs reported that the triage had been taken out 
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of primary care and that breast complaints were now the exclusive 
responsibility of the hospital.  
 
“I wouldn’t be worried about that, losing autonomy, it doesn’t get on top 
of me.” (GP 30, Male, DNE) 
 
“I think that they’ve taken the triage out of general practice.” (GP 9, 
Male, South) 
 
“We’re kind of disregarded and also in our local area we cannot access 
results.” (GP 18, Male, West) 
 
GP confidence 
A number of GPs did not feel confident in their practical skills of some 
procedures such as doing clinical breast examinations and felt they needed 
some training, up-skilling or clinical information updates in this area.  Many 
GPs had confidence in their clinical practice and competence but would 
welcome more access to diagnostic tests to assist their diagnosis. A second 
opinion from the breast clinic was frequently cited as a reason for patient 
referral. Some GPs were confident with their clinical decisions; others felt 
they had developed greater confidence with longer experience. 
 
“I could stand over my clinical decisions in anything that I would do.” 
(GP 10, Female, South) 
 
“The longer you’re qualified obviously the more you know, and then the 
more confident you are.” (GP 6, Female, West) 
 
“I suppose I’m in it ten years now.  You feel you have a good feel for 
what should be done.” (GP 16, Female, South) 
 
“We can’t be a hundred percent sure ever that there’s nothing wrong.” 
(GP 25, Female, West) 
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9.7.9  Social/professional role and identity 
Definition: A coherent set of behaviours and displayed personal qualities of 
an individual in a social or work setting.  
 
Themes mapped to this domain included: 
• GP responsibility and ownership 
• Gatekeeping 
 
GP responsibility and ownership 
GPs reported some uncertainty in relation to responsibility and ownership of 
breast disease in primary care. Whilst GPs felt responsibility for and 
obligation to their patients, the majority of GPs felt reluctant to manage 
benign breast disease in primary care.  A number of factors, both barriers 
and facilitators, contributed to this approach, including:   
• a perceived lack of autonomy   
• pressure from patients to be referred   
• ease of access to the breast clinics in the designated cancer centres  
 
Professional role and identity was important to GPs. They “know the patient” 
and their commitment to the patient and social identity has earned them the 
respect and trust of their patients. Allegiance to their patients was discussed, 
with a commitment to deliver the service the patient expected.  
 
“I now think to myself, why do I burden myself with the responsibility of 
worrying about people when, you know, they can go to the clinic.”   (GP 
10, Female, South) 
 
“I’ve probably referred a hundred percent of breast complaints.” (GP 12, 
Male, DNE) 
 
“That’s the nice thing about them being our patients.  We know them, 
so you know the character you’re dealing with.” (GP 7, Female, South) 
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Professional boundaries were challenged in the area of breast care and GPs 
felt that, due to patient expectations, they are now referring people into the 
hospital clinics that they would have previously managed in primary care.  
Some GPs reported being reliant on technical aids, such as diagnostic 
imaging.  Many GPs took on a leadership role as GP tutors to train other 
GPs.  Group identity, either in terms of organisational commitment to a group 
practice or as part of a professional community of GPs, was high.  
 
Responsibility for management of breast disease was seen to be migrating 
exclusively to the hospital setting. 
 
“I mean there’s no point trying to sit on somebody and keep them, you 
know here with me examining them if they’re just worried out of their 
mind.” (GP 10, Female, South) 
 
“I think it’s moving towards the situation where, basically breast 
complaints are regarded as the exclusive territory of the breast team.” 
(GP 24, Male, South) 
 
Gatekeeping  
There was some debate regarding the gatekeeping role of the GP. Whilst 
GPs felt they possessed sufficient gatekeeping skills, there was divided 
opinion on whether this was their role. Some GPs saw this as part of their 
role and others considered that it was outside the professional boundaries of 
the GP. This differed quite considerably between GPs who had trained or 
practiced in Ireland and those who had trained or practiced in the UK. GPs 
who had worked in the UK expressed that gatekeeping was a key part of 
their GP role while this was not expressed by others.    
 
“I trained in England where we were taught to be the gatekeepers of the 
hospitals.” (GP 10, Female, South) 
 
“I was trained in the UK so I certainly kind of feel that GPs should be in 
a better position to say ‘no I’m not going to refer you’.” (GP 7, Female, 
South) 
 
 “If it’s in the breast, I just refer in.” (GP 3, Male, West) 
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“You want to do the best for the patients.” (GP 19, Female, DML) 
 
9.7.10  Emotion 
Definition: A complex reaction pattern, involving experiential, behavioural, 
and physiological elements, by which the individual attempts to deal with a 
personally significant matter or event.  
 
Themes mapped on to this domain included: 
 
• Provider anxiety (GP anxiety) 
 
GP Anxiety  
Anxiety was a consistent theme throughout the GP interviews, focusing both 
on GP anxiety and patient anxiety. GP anxiety was predominantly based on 
fear of missing a cancer and anticipated future outcomes. Repeated media 
coverage of critical incidents in the past, sensitisation and salient events 
reinforced this anxiety.  
 
“A lot of medicine nowadays is anxiety driven.” (GP 25, Female, West) 
 
“If you miss one case of cancer then people will come down on your 
back and say ‘oh you should have referred me to the clinic’ and I think 
that’s what worries doctors.” (GP 3, Male, West) 
 
“If you were the one that didn’t send somebody in for six weeks and 
they had some weird thing and they had a breast cancer, it would be 
such a huge deal.” (GP 12, Male, DNE) 
 
9.7.11  Reinforcement  
Definition: Increasing the probability of a response by arranging a dependent 
relationship, or contingency, between the response and a given stimulus.  
 
Themes mapped under this domain included: 
• HIQA    
 
NCCP was also a related theme under this domain. 
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The Health Information and Quality Authority (HIQA) and the National 
Cancer Control Programme (NCCP) were viewed by GPs as enforcement 
bodies to which hospitals were accountable for maintaining the standards of 
the breast service.    
 
“It’s certainly a big improvement on what things were before the formal 
National Cancer Programme was in place.” (GP 29, Male, West) 
 
9.7.12  Optimism 
Definition: The confidence that things will happen for the best or that desired 
goals will be attained.  
 
There were no themes which mapped directly on to this domain as their 
primary focus.  Related themes included NCCP and the cancer centralisation 
process.  
 
GPs reported great optimism and belief in the breast service and identified 
the role of HIQA and the NCCP in the establishment of the cancer centres.  
GPs identified cancer services as a quality service in which they had 
confidence and commented on the role of the NCCP and the success of the 
cancer services in general. The quality of the service in the Symptomatic 
Breast Units was praised and recommended as a structure for other areas in 
the health service to adopt.  
 
“One of the very few parts of it that’s actually working well in my opinion 
is the whole cancer service.” (GP 6, Female, West) 
 
“It will all be done in a one-stop-shop. People want to walk away at the 
end of the day with an answer.” (GP 7, Female, South) 
 
“I think it’s the best thing about the health service.” (GP 12, Male, DNE) 
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9.7.13  Intentions 
Definition: A conscious decision to perform a behaviour or a resolve to act in 
a certain way. 
 
There were no themes which mapped directly on to this domain as their 
primary focus.  Related themes included protocols and compliance. The GP 
referral guidelines prompted GPs to reflect on the management plan for their 
patients and to take the guidelines into consideration in their professional 
judgement. 
 
“I think in the main we try and keep to that regime, that what we mean 
urgent is urgent.” (GP 16, Female, South) 
 
9.7.14  Goals 
Definition: Mental representations of outcomes or end states that an 
individual wants to achieve. 
 
There were no themes which mapped directly on to this domain as their 
primary focus. While GPs intended to implement the GP referral guidelines in 
their practice, these goals were not always followed. The priority for GP was 
to do the best for their patients.  
 
The targets set by the NCCP were seen to be ambitious but in the most part 
were being achieved. The target to see urgent patients within 10 working 
days was seen as a model of good practice and GPs were satisfied with this 
service.  GPs recommended that similar targets be set for other diseases, 
particularly for diagnostics.    
 
 “You want to do the best for the patients.” (GP 19, Female, DML) 
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9.8  Summary of findings 
Findings are summarised below, with the main theoretical domains identified 
in parentheses.  Similar to the hospital interviews, results have been 
summarised into health service, patient and provider factors affecting 
referrals. Whilst GPs were satisfied with the breast service, this was not 
reflected in their comments on other cancers. There were conflicting views 
on the gatekeeping role of the GP.  
 
Health service factors 
The rapid-access breast clinics were seen by the GPs as a high-quality 
service and a model for other parts of the health service to emulate 
(environmental context and resources). Ease of access to the breast clinics 
was seen as a contributing factor to increased referrals (environmental 
context and resources). However, GPs indicated that demand for clinic 
appointments was growing.  GPs attributed this increase in demand to 
media-induced anxiety (social influences), lack of GP autonomy (beliefs 
about capabilities) and pressure for referral (social influences). The 
emergence of a new group of patients seeking breast screening following 
their completion with the BreastCheck screening programme was 
unexpected and needs to be considered in future service planning. 
 
GP (provider) factors 
GPs attributed the increase in GP referrals to their fear of missing a cancer 
(emotion).  GPs were cognisant of medico-legal issues and opted to take a 
cautious approach to the management of breast referrals (beliefs about 
consequences).  GPs articulated a need for reassurance through specialist 
opinion and diagnostic imaging (beliefs about capabilities, beliefs about 
consequences).  GPs saw their role as an advocate of the patient rather than 
a gatekeeping role for the hospital (professional role and identity).   
 
Patient and social factors influencing GP referral decisions 
There were a number of patient factors which influenced the GP decision to 
refer to the specialist breast units.  Some of these were linked to decisions 
based on clinical disease factors, such as family history of breast cancer, 
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mastalgia or follow-up after breast cancer (memory, attention & decision 
processes, skills), whilst others were based on more psychosocial factors, 
including patient anxiety and perceived expectations (social influences). 
Patient anxiety was perceived to be fuelled by media reports, publicity and 
breast awareness initiatives (social influences). 
 
The following is a summary of the recommendations made by the 
participating GPs. A number of these recommendations have already been 
initiated or implemented.  These initiatives have been included in 
parentheses and are presented in more detail in the discussion chapter 
(Chapter 11). 
 
• Information in relation to health and well-being should be realistic and 
proportionate (joint planning commenced between NCCP and 
advocacy groups for awareness campaigns). 
• Clear referral pathways are required for patients with a family history 
of breast cancer, with information for GPs and for patients on referral 
criteria (GP referral guideline updated with advice on family risk).   
• Clear advice is required for patients and GPs on the management of 
breast pain (Information developed for GPs and patients on 
mastalgia).   
• The provision of GP direct access mammography should be 
considered (BreastCheck age-range extended in 2015). 
• Training/up-skilling for GPs in breast examination should be provided 
(GP education programme commenced). 
• The hospital–GP interface should be strengthened, with greater 
access to consultants to discuss individual cases (Healthlink 
integrated into accredited GP software systems, breast cancer 
guidelines for diagnosis and staging developed). 
• Education for practice nurses on breast disease should be provided 
(national training programme commenced for nurses caring for cancer 
patients). 
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Overall, GPs have confidence in public hospital care for their breast cancer 
patients since the establishment of designated cancer centres. However, 
GPs’ confidence in their own referral decisions was varied.  A second opinion 
from the breast clinic was frequently cited as a reason for patient referral. 
Whilst some cases were straightforward, the likelihood of referral increased 
when the cognitive task of diagnosis was more complex.  
 
In conclusion, GP referral practices are influenced by patient, provider and 
health service factors, which can be both social and contextual in nature and 
do not follow strictly Bayesian reasoning  (282).  Social influences coupled 
with beliefs about consequences are challenging barriers to address and will 
require multifaceted interventions to overcome.  
 
9.9  Comparison of GP and Hospital interviews  
The qualitative datasets from hospital and GPs interviews were triangulated 
to address completeness, convergence and dissonance of key themes (415). 
Triangulation is a methodological approach that contributes to the validity of 
research results when multiple methods, sources, theories and/or 
investigators are employed (415). 
 
Using the domains from the Theoretical Domains Framework used in the 
analysis of GP and hospital interviews, a convergence coding matrix was 
created to summarise the similarities and differences between the two sets of 
data, as seen in Table 9.5.  This table shows a comparison of the ranking of 
domains from GP and consultant interviews.  Whilst environmental context 
and resources featured most frequently for both groups, the order differs 
slightly for subsequent domains.  
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Table 9.5: Convergence coding matrix  
Primary TDF domain  
GPs (n=24) 
Frequency of 
responses 
Rank Hospitals (n=9) 
Frequency of 
responses 
Rank 
Environmental context & 
resources 
481 1 219 1 
Social influences 204 2 73 3 
Knowledge 119 3 80 2 
Behavioural regulation 114 4 44 6 
Beliefs about consequences 91 5 28 7 
Memory, attention and 
decision  processes 
88 6 61 4 
Skills 86 7 59 5 
Beliefs about capabilities 33 8 20 9 
Social/Professional role and 
identity 
18 9 21 8 
Emotion 11 10 15 10 
Reinforcement 0 11 4 11 
Optimism 0 12 0 12 
Intentions 0 13 0 13 
Goals 0 14 0 14 
 
9.9.1  Convergence coding  
Examination of convergence, complementarity and dissonance increases the 
likelihood that findings will be found credible, thereby  enhancing the validity 
of the research (455).  Convergence coding was used in this analysis to 
assess the extent to which the different findings in the GP and 
consultant/hospital interviews showed convergence, complementarity, 
dissonance or silence.  (adapted from Farmer) (415).  
 
9.9.1.1 Convergence  
Convergence is when findings from each data source agree and can be 
described as full or partial agreement. The two sets of data were assessed 
for agreement on the meaning and prominence of themes presented and 
also on the similarity of examples provided.   
 
There was full agreement across both GP and consultant/hospital interviews 
in relation to: 
• The high quality of the centralised service for breast cancer  
• Increase in patient expectations/demand for the service  
• Negative impact of the media on patient anxiety  
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 There was agreement across both GP and consultant/hospital interviews in 
relation to the following themes, but the level of prominence differed. In each 
of these cases, the theme was more prominent in the GP interviews:  
 
• Requirement for GP direct access to imaging  
• Requirement for patient reassurance  
• Risk aversion of GPs  
• Health provider anxiety  
• Patient anxiety  
• Geographical factors  
 
There were no common themes identified where the level of prominence was 
higher in the consultant/hospital group than the GP group.  
 
9.9.1.2 Complementarity  
Findings from different studies can be assessed for complementary 
information on the same issue. Through ascertaining the complementarity of 
different data sources, it is possible to increase understanding of the 
phenomenon being studied (415).  
 
Through exploration of factors influencing referral patterns from the 
perspectives of both the referring GPs and the hospital SBD units, multiple 
dimensions of the phenomenon could be examined, providing a more 
complete picture of the issue. This assessment highlighted the impact of a 
successful service on subsequent demand in both GP and hospital services. 
Clinician’s beliefs about consequences and tolerance of risk in both settings 
influenced the management of these patients which may have accentuated 
the demand on the service.  
 
268 
 
9.9.1.3 Dissonance  
Dissonance refers to disagreement,  unexplainable divergence in meaning or 
prominence (415), or findings which appear to contradict each other (416). 
The GP and hospital interviews were assessed for possible areas of 
dissonance. Four areas of dissonance were identified, as follows:  
 
Access to service: Consultants stated that access to the breast service was 
now too easy, while GPs were very satisfied with this arrangement.  
Hospitals declared that they could not continue to provide an equivalent 
service if the demand kept increasing.  
 
Ownership and responsibility: Consultants wanted GPs to manage the non-
urgent referrals in primary care and take on more of a gatekeeping role, 
while GPs felt the ownership of this condition now lay exclusively with the 
specialist breast units, with no consensus on the gatekeeping role. 
 
Follow-up after breast cancer: Neither the consultants, nor the majority of 
GPs, felt that the responsibility of patient follow-up after their hospital 
discharge (five years after treatment) belonged with them.  
 
Seasonal variation: Although hospitals felt that there was an increase in 
referrals during breast cancer awareness month in October, GPs did not feel 
their referrals increased during this time. 
 
9.9.1.4 Silence  
The two sets of data were assessed for silence, i.e., where one set of 
findings is silent on a theme or an example. Themes which featured in 
consultant interviews but not in GP interviews included:  
 
• Pride in the professional service they provide  
• Accuracy of GP referrals  
• Impact of the HIQA review 
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There were no themes which featured in GP interviews but not in hospital 
interviews. 
 
Multiple-level societal issues were raised at the hospital and GP interviews.  
However, the findings illuminate issues at various different levels. 
Consultants refer to macro-level issues as impacting more on referral 
patterns while micro-level concerns such as patient anxiety influenced GP’s 
decisions. 
 
Richards (p.146) (469) describes five signs of sufficiency for qualitative 
analysis:  
• Simplicity – a small polished gem of a theory rather than ‘a mere 
pebble of truism’ 
• Elegance and balance – it is coherent 
• Completeness – it explains all 
• Robustness – it doesn’t fall over with new data 
• It makes sense to relevant audiences  
 
These two qualitative studies (hospital and GP) have sought to fulfil these 
five signs of sufficiency though a clear and comprehensive account of factors 
which GPs and consultants/hospitals identified as influencing referrals to 
SBD units. The findings are intended to be relevant to and useful for 
hospitals, GPs, GP training bodies and policy-makers. 
 
Using the COM-B behaviour change model outlined in Chapter 5, an 
intervention plan has been developed for adherence to GP referral 
guidelines for suspected cancer.  By identifying the barriers and facilitators to 
use of evidence-based practice in the qualitative studies, an intervention plan 
was developed applying the principles of behaviour change. This plan was 
developed by the author (NO’R) at the Centre for Behaviour Change 
Summer School in University College London in 2014 and can be found in 
Appendix D.  
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Findings that are consistent across different data sources enhance the 
credibility and transferability of results (415).  The two qualitative studies 
explored the perceptions, beliefs and expectations of hospitals and GPs in 
relation to the symptomatic breast service, the referral process and the 
impact of the centralisation policy. Participants were satisfied that patients 
were being seen more quickly in the new centralised service in designated 
cancer centres and recommended that this structure be replicated in other 
health services.  However, the impact of the centralisation policy had not yet 
been measured.  A quantitative study using the National Cancer Registry of 
Ireland (NCRI) database was designed as the fourth and final study of this 
thesis to examine the impact of centralisation on cancer referral patterns in 
Ireland.  
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Chapter 10: Study 4: Impact of Centralisation on 
Breast Cancer Referral Patterns  
 
10.1  Introduction  
The organisation of cancer services and the literature examining the impact 
of service reorganisation on cancer outcomes have been described in earlier 
chapters. There is strong evidence that centralisation of cancer services 
results in higher-quality cancer care, improved evidence-based care delivery  
(19) and better clinical outcomes (7-9, 82, 83).  Diagnosing patients at an 
earlier stage of disease, combined with timely access to diagnostics and 
treatment, improves patients’ prognosis (6, 11, 48, 157, 159, 166). In order to 
improve cancer survival, the focus of cancer programmes should be on 
identification of cancer at the earliest possible stage (280, 470, 471). 
 
The patterns of care and survival of patients with breast cancer can be 
influenced by both patient and hospital characteristics. Older age, those of 
African-American race, poor insurance status and later stage at diagnosis 
have all been associated with poorer survival in the USA (151). Hospital 
characteristics such as centralisation of breast cancer surgery in high-volume 
specialist centres have been shown to improve patient outcomes (7-9, 152).  
 
Study 1 highlighted the change in referral patterns in terms of quantity of 
referrals to the breast clinics. Studies 2 and 3 explored referral patterns from 
both the hospital and GP perspectives. This final study (Study 4) examines 
the implications of breast cancer service centralisation on breast cancers 
diagnosed before and after the centralisation process (2008 vs. 2010), to 
ascertain if there were changes in the method of presentation, type of 
hospital where the patient was treated, tumour characteristics and time-to-
treatment between the two cohorts. 
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In the qualitative studies described in Chapter 8 and Chapter 9, consultants 
and GPs endorsed the policy of centralisation of cancer services in Ireland, 
and acknowledged the process as a successful health service development 
in the Irish healthcare system. However, the impact of this health policy on 
cancer referral patterns and patient outcomes has not previously been 
investigated in Ireland.  
 
Both consultants/hospitals and community-based GPs highlighted the 
importance and the success of the cancer centralisation process in terms of 
access to cancer services through GP referral guidelines, standardised GP 
referral forms and referral to rapid-access clinics in designated cancer 
centres with multidisciplinary teams.  This study investigated if, indeed, 
patients are being referred at an earlier stage of disease, whether they are 
being referred to designated cancer centres and whether they are receiving 
their cancer treatment sooner.  
 
Patient survival is one of the best indicators of the efficiency of diagnostic 
and treatment methods in a geographic area and is widely used as a broad 
indicator of the effectiveness of health services in the treatment of cancer 
(165, 472). Whilst the referral and access to initial cancer diagnosis and 
treatment was the primary focus of this study, it is recognised that additional 
factors such as radiation therapy, hormonal therapy, recurrences and 
metastases will also impact on survival outcomes. Whilst it is too early to 
examine the effect of the centralisation policy on survival rates (5-year 
survival rates for patients referred from 2010 onwards will be available after 
2015), early indicators of effects have been investigated in this study, 
including changes in stage at diagnosis and access to services.  Eurocare 
studies (473) have shown that tumour stage at diagnosis explains much of 
the survival differences in breast cancer.   
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Centralisation of cancer services:  
The second National Cancer Strategy (11) in Ireland in 2006 recommended 
the establishment of a National Cancer Control Programme and outlined key 
recommendations in relation to centralisation and standardisation of cancer 
services (Appendix C).   
 
These included:  
• The establishment of four cancer control networks 
• Review of the number of centres required for the management of 
symptomatic breast disease 
• Comprehensive information available for General Practitioners to 
enable informed referral and other management decisions 
• The development of cancer care pathways to link primary care 
services, hospital services and other relevant services 
• Diagnosis and treatment by site-specific multidisciplinary teams (e.g., 
breast cancer). 
 
These recommendations form the key policy changes implemented for 
breast cancer as part of the centralisation programme completed in 2009, 
outlined in Table 10.1.  
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Table 10.1: Cancer centralisation policy in Ireland  
Policy 
change  
(inputs) 
Intended effects Expected outcomes 
Proximal 
(i.e., within 1-5 
years) 
 
Distal 
(i.e., 5+ years) 
GP referral 
guidelines, 
standardised 
referral forms 
and electronic 
referral.   
• Increased GP 
awareness of 
indications and 
processes for 
referral.  
• Streamlined GP 
referral process. 
• Reduced delays in 
processing GP 
referrals. More 
efficient and safer 
referral process. 
• Decreased 
time to 
referral, 
diagnosis and 
treatment. 
• Earlier tumour 
stage at 
diagnosis. 
• Less invasive 
treatment 
required. 
• Increased survival 
• Decreased 
morbidity (e.g., 
lymphoedema)  
 
Centralisation 
of cancer care 
services into 
designated 
centres. 
 
Standardised 
care 
pathways.  
• Standardised care 
by a 
multidisciplinary 
team in a 
designated cancer 
centre. 
• High-volume 
multidisciplinary 
cancer centres with 
full range of 
diagnostic and 
treatment 
specialties. 
• Higher caseloads – 
experienced 
specialist clinicians.   
• Enhanced system 
of coordination and 
redefined work 
practices.  
• Treatment 
and planning 
by MDT 
meeting.  
• Patients 
treated in 
designated 
cancer 
centres. 
• Method of 
presentation 
via 
standardised 
pathways. 
• “Ireland will have 
a system of 
cancer control 
which will reduce 
our cancer 
incidence, 
morbidity and 
mortality rates 
relative to other 
EU15 countries by 
2015.” 
 
    (2006 Cancer 
Strategy). 
Quality 
assurance, 
research and 
audit  
• Audit and other 
quality-assurance 
programmes.  
• Key Performance 
Indicators and 
standard operating 
procedures: 
Targets for time to 
diagnosis and 
treatment.  
• Access to clinical 
trials and cancer 
research.  
• Adherence to 
quality 
indicators.  
 
• Governance 
framework – 
clinical leads. 
 
• Decrease in 
waiting times 
to access 
service.  
• “Internationally-
recognised 
location for 
education and 
research into all 
aspects of cancer”   
 
    (2006 Cancer 
Strategy). 
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10.2  Aim and objectives  
The aim of this study (Study 4) is to determine the impact of the policy of 
centralisation of cancer services on breast cancer referral patterns in Ireland 
and to ascertain if this policy has achieved early indicators of success. These 
aims reflect the intended proximal outcomes of the cancer centralisation 
policy, outlined in Table 10.1 above.   
 
Specifically, the study objectives are as follows:   
 
1. To identify referral route (method of presentation) of patients with 
breast cancer in Ireland (e.g., screening programme, GP referral).  
2. To determine proportion of patients with breast cancer being 
diagnosed and treated at designated cancer centres vs. non-cancer 
centres, since service centralisation.   
3. To compare breast cancers referred before and after centralisation, in 
terms of patient, tumour and hospital characteristics. 
4. To determine if patients with breast cancer are being referred and 
diagnosed at an earlier stage of disease since service centralisation. 
5. To determine if waiting times from GP referral to diagnosis and 
treatment (biopsy, surgery, chemotherapy) have changed since the 
centralisation policy. 
 
10.3  Methods 
10.3.1  Study design  
This study involved secondary data analysis of an anonymised national 
dataset from the National Cancer Registry Ireland (NCRI). Specifically, this 
study compared breast cancers diagnosed in 2008 (pre-centralisation) with 
those diagnosed in 2010 (immediately post-centralisation). Whilst a longer 
timeframe may be preferred to show evidence of change, national cancer 
registry data later than 2010 were not available at the time of the study.  
 
This ‘before and after’ study design examines the implications of 
restructuring cancer services by centralising cancer surgery, effectively 
creating a ‘natural experiment’ in the Irish healthcare system.  Centralisation 
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of cancer services encompassed the development of GP referral guidelines 
and defined referral pathways to multidisciplinary teams in designated cancer 
centres.  These initiatives were implemented throughout 2009.  
 
Interrupted time series designs are recommended for quasi-experimental, 
longitudinal analysis of interventions and are frequently used to evaluate 
programme impact in health services research and naturally-occurring 
situations (435, 437). While comparing several years before and after this 
initiative would have provided greater insight into the effects of the 
centralisation policy as distinct from underlying trends, insufficient post-
centralisation data were available for an interrupted time series approach, 
given the case follow-up period and time-lag before NCRI data is made 
available for analysis. The current study, therefore, compares data from 2008 
(pre-centralisation), to 2010 (post-centralisation), using regression analysis 
and time-to-event (survival) analysis, which is the best available approach at 
this time, given data constraints.  
  
10.3.2  Research ethics    
Research ethics approval was granted by the Research Ethics Committee of 
each of the 8 cancer centres and the satellite centre between December 
2010 and May 2011. This was required by the NCRI in order to provide the 
data for this study, as provision of data on the activity of a specific hospital 
requires consent from that hospital. Copies of these approval letters are in 
Appendix I.   
 
10.3.3  Data 
This study used anonymised national data from the National Cancer Registry 
database. The NCRI is a statutory body that began full registration of all 
cancers in the Republic of Ireland in 1994. Tumour Registration Officers 
collect data from patient charts (such as medical records, imaging reports 
and pathology reports) and death certificates. The reporting of cancer is not 
mandatory in Ireland.  The cancer registry receives data from other sources 
such as the Hospital Inpatient Enquiry (HIPE) Scheme, which records all 
discharge data from public hospitals in Ireland, including all cases of cancer. 
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The General Registry Office in Ireland also provides copies of death 
certificates to the NCRI, which are then cross-checked with the cancer 
registry data. Information on treatment is retrieved from patient’s medical 
charts 6 – 12 months following diagnosis. The cancer registry uses the 
IARC-CHECK programme (474) to perform validity checks on the dataset.  
The registry also checks data for duplication. The Health (Provision of 
Information) Act 1997 permits the use of anonymised data from the NCRI for 
research purposes. 
 
The registry data is coded and classified under International Classification of 
Diseases (ICD10) codes, according to international guidelines, so that Irish 
cancer statistics can be compared to other countries worldwide (475). 
Independent case ascertainment has been carried out by the NCRI using 
breast cancer cases diagnosed through BreastCheck (the National Breast 
Screening Programme). The completeness of breast cancer ascertainment 
for the screening age-group (50 – 65 years) was found to be over 99% (476). 
 
Individual hospitals were identified in the dataset by hospital name for the 9 
cancer hospitals (8 cancer centres and 1 satellite centre) (Figure 8.1). The 
remaining hospitals were labelled by category of hospital (other acute 
hospital, private hospital or hospital in the UK).  The anonymised NCRI 
national dataset on cases and treatments for breast cancer were imported 
into Stata V12.1 and merged by a unique patient identification number.   
 
10.3.4  Study cohort 
All incident primary breast cancers (coded as C50 (invasive breast cancer) or 
D05 (in-situ breast cancer) in ICD10) diagnosed in the population usually 
resident in Ireland, both males and females, in all acute hospitals, including 
private hospitals, were included in this study. A total of 6,624 cases of 
primary breast cancers in 6,380 patients were included in the NCRI dataset. 
A primary cancer is one that originates in a primary site or tissue and is not a 
recurrence or metastasis.  
 
278 
 
Cases were excluded if they were diagnosed at the time of death or autopsy 
(n =17), consistent with the NCRI data quality and completeness protocol 
(475), and standard international practice, e.g., the Eurocare project (477).  
Second and subsequent primary breast cancers were excluded (n = 251), 
consistent with the guidelines developed jointly by the International 
Association of Cancer Registries (478) and International Agency for 
Research on Cancer (478) (see Figure 10.2).   
 
Breast cancers in male patients (n = 46) were included in this study.  Studies 
have shown that men with cancer are older, have larger tumours, have less 
Stage 0 or Stage I disease and a lower overall survival. However, when 
differences in method of presentation, absence of data on disease-specific 
survival and data deficiencies have been accounted for, breast cancers in 
men and in women appeared more alike than different (479). While the 
centralisation process and GP referral pathways are applicable to both men 
and women, BreastCheck would not have had an impact on male breast 
cancers, as males are not included in the breast screening programme. Of 
the 6,356 eligible cases, 3,211 were diagnosed in 2008 and 3,145 in 2010. 
Figure 10.2 shows the study cohort at each stage of analysis, with inclusion 
and exclusion criteria. 
 
For the analysis of route of referral (method of presentation), all eligible 
breast cancers were included (n = 6,356). Breast cancers detected 
incidentally (n = 121) and through screening programmes (n =1,751) were 
excluded when examining the type of hospital where treatment was received, 
as the centralisation of breast cancer surgery applied only to symptomatic 
breast disease (SBD) services and not to the breast screening service.  
 
Finally, cases treated in private hospitals (n = 824) and in the United 
Kingdom (n = 21) were excluded when examining time to diagnosis and 
treatment, as the centralisation policy only applied to the public hospital 
service in the Republic of Ireland and not to the private hospitals. The 
majority of cases presenting in the Republic of Ireland who were treated in 
the United Kingdom were treated in Northern Ireland. The final cohort 
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included in the analysis of tumour stage at diagnosis and time-to-event 
comprised 3,639 patients (Figure 10.2). 
 
10.3.5  Outcomes  
This study’s objectives and related outcomes are summarised in Table 10.2. 
 
Table 10.2: Outcomes for study objectives 
Objective  Outcomes 
1 Referral route (method of presentation):  
Definition: Route by which patient presented or was referred to 
the cancer service, e.g., screening service, GP referral to 
symptomatic service, or incidental diagnosis. 
2 Hospital of diagnosis/treatment:  
Definition: The type of hospital where the patient received their 
treatment, e.g., designated cancer centre, other acute hospital, 
private hospital, hospital in the UK. 
- Hospital type where biopsy carried out 
- Hospital type where surgery carried out 
3 Tumour characteristics 
4 Stage of disease at diagnosis: 
Definition: Stage of disease at diagnosis using TNM* summary 
stage partial (Stage 0, I, II, III, IV) based on AJCC* cancer 
staging rules, 5th edition. 
5 Time from GP referral to diagnosis and treatment:  
Definition: The time in days:   
- from GP referral to diagnosis (biopsy) 
- from diagnosis to surgery 
- from diagnosis to chemotherapy  
*TNM:  Tumour, node, metastases.  Summary stage of disease is derived 
from the individual T (Tumour), N (Node), and M (Metastases) 
categories 
*AJCC:   American Joint Committee on Cancer 
 
 
10.3.5.1 Objective 1: Referral route  
Centralisation of breast cancer services could be expected to affect the route 
by which patients present to cancer services and whether they enter via 
screening services, GP referrals to the symptomatic service, or are identified 
incidentally at the time of an unrelated procedure or surgery. As such, the 
referral route (method of presentation) was compared before and after the 
implementation of the centralisation policy.  
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Hypothesis: More breast cancers are diagnosed through structured 
programmes such as the BreastCheck screening programme and GP referral 
and less cancers present incidentally (i.e., while being investigated for a 
different disease) or through opportunistic screening, since implementation of 
the centralisation policy with defined referral pathways. 
 
[Outcome 1: Referral route: 1 Symptomatic, 2 Incidental, 3 BreastCheck, 4 
Other screening] 
Outcomes were compared for breast cancer cases diagnosed in 2008 (pre-
centralisation) to those diagnosed in 2010 (post-centralisation), as indicated 
by the year of incidence (0 = 2008, 1 = 2010).   
 
10.3.5.2 Objective 2: Hospital of diagnosis and treatment 
The main aim of the cancer service reorganisation was to centralise breast 
cancer diagnosis and treatment. To determine if the policy was effective in 
achieving this aim, the proportion of patients with breast cancer diagnosed 
(biopsied) and treated (surgery) was compared by hospital type before and 
after the implementation of the centralisation policy. Chemotherapy services 
continue to be delivered in general acute hospitals, as close to the patient’s 
home as possible.  
 
Hypothesis: Breast cancers are more likely to be diagnosed and have 
surgery conducted at a cancer centre vs. non-cancer centre since service 
centralisation.  
 
[Outcomes 2 & 3:  Hospital type where biopsy/surgery carried out:                           
1 Cancer Centre, 2 Other acute hospital, 3 Private hospital, 4 UK hospital] 
 
10.3.5.3 Objective 3:  To compare breast cancers referred pre- and 
post- centralisation 
The profile of the cohort of patients with breast cancer diagnosed pre-
centralisation (2008) was compared with those diagnosed post-centralisation 
(2010) to detect any differences in the two cohorts in terms of patient 
characteristics (age at diagnosis, gender, marital status, smoking status and 
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region of residence), HSE geographical region of treatment and tumour 
characteristics (tumour stage, nodal stage, metastases, TNM summary stage 
and tumour grade).  
 
Hypothesis: the two cohorts (2008 and 2010) are similar in terms of patient 
characteristics and demographics but show differences in tumour 
characteristics.    
 
10.3.5.4 Objective 4: Tumour stage at diagnosis 
(To determine if centralisation of cancer services has led to earlier 
stage of disease at diagnosis) 
Tumour stage at diagnosis explains much of the survival differences in 
breast cancer (34, 473, 480). Marital status (481), socioeconomic deprivation 
(33, 482-485), race (483) and age (486) have been shown to influence 
tumour stage at diagnosis.  Rural patients have been found to have more 
advanced disease on presentation than urban patients (174). Earlier 
diagnosis can be  associated with less advanced stage of disease at 
diagnosis and improved cancer outcomes (487). Patient awareness of 
symptoms and early detection are key to improving breast cancer survival 
(471). 
 
The cancer centralisation process in Ireland encompassed GP referral 
guidelines and streamlined referral pathways to facilitate earlier GP referral, 
with the aim of detecting cancers earlier. Cancers detected earlier are more 
likely to have an earlier tumour stage at diagnosis and therefore a better 
prognosis. This study examined tumour stage at diagnosis in the two 
cohorts.  Breast cancers detected pre-centralisation (2008) were compared 
with those detected post-centralisation (2010). 
 
Hypothesis: Patients with breast cancer are being referred at an earlier stage 
of disease since the centralisation policy was implemented, with GP referral 
guidelines and defined referral pathways to designated cancer centres.   
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Summary stage of disease at diagnosis using TNM summary stage was 
compared for breast cancers diagnosed pre- and post-centralisation.  
 
[Outcome 4: Stage of disease at diagnosis 1 Stage 0,   2 Stage I,  3 Stage II, 
4 Stage III, 5 Stage IV].   
 
10.3.5.5 Objective 5. Time to diagnosis and treatment  
(To determine if waiting times from GP referral to diagnosis and treatment 
(biopsy, surgery, chemotherapy) have improved since the centralisation 
policy).   
Prior to centralisation, GPs reported lengthy waiting times for cancer services 
(260).  As part of the centralisation process, national targets were 
established for waiting times from GP referral to hospital appointment and 
from diagnosis to treatment for breast cancer. For example, a target of 10 
working days has been set by the NCCP from time of GP referral to time of 
hospital appointment for urgent referrals. A summary of the NCCP Key 
Performance Indicators (KPI) for waiting times in SBD units is in Appendix P. 
 
Hypothesis: Waiting times from GP referral to diagnosis and treatment 
(biopsy, surgery, chemotherapy) have improved (decreased) since the 
centralisation policy was implemented: 
 
Outcome 5:  The time in days from GP referral to diagnosis (biopsy) has 
decreased 
Outcome 6:  The time in days from diagnosis to surgery has decreased 
Outcome 7:  The time in days from diagnosis to chemotherapy has 
decreased 
 
Table 10.6 summarises the outcomes of interest for each objective of this 
study. These outcomes were selected as early indicators of the effects of the 
centralisation policy. 
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10.3.6  Study variables  
Study variables were categorised into patient demographics, tumour/disease 
factors, lifestyle/socio-economic factors and health service factors, as shown 
in Figure 10.1 below:  
 
 
Figure 10.1:  Categories of study variables. 
 
Table 10.3 describes the coding of variables and covariates in this study. All 
covariates were categorical variables.  
 
 
 
 
 
 
 
 
 
 
284 
 
Table 10.3: Description of study variables  
 Coding                        Description 
Gender Male = 0 
Female  = 1 
While breast cancer is predominantly a 
female disease, cases do present in 
males. There were a total of 46 breast 
cancers diagnosed in males in the two 
years being investigated.  
Age group at 
diagnosis 
20-34 =  1 
35-49 =  2 
50-64 =  3 
65-79 =  4 
80+    =  5 
Age was categorised into 15 year age-
groups, keeping the BreastCheck age 
cohort in one group. There were no cases 
under 20 years of age. 
 
Marital status Ever married = 1 
Never married = 2 
Marital status of patients was recorded as 
‘never married’ or ‘ever married’ which 
included divorced, separated and 
widowed.  
Region of 
residence  
Dublin North East = 1 
Dublin mid-Leinster = 2 
South = 3 
West = 4 
The patient’s region of residence was 
coded by HSE region; HSE Dublin 
Northeast (n=1227), HSE Dublin mid-
Leinster (n=1758), HSE South (n=1836) 
and HSE West (n=1528).   
 
Deprivation index Deprivation index 1 = 1 
Deprivation index 2 = 2 
Deprivation index 3 = 3 
Deprivation index 4 = 4 
Deprivation index 5 = 5 
Deprivation index was derived from the 
electoral register of patient residence, at 
electoral district (ED) level, based on the 
2006 census. The NCRI incorporated the 
SAHRU Index of Deprivation (488)  into 
their dataset, which provides a measure 
of relative material deprivation.  The 
scores were presented in quintiles, with a 
score of 1 given to the least deprived and 
a score of 5 to the most deprived (488). 
Smoking status  Never smoked = 0 
Ex-smoker = 1 
Current smoker = 2 
Smoking is categorised as current 
smoker, ex-smoker or never smoked.  
 
Year of incidence 2008 = 0 
2010 = 1 
Year in which breast cancer was 
diagnosed. 
2008 (pre-centralisation)  
2010 (post centralisation)  
Tumour  T0,Tis,T1,T2,T3,T4, 
  
Tumour stage at diagnosis. Describes the 
size or extent of local invasion of the 
tumour, with T4 indicating a larger tumour.  
Node  N0, N1, N2, N3  Nodal stage at diagnosis. Describes the 
presence or absence of spread to the 
lymph nodes, with N3 indicating more 
advanced disease.  
Metastases M0, M1 Metastases at diagnosis. Describes the 
presence or absence of distant spread of 
metastases to other organs or tissues, 
with M1 indicating the presence of 
metastases.   
TNM summary 
stage  
Stage 0 = 1 
Stage I  = 2 
Stage II = 3 
Stage III = 4 
Stage IV = 5 
Summary stage of disease was derived 
from the individual T (Tumour), N (Node), 
M (Metastases) categories and is 
presented as an overall summary stage 0, 
I, II, III and IV in Table 10.4 below, with 
Stage IV indicating more advanced 
disease. 
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 Coding                        Description 
Tumour grade  Grade 1 = 1 
Grade 2 = 2 
Grade 3 = 3 
Grade 4 = 4 
Degree of differentiation of individual 
tumour cells. Grade 1 (well-differentiated), 
Grade 2 (moderately differentiated), 
Grade 3 (poorly differentiated) and Grade 
4 (undifferentiated). 
ICD In-situ = 0 
Invasive = 1 
The International Classification of Disease 
(ICD 10) codes in situ breast cancer as 
D05 and invasive breast cancer as C50.    
Hospital type  Cancer centre = 1 
Other acute hosp = 2 
Private hospital = 3 
UK  = 4 
Hospitals were grouped by type:  cancer 
centre, acute general hospital (other than 
cancer centre), private hospital, hospital in 
the UK.  
Region of 
treatment  
Dublin North East = 1 
Dublin mid Leinster = 2 
South = 3 
West = 4 
The patient’s region of treatment (biopsy, 
surgery, chemotherapy) was coded by 
HSE region; Dublin Northeast (n= 648), 
Dublin mid-Leinster (n=583), South 
(n=899) and West (n=805).  As the patient 
may not have received treatment in the 
same region as they live, both region of 
residence and region of treatment were 
examined.  
 
The TNM classification of malignant tumours, fifth edition (489) is used by 
the NCRI to stage all malignant cancers. The system is used to describe the 
clinical and pathological anatomic extent of malignant tumours. The 
pathological stage has been used in this study.  After TNM categories are 
assigned to a tumour, they are grouped into stages, I-IV (475). The summary 
stage of disease is derived from the individual T (Tumour), N (Node), M 
(Metastases) categories and is presented as an overall summary Stage 0, I, 
II, III and IV in Table 10.4 below.  
 
Table 10.4: TNM summary stage 
 Tumour stage Nodal 
stage  
Metastases 
stage  
Stage 0 Tis N0 M0 
Stage 1 T1 N0 M0 
Stage IIA T0 
T1 
T2 
N1 
N1 
N0 
M0 
M0 
M0 
Stage IIB T2 
T3 
N1 
N0 
M0 
M0 
Stage IIIA T0 
T1 
T2 
T3 
N2 
N2 
N2 
N1, N2 
M0 
M0 
M0 
M0 
Stage IIIB T4 
Any T 
Any N 
N3 
M0 
M0 
Stage IV Any T Any N  M1 
Source: (NCRI, 2012)(490), adapted from Sobin (491).   
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10.3.7 Data cleaning and missing data 
Accuracy of data was assessed through inspection of data frequencies and 
values, minimum, maximum and negative values (492).  The quality of NCRI 
data has been discussed in Section 10.3.3. 
 
The completeness of data in relation to staging varies between cancers and 
is better in breast cancer than other cancers. In an NCRI assessment of data 
completeness, breast cancer was missing information on stage for 5% of 
cases.  This compares to 42% missing information on staging in 
oesophageal cancer and 20% in prostate cancer (475). Information on 
staging may be incomplete because staging investigations were not carried 
out, or were not recorded in the patient’s medical notes.  
 
In relation to waiting times for diagnosis (biopsy), if the GP referral letter is 
not contained in the patient’s chart, the time from referral to diagnosis will not 
be available from NCRI data. This was the case for a high number of patients 
in the database (n = 2,701). For this reason, national NCCP data for this 
parameter is also presented.  
 
The misscheck function in Stata was used to check for missing values, 
summarise missing values and provide patterns of those values. Cases with 
missing values on any variable used in the analysis were dropped using the 
listwise deletion method in Stata. Table 10.5 below provides details of 
missing data for predictors in the study dataset. The final sample size in the 
analysis was Objective 1 (n = 5,722), Objective 2 (n = 4,086) for biopsy 
hospital and (n = 3,716) for surgery hospital, Objective 3 (n = 3,639), 
objective 4 (n = 3,377) and Objective 5 (n = 1,208) for time to diagnosis, (n = 
2,709) for time to surgery and (n = 1,626) for time to chemotherapy.  
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Table 10.5:  Overview of missing data in study dataset  
Missing data  
(Total number of cases: 4,484) 
n (%)    
Deprivation index  741 (16.5%) 
Smoking status   243 (5.4%) 
Method of patient presentation   225 (5.0%) 
Marital status  194 (4.3%) 
TNM summary stage     10 (0.2%) 
Region of patient residence       7 (0.16%) 
 
10.3.7.2 Descriptive analysis 
Descriptive statistics were used to examine the prevalence of the study 
variables in the two cohorts pre- and post-centralisation. Frequencies and 
proportions were calculated for categorical and binary variables. 
Demographics (age-group at diagnosis, gender, deprivation index, smoking 
status, marital status) and tumour characteristics (ICD10, tumour, node, 
metastases, tumour grade) were compared across the two cohorts to assess 
similarity and differences. The geographical region of patient residence was 
also compared with region of treatment.  
 
The chi-squared χ2 test was used to examine whether the distribution of 
categorised cases in one variable was independent of their categorical 
distribution for another variable (493). In this study, the chi-squared test (χ2) 
was used to test for differences between the distributions of patient or tumour 
characteristics in the two separate cohorts. 
 
10.3.7.3  Statistical analyses 
To determine if patients with breast cancer were being referred at an earlier 
stage of disease, the median summary stage at presentation was calculated 
for each year, as data were not normally distributed. Differences between the 
median summary stage at presentation were compared using the Mann-
Whitney test, also known as Wilcoxon rank-sum test (494), which is a non-
parametric independent samples t-test for data where the underlying 
distribution is not normally distributed. The Mann-Whitney test adds the 
ranks, divides by the total number of cases and then compares groups to 
what would be expected if the two groups were the same.  
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Univariable and multivariable ordinal logistic regression models were used to 
explore the effect of the centralisation policy (year of incidence) on stage of 
disease at presentation. Odds ratios (OR) and 95% confidence intervals 
(95% CI) were calculated, with an OR of greater than 1 indicating greater 
odds of the outcome occurring, an OR of less than 1 indicated a decrease in 
the odds of the outcome occurring and an OR of one indicating no 
association between the exposure variable and the outcome (493).  In this 
study an odds ratio of less than 1 indicated a decrease in the odds of the 
outcome (later stage at diagnosis) occurring in 2010 (post-centralisation).  
 
Variables for the model were assessed for multicollinearity and singularity. 
Multicollinearity occurs when variables are very highly correlated and 
singularity occurs when a variable is a combination of two or more of the 
other variables (495). The region of patient residence and region of patient 
treatment had a high variance inflation factor (VIF) of 8.17, when tested for 
multicollinearity and therefore region of residence was dropped from the 
model.  
 
In health services research, application of the usual assessment of 
significance at 0.05 in bivariate models can fail to identify factors which are 
known to predict outcomes. For this reason, hypothesised predictors (e.g., 
age at diagnosis), which were found to be significant at p<0.10 at bivariable 
level in addition to confounders and effect modifiers, were considered for 
inclusion in the multivariable model (496, 497). A p-value of <0.05 in the 
regression model was considered statistically significant. In logistic 
regression modelling, a sample size of at least 10-15 events per predictor 
variable is recommended to avoid biased estimates of effect size (498-500).   
 
To test whether each variable added to the predictive value of the model, the 
full model was compared to a nested model, removing one variable at a time, 
using the likelihood ratio test (501). The variables which did not significantly 
improve the model were dropped from the model. Where the chi-square 
statistic was statistically significant, this meant that the variable that was 
removed to produce the reduced model resulted in a model that had a 
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significantly poorer fit, and therefore that variable should be included in the 
model.  The most efficient model was identified using this process.  
 
The goodness of fit of the final regression model was assessed using the 
Hosmer and Lemeshow goodness-of-fit test (496). The Lfit command in 
Stata 12.1(502)  was used to compare the predicted and the observed 
frequencies, based on the assumption that a model with good fit would 
produce predictions that closely matched the observed frequencies.   
 
Time to event (survival) analysis using Cox proportional hazards models was 
used to assess waiting times (Objective 5) including: time to diagnosis 
(Outcome 5), time to surgery (Outcome 6), and time to chemotherapy 
(Outcome 7). Variables relating to time-to-event (biopsy, surgery, 
chemotherapy) were assessed for normality of distribution using tests for 
skewness and kurtosis. Skewness relates to the symmetry of the distribution 
within a variable and kurtosis relates to the heaviness of the tails of a 
distribution. None of the variables had a score greater than 3.29 and 
therefore were considered to be normally distributed (503). The time-to-event 
data were examined on a continuous scale (in days) and were also 
categorised into time bands, based on current targets within the health 
service.   
 
The hazard ratio represents the likelihood of the event (diagnosis/treatment) 
happening at any point after the referral.  Hazard Ratios (HR) for factors 
associated with time-to-diagnosis/time-to-treatment were modelled, and 
crude and adjusted models are presented. A hazard ratio greater than one 
represents a greater likelihood of the patient reaching the event earlier.    
 
Factors which were found to be significant at p<0.10 at bivariable level were 
considered for inclusion in the multivariable model, in addition to potential 
confounders, such as smoking status, deprivation index and age at diagnosis  
(496, 497). Gender was not included in the model as males comprised less 
than one percent of the total cases.   
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For variables which were not ordinal (e.g., region of residence, region of 
treatment), the reference (base) level was specified using the largest 
category for that variable. For example, for region of patient residence and 
for region of treatment, the HSE region with the greatest number of patients 
was HSE South. Therefore, this was designated as the reference region in 
the model.   
 
Cases with zero delay (e.g., biopsy the same day as surgery) were re-coded 
to 0.5 days as Stata omits values of zero for time-to-event analysis.  
Negative values are automatically excluded from the analysis by Stata. 
Kaplan-Meier failure curves are presented to graphically represent the effect 
of year (centralisation) on the cumulative proportion of patients reaching the 
event of interest (time-to-diagnosis) over time, in days. 
 
10.3.7.4 Summary of statistical analysis 
Table 10.6 shows a summary of the statistical analysis used for this study.  
Year of incidence was the predictor variable for each of the objectives.  
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Table 10.6:  Summary of statistical analysis  
Objective Primary Outcome Predictor Covariates Methods 
1. To review referral route of 
patients with breast cancer in 
Ireland. 
 Referral route (method 
of presentation)  
 
 
Year of incidence       
(2008, 2010) 
Frequency tables and chi-
squared analysis.  
2. To determine proportion of 
patients with breast cancer 
being diagnosed and treated 
at designated cancer 
centres.   
Hospital of diagnosis / 
treatment  
 
Year of incidence       
(2008, 2010) 
Frequency tables and chi-
squared analysis.   
Agresti Coull method  to 
calculate binomial confidence 
intervals for proportions 
3. To compare breast 
cancers diagnosed  before 
and after centralisation 
Demographics.            
Socio economic factors.  
Disease factors.          
Health service factors. 
Year of incidence       
(2008, 2010) 
Descriptive statistics – 
demographic characteristics. 
Statistical comparisons: 
Frequencies, proportions and 
chi-squared analysis 
4. To determine if patients 
with breast cancer are being 
referred at an earlier stage of 
disease. 
Stage of disease at 
diagnosis. 
 
Year of incidence       
(2008, 2010) 
Age group at 
diagnosis.  
Marital status.          
Smoking status.   
Deprivation index. 
Region of residence. 
Mann-Whitney test. 
Ordinal logistic regression.  
 
5. To determine if waiting 
times from GP referral to 
diagnosis and treatment 
have improved since the 
centralisation policy.   
Time from GP referral to 
diagnosis (biopsy) & 
treatment (surgery, 
chemotherapy).  
 
Year of incidence       
(2008, 2010) 
Age group at 
diagnosis.  
Deprivation index. 
Tumour summary 
stage.  
Region of treatment. 
Kaplan Meier failure curves. 
Time-to-event (survival) 
analysis. 
Cox proportional hazards 
regression.  
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10.4  Results 
Of the 6,356 eligible cases, 3,211 were diagnosed in 2008 and 3,145 in 
2010. Figure 10.2 shows the study cohort at each stage of analysis, with 
inclusion and exclusion criteria. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10.2: Study cohort. 
 
10.4.1  Objective 1:  Referral route  
Referral route (method of patient presentation) is presented in Figure 10.3. 
The proportion of breast cancers detected through the BreastCheck 
screening programme increased from 22.8% in 2008 to 29.8% in 2010 (χ2= 
54.1, p <0.001), while the proportion of breast cancers detected incidentally 
or at unofficial screening decreased (Table 10.7).  
 
 Objective 3: Comparison of the 2 
cohorts   
Objective 4: Tumour stage at 
diagnosis  
Objective 5: Time to 
diagnosis/treatment   
 
 
 
All incident primary breast cancers (C50 or D05, ICD10) diagnosed in 2008 or 2010 
n = 6,624 primary breast cancers 
Exclusions n = 268 
Cases diagnosed at death (n = 17) 
Second and subsequent primary breast cancers (n = 251) 
Primary breast cancers (n = 6,356) 
Year of incidence: 2008 (n =3,211), 2010 (n=3,145) 
Objective 1: Referral route 
(method of presentation)  
Objective 2: Hospital type                
(cancer centre vs. non- 
cancer centre) 
Screen 
detected 
(n=1,751) 
Incidental 
detection 
(n=121) 
Symptomatic 
(n=4,484) 
UK Hospitals  
(n=21) 
Private 
Hospitals 
(n=824) 
Cancer 
Centres 
(n=3,639) 
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Figure 10.3: Referral route – breast cancers. 
 
The increase in cancers detected through screening, with slight decrease in 
those detected at SBD clinics corresponds to the availability of BreastCheck, 
which was being rolled-out nationally during the period of this research. 
BreastCheck was available in all areas of the country by December 2011. 
 
Table 10.7:  Referral route - breast cancers 
n = 5722  Year of Incidence 
2008  
n (%) 
Year of incidence  
2010 
n (%) 
χ2 
p -value  
Method of 
presentation   
n = 2936 n = 2786 χ2= 54.1 
p <0.001 
Symptomatic 2,029 (69%)   1,821 (65%)  
Incidental      73 (2.5%)            48 (1.7%)  
BreastCheck 670 (22.8%)        831(29.8%)   
Other screening    164 (5.6%)          86 (3.1%)  
 
10.4.2  Objective 2: Hospital type  
The type of hospital where diagnosis (biopsy) and treatment (surgery) was 
carried out was examined to ascertain if patients were being treated in 
designated cancer centres.  
 
10.4.2.1  Hospital of diagnosis before and after centralisation policy 
Table 10.8 shows that the proportion of breast cancer cases diagnosed 
(biopsied) in a cancer centre rose significantly from 58.4% in 2008 to 85.7% 
in 2010 (χ2= 576.5, p<0.001), an absolute increase of 27%. There was a 
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corresponding drop in cases diagnosed in other acute hospitals which are 
not cancer centres from 26.5% to 1.2%.  The confidence intervals of 
proportions attending cancer centres give a plausible estimate of value and 
indicate high study precision (see Table 10.8). The proportion of breast 
cancers being diagnosed in private hospitals dropped from 14.6% to 12.9% 
during the same period.   
 
Table 10.8: Type of hospital where diagnosis (biopsy) carried out  
n = 4086 Year of incidence 
2008  
n (%) 
Year of incidence  
2010 
n (%) 
χ2 
p -value  
Biopsy  n = 2076 n = 2010 χ2= 576.5 
p < 0.001 
Cancer centre  1,213 (58.4%)  
CI: 56-61%     
1,723 (85.7%)   
CI: 84-87% 
 
Other acute 
hospital  
551 (26.5%)        24 (1.2%)  
Private 
hospital  
302   (14.6%)       259 (12.9%)  
UK  10 (0.48%)       4 (0.20%)  
 
Figure 10.4 below shows the observed proportions in the two separate 12-
month windows, which is an indicator of the underlying process.  
 
Figure 10.4: Type of hospital where diagnosis (biopsy) carried out. 
 
0 20 40 60 80 100 
percent 
2010 
2008 
Cancer centre Other acute Hospital Private Hospital Hospital in UK 
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10.4.2.2  Hospital of surgery  
Table 10.9 shows that the proportion of patients having their breast cancer 
surgery in designated cancer centres rose from 50.8% in 2008 to 80.7% in 
2010 (χ2= 687, p<0.001), an absolute increase of 30%. The confidence 
intervals indicate a high study precision. There was a corresponding drop in 
breast cancer surgery carried out in other acute hospitals (non-cancer 
centres) from 32.1% to 0.3%. The proportion of patients having surgery in 
private hospitals also increased slightly from 16.8% to 18.9% during the 
same period.   
 
Table 10.9: Hospital type for breast surgery  
n = 3716 Year of      
incidence 
2008  
n (%) 
Year of 
incidence  
2010 
n (%) 
χ2 
p -value  
Surgery   n = 1940 
 
n = 1776 
 
χ2= 687.0 
p <0.001 
Cancer 
centre  
985 (50.8%)       
CI: 49 – 53%  
1,433 (80.7%)   
CI: 79 – 82% 
 
Other acute 
hospital  
623 (32.1%)           5 (0.3%)                       
Private 
hospital  
325 (16.8%)       335 (18.9%)  
UK   7 (0.4%) 3 (0.2%)  
 
Figure 10.5 below shows that the majority of cancers previously treated at 
acute general hospitals are now, since the centralisation policy, being treated 
in designated cancer centres.  
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Figure 10.5: Hospital type for breast surgery.  
 
10.4.3  Objective 3:  Comparison of 2008 and 2010 samples 
Table 10.10 shows the demographic characteristics of the 2008 and 2010 
samples.  Age-group at diagnosis, marital status and deprivation index are 
similar in the two cohorts. Less than 1% of cases occurred in males in both 
cohorts. There was an increase in the proportion of those who had never 
smoked in the 2010 cohort which was statistically significant (χ2= 6.43, p = 
0.040).  The age-group at death was older in the 2010 cohort, which was 
also statistically significant (χ2= 11.17, p = 0.025).  
 
0 20 40 60 80 100 
percent 
2010 
2008 
Cancer centre Other acute Hospital Private Hospital Hospital in UK 
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Table 10.10: Demographic characteristics of 2008 and 2010 
samples   
n = 3639 Year of incidence 
2008  
n (%) 
Year of 
incidence  
2010 
n (%) 
 χ2 
p-value  
Age group at diagnosis (n = 3639)   p = 0.499 
 
  20-34 35      (1.9 %)           44    (2.5%)  
  35-49 537    (28.9%)       520 (29.2%)  
  50-64 531    (28.6%)         472 (26.5%)  
  65-79 519    (27.9%)       508 (28.5%)  
  80+ 235    (12.7%)       238 (13.4%)  
Gender  (n = 3639)   p = 0.502 
 
Male 13 (0.7%) 16 (0.9%)  
Female 1844 (99.3%) 1766 (99.1%)  
Deprivation index  (n = 3042) 
 
 p = 0.506 
DI 1 259 (15.5%) 216 (15.5%)  
DI 2 231 (13.8%) 180 (13.1%)  
DI 3 272 (16.3%) 201 (14.7%)  
DI 4 331 (19.8%) 261 (19.1%)  
DI 5 (most 
deprived) 
579 (34.6%) 512 (37.4%)  
Smoking status (n = 2484) 
 
 p = 0.040 
Never smoked 780 (57.4%) 702 (62.3%)  
Ex-smoker 206 (15.2%) 158 (14.0%)  
Current smoker  372 (27.4%) 266 (23.6%)  
Marital status  (n = 3380) 
 
 p = 0.297  
Ever married  1505 (83.2%) 1284 (81.8%)  
Never married  305 (16.9%) 286 (18.2%)  
Age-group at death  (n = 628) 
 
 p = 0.025 
  20-44 23 (5.5%) 14 (6.7%)  
  45-54 47 (11.2%) 17 (8.1%)  
  55-64 58 (13.8%) 23 (11.0%)  
  65-74 93 (22.2%) 30 (14.4%)  
  75+ 198 (47.3%) 125 (59.8%)  
Exclusions: Incidental cancers, screen-detected cancers, private hospitals, 
hospitals in the UK. 
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Table 10.11 shows a comparison of tumour characteristics across the two 
cohorts. There was an increase in in-situ breast tumours and T0 tumours in 
2010, with a decrease in more advanced T4 tumours (χ2= 12.25, p = 0.032).  
There was a slight increase in N0 and N3 tumours in 2010.  The overall p-
value was statistically significant (χ2= 9.16, p = 0.027). There were no 
significant changes in tumour summary stage, tumour grade or metastases 
detected at diagnosis.  
 
Table 10.11: Tumour characteristics of 2008 and 2010 cohorts       
n = 3639  
 
Year of incidence 
2008  
n (%) 
Year of incidence  
2010 
n (%) 
χ2 
p-value  
 
ICD   (n = 3639) 
  p =  0.105          
D05 in-situ 123 (6.6%) 143 (8.0%)  
C50 invasive 1734 (93.4%) 1639 (91.9%)  
 
Tumour stage (n = 2820) 
 p = 0.032 
pTis  123 (8.8%) 147 (10.4%)  
pT1 510 (36.4%) 476 (33.5%)  
pT2 629 (44.9%) 633 (44.6%)  
pT3 94 (6.7%) 121 (8.5%)  
pT4 41 (2.9%) 32 (2.3%)  
pT0  3 (0.2%)  11 (0.8%)   
 
Nodal stage (n = 2691) 
 p = 0.027 
pN0 726 (54.8%) 764 (55.9%)   
pN1 482 (36.4%) 467 (34.2%)   
pN2 69 (5.2%)  58 (4.2%)   
pN3 47 (3.6%)  78 (5.7%)  
 
Mets stage (n = 435) 
 p= 0.456 
pM0 277 (93.0%)  174 (91.1%)   
pM1 17 (6.9%) 18 (8.9%)   
 
Summary stage  (n = 3378) 
 p= 0.163 
Stage 0 129 (7.3%) 148 (9.2%)  
Stage I 408 (23.1%) 372 (23.1%)  
Stage II 808 (45.7%) 729 (45.3%)  
Stage III 265 (14.9%) 240 (14.9%)  
Stage IV 160 (9.0%) 119 (7.4%)  
 
Tumour grade (n = 3384) 
 p = 0.099 
Grade 1 7     (0.4 %) 6     (0.4%)  
Grade 2 659 (38.2%) 606 (36.5%)  
Grade 3 875 (50.7%) 824 (49.7%)  
Grade 4 184 (10.7%) 223 (13.4%)  
Exclusions: Incidental cancers, screen-detected cancers, private hospitals, 
hospitals in the UK.   
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Table 10.12 shows the region in which the patient lived and the region in 
which their treatment was received. More patients resided in HSE South than 
in other regions in both cohorts.  The region where most surgery was 
performed was also HSE South in both cohorts. The region where most 
chemotherapy was administered changed from HSE West in 2008 to HSE 
South in 2010. 
 
Table 10.12: Region of residence and region of treatment 
 2008                                           2010  
Region of patient residence (n = 3632) p = 0.057 
    
  DNE  344 (18%)  346 (20%)  
  DML  425 (23%)  465 (26%)  
  South  568 (31%)  497 (28%)  
  West  520 (28%)  467 (26%)  
    
Region of surgery (n = 2935)                                                       p = 0.593 
    
  DNE 336 (22%)  312 (22%)  
  DML 288 (19%)  295 (21%)  
  South  476 (31%)  423 (30%)  
  West  421 (28%)  384 (27%) 
 
 
Region of chemotherapy (n = 1627)                                           p = 0.193 
    
  DNE  187 (21%)  155 (21%)  
  DML  178 (20%)  124 (17%)  
  South  256 (29%)  241 (33%)  
  West  274 (31%)  212 (29%)  
The proportion of patients having their surgery in the region in which they live 
is presented in Table 10.13.  The majority of patients had their surgery within 
their own geographical region at both time points. Of those cases resident in 
HSE Dublin mid-Leinster, 18% travelled to other HSE regions for their breast 
surgery in both 2008 and 2010, usually to the adjacent region of Dublin-North 
East.  
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Table 10.13: Region of residence compared to region of treatment  
2008 HSE Region of Surgery 
HSE region of 
patient 
residence 
DNE DML South West 
DNE 95% 4% 0.5% 0.5% 
DML 16% 82% 0.5% 1.5% 
South 1% 3% 94% 2% 
West 2% 2% 2% 94% 
 
2010 HSE Region of Surgery 
HSE region of 
surgery 
DNE DML South West 
DNE 96% 4% 0% 0.5% 
DML 13% 82% 1% 4% 
South 1% 2% 94% 3% 
West 1% 2% 3% 94% 
10.4.4  Objective 4:  Tumour stage at diagnosis  
The tumour stage at diagnosis was compared for the two cohorts. Data on 
TNM summary stage were available for 3,377 cases. The median stage 
remained at Stage II for both years being examined. The mean summary 
stage is shown for each year.  Table 10.14 shows a slight reduction in the 
mean in 2010.    
(1= Stage 0, 2= Stage I, 3 = Stage II, 4 = Stage III, 5 = Stage IV) 
 
Table 10.14:  TNM summary stage at diagnosis, by year 
TNM  
Summary Stage  
n Mean  Median  
2008  1,770 Mean = 2.95     Stage II 
2010  1,608 Mean = 2.88     Stage II 
Overall  3,377 Mean = 2.92 Stage II 
 
The rank-sum for both years was calculated using the Mann-Whitney test; 
the 2010 rank-sum was found to be lower than expected. However, there 
was no statistically significant difference between the underlying distributions 
of summary stage between years (z = 1.8, p = 0.0724).  
The ‘P order’ command in Stata 12.1 was used to test the hypothesis that 
there was a lower stage at diagnosis in 2010. The measure of effect size 
produced a 51.7% probability of a lower stage in 2010, showing that there 
was no appreciable effect size (p order = 0.517). 
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Ordinal logistic regression was used to assess the impact of centralisation 
(year of diagnosis) on the tumour stage at diagnosis. Table 10.15 shows the 
univariable model for stage of disease at diagnosis and the multivarible 
model. Gender was not included in the model as the number of males was 
too small.  
 
Table 10.15:  Impact of centralisation of services on tumour stage 
(stage of disease) at diagnosis  
 Univariable 
Crude model  
OR (95% CI)  
p-value Multivariable 
adjusted model* 
OR (95% CI)  
p-value 
Year of incidence 
2008 (reference) 
2010   
 
 
0.78 (0.61 - 0.99)  
 
 
0.043 
 
 
.94 (.80 - 1.1)  
 
 
0.438 
Age-group at diagnosis 
(15-year increments)  
    
20-34 (reference)      
35-49 0.82 (0.34 - 1.9)  0.642 0.85 (0.47 - 1.5)  0.576 
50-64 0.99 (0.42 - 2.4)  0.985 0.93 (0.52 - 1.7)  0.817 
65-79   1.1 (0.48 - 2.7)  0.771 0.88 (0.49 - 1.6)  0.681 
80+   2.2 (0.84 - 6.0)  0.107   1.9 (0.99 - 3.5)  0.053 
     
Marital status (reversed)      
Never married (reference)      
Ever married  1.4 (1.1 - 1.9)  0.011 0.92 (0.74 - 1.2)  0.444 
     
Smoking status      
Never smoked 
(reference) 
    
Ex-smoker    1.7 (0.97 - 2.8)  0.065 1.1  (0.89 - 1.4)  0.337 
Current smoker  0.95 (0.67 - 1.3)  0.762 0.95 (0.78 - 1.1)  0.565 
     
Deprivation - quintiles      
Deprivation index = 1 
(reference) 
    
Deprivation index = 2 1.1 (0.69 - 1.8)  0.627  1.0 (0.75 - 1.3)  0.983   
Deprivation index = 3 1.1 (0.68 - 1.8)  0.702  1.0 (0.78 - 1.4)  0.860 
Deprivation index = 4 1.1 (0.69 - 1.7)  0.736  1.3 (0.98 - 1.7)  0.068 
Deprivation index = 5 1.3 (0.86 - 1.9)  0.213  1.1 (0.90 - 1.5)  0.266 
(most deprived)     
Region of residence      
HSE South (3) (reference)     
HSE Dublin North East (1) 1.2 (0.85 - 1.8)  0.284 0.97 (0.75 - 1.3)  0.799 
HSE Dublin mid Leinster (2) 1.2 (0.85 - 1.7)  0.313   1.2 (0.94 - 1.4)  0.162 
HSE West (4) 1.0 (0.74 - 1.4)  0.929   1.1 (0.91 - 1.4)  0.292 
*Adjusted for age at diagnosis (20-34, 35-49, 50-64, 65-79, 80+), marital status 
(never married, ever married) smoking status (never smoked, ex-smoker, current 
smoker) deprivation index (DI 1, DI2, DI3, DI4, DI5) and HSE region of residence 
(Dublin North east, Dublin mid Leinster, South, West). 
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Year of incidence and marital status were significantly associated with stage 
of disease at the unadjusted level of analysis, indicating that those 
diagnosed in 2010 and those ever married were at an earlier stage of 
disease when diagnosed. However, when entered into the multivariable 
model, controlling for age at diagnosis, smoking status, deprivation index and 
region of residence, neither retained significance.   
 
Using the likelihood ratio test, none of the independent variables significantly 
contributed to the explanation of variation in stage of disease at diagnosis.  
 
The goodness-of-fit of the final regression model was not assessed using the 
Hosmer and Lemeshow goodness-of-fit test (496) as a poor model fit had 
already been established. This poor model fit suggests either centralisation 
(year of diagnosis) is the main influencing factor or that additional factors 
may have influenced staging, such as number of nodes excised and more 
thorough investigations in specialist centres.  However, the data were not 
available to investigate this hypothesis further – this is one of the limitations 
of secondary data analysis. It may also be too early to detect a change in 
tumour stage at diagnosis, given that these data were collected immediately 
after the centralisation process was introduced. In addition, breast cancer is 
a slow-growing disease and therefore a more significant shift in timelines 
would be required to show a difference in staging.  
 
Table 10.16 shows the final model of the impact of year of incidence on 
tumour stage at diagnosis. Using the likelihood ratio test, none of the 
independent variables significantly contributed to the explanation of variation 
in stage of disease at diagnosis. Therefore these variables were dropped 
from the model and the final model is the unadjusted univariable crude 
model.  
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Table 10.16: Impact of year (centralisation) on stage of disease at 
diagnosis  
Odds ratio Confidence interval  p-value 
0.78 (0.61-0.99) 0.043  
 
The odds ratio shows that there was a significant reduction in the odds of 
having a more advanced stage at diagnosis post-centralisation, with a 22% 
lower chance of more advanced stage of disease at diagnosis in 2010.   
 
10.4.5  Objective 5: Time to diagnosis and treatment   
Table 10.17 below compared the waiting time to diagnosis and treatment in 
the two cohorts. The time from GP referral to diagnosis has decreased 
significantly, with 73% of cases diagnosed within 2 weeks of GP referral in 
2010 compared with 56% in 2008 (χ2 = 46.67, p < 0.001). Slightly more 
cases are having surgery in 2010 within 6 weeks of diagnosis, which is the 
target set by the NCCP for cases whose first line of treatment is surgery.  
Patients generally have their surgery first, followed by chemotherapy. 
Patients being treated with neo-adjuvant chemotherapy (NAC) (i.e., 
chemotherapy before surgery) are excluded from the analysis examining 
time to surgery.  However, time from diagnosis to chemotherapy showed a 
slight drop in the proportion of cases commencing therapy within 14 weeks of 
diagnosis; the target set by the NCCP for patients to have undergone 
diagnosis (biopsy) and surgery, and commenced chemotherapy.    
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Table 10.17: Comparative analysis of time to diagnosis and 
treatment  
 Year of 
incidence 
2008  
n (%) 
Year of 
incidence  
2010 
n (%) 
χ2 
 p-value  
Time from GP 
referral to diagnosis  
(biopsy) 
n = 1,208 
n = 639 n = 569 χ2=46.67 
p <0.001 
 <= 2weeks 357 (55.9%) 417 (73.3%)  
2 - 6 weeks 186 (29.1%)  82 (14.4%)  
6 - 12 weeks   57 (8.9%)  36 (6.3%)  
3 - 6 months   27 (4.2%)  26 (4.6%)  
Over 6 months   12 (1.9%)    8 (1.4%)  
    
Time from diagnosis 
to surgery   
(excl. NAC) 
n = 2,709 
n  = 1407 n = 1302 χ2=6.15 
p= 0.104 
<= 6 weeks 1,233 (87.6%) 1,146 (88%)  
6 – 12 weeks 131 (9.3%) 98 (7.5%)  
3 – 6 months 25 (1.8%) 35 (2.7%)  
Over 6 months 18 (1.3%) 23 (1.8%)  
    
Time from diagnosis 
to chemotherapy  
n =1,626 
n = 895 n = 731 χ2=4.12 
p=0.249 
<= 14 weeks  684 (76.4%)  546 (74.7%)  
14- 20 weeks  140 (15.6%) 125 (17.1%)  
20-34 weeks  49 (5.5%) 32 (4.4%)  
Over 34 weeks      22 (2.5%) 28 (3.8%)  
 
10.4.5.1  Time to biopsy  
The time to event data for time from GP referral to diagnosis (biopsy) are 
summarised in Table 10.18 below.  Negative values were automatically 
excluded from the analysis by Stata (n = 27). 
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Table 10.18: Time from GP referral to diagnosis   
Year  Number of 
patients 
(cases) 
Mean  
(days) 
Time from GP referral to diagnosis, in days  
 
25%            50% (median)        75% 
2008 639 29.0 7 14 31 
2010 569 22.6 7 11 18 
Total  1,208 25.9 7 12 27 
 
Table 10.18 shows the decrease in median time from GP referral to biopsy 
from 14 to 11 days (IQR = 7-18) in 2010.  In 2010, 75% of patients had their 
biopsy within 18 days of GP referral, compared to 31 days in 2008.  The 95th 
percentile remained at 92 days in both years.  
 
Figure 10.6 graphically presents the time from GP referral to diagnosis, 
indicating that the reduction in referral time from 2008 and 2010 takes place 
most prominently within the first 2-3 weeks of referral. The Cox regression for 
time to diagnosis was statistically significant overall, with a particular 
increase in the number of patients receiving a diagnosis within 3 weeks of 
GP referral.  
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Figure 10.6: Kaplan Meier failure curve: Time from GP referral to diagnosis 
(biopsy). 
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The graph for time to biopsy was truncated at six months (182 days); twenty 
cases exceeded this value.  
 
In order to analyse the effects of several prognostic variables simultaneously 
on time from GP referral to diagnosis, a Cox proportional hazards regression 
analysis was conducted (see Table 10.19). Adjusted analysis was carried out 
to control for the confounding effects of covariates (age at diagnosis, 
deprivation index, region of biopsy). The crude and adjusted models are 
presented.  
 
Table 10.19: The influence of potential prognostic factors on time 
from GP referral to biopsy (Cox proportional hazards regression) 
Factor  Crude HR  
(95% CI)  
p-value Adjusted HR*  
(95% CI)  
p-value 
Year of incidence     
2008 (reference)     
2010  1.2 (1.0 -1.3)  0.010 1.2 (1.0-1.3)  0.015 
Age at diagnosis  
(15-year 
increments) 
    
     20-34  
(reference) 
     
     35-49 1.5 (1.0 - 2.3)   0.042 1.6 (.98 - 2.4)  0.059 
     50-64 1.6 (1.1 - 2.4)   0.021 1.7 (1.1 - 2.6)  0.029 
     65-79 1.8 (1.2 - 2.7)   0.004 1.8 (1.1 - 2.8)  0.011 
     80+ 1.9 (1.2 - 2.9)   0.003 2.0 (1.3 - 3.3)  0.004 
     
Deprivation index 
(quintiles) 
    
DI 1 (reference) 
Least deprived  
    
DI 2 1.1 (0.90 - 1.4)  0.277 1.2 (0.92 -1.5)  0.205 
DI 3 1.1 (0.89 - 1.4)  0.393 1.1 (0.87 -1.4)  0.447 
DI 4 1.1 (0.89 - 1.3)  0.382 1.1 (0.88 -1.3)  0.430 
DI 5 1.1 (0.88 - 1.3)  0.569 1.1 (0.90 -1.3)  0.364 
     
Region of biopsy      
South (reference )      
DNE (1) .87 (0.48 - 1.6)  0.649 1.1 (0.44 - 2.7)  0.872 
DML (2) .88 (0.75 - 1.0)  0.113 .89 (0.75 -1.1)  0.192 
West (4)  .93 (0.81 - 1.1)  0.301 .91 (0.79 -1.1)  0.232 
* Adjusted for age at diagnosis (20-34, 35-49, 50-64, 65-79, 80+), 
deprivation index (DI1, DI2, DI3, DI4, DI5) and region of biopsy (Dublin 
North East, Dublin mid Leinster, South, West). 
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In crude modelling, year of incidence and age at diagnosis were statistically 
significantly associated with shorter time to event (diagnosis), both of which 
retained significance in the multivariate model. A hazard ratio greater than 1 
represents a greater likelihood of reaching the event, in this case, shorter 
waiting time from GP referral to diagnosis. Age over 80 years increased the 
likelihood of shorter time to event (diagnosis) two-fold, indicating that older 
age-groups may have been prioritised in the triage and appointments 
process. This is appropriate, given the epidemiology of the disease.   
 
Generally, in time-to-event (survival) analysis, the event of interest is death 
or disease. In this study the event is receipt of biopsy (diagnosis).  Patients 
with breast cancer diagnosed in 2010 were 20% more likely to have a shorter 
time to event (diagnosis) than those diagnosed in 2008, when adjusted for 
age, deprivation and HSE region where biopsy was carried out. 
 
10.4.5.2  Time to surgery  
Patients who received neo-adjuvant chemotherapy (chemotherapy before 
surgery) were excluded from this analysis, as surgery is postponed for these 
patients until chemotherapy has been completed, usually to decrease the 
size of the tumour before surgery (n = 224; 114 in 2008, 110 in 2010). An 
additional two negative values were automatically excluded from the analysis 
by Stata. The time-to-event data for surgery is summarised in Table 10.20 
below. 
 
Table 10.20: Time from diagnosis to surgery  
Year  Number 
of 
patients 
(cases) 
Mean  
(days) 
Time from diagnosis to surgery, in days 
  
25%          50% (median)     75% 
2008 1,407 Mean =  30.4    15 22 32 
2010 1,302 Mean =  33.6 17 25 34 
Total  2,709 Mean =  31.9 15 24 34 
 
Table 10.20 shows that the median time to surgery has increased slightly 
from 22 to 25 days. The 95th percentile increased from 64 days in 2008 to 80 
days in 2010.  Table 10.21 shows the Cox proportional hazards regression 
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for analysing several prognostic variables simultaneously for time from 
diagnosis to surgery.  The crude and adjusted models are presented.  
 
Table 10.21:  The influence of potential prognostic factors on time 
from diagnosis to surgery (Cox proportional hazards regression) 
Factor  Crude HR  
(95% CI)  
 
p-value Adjusted* HR 
(95% CI)  
 
p-value 
Year of incidence      
   2008 (reference)     
   2010 0.88 (0.82-0.95)  0.001 0.89 (0.82-0.97)  0.006 
Age at diagnosis  
(15-year 
increments) 
    
     20-34(reference)     
     35-49 1.2 (0.91 - 1.6)  0.201  1.0 (0.75 - 1.4)  0.876 
     50-64 1.2 (0.94 - 1.6)  0.130  1.0 (0.75 - 1.4)  0.917 
     65-79 1.0 (0.79 - 1.4)  0.791  .85 (0.63 - 1.2)  0.306 
     80+ 0.89 (0.66 - 1.2)  0.491  .81 (0.58 - 1.1)  0.243 
     
Deprivation index 
(quintiles) 
    
DI 1 (reference)  
Least deprived 
    
DI 2 0.94 (0.81 - 1.1)  0.394 0.94 (0.80 - 1.1)  0.339 
DI 3 0.96 (0.83 - 1.1)  0.591 0.97 (0.84 - 1.1)  0.719 
DI 4 0.88 (0.76 - 1.0)  0.066 0.88 (0.76 - 1.0)  0.079 
DI 5 0.87 (0.77 -0.98)  0.025 0.89 (0.78 - 1.0)  0.064 
     
Tumour summary 
stage 
    
Stage 0 (reference)        
Stage I 1.2   (1.0 - 1.4)  0.022 1.1   (0.96 - 1.3)  0.129 
Stage II 1.1   (0.97 - 1.3)  0.117 1.1   (0.91 - 1.2)  0.408 
Stage III 0.87 (0.74 - 1.0)  0.112 0.83 (0.69 - 0.99)  0.050 
Stage IV 0.87 (0.67 - 1.1)  0.333 0.88 (0.65 - 1.2)  0.415 
     
Region of surgery      
South (3)(reference)       
DNE (1) 0.99 (0.89 - 1.1)  0.967 0.96 (0.85 - 1.1)  0.444 
DML (2) 0.89 (0.79 -0.99)  0.039 0.90 (0.79 - 1.0)  0.100 
West (4) 1.0   (0.91 - 1.1)  0.863 1.0   (0.92 - 1.1)  0.632 
* Adjusted for age at diagnosis (20-34, 35-49, 50-64, 65-79, 80+), 
deprivation index (DI 1, DI2, DI3, DI4, DI5), TNM summary stage (0, I, II, 
III, IV), and HSE region of surgery (Dublin North-East, Dublin mid-
Leinster, South, West). 
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In crude modelling, tumour summary stage I was statistically significantly 
associated with shorter time to surgery, while year of incidence, deprivation 
index 5 (most deprived) and the HSE region of Dublin mid-Leinster were 
statistically significantly associated with longer time to surgery.  However, 
only year of incidence retained significance in the multivariable model.   
 
A hazard ratio less than 1 represents a lesser likelihood of reaching the 
event (shorter time to surgery). Patients with breast cancer diagnosed in 
2010 were 11% less likely to have a shorter time to event (surgery) than 
those diagnosed in 2008 when adjusted for age, deprivation, tumour 
summary stage and HSE region of treatment.   
 
10.4.5.3  Time to chemotherapy  
Time to event data from diagnosis to receipt of chemotherapy is summarised 
in Table 10.22 below. One negative value was automatically excluded from 
the analysis by Stata.  
 
Table 10.22: Time from diagnosis to chemotherapy  
Year  Number 
of 
patients 
(cases) 
Mean  
(days) 
Time from diagnosis to chemotherapy, in days  
25%              50% (median)        75% 
2008 895 Mean=  86.2 54 76 98 
2010 731 Mean=  89.6 56 76 99 
Total  1,626 Mean=  87.7 55 76 98 
 
Table 10.22 shows that the median time to chemotherapy has remained 
unchanged. The 95th percentile increased slightly from 179 days in 2008 to 
186 days in 2010.  Table 10.23 shows the Cox proportional hazards 
regression, analysing several prognostic variables simultaneously for time 
from diagnosis to chemotherapy.  The crude and adjusted models are 
presented. 
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Table 10.23: The influence of potential prognostic factors on time 
from diagnosis to chemotherapy (Cox proportional hazards 
regression) 
Factor  Crude HR  
(95% CI)  
p-
value 
Adjusted* HR  
(95% CI)  
p- 
value 
Year of incidence     
2008 (reference)     
2010 0.96 (0.87 - 1.1)  0.385 0.93 (0.83 - 1.0)  0.168 
Age at diagnosis  
(15-year increments) 
    
     20-34   (reference)     
     35-49 1.0 (0.77 - 1.4)  0.896 0.91 (0.67 - 1.2)  0.537 
     50-64 1.0 (0.78 - 1.4)  0.805 0.94 (0.69 - 1.3)  0.671 
     65-79 0.92 (0.69 - 1.2)  0.583 0.85 (0.62 - 1.2)  0.324 
     80+ 0.67 (0.39 - 1.2)  0.150 0.48 (0.25 - 0.92)  0.026 
     
Deprivation index 
(quintiles) 
    
DI 1 (reference) 
Least deprived  
    
DI 2 1.1 (0.87 - 1.3)  0.584 1.0 (0.86 - 1.3)  0.669 
DI 3 1.1 (0.88 - 1.3)  0.526 1.1 (0.87 - 1.3)  0.588 
DI 4 1.0 (0.85 - 1.2)  0.926 1.0 (0.87 - 1.2)  0.686 
Di 5 1.1 (0.92 - 1.3)  0.356 1.1 (0.92 - 1.3)  0.317 
     
Tumour summary 
stage  
    
Stage I 0.23 (0.09 - 0.56)  0.001 0.23 (0.09 - 0.63)  0.004 
Stage II 0.25 (0.10 - 0.59)  0.002 0.25 (0.09 - 0.68)  0.006 
Stage III 0.27 (0.11 - 0.65)  0.004 0.28 (0.10 - 0.76)  0.012 
Stage IV 0.31 (0.13 - 0.76)  0.010 0.35 (0.12 - 0.97)  0.043 
     
Region of 
chemotherapy 
    
South (3)   
(reference)   
    
DNE (1) 1.1 (0.95 - 1.3)  0.201 0.99 (0.85 -1.2)  0.969 
DML (2) 1.3  (1.2 - 1.5)  0.000 1.2   (1.0 -1.4)  0.011 
West (4) 1.2  (1.1 - 1.4)  0.005 1.2   (1.0 -1.3)  0.033 
* Adjusted for age at diagnosis (20-34, 35-49, 50-64, 65-79, 80+), 
deprivation index (DI1, DI2, DI3, DI4, DI5), TNM summary stage (0, I, II, 
III, IV) and HSE region of treatment (Dublin North East, Dublin mid 
Leinster, South, West). 
 
A hazard ratio less than 1 represents a lesser likelihood of reaching the 
event (shorter time to chemotherapy).  Patients with breast cancer diagnosed 
in 2010 were 7% less likely to have a shorter time to event (chemotherapy) 
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than those diagnosed in 2008 when adjusted for age, deprivation, tumour 
summary stage and region of treatment. This was not statistically significant.  
 
In crude modelling, tumour summary stage was associated with longer time 
to chemotherapy, while the HSE regions of Dublin mid-Leinster and the West 
were associated with shorter time to chemotherapy, indicating some regional 
variation.  Significance was retained in the multivariate model.  Age over 80 
years was also associated with longer time to chemotherapy in the 
multivariate model.  
 
10.5  Conclusion  
The National Cancer Control Programme centralised breast cancer surgery 
into 8 specialist centres in 2009.  The final study in this thesis (Study 4) 
investigated whether this policy of centralisation achieved proximal indicators 
of success. The proportion of patients having their diagnosis and surgery at 
designated cancer centres rose significantly, indicating a high level of policy 
implementation. Waiting time from GP referral to diagnosis was also 
significantly improved.  Waiting time to surgery and chemotherapy has 
increased. However, these waiting times are still within national targets. 
These results show some early indicators of success in relation to the 
implementation of centralisation policy and prompt access for GP referrals. 
Additional parameters such as stage at diagnosis and access to 
surgery/chemotherapy will require monitoring over a longer timeframe, along 
with patient outcome data.  
 
Chapter 11 will discuss the findings of the studies in this thesis in relation to 
centralisation of cancer services and the implications for our cancer services.  
Findings will be discussed in the context of current international literature in 
this area. The strengths and limitations of the studies and directions for 
future research will be discussed. Finally, the impact of the findings of this 
research will be discussed in the areas of research-related impact, policy 
impact, service impact and societal impact.   
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Chapter 11: Discussion 
 
11.2 Introduction  
This health services research thesis examined factors influencing GP 
referrals to symptomatic breast disease (SBD) units in Ireland. The 
phenomena of unexplained substantial increases in GP referrals had been 
identified as an issue by practitioners and policy makers in the Irish 
healthcare system. This research sought to investigate the factors 
influencing GP referrals to SBD clinics and to make policy recommendations, 
so that urgent cases can be seen quickly and non-urgent cases can be seen 
in the most appropriate setting. Taking an investigative approach which 
spanned macro, meso and micro levels, this thesis investigated whether 
health systems and organisational structures were the dominant factors 
influencing referral patterns to breast clinics or, alternatively, if other non-
medical or social factors were the main drivers of change in GP referral 
patterns.  
 
This discussion chapter will summarise the key findings of each study 
individually and then outline strengths, limitations and recommendations for 
further research.  A comparison with an Irish study with GPs in 2006 is 
included to demonstrate the changes which have been implemented since 
that time. The impact of this research on policy and practice will then be 
outlined, using the Kuruvilla Research Impact Framework (352).  
 
11.2 Aims of this thesis 
The 2006 National Cancer Strategy (11) recommended timely access to 
cancer services in Ireland for earlier detection and treatment.  The National 
Cancer Control Programme was established in 2007 to implement the 
recommendations of this strategy. Through these strategy initiatives, breast 
cancer surgery was centralised into 8 cancer centres and one satellite 
centre, with GP referral guidelines and specialist multidisciplinary teams in 
place, by the end of 2009. However, since the reorganisation of cancer 
services, GP referrals for symptomatic breast disease have risen 
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substantially nationally, without a corresponding increase in breast cancers 
detected. This increasing number of benign referrals to specialist clinics has 
implications for increased healthcare costs, unnecessary exposure to 
radiation from diagnostic imaging and high levels of patient anxiety whilst 
waiting for appointments and test results.  Moreover, there are concerns that 
the service for urgent cases could be jeopardised if the clinics are “over-run 
by the worried well” (p.1251)(315).  
 
Factors influencing GP referrals to SBD clinics were the focus of this study. 
The phenomenon of increasing referrals was investigated in this research 
from several perspectives, to ascertain whether structural or organisational 
level forces, such as centralisation of cancer services and GP referral 
guidelines, were the predominant factors influencing GP referral behaviour, 
or if there were other non-medical societal factors influencing referral 
behaviour. 
 
The overarching research question of this thesis was: 
What are the factors influencing GP referrals to symptomatic breast units in 
Ireland? 
 
The research was conducted through four inter-related studies which sought 
to address the current knowledge deficits relating to breast cancer referral 
patterns in Ireland. Specifically, the individual studies explored the following 
areas:  
 
• What are the referral patterns for GP referrals to SBD units in Ireland? 
(Study 1) 
• What are the factors which influence GP referrals to SBD units in 
Ireland?  (Studies 2 and 3) 
• Has centralisation of cancer services in Ireland had an impact on 
breast cancer referral patterns? (Study 4) 
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11.3 Summary of thesis findings  
11.3.1 Study 1: Mapping study 
The HIQA review of SBD services identified variation in breast referrals and  
recommended a review of referral and triage processes (6).  Breast care 
units also reported trends of increasing GP referrals to their symptomatic 
units. 
 
Study 1 sought to explore referral patterns to symptomatic breast units to 
identify variation, if present, and to examine overall trends, using data from 
the National Cancer Control Programme, the HSE and HIQA. The analysis 
outlined in Chapter 7 found that the level of variation between hospitals 
found in the HIQA review (6) (based on 7 months of 2009 data before 
centralisation was completed) had decreased substantially by 2010.  A 60% 
national increase in GP referrals to Symptomatic Breast Units was identified 
between 2006 and 2010, without a corresponding increase in cancers 
detected. An examination of referrals to SBD units found that 9.1% of 
referrals were received for assessment of breast cancer family history and 
15.3% were referred for mastalgia. Studies have shown that family history 
and mastalgia are not predictive of breast cancer (49, 184, 187). 
Management of these women in primary care would significantly reduce the 
number of GP referrals to SBD units.  SBD units reported an ‘October surge’ 
in referrals, coinciding with breast cancer awareness month each year. While 
increases in referrals were seen in some years following breast cancer 
awareness campaigns, this was not consistent across all years.   
 
This was the first study, to the author’s knowledge, examining referral 
patterns before and after the centralisation of breast cancer services in 
Ireland and provides useful evidence on the impact and effectiveness of this 
policy initiative in Ireland.  
 
The findings from Study 1 set the context for Studies 2 and 3, as participants 
in the qualitative studies were presented with these national data on referral 
trends for discussion at the qualitative interviews. This is described as the 
development stage in mixed-methods research (417). While this could have 
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created a bias in the participants’ responses, this data was already in the 
public domain through media reports and publications e.g.  HIQA (6) and had 
also been highlighted at national conferences on breast cancer.   
 
11.3.2 Studies 2 and 3: Factors influencing GP referrals to SBD units  
The literature reviewed in this thesis (Chapter 2) described GP, patient and 
health system factors which can influence referrals to specialist care (15, 
118, 183, 235). The analysis presented in Studies 2 and 3 sought to explore 
these and other influencing factors on GP referrals to symptomatic breast 
units.  These qualitative studies explored the perceptions of hospital SBD 
staff and GPs of the factors influencing referrals to SBD units. Analysis of 
interviews found that referral patterns can be affected by a combination of 
medical and non-medical factors which include GP, patient, health service 
and social factors. 
 
Hospitals attributed the increase in referrals to enhanced patient awareness, 
media-induced anxiety, ease of access to the breast clinics and transfer of 
ownership from primary care to hospital teams.  These perceptions were 
consistent across all units. Consultants recommended that patients should 
receive care in the most appropriate setting and should not be subjected to 
unnecessary investigations. One consultant also had concerns about 
effective use of resources in the Irish health-care system, an area which was 
not raised in the GP interviews. An alternative explanation for the increase in 
referrals could be the increased awareness of the benefits of screening 
through the national breast screening programme. While the symptomatic 
service was not established to provide opportunistic screening for 
asymptomatic women, those outside the age-group eligible for breast 
screening may seek this service.  
 
There was a high level of pride evident from SBD unit personnel in the 
service they provide. Participants also remarked on the level of confidence 
patients now have in public breast cancer services. However, there was a 
concern that ‘we have become victims of our own success’, in that patients 
and GPs are now seeking to use the service more because of its improved 
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access and efficiency. Consultants felt that this has implications for the 
establishment of other ‘rapid-access’ services for suspected cancers, e.g., 
prostate cancer, lung cancer and melanoma, and for the wider health service 
delivery mechanism. In contrast, whilst GPs acknowledged the quality of the 
breast service, they highlighted the deficits in other health services.  
 
Psychological factors are an integral component of decision-making models 
– referral decisions are rarely based on clinical factors only, but rather “a 
complex interaction of clinical and non-clinical factors” (p.309)(218), including 
the doctor’s anxiety, their level of confidence and their tolerance of 
uncertainty (218, 253). Bate (293) describes cognitive and affective biases in 
decision making, including personal problems, stress and fatigue.  Anxiety 
can impact on information processing and decision-making. Mathews, for 
example, describes how “anxious subjects selectively attend to threatening 
information, and interpret ambiguous events in a relatively threatening way” 
(p.455)(504).The impact of anxiety on information processing in the referral 
process should be considered.  Fear of missing a cancer and fear of legal 
implications can increase a GPs’ tendency to refer (218, 232, 256). It is likely 
that fear and anxiety affect referral patterns leading to defensive practice and 
over-cautious management. Interventions to increase management of breast 
symptoms in appropriate settings need to take into account the influence of 
anxiety on referral patterns.  The Kings Fund (238) described two 
approaches to clinical decision making – one which uses rule based systems 
such as referral guidelines and decision support tools and the other which 
involves negotiation as part of a social process of diagnosis and referral, 
through communications and shared decision making.  GPs in this study 
tended to use both approaches, based on the presenting features and 
patient wishes.  
 
The difference in opinion between participating GPs regarding the 
gatekeeping role of the GP was interesting. Some GPs considered 
gatekeeping as part of their role and others considered that it was outside 
their professional boundaries. A notable difference was evident between GPs 
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who had trained or practiced in Ireland and those who had trained or 
practiced in the UK; with GPs who had worked in the UK expressing that 
gatekeeping was a key part of their GP role.  There was evidence of role 
conflict in relation to responsibility and ownership in the management of 
patients with breast complaints, with many GPs concluding that responsibility 
for this cohort of patients now lay exclusively with the specialist breast units.   
 
GPs requested standardised information on family risk of breast cancer. 
Approximately 3,500 patients were referred to SBD Clinics in Ireland in 2011 
for assessment of breast cancer family risk.  Clear referral pathways are 
required for patients with a family history of breast cancer, with information 
for GPs and for patients on referral criteria. Based on this recommendation, 
the NCCP has developed referral criteria for GPs on family risk, which will be 
disseminated in 2015.  
 
An additional 5,807 patients were referred to SBD units in 2011 for 
assessment of mastalgia. GPs recommended the development of 
information materials for mastalgia, differentiating bilateral cyclical mastalgia 
from unilateral non-cyclical mastalgia. Based on these recommendations, the 
National Cancer Control Programme has developed information materials for 
GPs and for patients which were disseminated in 2014, including an 
algorithm for GPs on the management of mastalgia in primary care, an 
information leaflet for women and a mobile phone app’.  A nursing role for 
the management of benign breast conditions was recommended and this is 
being considered by the NCCP in future service development plans.  
 
Analysis of the GP interviews highlighted an apparent cycle of reinforcement 
that strongly increased GP referral behaviour. Commencing with patient 
anxiety, the referral behaviour of the GP may reinforce the referral-seeking 
behaviour of the patient. GP referral behaviour may also be negatively 
reinforcing the patient’s anxiety, i.e., it takes away anxiety (negative 
reinforcement) and confirms the belief that the patient was right to seek 
referral (positive reinforcement).  Referral to the specialist units generates 
positive reinforcement for the GP by generating a good feeling, i.e., they are 
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doing the best for their patient.  However, this can also serve as a negative 
reinforcement by doing something to remove an unpleasant stimulus, e.g., 
patient anxiety, perceived social pressure and the GP’s own self-doubt or 
fear of consequences of missing a cancer.  In combination, these two 
influencing factors of positive and negative reinforcement are powerful 
drivers of GP referral behaviour.  
 
Risk aversion of GPs was identified by participating GPs as a significant 
factor influencing referral decisions. Tolerances of uncertainty and tendency 
to take risks have been identified as important factors influencing GP 
referrals  (205, 206, 218, 232, 252, 254, 256). It appears from this study that 
GPs’ inflated perception of misdiagnosis or malpractice may have reduced 
their diagnostic threshold. GPs reported a reliance on diagnostic imaging as 
a source of reassurance. 
 
Concerns were expressed about exaggeration of risk in breast cancer 
educational messages and campaigns.  GPs and consultants felt that current 
media messages and campaigns were not in proportion to the incidence of 
the disease and should be more measured and age-appropriate, i.e., 
targeted towards the older age-groups most at risk.  There is an onus on the 
media to deliver an accurate message. To maximise the reach of the 
message, it may also need to be supplemented by diffusion (505). For an 
innovation to be integrated at a system level, it must be seen to be superior 
to what was there before (the concept of relative advantage), compatible 
(compatible with the beliefs and perceived needs of the intended audience) 
and observable (visibility of potential benefits) (505).  Therefore, awareness 
campaigns on breast cancer and the services available need to be tailored to 
the target audience, with information relevant to specific groups, e.g., women 
under 30 with breast pain or women over 65 when they have moved beyond 
screening age.  
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GP perceptions of patient anxiety or patient expectations combined with 
prompt access to the breast clinics may influence GP referral. In the absence 
of clinical symptoms, the perceptions of the GP may drive their referral 
behaviour.  
 
GP referral practices are influenced by GP, patient and health service 
factors, which can be both social and contextual in nature (15, 118, 183, 
282). Interventions aiming to influence referral decisions should include an 
implementation plan specifying behavioural endpoints of the intervention, 
using a framework such as the Behaviour Change Wheel (251) and the 
Behaviour Change Taxonomy (379). These behavioural endpoints need to 
be included as implementation outcome variables (506, 507), to assist 
measurement of effectiveness (508). This approach has previously been 
used in guideline implementation (248, 345) and provides a transparent 
structure for evaluation and audit.  Use of the Behaviour Change Taxonomy 
also assists future replication of successful initiatives, as the components of 
the intervention are clearly defined (379).   
 
As described in Chapter 9, an action plan for an intervention using the 
Behaviour Change Wheel has been developed based on the findings of this 
research and is presented in Appendix D. Examples of recommended 
interventions and policies include:  
 
Interventions with GPs: 
• Education (about cancer risk) 
• Persuasion (to refer appropriately) 
• Training (dealing with patient expectations, interpersonal skills) 
• Environmental restructuring (clinic types, access to imaging) 
• Enablement (risk management, confidence in referral decision)  
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Policy: 
• Communication/marketing (role of breast clinics, appropriate health 
messages) 
• Guidelines (ensure guidelines are evidence-based)   
• Regulation (via professional bodies) 
• Environmental/social planning (social norms and reporting) 
• Service provision (alternative clinic for benign/non-urgent conditions,  
GP access to imaging)   
 
Both consultants and GPs in this study praised the success of the 
centralisation process in terms of access to services and standardisation of 
care. However, the impact of this centralisation process had not yet been 
evaluated.  Study 4 was conducted to determine if the centralisation policy in 
Ireland has achieved early indicators of success. 
 
11.3.3 Study 4: Impact of centralisation on cancer referral patterns  
The literature review presented in Chapter 2 outlined the evidence 
supporting centralisation of breast cancer surgery into specialist centres to 
improve patient outcomes.  However, the impact of centralisation of breast 
cancer services had not yet been examined in Ireland. The analysis 
presented in Study 4 sought to address this research gap by comparing 
breast cancers diagnosed immediately before and after the centralisation 
process (2008 vs. 2010).  
 
Findings indicated a significant drop in cases diagnosed in acute hospitals 
which are not cancer centres from 26.5% in 2008 to 1.2% in 2010, signifying 
the success of implementation of the national centralisation policy in Ireland. 
There was a smaller change in the proportion of patients being diagnosed in 
private hospitals, from 14.6% to 12.9%. Clinicians attributed the continued 
referral of some patients to private hospitals to patients wishing ‘to get value’ 
from their health insurance. Whilst none of the private hospitals in Ireland are 
designated cancer centres, many of consultants in the public service also 
have sessions in the private hospitals. The centralisation policy was only 
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applicable to the public health system and therefore only the data from the 
public centres was used to measure outcomes of this study (stage at 
diagnosis, time to event).  
 
A majority (80.7%) of breast cancer cases are now having their breast 
cancer surgery in designated cancer centres. The proportion having breast 
surgery in private hospitals increased slightly from 17% to 19%. The results 
show that a cohort of patients is presenting to the SBD clinic for assessment 
and diagnosis with the multidisciplinary team and subsequently transferring 
to private hospitals for their surgery. This was higher in co-located hospitals, 
i.e., hospitals with both a public and private hospital in the same 
geographical location, with consultant appointments across both sites.  
 
The results suggest that there was not a statistically significant difference 
between the underlying distributions of TNM summary stage of disease 
between years, although a positive trend in that direction was detected.  This 
finding is not surprising, as the study was carried out immediately after the 
centralisation process and probably too early to detect a change in stage at 
presentation. The change in time to diagnosis pre- to post-policy 
implementation is probably not large enough to materially impact stage, 
except perhaps in the most aggressive cases. Stage at presentation is also 
affected by other factors such as patient delay, in addition to GP or hospital 
delay.  
 
The stage of disease at diagnosis may also be influenced by stage migration 
– patients diagnosed more recently or in a specialist hospital may be more 
likely to be assigned a higher category of tumour stage because more 
thorough staging investigations are performed. The accuracy of staging 
classification has improved as more sensitive imaging technologies become 
available (37). Cancer centralisation, approach to axillary surgery and 
regional differences in diagnostic activities have been shown to result in 
more extensive investigations, causing stage migration (509). 
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The results showed an increased detection of metastases at diagnosis. This 
may be due to stage migration, more intensive testing and more advanced 
technology in cancer centres. This is consistent with international studies 
examining specialisation of breast cancer services (7, 26, 509). Gillis found 
that less information on staging data was recorded and was more likely to be 
missing in patients cared for by non-specialists. New technology has resulted 
in stage migration, by detecting metastases that had previously been silent 
and unidentified, thereby migrating these cases to higher TNM stages than 
would have been recorded previously (p.1604)(26). Stage is also “highly 
sensitive to the diagnostic procedures used to define it” (p.416)(473) and is 
influenced by the thoroughness of the investigations carried out.  
 
The time from GP referral to diagnosis has improved, reduced from a median 
of 14 days to 11 days since the reconfiguration of services. The results show 
that the changes which have occurred are within the first 2-3 weeks of 
referral. This is in line with the NCCP target of 10 working days from receipt 
of GP referral to diagnosis for urgent referrals. While there has been notable 
improvement, a quarter of patients waited longer than 18 days from GP 
referral to diagnosis. Ensuring that 100% of cases are diagnosed in the 
appropriate timeframe is an important goal for cancer services. 
 
The median time from diagnosis to surgery has increased slightly from 22 to 
25 days. This is still within the NCCP national target of surgery within 4 
weeks of diagnosis.  This may suggest that when more time is available to 
treat the patient, this treatment may be delayed. This paradoxical effect has 
been observed in other scenarios where target times have been established, 
such as time to thrombolysis for stroke (510, 511). This has implications for 
the setting of Key Performance Indicators across the health system. 
However, there are still 12% of cases having surgery outside this timeframe.  
Data from the NCCP (personal communication) on reasons for delay in 
surgery in 2010 showed that 30% of surgical delays were due to patient’s 
personal choice, 29% due to medical reasons and 24% due to capacity 
issues in hospitals. 
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The median time from diagnosis to chemotherapy has remained unchanged 
at 76 days. This is within the NCCP national target of commencing 
chemotherapy within 8 weeks of surgery, which equates to 98 days from 
initial GP referral.  However, there are still 25% of breast cancer cases 
receiving chemotherapy outside of this timeframe, indicating a need for 
improvement.  Data from the NCCP (personal communication) on reasons 
for delay in chemotherapy in 2010 showed that 22% of delays were due to 
patient’s personal choice, 43% due to medical reasons and 2% were due to 
capacity issues in hospitals.  
 
11.3.4   Comparison of GP needs assessment pre- and post-centralisation 
of breast cancer services  
A comparison with a previous Irish study (260) is presented here, to illustrate 
how this research has contributed to and created new knowledge.  The ICGP 
carried out a needs assessment with General Practitioners in Ireland in 2006 
in relation to the early detection of cancer in primary care (260). The aim of 
their study was to identify the barriers experienced by GPs to early diagnosis 
of cancer in order to improve early detection, increase the number of patients 
diagnosed at an early stage of disease and maximise potential for cure.  The 
needs assessment included five focus groups (n = 47 participants in total) 
and a postal survey, to which 950 GPs (47% of the ICGP membership) 
responded.  
 
The findings of the ICGP qualitative study showed that barriers to early 
detection of cancer identified by GPs in 2006 were mainly delay in patient 
presentation; lack of GP direct access to radiological and endoscopic 
investigation; difficulties referring patients to hospital services for 
investigations and/or assessment; lack of clear recommendations for cancer 
screening; poor communication between GPs and hospital staff; and 
inequitable access with long waiting lists for investigations and referral.  
 
This current study has demonstrated that significant changes have been 
made in the area of cancer services, particularly for breast cancer services, 
since the ICGP study was carried out in 2006. In relation to the barriers 
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previously listed by GPs above, this study found that GPs are not currently 
experiencing difficulties referring patients to breast services and have clear 
criteria for breast screening. Gaps identified in this study on patient 
information have now been addressed. Only one of the original barriers was 
raised in this study as a remaining issue, which was communications with 
hospital staff. GPs in the current study expressed a preference to be able to 
contact a hospital consultant directly for advice on particular patients, when 
required.  In relation to access to imaging, whilst this is now readily 
accessible through the SBD clinics, GPs  who were interviewed also 
expressed a need for access to diagnostics for asymptomatic patients,  e.g., 
for screening (outside the BreastCheck programme) or for reassurance. 
However, the 2006 National Cancer Strategy (11) specifically states that 
opportunistic testing of asymptomatic individuals for cancer is not 
recommended. The recent announcement by Government to extend the 
BreastCheck screening programme to the age-group 65-69 will provide 
access to mammography for an extended cohort of the population, 
commencing at the end of 2015.  
 
In the ICGP quantitative postal survey, the factors identified by GPs which 
would assist them in the early detection of cancer were listed in order of 
importance as: agreed criteria for screening high-risk individuals; agreed 
referral criteria for suspected cancers; a ring-fenced budget for community 
diagnostic services; increased public awareness of early cancer symptoms; 
earlier patient presentation/increased patient awareness; further GP 
education on identification of early-stage cancer and clinical practice 
guidelines; appropriate investigative pathways; a hospital-based GP liaison 
nurse; and meaningful GP representation at senior level of local hospitals.  
 
This study found that the majority of these factors have since been 
addressed for the breast service.  GPs who participated in the interviews 
acknowledged the progress and developments in breast disease, including 
criteria for screening, public awareness campaigns, electronic referral, rapid-
access clinics in designated cancer centres and the recruitment of cancer 
nurse specialists. Whilst a budget for community diagnostics is not ‘ring-
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fenced’, GPs found that access to mammography and ultrasound for 
symptomatic breast patients is generally available within 10 days for urgent 
referrals.  Additional recommendations were made by participants in this 
study in the areas of GP e-learning, GP referral guidelines and development 
of national clinical guidelines, which have resulted in developments in these 
areas.    
 
Areas of cancer in which GPs wished to receive further education and clinical 
practice guidelines in the 2006 study included identification of early-stage 
cancer, appropriate investigative pathways for suspected cancer, referral 
criteria for suspected cancer, familial cancers, identification of high-risk 
individuals, and targeted cancer screening for high-risk individuals. This 
study found that education on each of these topics has now been addressed 
through a GP e-learning programme, GP study days, GP CME sessions, GP 
referral guidelines, clinical practice guidelines, the national cancer screening 
programme and a newly-established national hereditary cancer programme. 
The need for additional education in breast examination was highlighted in 
this study as a gap, which has now been incorporated into an e-learning 
programme. Based on recommendations from this study, information on 
familial cancers has been added to the national GP referral guideline and 
hospital cancer treatment care pathways have also been developed.  
 
Significant progress has been made in health services to assist GPs in the 
early detection of cancer since the initial needs assessment was carried out 
by the ICGP in 2006. Remaining areas identified in this thesis where GPs 
would like to see further development include communications between 
hospitals and GPs, and increased access to diagnostics (mammography).  
 
Whilst GPs in the current study acknowledged current initiatives to improve 
GP-hospital communication, such as the use of HealthLink for electronic 
messaging in the areas of referral, laboratory results and discharge letters, 
they felt there was still room for improvement, in particular in the area of 
specialist opinion, when required by the GP.  GPs reported that direct access 
to imaging varies in different centres and is not standardised. However, the 
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extension of the BreastCheck age range to 69 later in 2015 will help to 
alleviate this issue in that particular age-group.   
 
11.3.5   Overall thesis findings  
Convergence coding (415) was used in Chapter 9 to assess convergence, 
complementarity, dissonance and silence in the GP and hospital interviews. 
Convergence assessment and completeness assessment is used here to 
assess the global findings of all 4 studies combined. This convergence 
approach can facilitate the identification of overriding meta-themes. Farmer 
et al. (415) describe how this approach generates higher-level interpretations 
of the data which enhances both the credibility and the transferability of the 
findings: “Findings that are consistent across diverse data sources and 
confirmed by multiple data sets provide greater confidence in the credibility 
of interpretations and the potential to transfer key learnings to other similar 
contexts” (p.390)(415). 
 
Completeness assessment was conducted by comparing the nature and 
scope for each data source, to enhance the completeness of the combined 
findings (415). The findings from the 4 studies demonstrated a complex 
interaction of patient, provider and health system factors influencing referral 
patterns. Using a mixed-methods approach facilitated an iterative research 
design to build on each study sequentially and explore emerging hypotheses 
throughout the research.  An area which was found to be similar across 
studies was the increased demand following restructuring of the service, 
which has been reported in other international studies (5, 46, 210, 227). 
Factors which were missing or undocumented in official reports or audits, 
such as the contextual social factors, were supplemented by the results of 
the qualitative studies. These broadened the perspective, providing a richer 
more complete view,  “a higher level of analysis, and a broader 
understanding of the research question” (p.388)(415).  A unique contribution 
was related to costs, as this was only raised by one hospital in the qualitative 
studies.  Areas missing from the analysis were consensus on ‘ownership’ or 
responsibility for care of the patient with benign breast symptoms or defined 
pathways for integrated care. 
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 11.4 Strengths of this thesis 
This study was the first to quantify rates of referral to SBD units in Ireland 
pre- and post-centralisation of cancer services. It was also the first study to 
quantify referrals to SBD units for breast cancer family history and for 
mastalgia on a national basis in Ireland.  This study was also, to the author’s 
knowledge, the first to explore seasonal variation in breast cancer referrals in 
Ireland.  
 
All SBD units agreed to participate in the hospital interviews. This ensures 
that the views of all units are included and makes the results transferable to 
our public health service as a whole. The response rate for the GP study was 
49%, which, although low,  is similar to the response rate of 47% in the ICGP 
study on needs assessment of GPs in early detection of cancer in Ireland 
(260).  Data saturation was reached, with no new themes emerging.  
Participants included GPs from each of the four geographical regions with 
equal numbers of male and female GPs. Single-handed and group-practice 
GPs, and GPs caring for both public and private patients were included in 
this study to enhance representativeness.  
 
This research portrays a dual perspective, i.e., the hospital perspective and 
the GP perspective, of factors influencing referrals to breast units. 
Convergence coding was used to compare the two qualitative studies and to 
enhance their validity (415, 455).  The qualitative studies illuminated the 
richness and diversity of factors influencing referral which could not be 
explored in the quantitative analyses in Studies 1 and 4.   
 
Sample size was a considerable strength in the dataset used for Study 4, 
which allowed for greater power for investigating relationships between 
variables and detecting small differences in outcome with some statistical 
validity. These data contain all breast cancers diagnosed in the Republic of 
Ireland in 2008 and 2010 (n = 6,624). Cancer is the only disease to have an 
established registry in all hospitals in Ireland and the quality of the data for 
cancer is therefore more comprehensive than other diseases.  Using a 
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national tumour registry database minimizes the chances of institutional bias 
and selection bias. 
 
The use of mixed-methods as the methodology for this thesis helped to 
counteract weaknesses in individual studies. Morgan (512) has described 
mixed methods as  ‘the third effort’ of integrating quantitative and qualitative 
results.  Lingard et al. (513) emphasised that central to the effectiveness of a 
mixed-methods study is a clear and strategic relationship among the 
methods, to ensure that the data converge to produce greater insight than a 
single method could. Using a mixed-method approach in this thesis 
facilitated a more comprehensive analysis than a single approach in isolation 
(399, 400),  offering strengths to offset any weaknesses of individual studies 
(398).  
 
The qualitative studies illuminated the richness and diversity of factors 
influencing referral which could not be explored through the other studies. 
The quantitative data in Study 1 provided a development function for the 
design of the qualitative studies (Studies 2 and 3) and the quantitative 
analysis in Study 4 tested the hypotheses generated in the earlier studies.  
 
11.5 Limitations of this thesis 
National data is available for GP breast referrals since 2009 from the NCCP. 
However, comparative data for all variables was not available for the period 
pre-centralisation, as these referrals were recorded under general surgery at 
that time. In addition, data on patients who presented to their GP but were 
not referred to the SBD units are not routinely collected or collated. Data on 
2006 referrals was collected through a national audit. Whilst data collection 
mechanisms were not as developed in 2006 and were collected from a 
greater number of hospitals, the audit data were consistent with HIPE data 
for that period. 
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The national roll-out of the BreastCheck screening programme was not fully 
completed in all areas at the time of the study. Therefore, some areas did not 
have access to structured screening services, which may have influenced 
referrals to symptomatic breast clinics for that particular age-group.  
 
It is possible that there was a social desirability bias in relation to some of the 
respondents’ answers to questions during the interviews, respondents 
providing what they believed to be the ‘correct’ answers. However, 
participants spoke openly and spontaneously about their experiences and 
referral practices, and their responses in relation to mode of referral and 
trends in referrals are consistent with national reports (3). GPs openly 
criticised their own actions and acknowledged that they would not consider 
all of their referrals to be appropriate.   The interview method allowed an 
open and honest conversation, enabling the collection of rich data to answer 
the research question. In addition, the hypotheses created from the 
qualitative studies in relation to the impact of centralisation were tested in 
Study 4 using a national dataset. 
 
Presenting data from the mapping study (Study 1) may have influenced 
participant’s responses in the qualitative interviews. However, this data was 
already in the public domain through media coverage, a HIQA report (6) and 
through discussions and presentations at GP study days and national breast 
cancer conferences (1) (2).  
 
The majority of the GPs chose to conduct their interview by telephone. Irvine 
(444) found that the duration of telephone interviews was generally shorter 
than face-to-face. However, when interview duration of telephone vs. face-to-
face interviews was compared for this thesis, there was little difference in 
duration. For GP interviews the average duration of face-to-face interviews 
was 19.3 minutes (range 15-26), while the average duration of telephone 
interviews was 18.8 minutes (range 10-30). Similarly for hospital interviews, 
the average duration of face-to-face interviews was 42.8 minutes, while the 
average duration of telephone interviews was 41.5 minutes. 
 
330 
 
GP and hospital interviews may have been influenced by recall bias. This is 
particularly pertinent in the GP interviews as it may be several weeks since a 
breast referral was made. 
 
In terms of respondent bias, GPs who did not respond were more likely to be 
male and from urban areas. This is a potential bias, however, participating 
GPs were stratified to provide an equal number of male and female GPs and 
also an equal number of GPs from each of the four HSE geographical 
regions. 
 
The use of the TDF as an interview topic guide has been criticised as being 
too focussed and constraining (380). However, for this study the TDF 
framework was not used in the formulation of the topic guide, but rather, 
introduced at the coding and analysis stage. Inter-coder agreement has also 
been reported as low in interview studies using the TDF (393) but coding in 
this study was carried out by the same researcher (NO’R).  
 
Given that the centralisation policy had just been implemented, it was 
probably too early to examine stage of disease at diagnosis. The change in 
time to diagnosis pre- to post-policy implementation is probably not large 
enough to materially impact stage, except perhaps in the most aggressive 
cases. However, this will provide useful baseline data for further studies.  
 
A major limitation of an uncontrolled before-and-after study is that it is not 
possible to discern the effect of the centralisation policy as distinct from other 
changes that may have been happening simultaneously.  A degree of 
centralisation had been ongoing in the Irish health system over a number of 
years in the smaller regional hospitals.  For this reason, the years for this 
before-and-after study were chosen directly before and after the year when 
the major interventions took place in 2009 (centralisation of cancer surgery 
into designated centres with multi-disciplinary teams and GP referral 
guidelines).  However, additional health service developments may have 
contributed to the changes observed. Whilst the focus of the NCCP was on 
centralisation of surgery and GP referral processes, additional elements of 
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the 2006 Cancer Strategy were also in progress such as health promotion 
and breast screening. The additional studies in this thesis mediated this 
limitation by providing insights into the effect of the centralisation policy from 
those working directly in the service.  
 
A limitation encountered in quantitative analysis in Study 4 was that the 
national cancer dataset was missing data in some areas under investigation 
in this thesis, in particular in relation to date of GP referral, as a copy of the 
GP letter was not always available in the patient’s file. This reduced the size 
of the cohort for this area of investigation.  
 
A number of additional phenomena may also have impacted on the findings 
of the quantitative analysis, including the following:  
 
Lead-time bias: Patients diagnosed earlier can appear to survive longer even 
if no true survival benefit occurs. This has also been described as ‘zero time 
shift’ (26). Lead-time bias can therefore exaggerate the differences seen. 
Length bias where slower-growing tumours are more likely to be detected 
earlier is common in breast screening programmes.  
 
Stage migration: The ‘Will Rogers effect’ is described as stage migration 
resulting from new diagnostic techniques – new technology identifies 
metastases that were previously silent or unidentified. Will Rogers was a 
humorist–philosopher in the USA who commented on geographical migration 
during the US economic depression in the 1930s (26).  The statistical 
consequences of stage migration are now termed ‘the Will Rogers 
Phenomenon’ and have been described as a source of misleading statistics 
for survival in cancer.   
 
Stage shift:  The introduction of the national breast screening programme 
(BreastCheck) is already showing a stage shift towards less advanced more 
treatable breast cancers (514).  
 
332 
 
11.6  Directions for future research  
Statistical analysis using time-series analysis (Poisson segmented 
regression) is recommended to examine seasonal variation in more detail. 
Interrupted time series analysis is the strongest quasi-experimental study 
design to analyse longitudinal effects of interventions (435-437), including 
natural experiments or ‘real world events’.  Autoregressive integrated moving 
averages (ARIMA) models could also be used to smooth out curves and test 
for trend. The impact of campaigns such as breast cancer awareness month 
could be assessed using these methods, to explore if the type of referrals 
received during these campaigns is different, e.g., is there a higher cancer 
detection rate in these referrals or are they predominantly benign? This 
would assess the effectiveness of such campaigns and help inform the future 
direction of awareness and education initiatives. 
 
Ongoing monitoring of referral trends is recommended; particularly in the 
area of benign referrals, with a focus in particular on age groups and 
presenting symptoms.  
 
The ‘ownership’ and responsibility for the patient with breast disease was 
discussed in both the hospital and GP interviews. Joint research between 
primary and secondary care into effective care pathways is recommended to 
ensure an integrated service, with care provided in the most appropriate 
setting. 
 
While this study focussed on GP referral, it is only one component of the 
patient journey. Interviews with patients in Ireland on their reasons for 
presentation to their GP and also with those who had concerns but did not 
present to their GP would be useful to explore reasons for any delays in 
presentation to GP. Prompt presentation to the GP in addition to prompt 
referral onwards to specialist centres facilitates earlier diagnosis and 
improved prognosis.  
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Both the consultant and GP studies commented on patients’ expectations of 
specialist review and diagnostic imaging and also on patients’ own 
heightened assessment of their risk. Research into patient expectations is 
recommended, particularly in relation to referrals to specialist clinics, the 
perceived need for diagnostic imaging and the perception of risk in relation to 
breast disease.  The Health Research Board (HRB) Centre for Primary Care 
Research has commenced a study at the Royal College of Surgeons in 
Ireland (RCSI) in 2014 on patient preferences for breast cancer screening 
and referral which investigates these research questions.  The aim of this 
study is to find out participants’ preferences about referral to a breast cancer 
clinic compared to watchful waiting, using decision analysis.  
 
The methods used for disseminating information have changed in recent 
years. The role of social media as a conduit for information and education 
about breast cancer in Ireland should be explored.  
 
It is recommended that further research is carried out on the impact of 
centralisation of breast cancer services 5 years post-centralisation. 
Interrupted time series designs are recommended for quasi-experimental, 
longitudinal analysis of interventions. In addition, 5-year survival rates for 
cases diagnosed post-centralisation (2010) will be available after 2015. 
Regional variation in access to treatment should also be monitored.  
 
The influence of non-medical factors on medical decision-making has 
implications for the scope and structure of our health services.  With 
increasing levels of specialisation and centralisation, it is recommended that 
research on the development of referral pathways, clinical prediction rules 
and decision models is conducted in advance of reconfiguration of clinical 
services. The role of the Nurse Specialist (CNS/ANP), breast physicians and 
GPs in breast cancer clinics should be explored for planning of future service 
provision.  
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11.7 Impact of the findings arising from this thesis  
11.7.1 Research translation: research to policy and practice 
While maintaining the integrity of the research, the researcher was located in 
the health services in an area where the findings were important and 
relevant, facilitating the potential for immediate impact in terms of translation 
into policy and practice.  
 
The Kuruvilla Research Impact Framework (352) is described in Chapter 4, 
outlining areas where this research can have an impact, specifically in the 
areas of research, policy, societal impact and service impact. Each of these 
areas of impact will be examined separately in the context of the findings of 
the current study.  
 
11.7.2    Research-related impacts  
The findings from this study have several research-related impacts. The 
proportion of referrals for conditions such as family history of breast cancer 
and mastalgia has now been quantified in Ireland and has provided the 
evidence and justification for interventions in this area. A report on the 
findings of the hospital study (Study 2) was circulated to those involved and 
key professional stakeholders in the NCCP and HSE, entitled Review of 
Referral Practices and Triage Processes in Symptomatic Breast Units – a 
hospital perspective’ (3) and is now available on the NCCP website  
www.cancercontrol.hse.ie  
 
Findings from this study have identified changes for current GP referral 
guidelines in relation to inclusion of referral advice for family risk.  The use of 
theory in the development of health service interventions using the Behaviour 
Change Wheel has been adopted for use in the development of national 
clinical guidelines for breast cancer.  These guidelines were completed in 
December 2014 and were widely disseminated in Ireland, and are available 
on the NCCP website www.cancercontrol.hse.ie   
 
335 
 
This study provides the first evaluation of outcomes of centralisation of 
cancer services in Ireland. The findings in Study 4 provide a baseline for 
future longer-term studies on the impact of centralisation in the Republic of 
Ireland. 
 
A list of conference presentations is contained in Appendix Q. 
 
11.7.3   Policy impacts 
Table 4.1 in Chapter 4 outlines the expected research impact from this 
thesis. Policy impact can be described under 4 headings developed by 
Weiss (515) and Kuruvilla et al. (352):  
 
1) Instrumental use, where research findings directly drive or define 
policy. 
2) Mobilisation of support, where research findings provide persuasive 
evidence to back ongoing and proposed policy activities or raise 
awareness and support for new policy making. 
3) Conceptual use, where research leads to new ideas and language 
that influence the nature and substance of policy discourse.   
4) Redefining/wider influence – research impact that leads to a wide 
change or transformation of accepted beliefs and practices.  
 
The policy impact of this research will now be outlined under these headings.  
 
1) Instrumental use, where research findings directly drive or define policy. 
Reasons for GP referral, such as mastalgia and family history have now 
been quantified in Ireland and have been used as a basis for development of 
information materials and services in these areas.  
 
Training needs for GPs have been identified and incorporated into training 
programmes, e.g., breast examination. Information needs for patients have 
been identified and information materials have been developed to address 
these areas, e.g., mastalgia. 
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A GP algorithm and referral pathway for mastalgia has been developed and 
distributed to all GPs.  National clinical guidelines for diagnosis, staging and 
treatment of breast cancer have been developed and disseminated. 
 
2) Mobilisation of support, where research findings provide persuasive 
evidence to back ongoing and proposed policy activities or raise 
awareness and support for new policy making. 
 
The national GP referral guidelines for breast cancer have been updated, 
with specific guidance on family risk of breast cancer. Recommendations 
from GPs in this study in relation to standardised care pathways have been 
incorporated into national guidelines for diagnosis, staging and treatment of 
breast cancer.  
 
Findings from this research on awareness campaigns and recommendations 
from GPs and consultants on targeted age-appropriate information have 
been discussed with charity and advocacy groups to inform future 
campaigns. 
 
3) Conceptual use, where research leads to new ideas and language that 
influence the nature and substance of policy discourse. 
Based on the findings of this research, recommendations have been made 
regarding the scope and structure of clinics for future delivery of cancer 
services to ensure that those with urgent symptoms are seen quickly and 
those with non-urgent presentations are seen in the most appropriate setting. 
 
4) Redefining/wider influence – research impact that leads to a wide 
change or transformation of accepted beliefs and practices. 
The findings from this research have been used to input into national reports 
and planning in relation to scope and structure of SBD clinics and access to 
diagnostic imaging.   
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Findings from this research were used for the external evaluation of the 
implementation of the 2006 Cancer Strategy, carried out in 2014. In 
particular, findings from the qualitative studies and impact of centralisation 
study will contribute to the evidence base for the development of a new 
national cancer strategy for 2016. 
 
11.7.4 Service impacts 
The findings from this research have already impacted on the health service. 
Identification and prioritisation of service needs have been used for resource 
planning, e.g., GP sessions and Advanced Nurse Practitioners in breast 
clinics. Identification of GP education and training needs have been used in 
the development of an e-learning programme for GPs and the national GP 
referral guideline has been updated with advice on family risk following a 
need expressed by GPs.  
 
Identification of information needs for GPs and for patients in the area of 
mastalgia has resulted in the development of a referral pathway, algorithm, 
patient booklet and mobile phone app’ for mastalgia. Recommendations from 
consultants and GPs in this study have been incorporated into national 
clinical guidelines for diagnosis, staging and treatment of breast cancer. 
 
11.7.5 Societal impacts  
This thesis is broadly concerned with GP referral. However, findings have 
some societal impact and relevance, such as the development of education / 
health promotion materials and patient-centred services.  One example of 
developing patient-centred services in this context relates to identification of 
the need for patient information in relation to mastalgia. The influence and 
advice from family and friends triggered many patients to seek referral to 
specialist units, according to GPs. The social impact of the media was also a 
strong influencing factor. The role of the media in health information and 
awareness should be a collaborative approach with the health services, to 
ensure consistent and evidence-based messages. Where such an approach 
has been adopted (e.g., the stroke FAST campaign), there is evidence of 
significant increases in knowledge and awareness of the condition (516).  
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11.7.6. Contribution of this study  
 
Methodologically 
Mixed methods have been used in implementation research to explore 
barriers to implementation (404) and in health services research for 
comprehensiveness in the complex area of healthcare (401) (402) (396).  
The model chosen for this study is Teddlie & Tashakkori’s  iterative 
sequential mixed design (349).  Pragmatism is used for solving practical 
problems in the real world, providing an innovative approach to address 
contemporary issues in the health services (402) (412).  
 
This research methodology sought to take account of the multi-factorial 
nature of the phenomenon under study. This required a research approach 
which recognised that reality is “subjective, constructed, multiple and 
diverse” (p.41) (418), yet is cognisant of seemingly objective forces that 
influence referral patterns e.g. policy and evidence based medicine. 
Lingard et al. (513)(p.460) describe how, in medicine, “mixed methods have 
arisen in the wake of attention to the psychosocial determinants of health 
and the human aspects of medical care”.  The effectiveness of a mixed-
methods study is a clear and strategic relationship among the methods, to 
ensure that the data converge to produce greater insight than a single 
method could. 
 
Mixed methods in health research has shown a lack of integration, which 
limits the overall yield (416).  The justification for using this method and the 
level of integration should be clearly outlined (405) (517).  According to 
Teddlie and Tashakkori, a study is only truly mixed if approaches are 
integrated across the stages of the study (349).  As described by Morse 
(417), “each component should fit like pieces of a puzzle” (p.122).  Leech 
(403) discusses the difference between partially mixed methods, where the 
quantitative and qualitative components are only linked at the data 
interpretation stage, and fully mixed methods where mixing occurs within or 
across stages.  
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Mixed methods, using data from primary care, secondary care and the 
National Cancer Registry database were used to examine a complex health 
services phenomenon from several perspectives. The individual studies 
which were integrated across all stages, related in an organic way, 
combining to add an additional layer of meaning.  This is the first mixed 
methods study to examine factors influencing referrals to breast clinics, 
combining the qualitative data from primary and secondary care with a 
national population based cancer registry.   
 
Conceptually  
Conceptual use refers to where research leads to new ideas and language 
that influence the nature and substance of policy discourse (515) (352). 
Based on the findings of this research, recommendations have been made 
regarding the scope and structure of clinics for future delivery of cancer 
services, to ensure that those with urgent symptoms are seen quickly and 
those with non-urgent presentations are seen in the most appropriate setting. 
 
GPs reported pressure from some patients for onward referral. This is 
perceived by the doctors and as patient interviews were not conducted, 
pressure from patients cannot be verified. While GPs perceived pressure 
from patients for onward referral, research suggests that “pressure from 
patients may be stronger in the doctor’s mind than in the patient’s mind” 
(p.416)(231).This has implications for communications and shared decision 
making.  
 
A number of findings were unexpected and were not reflected in previous 
literature. The first related to the finding that GPs favoured the public 
hospitals over the private hospitals to refer their patients with breast 
complaints, as they felt the care was better and more coordinated. This was 
in contrast to other medical conditions that they tended to refer privately, if 
their patients had private health insurance, to avoid any delays.  
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The second are related to seasonal variation. While the hospital units 
perceived an ‘October surge’ during Breast Cancer Awareness Month each 
year, this was not apparent in the data. This research has therefore dispelled 
the myth of the October surge.  In addition, clinicians in this study reported 
that some patients believe that they won’t get breast cancer after the age of 
65 (the age when the Breast Screening programme ceases), which has 
implications for health promotion and disease prevention messages.   
 
While this study focused on GP referrals to Symptomatic Breast units, this 
has wider implications for health services research. Restructuring of health 
services has implications for education and training. Referral pathways are a 
core component of integrated care models, as proposed by the Government 
in ‘Future Health’ (108) and has implications for the wider health system.  
 
The Department of Health report into the perinatal deaths in Portlaoise in 
2014 (518) recommended that national standards be developed for clinical 
practice guidance to ensure consistency of approach and utilisation of 
appropriate methodology.  This research provides recent evidence on the 
attitudes of clinicians in Ireland towards evidence based medicine and 
adherence to clinical practice guidance.  
 
Mixed methods using a theoretical framework to facilitate analysis provided a 
comprehensive exploration of factors influencing referrals, from several 
perspectives. Whilst the National Cancer Registry data is a robust 
population-based registry, it only collects data on diagnosed cancers. To 
provide a deeper understanding of referral patterns, the benign as well as the 
malignant referrals were investigated.  
 
This research adds data on family risk, mastalgia and seasonal variation, 
areas which had not heretofore been investigated on a national basis in 
Ireland.  This is also the first research to examine the effectiveness of the 
centralisation policy of cancer services in Ireland, which has implications for 
the centralisation of other cancer services and other parts of the health 
service.  
341 
 
Findings from this study showed increased waiting times for surgery and 
chemotherapy, which had lengthened towards the outer limit of the national 
targets set (e.g. 20 days from diagnosis to surgery).  Whilst the paradoxical 
effect has been described in the literature about thrombolysis for stroke (510, 
511), there was evidence lacking in the area of cancer. This has implications 
for the setting of KPIs and the possible negative effects arising when 
treatment can be delayed if there is more time available.   
 
This research addressed several areas which were previous unexplored and 
represented significant gaps in the current literature. Conceptually it sought 
to examine a major health service restructuring with many components, 
using a psychological framework.  
 
Practically / clinically  
Many interventions which are found to be effective in health service research 
fail to translate research into practice and policy (519) and more importantly 
“fail to translate into meaningful patient care outcomes” (p.1) (520). 
 
The impact of this thesis in the areas of research, policy, societal and service 
impact has been described in the previous section using the Kuruvilla 
Research Impact framework (352).  
 
Based on the findings of this research, education and health promotion 
materials for GPs and patients have been developed for mastalgia, GP 
referral advice has been developed for family risk and GP e-learning has 
been expanded to include areas identified by GPs in this study.  
 
Data from this research on proportion of referrals for mastalgia and for family 
history have been used to support proposals to develop services in these 
areas and to reconfigure the overall structure of the breast service. The 
findings from Study 4 provide a baseline for future longer-term studies on the 
impact of centralisation and health service restructuring.  
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The unwanted consequences of unnecessary diagnostic and therapeutic 
procedures have been documented in the literature on breast screening 
(521) but this has not been researched as much in relation to the 
symptomatic service. It is important that patients are aware of the possible 
risks and side effects of undergoing investigations, weighing up the 
magnitude of benefits and harm.  
 
Findings from this thesis have been used to inform the review of the 
implementation of the 2006 cancer strategy (11) (4) and to address a 
recommendation from HIQA (6) in 2012 to review referral and triage patterns 
(3).  In addition this work has contributed to the development of national 
clinical guidelines for breast cancer (345) and the development of the next 
national cancer strategy, due for publication in 2016.   
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 Chapter 12:  Conclusion 
 
This research has raised important questions about the role of primary and 
secondary care in symptomatic breast disease, the role of the media and 
advocacy groups, the management of GP and patient anxiety, the impact of 
centralisation on breast cancer services and the challenge of meeting patient 
expectations while continuing to ensure an effective service for urgent cases. 
These are issues that can be addressed and have implications for the future 
structure and scope of services.  
 
This is the first study to examine the policy of centralisation of cancer 
services in Ireland and provides useful evidence on the impact and 
effectiveness of this policy initiative. 
 
Risk aversion and the cautious management by GPs of breast conditions, 
many of which are benign, are having an impact on the numbers referred to 
SBD clinics and the volume of diagnostic imaging.  The volume of benign 
referrals to symptomatic breast clinics remains a significant challenge to the 
health service. There are challenges meeting the target waiting times for 
these non-urgent referrals.  However, the rate of increase in referrals has 
lessened in recent years and the total number of referrals in 2013 was 
37,890, the first year a reduction in referrals has been recorded (although 
this is still very high relative to the number of cancers detected).  
 
It is opportune to examine the scope and structure of the SBD clinics in 
relation to suspected cancers and benign/non-urgent referrals, to ensure that 
suspected cancers are seen quickly and non-urgent referrals are seen in the 
most appropriate setting.  Based on the findings of this research, a range of 
initiatives to optimise care in the community are now being progressed within 
cancer services to ensure appropriate referrals to specialist centres, e.g., 
management of mastalgia, family risk and benign breast conditions. There 
are opportunities to look at a diversity of roles in the SBD Clinics, such as 
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Advanced Nurse Practitioner led clinics for some non-urgent referrals, which 
are used in other jurisdictions (522-524). Clear information for GPs on family 
history of breast cancer should assist the streamlining of the referral process.  
 
The findings from this research contributed to the development of national 
clinical guidelines for breast cancer in 2015 (345) which will assist in 
standardisation of practice nationally. The author (NO’R) coordinated the 
development of these guidelines with a multidisciplinary team of breast 
cancer specialists and the guidelines are internationally peer reviewed and 
published on the NCCP website. These guidelines were endorsed by the 
Minister for Health in June 2015.  
 
The findings of this thesis have been included in the NCCP evaluation of the 
2006 cancer strategy, which formed part of the external review carried out in 
2014. The evaluation and review will form the basis of the next national 
cancer strategy, to be published in 2016. Similar to the policy window (64) 
which enabled the implementation of the 2006 strategy, this research comes 
at an opportune time to influence national policy in this area.  
 
This thesis has addressed gaps in research, both nationally and 
internationally, in the areas of GP referral and societal impact on referral 
patterns.  The factors influencing GP referrals were explored to ascertain 
whether structural or organisational factors were the dominant factors 
influencing referrals, or if other non-medical factors such as social factors or 
changes in patient and clinician behaviour were the main drivers of change in 
referral patterns. A complex interaction of both medical and non-medical 
factors influencing GP referrals was found. The thesis highlighted that non-
medical factors such as anxiety and risk aversion (micro-level factors) have a 
significant impact on medical decision-making, over and above structural and 
organisational factors (macro- and meso-level factors), despite guidelines for 
referral being in place. 
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The role of evidence based guidelines, alongside patient values and shared 
decision making will need to be considered in the context of scare resources 
and iatrogenic consequences of unnecessary investigations.  
 
The combination of factors influencing referrals is complex and requires a 
multifaceted approach to optimise their appropriateness.  GP referral 
practices are influenced by factors which can be both social and contextual 
in nature and do not follow strictly Bayesian reasoning.  Social influences 
coupled with beliefs about consequences are challenging barriers to address 
and will require multifaceted interventions to overcome.  
 
The complexity of these social factors, alongside complex organisational and 
structural factors highlighted in this thesis, provides a basis for intervention 
and improvement of referral practices in asymptomatic and symptomatic 
breast disease.  
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Appendix B: Literature search strategy 
 
Research question:  What are the factors which influence GPs to 
refer patients to symptomatic breast units? 
 
PICO 
Population: General Practitioners (GPs) 
Intervention: (Influencing factors)  
- Symptoms: lump, pain, breast changes, family history  
- Patient factors: anxiety, media influences 
- GPs factors: anxiety, skill, knowledge, medical influences 
- Health service factors: Centralisation /specialisation / specialist centres 
Outcome: Referral of patients to symptomatic breast unit/clinic.  
 
Databases searched: Pubmed, MEDLINE, CINAHL, TRIP Database, Cochrane 
Library 
 
Limits 
10 years  
Humans    
 
Search terms 
Search strategy using combination of keywords and MeSH heading below: 
"general practitioners"[MeSH Terms] OR "general practitioners" [All Fields]   OR 
"general practitioner"  OR  “Family Doctor” OR  “Primary Care”  
"breast neoplasms"[MeSH Terms] OR "breast neoplasms"[All Fields] OR "breast 
cancer"[All Fields]  OR “Breast symptoms” 
"referral and consultation"[MeSH Terms] OR ("referral"[All Fields] AND 
"consultation"[All Fields]) OR "referral and consultation"[All Fields] OR 
"referral"[All Fields])  
“Specialist breast unit” OR “specialist breast clinic” 
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Research question:  Has the policy of centralisation of cancer services in 
Ireland had an impact on breast cancer referral patterns? 
 
PICO 
Population: Patients with suspected breast cancer/breast disease 
Intervention: Centralisation/ specialisation/ specialist centres 
Outcome: Referrals to breast clinics/units, overall survival, disease free survival, 
local/regional recurrence, diagnostic yield, stage at diagnosis. 
 
Databases searched: Pubmed, MEDLINE, CINAHL, TRIP Database, Cochrane 
Library. 
 
Limits 
10 years  
Humans    
 
Search terms 
Search strategy using combination of keywords and MeSH heading below: 
"breast neoplasms"[MeSH Terms] OR "breast neoplasms"[All Fields] OR "breast 
cancer"[All Fields]) 
"referral and consultation"[MeSH Terms] OR ("referral"[All Fields] AND 
"consultation"[All Fields]) OR "referral and consultation"[All Fields] OR 
"referral"[All Fields])  
Centralisation OR centralization OR centrali* 
Specialisation OR specialization OR speciali* 
Regionalisation OR regionalization OR regionali* 
Designated centre AND breast cancer AND referral 
Breast unit AND cancer AND referral 
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Appendix C: Recommendations from the 
National Cancer Strategy. 
 
A Strategy for Cancer Control in Ireland, Department of Health and Children, 2006   
 
  Recommendation  
1 A third National Cancer Forum should be appointed by the Minister with 
terms of reference and composition reflecting the changed health system.   
2 The recommendations of the Review of the National Health Promotion 
Strategy, 2004 should be implemented across all sectors.   
3 Compliance with all provisions of the Public Health (Tobacco) Acts, 2002 
and 2004 should be monitored.  
4 Excise duty on cigarettes should be substantially increased each year 
above the rate of inflation.  To this end the National Cancer Forum should 
produce a pre-budget submission to the Minister for Finance each year in 
order to continue advocating for price increases on tobacco.   
5 Nicotine replacement therapy should be made available free of charge to all 
medical card holders.   
6 The Report of the Strategic Task Force on Alcohol, 2002 should be 
implemented in full.   
7 The recommendations of the Report of the National Task Force on Obesity, 
2005 should be implemented in full.  In particular, there is a need for 
measures that raise the awareness of the links between diet and cancer.   
8 The health services should work with the food industry in order to 
encourage it to produce, market and improve access to attractive and 
healthy options.   
9 The recommendations of the Report of the National Task Force on Obesity, 
2005 in relation to physical activity should be implemented in full.   
10 In conjunction with campaigns to promote safe sun practices and to reduce 
exposure to ultraviolet radiation, regulation of sunbed use, including 
restriction to use by adults only, should be put in place.   
11 The public should be made aware that radon measurements can be 
undertaken by the Radiological Protection Institute of 
Ireland.  Consideration should be given to providing financial support for 
testing in high-radon areas and for any necessary remedial work, on a 
means-tested basis.  
12 The HSE should put in place arrangements to monitor inequalities in cancer 
risks, cancer occurrence, cancer services and cancer outcomes.   
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  Recommendation  
13 Population-based screening programmes should only be introduced where 
their population health benefit can be demonstrated using the National 
Cancer Forum criteria. 
14 Breast screening should be extended to include all women aged between 
50 and 69.   
15 The national roll-out of the Irish Cervical Screening Programme should be 
completed as a matter of priority.   
16 A colorectal cancer programme should be established to encompass 
population screening, high risk screening and necessary developments in 
symptomatic colorectal cancer services.  In preparation for this programme, 
the Department of Health and Children should establish a working group 
under the  aegis of the National Cancer Forum to address a range of 
implementation issues.   
17 The Department of Health and Children in conjunction with the HSE and 
BreastCheck should plan the alignment of population-based screening 
programmes. 
18 Population-based prostate screening should NOT be introduced in Ireland 
at present.  The National Cancer Forum should keep emerging international 
evidence on population screening for prostate cancer under review.     
19 Opportunistic testing of asymptomatic individuals for cancer is not 
recommended.    
20 The HSE should develop specific programmes that promote early detection 
of cancer.   
21  All cancer care should be delivered through a national system of four 
Managed Cancer Control Networks, each serving a population of 
approximately one million people. 
22 A Network Director should be appointed by the HSE as soon as possible to 
each Managed Cancer Control Network to support and direct 
implementation of cancer policy.  
23 A lead clinician for each Cancer Centre should be appointed.  In addition, a 
clinician should be appointed to lead the development of cancer care 
pathways for each major site specific cancer in partnership with all 
stakeholders within the network.  The Cancer Control Network Director 
should head this team of lead clinicians.  
24 The HSE should develop care pathways for cancer care to link primary care 
services, hospital services and other relevant services.   
25 Improved cancer information services should be available to primary care.   
26 The HSE should develop programmes that support primary care 
professionals in the provision of cancer services.    
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  Recommendation  
27 The HSE should ensure that systems are in place to identify and support a 
‘designated health professional’ as a contact person for each individual 
cancer patient who may require it.   
28 Cancer Centres that each serve a minimum population of 500,000 should 
be designated by the HSE as soon as possible.  Ireland will require about 
eight such centres.  
29 The HSE should conduct a needs assessment for cancer services with a 
particular emphasis on hospital-based cancer treatment that addresses the 
need for continued expansion in capacity and maximises the use of 
ambulatory care.   
30 The National Network for Radiation Oncology Services should be 
established by the HSE in accordance with the timelines set by 
Government.   
31 Patients should have their diagnosis established and their treatment 
planned by site-specific multidisciplinary teams.   
32 The HSE should conduct a review of the number of centres required for the 
management of symptomatic breast disease to bring them into line with 
designated Cancer Centres.    
33 The HSE should conduct a national needs assessment for rare cancers.   
34 A National Cancer Genetics Policy should be developed by the National 
Cancer Forum.  
35 The HSE should ensure that each Managed Cancer Centre Control 
Network has a comprehensive specialist palliative care service.   
36 A formal linkage should be established between the National Cancer Forum 
and the National Council for Specialist Palliative Care.   
37 The HSE should ensure that access to comprehensive psycho-oncology 
and psychosocial support is provided for cancer patients and their families 
in each Managed Cancer Control Network.   
38 A partnership framework should be developed between the HSE and the 
voluntary sector.   
39 A code of practice should be developed for self-help groups, support 
groups and support centres.   
40  HIQA should establish a National Framework for Quality in Cancer Control.   
41 HIQA should establish site-specific multidisciplinary groups at a national 
level to develop guidelines for quality in major cancers.  
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  Recommendation  
42 HIQA should develop a system of licensing and accreditation of Cancer 
Centres and services that should apply to both the public and private 
sectors.  The systems of licensing and accreditation should be given 
statutory effect.   
43 HIQA should develop a cancer surveillance system that will build on the 
existing system of cancer registration.   
44 Mandatory notification of cancer should be put in place through appropriate 
legislation.   
45 HIQA should ensure that a minimum national dataset should be collected 
for all cases of cancer.   
46 HIQA should ensure that the public has access to high-quality up to date 
information about all aspects of cancer.   
47 General practitioners should have comprehensive information that enables 
informed referral and other management decisions.    
48 Information systems and information technology should be developed by 
the HSE to support the management and delivery of cancer services.    
49 HIQA should establish a Cancer Health Technology Assessment Panel.   
50 The HSE should develop a National Cancer Workforce Plan designed to 
fully implement national cancer policy.  
51 The third National Cancer Forum, in partnership with the HRB, should 
advise on the development of a specific plan for cancer research.  
52 There should be improved clinical trial entry for patients, both in terms of 
the number of trials conducted and the enrolment to them.   
53 Ireland should establish a national tissue bio-bank to support research and 
service delivery.   
54 The HRB should establish a national cancer research database.   
55 The HSE should present a report on policy indicators each year to the 
National Cancer Forum.   
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Appendix D: Centre for Behaviour Change Summer 
School, UCL 2014 
 
Development of an action plan for behaviour change 
 
Workshop / Session: Development of an action plan for behaviour change 
In this session, you will be writing an ‘Action Plan’; a detailed plan of your 
project/intervention, applying the principles of behaviour change. Think about 
things which could potentially make it difficult (barriers) as well as things 
which could make it easier (facilitators) to carry out your project.  
ACTION PLAN 
 
Briefly describe your 
intervention 
 
 
 
 
Adherence to GP referral guidelines for 
suspected breast cancer 
 
GP referrals to Breast Cancer Units increased 
by 60% in Ireland in five years, without a 
corresponding increase in breast cancers 
detected.  
 
Interviews with hospital consultants and GPs 
suggested that existing GP referral guidelines 
were not being adhered to, due to: 
• GP fear of missing a cancer 
• GP risk aversion  
• Patient expectations 
• Ease of access to the breast clinics  
 
This is a retrospective study examining 
possible reasons why existing GP referral 
guidelines were not adhered to.  
Recommendations are made for future 
intervention design.  
 
Specify  the target behaviour of the intervention 
 
The target behaviour is: 
 
 
Adherence to GP referral guidelines for 
suspected breast cancer 
 
(Appropriate GP referral behaviour , resulting 
in reduction in the number of referrals to 
breast  clinics)  
 
Context: GP referral from primary to 
secondary care for suspected breast cancer 
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 Who needs to perform 
the behaviour?  
i.e. ‘target population’ 
GPs  (General Practitioners / Family Doctors) 
What do they need to do 
differently to achieve the 
desired change? 
Adhere to GP referral guidelines  
When do they need to do 
it? 
At time of each patient consultation / 
assessment,  when making referral decision  
How often do they need 
to do it? 
When referring any patient to Symptomatic 
Breast Clinics 
With whom do they need 
to do it? 
Patients who present to them with breast 
symptoms / concerns 
 
 
Developing an  intervention strategy 
Use the APEASE criteria to select appropriate intervention functions, 
policy categories and behaviour change techniques (BCTs) 
 
Affordability 
Practicability 
Effectiveness 
Acceptability 
Side effects / Safety 
 
 
The intervention functions 
I have selected are: 
 
i.e. functions that an 
effective intervention is 
likely to serve 
 
 
 
 
 
 
COM-B 
Capability (psychological) - knowledge & 
psychological skills. 
Opportunity (physical) – time, competing 
tasks, cues. 
Opportunity (social) – media, social norms, 
patient expectations.  
Motivation (reflective) – guidelines, 
confidence, beliefs. 
Motivation (automatic) – relationship with 
patient, emotional reactions. 
 
Interventions 
• Education  (about cancer risk) 
• Persuasion  (to refer appropriately) 
• Training (dealing with patient 
expectations, interpersonal skills) 
• Environmental restructuring (clinic 
types, access to imaging) 
• Enablement  (risk management, 
confidence in referral decision)  
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APEASE criteria 
Affordability: guidelines already in 
place, but alternative service for non-
cancer (benign) conditions not available. 
Practicability: Paper based, fax and 
electronic options available. 
Effectiveness: evidence based 
guidelines developed. 
Acceptability: acceptable to hospital 
consultants, not as acceptable to GPs 
and patients.  
Side effects / Safety: medico-legal 
risks, fear of missing a cancer. 
Equity: same service around the 
country in public hospitals but referral 
criteria not defined for private hospitals.  
 
Intervention functions removed following 
review of APEASE criteria: restriction, 
modelling, incentivisation & coercion.  
 
The policy category (or 
categories)    I have 
selected are: 
 
i.e. how I am planning to 
implement my intervention 
 
 
 
 
 
 
Policy categories 
• Communication / marketing: role of 
breast clinics, appropriate health 
messages. 
• Guidelines: ensure guidelines are 
evidence-based.   
• Regulation: via professional bodies. 
• Environmental / social planning: 
social norms & reporting. 
• Service provision: alternative clinic 
for benign / non urgent conditions / 
GP access to imaging.   
 
APEASE criteria 
Affordability: guidelines already in 
place, service provision needs to be 
expanded to include benign conditions. 
Practicability: fiscal measures and 
regulation not implementable. 
Effectiveness: guidelines shown to be 
effective if used. 
Acceptability: Fiscal measures & 
regulation not acceptable. 
Side effects / Safety: Regulation 
through professional bodies.  
Equity: does not apply to private 
hospitals. 
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Following review of APEASE criteria, the 
following policy categories were removed: 
fiscal measures & legislation.  
 
 
The BCTs (based on 
intervention functions 
above) I have selected 
are: 
 
i.e. the active ingredients 
of my intervention 
 
 
 
 
 
 
 
 
Education  
• Information about health 
consequences (BCT 5.1) – provide 
information about delay in 
appointments for genuine urgent 
cases due to volume of inappropriate 
referrals received. 
• Feedback on behaviour (2.2) – 
feedback to individual GPs on referral 
patterns and adherence to GP 
guidelines. 
• Prompts / cues (7.1) – use of 
standardised GP referral forms, 
incorporate cues into electronic 
referral.  
 
Training 
• Instruction on how to perform the 
behaviour (4.1) – training for GPs 
and trainee GPs in dealing with 
patient expectations, interpersonal 
skills. 
• Feedback on the behaviour (2.2) – 
feedback to individual GPs on referral 
patterns and adherence to GP 
guidelines. 
 
Environmental restructuring 
• Prompts / cues (7.1) – use of 
standardised GP referral forms, 
incorporate cues into electronic 
referral. 
• Restructuring the physical 
environment (12.1) – availability of 
referral forms in GP surgery, 
electronic referral, GP access 
diagnostics, alternative nurse-led 
clinic for family risk / mastalgia / 
benign conditions.  
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Persuasion 
• Credible source (9.1) – provide 
verbal or visual communication from 
a credible source such as their 
professional body e.g.  ICGP, IMO, 
CME tutor.  
• Social comparison (6.2) – Draw 
attention to other GP’s performance.  
• Information about health 
consequences (5.1) – provide 
information about delay in 
appointments for genuine urgent 
cases due to volume of inappropriate 
referrals received. 
• Feedback on behaviour (2.2)   – 
feedback to individual GPs on referral 
patterns and adherence to GP 
guidelines. 
 
 
Enablement  
• Incompatible beliefs (13.3) – Draw 
attention to discrepancies between 
behaviour and their self-identification 
as a proponent of evidence-based 
practice. 
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Thinking about barriers and facilitators… 
 
BARRIERS 
 
 
 
 
 
HELPFUL THINGS / 
FACILITATORS 
 
 
a) Places and things 
Is there anything about the 
physical surroundings that my 
target population are in that 
could make it difficult for them to 
achieve the target behaviour? 
What can I do to change this? 
 
• Availability of GP direct access 
diagnostics / imaging. 
• Lack of alternative service for 
benign conditions - look at nurse-
led clinic. 
• Competing activities / 
prioritisation.  
• Adequate time to spend with 
patient (physical opportunity). 
• Ease of access to the breast 
clinics (are we victims of our own 
success?). 
 
 
b) Places and things 
Is there anything 
about their physical 
surroundings that 
makes it easier for them 
to achieve the 
behaviour? What can I 
do to provide these 
helpful things? 
 
 
 
• Availability of  IT 
software for electronic 
referral  
• GP referral guidelines  
 
c) People 
Are there any people around 
my target population who could 
make it difficult for them to 
achieve the target behaviour? 
What can I do to change this? 
 
 
• Patient expectations / pressure 
to refer  (psychological 
capability) 
• Social norms:  Portrayed as new 
‘centres of excellence’ and now 
everyone wants to be referred for 
reassurance/ second opinion.  
• Media: responsible/ measured 
 
d) People 
Are there any people 
around my target 
population who make it 
easier for them to 
achieve their target 
behaviour? How can I 
ask these specific 
people/groups to help 
them? 
 
 
• Role for Practice Nurses 
• Other GPs in group 
practice  
• Hospital consultants  
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reporting.  
• Campaigns: non alarmist in 
nature. 
• Patient information: accurate 
realistic information.  
• Professional body – 
medical indemnity / 
back-up 
• CME group  
 
e) Thoughts and feelings 
Are there any feelings or 
emotions which could make it 
difficult for my target population 
to achieve their target 
behaviour? How can I overcome 
these things? 
 
 
• Fear of missing a cancer / 
anxiety  
• Risk aversion (medico-legal  
consequents) 
• GP – patient relationship 
• Motivation to continue behaviour 
 
 
 
f) Thoughts and feelings 
Is there anything that 
they are thinking or 
feeling that makes it 
easier for them to do 
this behaviour? How 
can I encourage these 
thoughts and feelings? 
 
 
• Practicing evidence 
based medicine  
• More appointments 
available for urgent 
cases, seen quicker  
• Social norms 
• Media portrayal  
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 Difficult situations and ‘if – then’ plans… 
 
Are there any situations that you can think of that 
could make it especially difficult for your target 
population to perform the behaviour? A time or a 
place or a feeling that might tempt them to go back to 
their old behaviour? 
 
Make a list of their difficult situations: 
 
 
• Patient anxiety 
• Patient expectations / pressure for referral  
Now make some plans for how to avoid these situations or make them 
more manageable. For each difficult situation, think of something you 
could do that would lower the chance of it interfering with your planned 
behaviour. 
 
 
Difficult situations  
IF…. 
 
 
Patient is anxious 
 
 
Patient expectations / 
pressure for referral  
 
 
 
 
 
How I will avoid or cope with them 
THEN… 
 
 
Reassurance 
Involve Practice nurse 
 
Active surveillance  
Patient information  
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Appendix E: Data from mapping study 
(Study 1) used for interviews. 
 
 
 
Figure 1. Referrals for breast disease.  
2006 2009 2010
Benign referrals 21,438 30,370 35,619
Breast Cancers detected 2,137 1,879 2,012
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Figure 2.  Triage categorisation, by hospital   
 
 
Figure 3. Diagnostic yields, by hospital  
Ratio of the number of patients seen and diagnosed as having benign conditions with 
the number diagnosed with primary breast cancer. i.e., in 2009 during the HIQA review 
there was one primary breast cancer diagnosed per 17 referrals (range 13-37), this has 
changed to one in 18 in 2010 (range 13-23). 
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Appendix F: Interview topic guide – Hospital 
Interviews 
 
Referral and Triage Processes – Symptomatic Breast Units 
“The HSE, together with the designated centres, should coordinate, as part 
of its wider development of clinical audit systems, a review of referral and 
triage processes, aimed at understanding and addressing any unnecessary 
variations in referral or triaging practices between the designated centres 
and their referring clinicians”. 
(National Quality Review of Symptomatic Breast Disease Services in Ireland,  
HIQA, 2010.  Recommendation # 12) 
 
Review of referral and triage processes 
In order to address the HIQA recommendation above, an interview will be 
scheduled with a nominee from each SBD unit to discuss:   
1. Referral patterns.  
2. Referral and triage processes in each unit. 
3. Level of agreement between GP triage categorisation and breast clinic 
triage categorisation.  
4. Mode of referral. 
5. Adequacy/completeness and accuracy of GP referral information 
received.  
6. Possible factors influencing local referral patterns.  
7. Possible actions / solutions. 
8. Feedback on NCCP referral guidelines / referral form and electronic 
referral - any recommendations for change?  
 
The participant(s) should be the Lead Clinician for Symptomatic Breast 
Disease or their nominee. 
The interview will be taped and transcribed, with the consent of the 
participants. 
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Appendix G:  Participant information leaflet 
– Hospital study  
 
 
Staff Information Leaflet  
Protocol Title:  
 
Principal Investigator’s Name:    Niamh O’Rourke  
Principal Investigator’s Title: HRB PhD Scholar in Health Services Research  
Telephone No. of Principal Investigator: xxx-xxxxxxx   
You are being invited to take part in a national research study which is being 
carried out at each of the Cancer Centres, including xxxxxxxx Hospital.  
Before you decide whether or not you wish to take part, you should read the 
information provided below carefully and if you wish, discuss it with 
colleagues and management at the hospital. Take time to ask questions – do 
not feel rushed or under any obligation to participate. You should clearly 
understand the purpose and benefits of participating in this study so that you 
can give informed consent.  
You are not obliged to take part in this study - participation is voluntary.  You 
may change your mind at any time (before the start of the interview or even 
after you have commenced the interview) for whatever reason without having 
to justify your decision.  
 
WHY IS THIS STUDY BEING DONE?  
The Health Information and Quality Authority (HIQA) conducted a national 
review of the Symptomatic Breast Disease services in 2009 which made 
several key recommendations with regard to cancer referral practices:  
“The HSE, together with the designated centres should coordinate, as 
part of its wider development of clinical audit systems, a review of referral 
and triage processes, aimed at understanding and addressing any 
unnecessary variations in referral or triaging practices between the 
designated centres and their referring clinicians”.  
Review of Referral and Triage processes in Symptomatic Breast Units  
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This study will address this requirement for the cancer centres, the National 
Cancer Control Programme (NCCP) and the HSE.  
This study is being done because referrals to symptomatic breast clinics in 
Ireland have increased rapidly in recent years, without a corresponding 
increase in breast cancer incidence. There were 23,575 referrals to the 
symptomatic breast disease (SBD) clinics in 2006, which increased to 32,249 
in 2009. The estimated number of referrals for 2010 is 38,000.  This study 
will explore reasons why the numbers of referrals have increased so rapidly. 
The interviews with a staff member from each Symptomatic Breast Unit will 
address the HIQA recommendation to conduct a review of referral and triage 
practices and also help to formulate the next stage of the research in which 
interviews will be held with individual GPs to discuss factors influencing their 
referral decisions. 
 
WHO IS ORGANISING AND FUNDING THIS STUDY? 
The Principal Investigator is undertaking this research as part of a PhD 
research project on cancer referral patterns for the HRB PhD Scholars 
Programme in Health Services Research (part time).  She is also an 
employee of the National Cancer Control Programme.  
The Principal Investigator is funding the PhD costs and there have been no 
grants or sponsorship received.  
 
HOW WILL IT BE CARRIED OUT? 
The interviews will be carried out in each of the 8 cancer centres and the 
satellite centre, with a key informant nominated by the Symptomatic Breast 
Unit in each hospital.  The interviews will commence in December 2010 once 
research ethics approval has been granted by the hospital. Each interview is 
expected to take 40 minutes in total. A pilot interview will take place in one 
hospital.  
 
Once the interview has been transcribed, a copy will be sent to the 
interviewee to check for accuracy.  
 
WHAT WILL HAPPEN IF I AGREE TO TAKE PART? 
Once the key informant has been nominated by the Symptomatic Breast 
Unit, an interview date, time and location will be agreed to suit the staff 
member. It is expected that the venue will be at the hospital site.  The list of 
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questions / themes will be sent to the staff member in advance.  The same 
questions / themes will be discussed in each hospital.  
 
BENEFITS: 
This research will examine factors influencing referrals to rapid access 
cancer clinics.  Based on study findings, recommendations will be made 
regarding the future delivery of services, to ensure that patients with urgent 
symptoms are seen quickly and those with non-urgent presentations are 
seen in the most appropriate setting. Service needs such as training 
requirements for GPs may also be identified.   
 
RISKS: 
There are no known risks to taking part in this study.   
 
CONFIDENTIALITY ISSUES 
Your identity will remain confidential. The interview will be taped (with your 
permission) and the interview transcript will be coded with a reference 
number. The identity of the interviewee and hospital will be kept in a 
separate secure location in the Royal College of Surgeons, accessible only 
to named individuals. The computer storing the data will be password 
protected.  
 
The identity of the staff member and the hospital will remain confidential. 
Study findings will be reported on a national or regional basis. The data will 
be kept for seven years, in keeping with the Data Handling guidelines of the 
Population Health Division of the RCSI.  Hard copy data will then be 
destroyed by shredding and electronic data will be erased from the system, 
including back-ups.  
 
IF YOU REQUIRE FURTHER INFORMATION 
If you have any further questions about the study, or if you wish to withdraw 
from the study, you may do so without justifying your decision.  
 
For additional information now or any future time, please contact:  
Name: Niamh O’Rourke  
Address: Royal College of Surgeons, (Population Health Division),   
123 St Stephens Green, Dublin 2.    Phone No: xxx-xxxxxxx 
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INTERVIEW THEMES / QUESTIONS  
 
• Overview of referral patterns and triage processes in that unit e.g. 
Standard Operating Procedures (SOPs), proportion of patients triaged 
as urgent and non-urgent, current audit processes, who triages the 
patients?  
• Discuss possible factors influencing local referral patterns (e.g. clinical 
need, demographics, availability of alternative services/providers, GP 
referral practices).  
• Discuss possible actions/solutions (GP education, patient education, 
differentiated service).  
• Feedback on NCCP referral guidelines / referral form and electronic 
referral. (e.g., usefulness of guidelines and referral forms, proportion 
of referrals coming in by letter format and NCCP referral forms, 
recommended changes, adequacy and accuracy of GP referral 
information received).  
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Appendix H:  Consent form – Hospital study  
 
 
STAFF CONSENT FORM 
 
 
Protocol Title:  Review of Referral and Triage processes  
 
Please tick the appropriate answer. 
 
 
I confirm that I have read and understood the  Information Leaflet dated December 
1st 2010 attached, and that I have had ample opportunity to ask questions, all of 
which have been satisfactorily answered.  Yes  
  No 
 
 
I understand that my participation in this study is entirely voluntary and that I may 
withdraw at any time, without giving reason.  Yes  
  No 
 
 
I understand that the interview transcript may be viewed by individuals with 
delegated authority from Niamh O’Rourke (Principal Investigator)  Yes  
  No 
 
 
I understand that my identity will remain confidential at all times.   Yes  
  No 
 
 
 
400 
 
          
 
 
 
I have been given a copy of the Information Leaflet and this Consent form for my 
records.  Yes  
  No 
 
 
FUTURE USE OF ANONYMOUS DATA:   
I agree that I will not restrict the use to which the results of this study may be put. I 
give my approval that unidentifiable data from this interview may be stored or 
electronically processed for the purpose of scientific research and may be used 
in related or other studies in the future.   Yes  
  No 
 
 
 
Staff member  
 
Name in block capitals:  
 
   
________________________________ 
Signature and date  
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To be completed by the Principal Investigator or nominee.  
 
I the undersigned, have taken the time to fully explain to the above staff member the 
nature and purpose of this study. I have explained the reason for the study and the 
possible benefits and have invited him/her to ask questions on any aspect of the 
study that concerned them. 
 
 
 
 
 
 
 
___________ Niamh O’Rourke  RGN, MPH, MSc ________ 
Signature: Name in Block Capitals: Qualification: Date: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Version number: V1.0    Date: December 1st 2010
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Appendix I: Research Ethics Approval  
– 9 Hospitals 
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Appendix K:  Letter of invitation – GP study  
 
March 1st 2012  
GP name 
GP address 
GP address 
 
Re: Research with GPs on Cancer Referrals – Barriers and Facilitators   
Dear Dr ____________ 
I would to invite you to participate in a 20-30 minute meeting or telephone call to 
discuss factors influencing GP referrals to cancer centres, in particular the breast 
clinics. This research has arisen from a recommendation in the Health Information 
and Quality Authority (HIQA) review of the Symptomatic Breast Services, carried out 
in 2009, to carry out a review of referral and triage processes.    
Based on study findings, recommendations will be made regarding the future 
delivery of cancer services, including the specific needs of GPs and their patients. 
This process will give GPs an opportunity to contribute to these recommendations.   
I enclose an information leaflet outlining the purpose of the review, along with the 
topics for discussion. Your details have been obtained through random selection 
from the Irish Medical Directory.  Your identity will remain confidential. 24 GPs have 
been invited to participate in this study - 6 GPs from each region.  Additional 
interviews have already been conducted with hospital consultants to explore factors 
influencing referral patterns, from the hospital perspective.   
The Principal Investigator of the study is an employee of the National Cancer 
Control Programme and also a participant on the HRB PhD Scholars Programme in 
Health Services Research. This review has obtained full research ethics approval 
from the ICGP.  
I would be very grateful if you could consider participating in this review to identify 
any barriers or facilitators influencing the referral process for suspected cancers. If 
you have any queries, you can contact me by phone or e-mail. If you are willing to 
take part, I would greatly appreciate if you could confirm your interest by fax, e-mail, 
phone call or by post (details overleaf).  An interview can then be arranged at a time 
and place to suit you, or by telephone.  
Yours sincerely 
____________________ 
Niamh O’Rourke. RGN, MPH, MSc
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Appendix L: Consent form – GP study  
 
GP CONSENT FORM 
 
Title of Study: Cancer Referral Patterns: Factors influencing GP referrals  
PI: Niamh O’Rourke.        Fax: 01-xxxxxxx      Ph: 01-xxxxxxx 
 
I confirm that I have read and understood the Participant (GP) Information Leaflet 
dated October 2011, and that I have had ample opportunity to ask questions, all of 
which have been satisfactorily answered. 
I understand that my participation in this study is entirely voluntary and that I may 
withdraw at any time, without giving reason.                                      
I understand that the research data may be viewed by individuals with delegated 
authority from the Principal Investigator (Niamh O’Rourke).              
I understand that my identity will remain confidential at all times.     
I have been given a copy of the Participant Information Leaflet and this Consent 
form for my records.                                                                                     
 
FUTURE USE OF ANONYMOUS DATA:   
I agree that I will not restrict the use to which the results of this study may be put. I 
give my approval that unidentifiable data  from this study may be stored or 
electronically processed for the purpose of scientific research and may be used 
in related or other studies in the future.                                                   
 
GP Name:  ________________ 
GP Practice: _______________ 
GP Signature: ______________ 
Date: ____________________ 
 
Please return signed consent form to Niamh O’Rourke, Population Health Division (Beaux 
Lane House), Royal College of Surgeons, St Stephen’s Green, Dublin 2.  Fax:  01-xxxxxxx 
Study ID____________ 
 
Participant Consent Form version number   V1.0     Date: October 2011
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Appendix M:  Participant Information leaflet 
and topic guide – GPs  
 
Participant (GP) Information Leaflet 
 
Study Title: Cancer Referral Patterns: Factors influencing GP referrals  
 
Principal Investigator’s Name:  Niamh O’Rourke, RGN, MPH, MSc  
Telephone No. of Principal Investigator: Ph:  ______________ 
 
You are being invited to take part in a research study carried out by the Royal 
College of Surgeons in association with the National Cancer Control Programme.  
Before you decide whether or not you wish to take part, you should read the 
information provided below and ask any questions you may have.  
You are not obliged to take part in this study.  You may change your mind at any 
time (before the start of the study, or even after you have commenced the study) for 
whatever reason without having to justify your decision.  
 
WHY IS THIS STUDY BEING DONE?  
The aim of the study is to examine factors influencing referrals to cancer centres in 
Ireland, including barriers and facilitators, since centralisation of cancer services 
and introduction of GP referral guidelines and rapid access cancer clinics.   
Referrals to Symptomatic Breast Clinics in Ireland have increased significantly in 
recent years. The Health Information and Quality Authority (HIQA) conducted a 
national review of the Symptomatic Breast Services in 2009, and made several key 
recommendations with regard to cancer referral practices, including:  
“The HSE, together with the designated centres should coordinate, as part of its 
wider development of clinical audit systems, a review of referral and triage 
processes, aimed at understanding and addressing any unnecessary variations 
in referral or triaging practices between the designated centres and their 
referring clinicians”.  
To address this HIQA recommendation, a study was designed in 3 parts to review 
cancer referral patterns and determine the influencing factors.   
• The first part of the study was conducted in 2011 in the 8 cancer centres and 
the satellite centre in Letterkenny to determine factors influencing referral 
patterns, from the hospital perspective.   
• This GP component will look at factors influencing referral patterns from the 
General Practice perspective.  
• The final component will examine national anonymised data on cancer 
referral patterns from the National Cancer Registry.  
 
 
          
 
 
 
WHO IS ORGANISING AND FUNDING THIS STUDY? 
This study is organised and funded by the Principal Investigator as part of a PhD 
research project on cancer referral patterns for the HRB PhD Scholars Programme 
in Health Services Research. She is also an employee of the National Cancer 
Control Programme.  
 
HOW WILL IT BE CARRIED OUT? 
This study will commence in January 2012 once research ethics approval is 
received from the ICGP. It will be a national study, interviewing approximately 24 
GPs from the four Cancer Network Regions (Dublin mid-Leinster, Dublin North East, 
HSE South and HSE West). 
The interview will be piloted before use.  GPs will be selected from each of the 4 
geographical regions and will also include both male and female GPs and GPs from 
urban, rural and mixed practices. It is expected that interviews will take place over 
12 months.  
 
WHAT WILL HAPPEN TO ME IF I AGREE TO TAKE PART? 
Your participation is entirely voluntary.   If you initially decide to take part, you can 
subsequently change your mind without difficulty.     
If you agree to participate, you will be requested to participate in an interview which 
will take about 20-30 minutes.  An interview date, time and location will be agreed to 
suit you. It is expected that the venue will be at the GP practice, or if preferred, by 
telephone.  The list of discussion themes is attached.  Once the interview has been 
transcribed, a copy will be sent to you on request, to check for accuracy.  The 
results of the study will be made available to all participants. 
 
BENEFITS: 
You will not benefit directly from taking part in this study but the information we will 
obtain will provide further knowledge of this area.   
Based on study findings, recommendations will be made regarding the future 
delivery of cancer services, including the specific needs of GPs and their patients. 
This process will give GPs an opportunity to contribute to these recommendations, 
based on their own experience.   
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RISKS: 
There are no known risks to taking part in this study. 
 
WILL THERE BE ANY ADDITIONAL COSTS INVOLVED? 
Will I be paid for taking part in this study? – No  
Will my expenses be covered for taking part in this study? – the interview will take 
place in a location of your choice so that no additional costs will be incurred.  
 
CONFIDENTIALITY ISSUES 
Your identity will remain confidential.  A study number will identify you, the code of 
which will be held by the PI.    Your name will not be published or disclosed to 
anyone.   Data which could be identifiable from the interview such as practice name, 
staff names or reference to geographical locations will be coded in any reports.  The 
data will not be leaving the country.  
The interview will be taped (with your permission) and the interview will be erased 
from the recording device once the interview has been transcribed.  The interview 
transcript will kept in a separate secure location, accessible only to named 
individuals. The computer storing the data will be password protected.  
Study findings will be reported on a national, regional or county basis. Anonymised 
data may be used in additional related studies.  
The data will be kept for seven years, in keeping with the Data Handling Guidelines 
of the Population Health Division of the RCSI.  Hard copy data will then be 
destroyed by shredding and electronic data will be erased from the system, 
including back-ups.  
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IF YOU REQUIRE FURTHER INFORMATION 
If you have any further questions about the study, or if you wish to withdraw from 
the study, you may do so without justifying your decision.  
 
For additional information now or any future time please contact:  
Name: Niamh O’Rourke   
Address: Royal College of Surgeons in Ireland, Population Health Division (Beaux 
Lane House), 123 St Stephen’s Green, Dublin 2.  
Phone No: __________ 
Fax: _______________  
e-mail: niamhorourke@rcsi.ie   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Participant Information Leaflet Version number    V1.0 
Date: October 2011 
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Cancer Referral Patterns: Factors influencing GP referrals 
 
Interview topic guide 
 
The following topics will be explored:   
 
1) Impact of centralisation of cancer surgery & development of GP 
referral guidelines.  
 
• GP use of the national cancer referral guidelines, referral form and electronic 
referral (Healthlink).   
• Change in GP referring practice (if any) since introduction of the GP referral 
guidelines.  
• Change in GP referring practice (if any) since centralisation of cancer 
surgery.   
• Barriers / pressures and facilitators relating to referral of patients with 
suspected cancer. 
 
2) Factors influencing GP referral decisions to cancer centres  
 
• Patient factors.  
• Provider factors (GP practice / individual GP). 
• Health service factors.   
 
3. Recommendations from GPs  
(in relation to management of patients with cancer / suspected cancer) 
• Additional services / training / support required by GPs (if any).  
• Changes recommended to cancer referral guidelines / referral forms / 
referral process.  
• Recommendations regarding additional information / support / services 
required by patients with cancer / suspected cancer. 
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Appendix O.  Research Ethics approval  
- GP study 
 
 
 Appendix P:  Key Performance Indicators 
(NCCP) 
 
 
National Cancer Control Programme  
Key Performance Indicators (KPIs) for Breast Cancer  
 
STANDARD 1: ACCESS 
Access   KPI No 1a  
Referrals triaged as urgent by the cancer centre shall be offered an 
appointment within 10 working days of the date of receipt of a letter of 
referral in the cancer office.           
Access   KPI No 1b 
Referrals triaged as non-urgent by the cancer centre shall be offered an 
appointment for a symptomatic breast clinic within 12 weeks (less than or 
equal to 84 days) of the date of receipt of the referral letter in the cancer 
office.             
Access   KPI No 1c 
A new patient deemed urgent following consultant surgeon assessment at 
the clinic [S4, S5] shall have imaging (mammography or ultrasound) done 
within a week of the first visit. 
Access   KPI No 1d 
Breast imaging requests (that is, mammography or ultrasound) for new 
patients shall be carried out within 12 weeks of the consultant surgeon’s 
assessment in the specialist clinic. 
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STANDARD 2: IMAGING 
Imaging   KPI No 2a 
Patients with primary operable breast cancer shall have pre-op 
mammography and ultrasound examination. 
Imaging   KPI No 2b 
A new patient aged 36 years or older with a clinically palpable focal 
abnormality (that is classified as S3, S4 or S5) shall have mammography 
and targeted ultrasound examination. 
Imaging   KPI No 2c 
Core biopsies shall be image guided, where an imaging abnormality 
classified as R3, R4 or R5 is identified. 
Imaging  Additional parameter 
Consultant radiologists shall report on at least 1,000 mammograms 
annually. 
 
 
STANDARD 3: DIAGNOSIS 
Diagnosis  KPI No 3a 
Patients with primary breast cancer (invasive or in situ) shall be diagnosed 
without an operative procedure [open biopsy].            
 Diagnosis  KPI No 3b 
For patients urgently triaged by the cancer centre and subsequently 
diagnosed with a primary breast cancer, the interval between attendance 
at the first clinic and the discussion at the multidisciplinary meeting (MDM) 
where a B5 or C5 is first identified shall not exceed 10 working days.            
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 STANDARD 4: MULTIDISCIPLINARY WORKING 
Multidisciplinary working  KPI No 4a 
All patients who have breast investigations that generate a histopathology 
report shall be discussed at MDM. 
Multidisciplinary working  KPI No 4b 
All patients with a diagnosis of primary breast cancer from the 
symptomatic service shall be discussed at MDM. 
 
STANDARD 5: TIME TO TREATMENT 
Time to treatment  KPI No 5a 
For primary invasive or in situ tumours, surgical intervention will be carried 
out within 20 working days of the date of the multidisciplinary meeting 
(MDM),  when a B5 or C5 diagnosis was first identified, provided surgery is 
the first treatment.          
Time to treatment  KPI No 5b 
For primary invasive or in situ tumours, following surgery, patients who 
require radiation therapy alone shall commence treatment within 12 weeks 
(less than or equal to 84 days) of the final surgical procedure. 
Time to treatment  KPI No 5c 
For primary invasive or in situ tumours, following surgery, patients who 
require adjuvant chemotherapy and radiation therapy, shall commence 
radiation therapy within 4 weeks (less than or equal to 28 days) of 
completing chemotherapy. 
Time to treatment  KPI No 5d 
For primary invasive or in situ tumours, following surgery, adjuvant 
chemotherapy shall commence within 8 weeks (less than or equal to 56 
days) of the final surgical procedure where required. 
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 STANDARD 6: SURGERY – AXILLARY STAGING 
Surgery – axillary staging  KPI No 6 
Patients with a diagnosis of primary operable breast invasive cancer shall 
have an ultrasound of the axillary nodes. 
 
STANDARD 7: SURGERY – SPECIALISATION 
Surgery – specialisation  KPI No 7 
Individual consultant surgeons shall assess and operate on a minimum of 
50 new patients with breast cancer per year. 
 
STANDARD 8: SURGERY – ACCURACY OF SURGICAL 
INTERVENTIONS 
Surgery – accuracy of surgical interventions   KPI No 8 
For patients having breast conserving surgery, the number of therapeutic 
interventions shall be recorded.  
 
STANDARD 9: PATHOLOGY 
Pathology  KPI No 9a 
Pathology reports include a standard set of prognostic indicators that will 
be available to the multidisciplinary team in a timely fashion. 
Pathology KPI No 9b 
Axillary lymph node status where sampled will be recorded. 
Pathology KPI No 9c 
Radial margin status shall be documented (superior, inferior, medial, 
lateral margins) for all patients who have wide local excision of a primary 
invasive breast cancer.                                                             
Pathology KPI No 9d 
The histopathology report containing prognostic data will be available 
within 10 working days. 
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 Appendix Q:  Conference presentations and 
publications  
 
 
Conference Presentations 
 
 
Cancer referral pathways. Annual GP study day, Mater Misericordiae 
University Hospital, Dublin, March 2011.  Oral presentation.  
 
A Pain in the Breast. Poster presentations:    
• National Cancer Registry of Ireland, National Conference on 
Population Based Cancer Research in Ireland. Dublin, November  
2011  
• Annual RCSI research day, Dublin, April  2012 
• NHS Health Services Research Network Conference, Manchester, 
UK, June  2012  
 
Mastalgia. Annual GP study day, Mater Misericordiae University Hospital, 
Dublin. February 2012. Oral presentation. 
 
Breast Cancer Family Risk - Referral Patterns in Ireland. Poster 
presentations:  
• International Association of Cancer Registries,  Cancer Epidemiology 
conference,  Cork, September  2012  
• Faculty of Public Health, Winter Scientific meeting, Dublin, December  
2012                 
• HSE Health Professionals Research Forum, Dublin, February 2013 
• RCSI annual research day, Dublin, March 2013  
 
Are Electronic Cancer Referrals better?  Poster presentations:   
• International Association of Cancer Registries,  Cancer Epidemiology 
conference,  Cork, September  2012  
• Faculty of Public Health, Winter Scientific meeting, Dublin, December  
2012                 
• HSE Health Professionals Research Forum, Dublin, February  2013 
• RCSI annual research day, Dublin, March 2013  
• Department of Health, Patient Safety Conference , Dublin, May 2013  
 
GPs endorse quality of breast cancer care.  Poster presentations:   
• HSE Health Professionals Research Forum, Dublin, February  2014 
• RCSI annual research day, Dublin, March 2014  
• Department of Health, Patient Safety conference, Dublin, November 
2014  
• UICC World Cancer Summit, Australia,  December  2014   
• SPHeRE annual conference, Dublin, January 2015 
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Efficacy of centralisation of breast cancer services in Ireland. Electronic 
Poster presentation:  
• UICC World Cancer Summit, Australia, December 2014  
 
 
Implementation of Cancer guidelines using the COM-B model. Poster 
presentations:     
• Cochrane in Ireland conference, Dublin, January 2014  
• Department of Health, Patient Safety Conference, Dublin, November 
2014 
• SPHeRE annual conference, Dublin, January 2015  
• The Ireland-Northern Ireland – National Cancer Institute, Cancer 
Consortium Conference, Belfast,  May 2015  
 
 
Non-medical factors influencing medical decisions: a study of breast cancer 
referral patterns in Ireland.  Poster presentation:  
• The Ireland-Northern Ireland – National Cancer Institute, Cancer 
Consortium Conference, Belfast,  May 2015  
 
 
Factors influencing breast cancer referral patterns in Ireland. RCSI academic 
lecture series, Dublin, November 2014.  Oral presentation   
 
 
Reports and policy papers  
Review of Referral Patterns and Triage Processes in Symptomatic Breast 
Units. National Cancer Control Programme, 2012  
Available on   www.cancercontrol.hse.ie 
 
 
Diagnosis, staging and treatment of patients with breast cancer. National 
Cancer Control Programme, 2015 
Available on www.cancercontrol.hse.ie  
 
 
 
Press coverage 
‘More Irish women are winning breast cancer fight as death rate drops by a 
third’.  
Published March 22nd 2014.  Irish Independent.  Eilish O'Regan, Health 
correspondent. 
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